Oaktree Specialty Lending (OCSL) 10-Q 6 Feb 23 2023 FY Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Dec. 31, 2022	Feb. 06, 2023
Cover [Abstract]
Document Type	10-Q
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Securities Act File Number	1-33901
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1219283
Entity Address, Address Line Two	28th Floor
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	OCSL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		77,079,805
Entity Central Index Key	0001414932
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false
Current Fiscal Year End Date	--09-30

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands		Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Assets [Abstract]
Investments at fair value		$ 2,642,870	$ 2,494,111
Cash and cash equivalents		17,382	23,528
Restricted cash		1,863	2,836
Interest, dividends and fees receivable		37,802	35,598
Due from portfolio companies		6,181	22,495
Receivables from unsettled transactions		8,657	4,692
Due from broker		39,760	45,530
Deferred financing costs		6,781	7,350
Deferred offering costs		32	32
Deferred tax asset, net		1,722	1,687
Derivative assets at fair value		0	6,789
Other assets		4,210	1,665
Total assets		2,767,260	2,646,313
Liabilities [Abstract]
Accounts payable, accrued expenses and other liabilities		3,035	3,701
Base management fee and incentive fee payable		16,871	15,940	$ 15,900
Due to affiliate		3,260	3,180
Interest payable		13,368	7,936
Payables from unsettled transactions		20,974	26,981
Derivative liability at fair value		44,139	41,969
Credit facilities payable		860,000	700,000
Unsecured notes payable (net of $4,650 and $5,020 of unamortized financing costs as of December 31, 2022 and September 30, 2022, respectively)		603,624	601,043
Total liabilities		1,565,271	1,400,750
Commitments and contingencies (Note 13)
Net Assets [Abstract]
Common stock, $0.01 par value per share, 250,000 shares authorized; 61,220 and 61,125 shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively (1)	[1]	612	611
Additional paid-in-capital		1,829,653	1,827,721
Accumulated overdistributed earnings		(628,276)	(582,769)
Total net assets (equivalent to $19.63 and $20.38 per common share as of December 31, 2022 and September 30, 2022, respectively) (Note 11) (1)		1,201,989	1,245,563	$ 1,325,061
Total liabilities and net assets		2,767,260	2,646,313
Control Investments
Assets [Abstract]
Investments at fair value		232,462	214,165
Control & Affiliate Investments
Assets [Abstract]
Investments at fair value		23,173	26,196
Non-control/Non-affiliate
Assets [Abstract]
Investments at fair value		$ 2,387,235	$ 2,253,750
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Parenthetical) $ in Thousands	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares
Investment owned, at cost	$ 2,778,014	$ 2,617,754
Unamortized financing costs	$ 4,650	$ 5,020
Common stock, par value, (in dollars per share) | $ / shares	$ 0.01	$ 0.01
Common stock, shares authorized (in shares) | shares	250,000,000	250,000,000
Common stock, shares issued (in shares) | shares	61,220,000	61,125,000
Common stock, shares outstanding (in shares) | shares	61,220,000	61,125,000
Net asset value per common share (dollars per share) | $ / shares	$ 19.63	$ 20.38
Control Investments
Investment owned, at cost	$ 281,911	$ 260,305
Affiliate Investments
Investment owned, at cost	24,327	27,353
Non-control/Non-affiliate
Investment owned, at cost	$ 2,471,776	$ 2,330,096

Consolidated Statements of Oper

Consolidated Statements of Operations $ in Thousands		3 Months Ended
		Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Revenues [Abstract]
Interest on cash and cash equivalents		$ 472	$ 1
Total interest income		69,978	55,450
Interest income, PIK		6,130	4,663
Fee income		2,021	912
Dividend income		1,050	3,916
Total investment income		79,179	64,941
Operating Expenses [Abstract]
Base management fee		9,917	9,952
Part I incentive fee		7,703	6,457
Part II incentive fee		0	1,751
Professional fees		1,500	1,322
Directors fees		160	123
Interest expense		20,719	9,400
Administrator expense		298	390
General and administrative expenses		746	693
Total expenses		41,043	30,088
Fees waived		(750)	(750)
Net expenses		40,293	29,338
Net investment income before taxes		38,886	35,603
(Provision) benefit for taxes on net investment income		0	(3,308)
Excise tax		(78)	0
Net investment income		38,808	32,295
Unrealized appreciation (depreciation):
Foreign currency forward contracts		(11,001)	(837)
Net unrealized appreciation (depreciation)		(22,982)	(4,586)
Realized gains (losses):
Foreign currency forward contracts		4,448	2,972
Net realized gains (losses)		(3,203)	9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)		549	2,378
Net realized and unrealized gains (losses), net of taxes		(25,636)	7,113
Net increase (decrease) in net assets resulting from operations		$ 13,172	$ 39,408
Net investment income per common share - basic and diluted (dollars per share) | $ / shares	[1]	$ 0.63	$ 0.54
Earnings (loss) per common share - basic (dollars per share) | $ / shares	[1]	0.22	0.66
Earnings (loss) per common share - diluted (dollars per share) | $ / shares	[1]	$ 0.22	$ 0.66
Weighted average common shares outstanding - basic (shares) | shares	[1]	61,142,000	60,127,000
Weighted average common shares outstanding - diluted (shares) | shares	[1]	61,142,000	60,127,000
Control Investments
Revenues [Abstract]
Interest income		$ 4,567	$ 3,480
Fee income		13	13
Dividend income		1,050	3,916
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		(3,309)	(667)
Realized gains (losses):
Realized gain (loss)		0	1,868
Control & Affiliate Investments
Revenues [Abstract]
Interest income		641	334
Fee income		5	5
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		3	(251)
Non-control/Non-affiliate
Revenues [Abstract]
Interest income		64,298	51,635
Interest income, PIK		6,130	4,663
Fee income		2,003	894
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		(8,675)	(2,831)
Realized gains (losses):
Realized gain (loss)		$ (7,651)	$ 4,481
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets $ in Thousands	3 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Net increase (decrease) in net assets resulting from operations
Net investment income	$ 38,808	$ 32,295
Net unrealized appreciation (depreciation)	(22,982)	(4,586)
Net realized gains (losses)	(3,203)	9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)	549	2,378
Net increase (decrease) in net assets resulting from operations	13,172	39,408
Stockholder transactions:
Net increase (decrease) in net assets from stockholder transactions	(58,679)	(27,956)
Capital share transactions:
Issuance of common stock under dividend reinvestment plan	1,933	786
Net increase (decrease) in net assets from capital share transactions	1,933	786
Total increase (decrease) in net assets	(43,574)	12,238
Net assets	$ 1,201,989	$ 1,325,061
Net asset value per common share (dollars per share) | $ / shares	$ 19.63	$ 22.03
Common shares outstanding at end of period (shares) | shares	61,220,000	60,156,000

Consolidated Statement of Cash

Consolidated Statement of Cash Flows $ in Thousands	3 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 13,172	$ 39,408
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation	22,982	4,586
Net realized (gains) losses	3,203	(9,321)
PIK interest income	(6,130)	(4,663)
Accretion of original issue discount on investments	(5,127)	(7,076)
Accretion of original issue discount on unsecured notes payable	170	170
Amortization of deferred financing costs	828	924
Deferred taxes	(35)	(959)
Purchases of investments	(261,404)	(246,623)
Proceeds from the sales and repayments of investments	108,831	235,020
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable	(1,842)	1,796
(Increase) decrease in due from portfolio companies	16,314	(803)
(Increase) decrease in receivables from unsettled transactions	(3,966)	(17,673)
(Increase) decrease in due from broker	5,770	(1,810)
(Increase) decrease in other assets	(2,546)	(564)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(554)	3,145
Increase (decrease) in base management fee and incentive fee payable	931	(6,459)
Increase (decrease) in due to affiliate	80	(854)
Increase (decrease) in interest payable	5,432	2,101
Increase (decrease) in payables from unsettled transactions	(6,007)	32,717
Increase (decrease) in director fees payable	0	123
Net cash provided by (used in) operating activities	(109,898)	23,185
Financing activities:
Distributions paid in cash	(56,746)	(27,170)
Borrowings under credit facilities	202,000	70,000
Repayments of borrowings under credit facilities	(42,000)	(50,000)
Deferred financing costs paid	0	(334)
Net cash provided by (used in) financing activities	103,254	(7,504)
Effect of exchange rate changes on foreign currency	(475)	(1,259)
Net increase (decrease) in cash and cash equivalents and restricted cash	(7,119)	14,422
Cash and cash equivalents and restricted cash, beginning of period	26,364	31,635
Cash and cash equivalents and restricted cash, end of period	19,245	46,057
Supplemental information:
Cash paid for interest	14,289	6,205
Non-cash financing activities:
Issuance of common stock under dividend reinvestment plan	1,933	$ 786
Reconciliation to the Consolidated Statements of Assets and Liabilities [Abstract]
Cash and cash equivalents	17,382
Restricted cash	1,863
Total cash and cash equivalents and restricted cash	$ 19,245

Consolidated Schedule of Invest

Consolidated Schedule of Investments € in Thousands, $ in Thousands	Dec. 31, 2022 USD ($) $ / shares shares		Dec. 31, 2022 EUR (€) shares		Sep. 30, 2022 USD ($) $ / shares shares		Sep. 30, 2022 EUR (€) shares		Dec. 31, 2021 $ / shares shares
Investment owned, at cost	$ 2,778,014				$ 2,617,754
Investments at fair value	$ 2,642,870				$ 2,494,111
% of Total Net Assets	219.87%	[1],[2],[3],[4],[5]	219.87%	[1],[2],[3],[4],[5]	200.24%	[6],[7],[8],[9],[10]	200.24%	[6],[7],[8],[9],[10]
Money market funds, at carrying value	$ 19,245				$ 26,364
Money market funds, percent of net assets	1.60%	[1],[2],[3],[4],[5]	1.60%	[1],[2],[3],[4],[5]	2.10%	[6],[7],[8],[9],[10]	2.10%	[6],[7],[8],[9],[10]
Investment owned and money market funds, percent of net assets	221.50%	[1],[2],[3],[4],[5]	221.50%	[1],[2],[3],[4],[5]	202.40%	[6],[7],[8],[9],[10]	202.40%	[6],[7],[8],[9],[10]
Total investment owned, at cost and money market funds, at carrying value	$ 2,797,259				$ 2,644,118
Total investment owned, at fair value and money market funds, at carrying value	2,662,115				$ 2,520,475
Control Investments
Investment owned, ownership percentage					17.20%	[6],[7],[8],[9],[10],[11],[12]	17.20%	[6],[7],[8],[9],[10],[11],[12]
Investment owned, at cost	281,911				$ 260,305
Investments at fair value	$ 232,462				$ 214,165
% of Total Net Assets	19.30%	[1],[2],[3],[4],[5],[13]	19.30%	[1],[2],[3],[4],[5],[13]					19.60%
Affiliate Investments
Investment interest rate					2.10%	[6],[7],[8],[9],[10],[11],[12]	2.10%	[6],[7],[8],[9],[10],[11],[12]
Investment owned, at cost	$ 24,327				$ 27,353
Investments at fair value	$ 23,173				26,196
% of Total Net Assets	1.90%	[1],[2],[3],[4],[5],[13]	1.90%	[1],[2],[3],[4],[5],[13]					1.40%
Non-control/Non-affiliate
Investment owned, at cost	$ 2,471,776				2,330,096
Investments at fair value	$ 2,387,235				$ 2,253,750
% of Total Net Assets	198.60%	[1],[2],[3],[4],[5]	198.60%	[1],[2],[3],[4],[5]	180.90%	[6],[7],[8],[9],[10]	180.90%	[6],[7],[8],[9],[10]
C5 Technology Holdings LLC
Investment owned, at cost	$ 34,984				$ 34,984
Investments at fair value	27,638				27,638
Dominion Diagnostic LLC
Investment owned, at cost	29,519				29,555
Investments at fair value	18,524				19,279
OCSI Glick JV LLC
Investment owned, at cost	49,961				50,194
Investments at fair value	49,536				50,283
Senior Loan Fund JV I, LLC
Investment owned, at cost	167,447				145,572
Investments at fair value	136,764				116,965
Assembled Brands Capital LLC
Investment owned, at cost	23,247				26,273
Investments at fair value	22,849				25,818
Caregiver Services Inc
Investment owned, at cost	1,080				1,080
Investments at fair value	324				378
107 Fair Street LLC
Investment owned, at cost	1,111
Investments at fair value	1,108
112-126 Van Houten Real22 LLC
Investment owned, at cost	3,167
Investments at fair value	3,159
109 Montgomery Owner LLC
Investment owned, at cost					356
Investments at fair value					727
A.T. Holdings II Ltd.
Investment owned, at cost	15,939
Investments at fair value	15,939
AT Holdings II SÀRL
Investment owned, at cost	15,640				33,960
Investments at fair value	15,722				34,891
Access CIG LLC
Investment owned, at cost	19,932				19,927
Investments at fair value	17,800				19,075
Accupac Inc
Investment owned, at cost	16,542				16,148
Investments at fair value	16,801				16,433
Acquia Inc
Investment owned, at cost	28,360				27,928
Investments at fair value	28,548				28,056
ADB Companies LLC
Investment owned, at cost	14,079				14,217
Investments at fair value	14,254				14,431
ADC Therapeutics SA
Investment owned, at cost	6,405				6,392
Investments at fair value	6,289				6,298
Aden & Anais Merger Sub Inc
Investment owned, at cost	5,165				5,165
Investments at fair value	0				0
AI Sirona Luxembourg Acquisition Sarl
Investment owned, at cost	27,775				27,752
Investments at fair value	24,255				22,143
AIP RD Buyer Corp
Investment owned, at cost	15,515				15,506
Investments at fair value	15,488				15,201
AirStrip Technologies Inc
Investment owned, at cost	90				90
Investments at fair value	0				0
All Web Leads Inc
Investment owned, at cost	22,547				22,057
Investments at fair value	22,354				22,141
Altice France SA
Investment owned, at cost	3,533				3,518
Investments at fair value	3,095				3,057
Alvogen Pharma US Inc
Investment owned, at cost	12,711				12,847
Investments at fair value	12,903				13,068
Alvotech Holdings SA
Investment owned, at cost	56,855				52,804
Investments at fair value	61,770				51,513
American Auto Auction Group LLC
Investment owned, at cost	14,503				14,492
Investments at fair value	11,439				13,284
American Tire Distributors Inc
Investment owned, at cost	9,747				9,772
Investments at fair value	9,081				9,293
Amplify Finco Pty Ltd
Investment owned, at cost	26,202				26,161
Investments at fair value	26,470				26,645
Anastasia Parent LLC
Investment owned, at cost	2,254				2,260
Investments at fair value	2,043				2,189
Ankura Consulting Group LLC
Investment owned, at cost	2,951				4,281
Investments at fair value	2,558				3,813
Apptio Inc
Investment owned, at cost	35,130				34,600
Investments at fair value	35,063				34,584
APX Group Inc
Investment owned, at cost	1,742				1,733
Investments at fair value	1,721				1,645
Ardonagh Midco PLC
Investment owned, at cost	39,268				35,628
Investments at fair value	39,057				33,081
ASP Unifrax Holdings Inc
Investment owned, at cost					7,628
Investments at fair value					5,567
Associated Asphalt Partners LLC
Investment owned, at cost	2,353				2,331
Investments at fair value	1,928				1,934
Astra Acquisition Corp
Investment owned, at cost	5,489				5,482
Investments at fair value	5,006				4,822
athenahealth Group Inc
Investment owned, at cost	18,264				18,264
Investments at fair value	15,606				16,575
Athenex Inc
Investment owned, at cost	21,768				22,166
Investments at fair value	20,692				21,137
Aurora Lux Finco SÀRL
Investment owned, at cost	22,050				22,086
Investments at fair value	21,274				21,326
The Avery
Investment owned, at cost	18,980				19,379
Investments at fair value	19,124				19,482
BAART Programs Inc
Investment owned, at cost	14,598				13,632
Investments at fair value	14,218				13,149
Berner Food & Beverage LLC
Investment owned, at cost	33,414				34,272
Investments at fair value	33,390				33,670
BioXcel Therapeutics Inc
Investment owned, at cost	7,741				7,589
Investments at fair value	7,735				7,565
Blackhawk Network Holdings Inc
Investment owned, at cost	30,300				30,276
Investments at fair value	26,391				29,017
Blumenthal Temecula LLC
Investment owned, at cost	5,869				5,869
Investments at fair value	5,898				5,884
Cadence Aerospace LLC
Investment owned, at cost	13,700				13,471
Investments at fair value	13,178				13,143
Carvana Co
Investment owned, at cost					5,825
Investments at fair value					4,724
CCO Holdings LLC
Investment owned, at cost					1,746
Investments at fair value					1,603
CircusTrix Holdings LLC
Investment owned, at cost	10,201				10,004
Investments at fair value	10,465				10,209
CITGO Holding Inc
Investment owned, at cost					7,857
Investments at fair value					7,807
CITGO Petroleum Corp
Investment owned, at cost					770
Investments at fair value					797
Clear Channel Outdoor Holdings Inc
Investment owned, at cost	4,960				6,188
Investments at fair value	3,668				4,807
Condor Merger Sub Inc
Investment owned, at cost	8,248				8,243
Investments at fair value	6,785				6,900
Continental Intermodal Group LP
Investment owned, at cost	19,934				22,290
Investments at fair value	18,113				20,853
Convergeone Holdings Inc
Investment owned, at cost	11,684				11,697
Investments at fair value	6,963				8,596
Conviva Inc
Investment owned, at cost	605				605
Investments at fair value	894				894
CorEvitas LLC
Investment owned, at cost	14,506				15,142
Investments at fair value	15,945				16,821
Covetrus Inc
Investment owned, at cost	9,733				9,716
Investments at fair value	9,711				9,681
Coyote Buyer LLC
Investment owned, at cost	17,753				17,777
Investments at fair value	17,772				17,817
Delivery Hero FinCo LLC
Investment owned, at cost	10,521				4,882
Investments at fair value	10,997				4,757
Delta Leasing SPV II LLC
Investment owned, at cost	8,786				4,604
Investments at fair value	8,786				4,604
Delta Topco Inc
Investment owned, at cost	6,647				6,647
Investments at fair value	5,319				5,934
Dialyze Holdings LLC
Investment owned, at cost	21,838				24,353
Investments at fair value	22,703				24,161
DigitalAI Software Holdings Inc
Investment owned, at cost	9,822				9,827
Investments at fair value	10,007				10,032
DirecTV Financing LLC
Investment owned, at cost	8,012				18,970
Investments at fair value	7,968				17,973
DTI Holdco Inc
Investment owned, at cost	4,897				4,906	[14]
Investments at fair value	4,607				4,760	[14]
Eagleview Technology Corporation
Investment owned, at cost	8,884				8,884
Investments at fair value	7,897				8,503
EOS Fitness Opco Holdings LLC
Investment owned, at cost	488				488
Investments at fair value	1,067				966
Establishment Labs Holdings Inc
Investment owned, at cost	12,108				10,278
Investments at fair value	11,794				10,231
Fairbridge Strategic Capital Funding LLC
Investment owned, at cost	31,000				27,850
Investments at fair value	31,003				27,853
FINThrive Software Intermediate Holdings Inc
Investment owned, at cost	24,685				24,685
Investments at fair value	19,273				21,646
Fortress Biotech Inc
Investment owned, at cost	9,511				9,476
Investments at fair value	8,948				9,074
Frontier Communications Holdings LLC
Investment owned, at cost	4,432				4,420
Investments at fair value	3,841				3,845
GKD Index Partners LLC
Investment owned, at cost	25,954				26,183
Investments at fair value	25,909				26,113
Global Medical Response Inc
Investment owned, at cost	865				5,435
Investments at fair value	899				4,848
Grove Hotel Parcel Owner LLC
Investment owned, at cost	13,943				13,960
Investments at fair value	13,904				13,985
Harbor Purchaser Inc
Investment owned, at cost	9,070				9,080
Investments at fair value	8,938				8,582
iCIMs Inc
Investment owned, at cost	21,753				18,843
Investments at fair value	21,230				18,835
Immucor Inc
Investment owned, at cost	30,796				30,563
Investments at fair value	31,910				30,682
Impel Neuropharma Inc
Investment owned, at cost	25,438				25,027
Investments at fair value	25,304				25,025
Innocoll Pharmaceuticals Limited
Investment owned, at cost	6,704				6,688
Investments at fair value	6,998				7,017
Integral Development Corporation
Investment owned, at cost	113				113
Investments at fair value	0				0
Inventus Power Inc
Investment owned, at cost	32,071				32,081
Investments at fair value	31,249				31,288
INW Manufacturing LLC
Investment owned, at cost	34,394				34,806
Investments at fair value	30,059				31,528
IPC Corp
Investment owned, at cost	33,660				33,612
Investments at fair value	32,553				32,639
Ivanti Software Inc
Investment owned, at cost	10,196				10,196
Investments at fair value	5,994				7,702
Jazz Acquisition Inc
Investment owned, at cost	35,398				35,648
Investments at fair value	36,659				36,873
Kings Buyer LLC
Investment owned, at cost	14,093				13,798
Investments at fair value	13,752				13,643
LaserShip Inc
Investment owned, at cost	24,034				2,370
Investments at fair value	25,864				1,867
Lift Brands Holdings Inc
Investment owned, at cost	1,399				1,399
Investments at fair value	0				0
Lightbox Intermediate LP
Investment owned, at cost	36,233				40,243
Investments at fair value	35,621				39,573
Liquid Environmental Solutions Corporation
Investment owned, at cost	7,063				7,059
Investments at fair value	6,923				6,942
LSL Holdco LLC
Investment owned, at cost	22,940				20,566
Investments at fair value	22,103				20,358
LTI Holdings Inc
Investment owned, at cost	2,095				2,092
Investments at fair value	1,712				1,890
Marinus Pharmaceuticals Inc
Investment owned, at cost	16,972				16,954
Investments at fair value	16,573				16,644
Mesoblast Inc
Investment owned, at cost	7,198				7,131
Investments at fair value	6,777				6,610
MHE Intermediate Holdings LLC
Investment owned, at cost	18,235				18,065
Investments at fair value	17,826				17,637
Mindbody Inc
Investment owned, at cost	44,568				44,635
Investments at fair value	44,398				44,423
Mosaic Companies LLC
Investment owned, at cost	45,266				45,802
Investments at fair value	45,127				45,421
MRI Software LLC
Investment owned, at cost	25,368				29,103
Investments at fair value	24,673				28,587
Navisite LLC
Investment owned, at cost	22,260				22,241
Investments at fair value	21,545				21,524
NeuAG LLC
Investment owned, at cost	49,271				49,301
Investments at fair value	52,292				51,972
NFP Corp
Investment owned, at cost	9,787				9,773
Investments at fair value	8,423				7,966
NN Inc
Investment owned, at cost	57,577				57,655
Investments at fair value	55,958				56,805
OEConnection LLC
Investment owned, at cost	10,561				10,551
Investments at fair value	10,388				10,444
OTG Management LLC
Investment owned, at cost	21,698				21,236
Investments at fair value	21,993				21,557
P & L Development LLC
Investment owned, at cost	7,817				7,820
Investments at fair value	6,318				5,846
Park Place Technologies LLC
Investment owned, at cost	4,703				9,460
Investments at fair value	4,575				9,374
Performance Health Holdings Inc
Investment owned, at cost	17,705				17,690
Investments at fair value	17,537				17,537
PFNY Holdings LLC
Investment owned, at cost	29,094				27,877
Investments at fair value	29,046				28,083
Planview Parent Inc
Investment owned, at cost	28,198				28,198
Investments at fair value	25,693				27,482
Pluralsight LLC
Investment owned, at cost	49,709				47,898
Investments at fair value	49,149				47,044
PRGX Global Inc
Investment owned, at cost	30,514				32,976
Investments at fair value	30,650				33,156
Profrac Holdings II LLC
Investment owned, at cost	22,496				22,722
Investments at fair value	22,432				22,810
Project Boost Purchaser LLC
Investment owned, at cost	5,173				5,168
Investments at fair value	4,955				5,047
Quantum Bidco Limited
Investment owned, at cost	4,655				4,646
Investments at fair value	3,599				3,367
QuorumLabs Inc
Investment owned, at cost	375				375
Investments at fair value	0				0
Radiology Partners Inc
Investment owned, at cost	7,942				7,922
Investments at fair value	5,547				5,989
Relativity ODA LLC
Investment owned, at cost	24,962				24,222
Investments at fair value	24,799				24,037
Renaissance Holding Corp
Investment owned, at cost	3,515				3,515
Investments at fair value	3,315				3,402
RP Escrow Issuer LLC
Investment owned, at cost					1,218
Investments at fair value					1,097
RumbleOn Inc
Investment owned, at cost	45,794				47,560
Investments at fair value	44,783				47,021
Sabert Corporation, First Lien Term Loan
Investment owned, at cost	27,926				1,610
Investments at fair value	27,925				1,623
ShareThis Inc
Investment owned, at cost	367				367
Investments at fair value	0				0
SiO Medical Products Inc
Investment owned, at cost	47,128				46,094
Investments at fair value	44,763				45,976
SM Wellness Holdings Inc
Investment owned, at cost	11,756				8,972
Investments at fair value	9,371				8,289
SonicWall US Holdings Inc
Investment owned, at cost	3,163				3,163
Investments at fair value	2,971				2,997
Sorrento Therapeutics Inc
Investment owned, at cost	197				197
Investments at fair value	44				79
Spanx LLC
Investment owned, at cost	4,727				5,268
Investments at fair value	4,675				5,223
SPX Flow Inc
Investment owned, at cost	1,410				1,410
Investments at fair value	1,401				1,393
SumUp Holdings Luxembourg SÀRL
Investment owned, at cost	19,415				19,414
Investments at fair value	17,732				16,360
Sunland Asphalt & Construction LLC
Investment owned, at cost	41,624				41,654
Investments at fair value	41,702				41,723
Supermoose Borrower LLC
Investment owned, at cost	3,162				3,141
Investments at fair value	2,994				3,056
SVP-Singer Holdings Inc
Investment owned, at cost	19,554				19,550
Investments at fair value	17,917				18,188
Swordfish Merger Sub LLC
Investment owned, at cost	12,476				12,474
Investments at fair value	11,434				11,469
Tacala LLC
Investment owned, at cost	9,343				9,338
Investments at fair value	8,610				8,692
Tahoe Bidco BV
Investment owned, at cost	22,805				22,786
Investments at fair value	22,840				22,815
Tecta America Corp
Investment owned, at cost	5,125				5,125
Investments at fair value	4,982				5,034
Telestream Holdings Corporation
Investment owned, at cost	19,153				19,166
Investments at fair value	18,947				19,052
TerSera Therapeutics LLC
Investment owned, at cost	31,403				31,380
Investments at fair value	33,719				33,108
TGNR HoldCo LLC
Investment owned, at cost	4,873				4,866
Investments at fair value	4,847				4,872
Thrasio LLC
Investment owned, at cost	65,585				63,044
Investments at fair value	66,001				65,662
TIBCO Software Inc
Investment owned, at cost	10,986				10,949	[14]
Investments at fair value	10,775				10,827	[14]
Touchstone Acquisition Inc
Investment owned, at cost	5,897				5,908
Investments at fair value	5,866				5,895
Uniti Group LP
Investment owned, at cost	4,334				4,318	[15]
Investments at fair value	3,230				3,264	[15]
Win Brands Group LLC
Investment owned, at cost	2,217				2,293
Investments at fair value	2,265				2,456
Windstream Services II LLC
Investment owned, at cost	26,670				26,690
Investments at fair value	25,105				25,299
WP CPP Holdings LLC
Investment owned, at cost	12,895				12,844
Investments at fair value	11,653				11,865
WPEngine Inc
Investment owned, at cost	39,991				39,947
Investments at fair value	40,131				40,131
WWEX Uni Topco Holdings LLC
Investment owned, at cost	4,925				4,925
Investments at fair value	4,191				4,538
Zayo Group Holdings Inc
Investment owned, at cost	214				212
Investments at fair value	185				201
Zep Inc
Investment owned, at cost	19,545				19,542
Investments at fair value	13,704				16,152
Zephyr Bidco Limited
Investment owned, at cost	23,839				23,804
Investments at fair value	16,369				$ 16,552
Alto Pharmacy Holdings, Inc.
Investment owned, at cost	8,546
Investments at fair value	8,559
AMMC CLO 27
Investment owned, at cost	2,037
Investments at fair value	2,087
Avalara, Inc.
Investment owned, at cost	40,366
Investments at fair value	40,326
Horizon Aircraft Finance I
Investment owned, at cost	5,697
Investments at fair value	5,838
Hayfin Emerald CLO XI
Investment owned, at cost	2,041
Investments at fair value	2,079
OCP EURO CLO 2022-6
Investment owned, at cost	5,180
Investments at fair value	5,304
Dryden 66 Euro CLO 2018
Investment owned, at cost	1,335
Investments at fair value	1,389
SCP Eye Care Services, LLC
Investment owned, at cost	8,779
Investments at fair value	8,823
scPharmaceuticals Inc.
Investment owned, at cost	5,120
Investments at fair value	5,219
Superior Industries International, Inc.
Investment owned, at cost	38,591
Investments at fair value	38,581
Trinitas CLO XV
Investment owned, at cost	810
Investments at fair value	$ 846
Investment, Identifier [Axis]: - Van Houten Real LLC, First Lien Delayed Draw Term Loan
Investment interest rate	12%	[1],[2],[3],[4],[5],[13],[16],[17]	12%	[1],[2],[3],[4],[5],[13],[16],[17]
Investment owned, balance, principal amount	$ 3,239	[13],[16],[17],[18]
Investment owned, at cost	3,167	[13],[16],[17]
Investments at fair value	$ 3,159	[13],[16],[17]
Investment, Identifier [Axis]: ADB Companies LLC, First Lien Term Loan
Investment, basis spread, variable rate	6.25%	[1],[2],[3],[4],[5],[12],[13]	6.25%	[1],[2],[3],[4],[5],[12],[13]	6.25%	[6],[7],[8],[9],[10],[11],[12]	6.25%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	11.34%	[12],[13]	11.34%	[12],[13]	9.80%	[11],[14]	9.80%	[11],[14]
Investment owned, balance, principal amount	$ 14,505	[12],[13],[18]			$ 14,685	[11],[14],[19]
Investment owned, at cost	14,079	[12],[13]			14,217	[11],[14]
Investments at fair value	$ 14,254	[12],[13]			$ 14,431	[11],[14]
Investment, Identifier [Axis]: ADC Therapeutics SA, Common Stock Warrants
Investment owned, balance (in shares) | shares	28,948	[1],[2],[3],[4],[5],[13],[20]	28,948	[1],[2],[3],[4],[5],[13],[20]	28,948	[6],[7],[8],[9],[10],[11],[15]	28,948	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 8.297	[1],[2],[3],[4],[5],[13],[20]			$ 8.297	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 174	[13],[20]			$ 174	[11],[15]
Investments at fair value	$ 50	[13],[20]			$ 73	[11],[15]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	7.50%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	7.50%	[6],[7],[8],[9],[10],[11],[12],[15],[21]	7.50%	[6],[7],[8],[9],[10],[11],[12],[15],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18],[20]			$ 0	[11],[14],[15],[19],[21]
Investment owned, at cost	(38)	[12],[13],[16],[20]			(38)	[11],[14],[15],[21]
Investments at fair value	$ (35)	[12],[13],[16],[20]			$ (37)	[11],[14],[15],[21]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13],[20]	7.50%	[1],[2],[3],[4],[5],[12],[13],[20]	7.50%	[6],[7],[8],[9],[10],[11],[12],[15]	7.50%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	12.23%	[12],[13],[20]	12.23%	[12],[13],[20]	11.20%	[11],[14],[15]	11.20%	[11],[14],[15]
Investment owned, balance, principal amount	$ 6,589	[12],[13],[18],[20]			$ 6,589	[11],[14],[15],[19]
Investment owned, at cost	6,269	[12],[13],[20]			6,256	[11],[14],[15]
Investments at fair value	$ 6,274	[12],[13],[20]			$ 6,262	[11],[14],[15]
Investment, Identifier [Axis]: AI Sirona Luxembourg Acquisition Sarl, Second Lien Term Loan
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12],[13],[20]	7.25%	[1],[2],[3],[4],[5],[12],[13],[20]	7.25%	[6],[7],[8],[9],[10],[11],[12],[15]	7.25%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	9.15%	[12],[13],[20]	9.15%	[12],[13],[20]	7.94%	[11],[14],[15]	7.94%	[11],[14],[15]
Investment owned, balance, principal amount	$ 24,838	[12],[13],[18],[20]			$ 24,838	[11],[14],[15],[19]
Investment owned, at cost	27,775	[12],[13],[20]			27,752	[11],[14],[15]
Investments at fair value	$ 24,255	[12],[13],[20]			$ 22,143	[11],[14],[15]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Common Units in RD Holding LP
Investment owned, balance (in shares) | shares	14,410	[1],[2],[3],[4],[5],[13]	14,410	[1],[2],[3],[4],[5],[13]	14,410	[6],[7],[8],[9],[10],[11]	14,410	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 1,352	[13]			$ 1,352	[11]
Investments at fair value	$ 1,528	[13]			$ 1,291	[11]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Second Lien Term Loan
Investment, basis spread, variable rate	7.75%	[1],[2],[3],[4],[5],[12],[13]	7.75%	[1],[2],[3],[4],[5],[12],[13]	7.75%	[6],[7],[8],[9],[10],[11],[12]	7.75%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	12.17%	[12],[13]	12.17%	[12],[13]	10.88%	[11],[14]	10.88%	[11],[14]
Investment owned, balance, principal amount	$ 14,414	[12],[13],[18]			$ 14,414	[11],[14],[19]
Investment owned, at cost	14,163	[12],[13]			14,154	[11],[14]
Investments at fair value	$ 13,960	[12],[13]			$ 13,910	[11],[14]
Investment, Identifier [Axis]: AMMC CLO 27, Class E Notes, Class E Notes
Investment, basis spread, variable rate	8.89%	[1],[2],[3],[4],[5],[12],[20]	8.89%	[1],[2],[3],[4],[5],[12],[20]
Investment interest rate	13.49%	[12]	13.49%	[12]
Investment owned, balance, principal amount	$ 2,275	[12]
Investment owned, at cost	2,037	[12],[20]
Investments at fair value	$ 2,087	[12],[20]
Investment, Identifier [Axis]: APX Group Inc, Fixed Rate Bond
Investment interest rate	5.75%	[1],[2],[3],[4],[5],[20]	5.75%	[1],[2],[3],[4],[5],[20]	5.75%	[6],[7],[8],[9],[10],[15]	5.75%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount	$ 2,075	[18],[20]			$ 2,075	[15],[19]
Investment owned, at cost	1,742	[20]			1,733	[15]
Investments at fair value	$ 1,721	[20]			$ 1,645	[15]
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 1
Investment interest rate					7.50%	[6],[7],[8],[9],[10]	7.50%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount					$ 5,500	[19]
Investment owned, at cost					5,408
Investments at fair value					$ 3,641
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 2
Investment interest rate					5.25%	[6],[7],[8],[9],[10]	5.25%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount					$ 2,500	[19]
Investment owned, at cost					2,220
Investments at fair value					$ 1,926
Investment, Identifier [Axis]: AT Holdings II Ltd, First Lien Revenue Interest Financing Term Loan
Investment interest rate	14.25%	[1],[2],[3],[4],[5],[13],[20]	14.25%	[1],[2],[3],[4],[5],[13],[20]
Investment owned, balance, principal amount	$ 15,939	[13],[18],[20]
Investment owned, at cost	15,939	[13],[20]
Investments at fair value	$ 15,939	[13],[20]
Investment, Identifier [Axis]: AT Holdings II SÀRL, First Lien Term Loan
Investment, interest rate, paid in kind	12.50%	[1],[2],[3],[4],[5],[13],[20]	12.50%	[1],[2],[3],[4],[5],[13],[20]	10.50%	[6],[7],[8],[9],[10],[11],[15]	10.50%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 15,643	[13],[18],[20]			$ 33,997	[11],[15],[19]
Investment owned, at cost	15,640	[13],[20]			33,960	[11],[15]
Investments at fair value	$ 15,722	[13],[20]			$ 34,891	[11],[15]
Investment, Identifier [Axis]: Access CIG LLC, Second Lien Term Loan
Investment, basis spread, variable rate	7.75%	[1],[2],[3],[4],[5],[12],[13]	7.75%	[1],[2],[3],[4],[5],[12],[13]	7.75%	[6],[7],[8],[9],[10],[12]	7.75%	[6],[7],[8],[9],[10],[12]
Investment interest rate	11.82%	[12]	11.82%	[12]	10.82%	[14]	10.82%	[14]
Investment owned, balance, principal amount	$ 20,000	[12],[18]			$ 20,000	[14],[19]
Investment owned, at cost	19,932	[12]			19,927	[14]
Investments at fair value	$ 17,800	[12]			$ 19,075	[14]
Investment, Identifier [Axis]: Accupac Inc, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[6],[7],[8],[9],[10],[11],[12],[21]	5.50%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	0	[12],[13],[16]			0	[11],[14],[21]
Investments at fair value	$ (6)	[12],[13],[16]			$ (6)	[11],[14],[21]
Investment, Identifier [Axis]: Accupac Inc, First Lien Revolver
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[6],[7],[8],[9],[10],[11],[12],[21]	5.50%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment interest rate	10.17%	[12],[13],[16]	10.17%	[12],[13],[16]	9.14%	[11],[14],[21]	9.14%	[11],[14],[21]
Investment owned, balance, principal amount	$ 908	[12],[13],[16],[18]			$ 500	[11],[14],[19],[21]
Investment owned, at cost	874	[12],[13],[16]			462	[11],[14],[21]
Investments at fair value	$ 904	[12],[13],[16]			$ 495	[11],[14],[21]
Investment, Identifier [Axis]: Accupac Inc, First Lien Term Loan
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[6],[7],[8],[9],[10],[11],[12]	5.50%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	10.16%	[12],[13]	10.16%	[12],[13]	9.12%	[11],[14]	9.12%	[11],[14]
Investment owned, balance, principal amount	$ 15,935	[12],[13],[18]			$ 15,976	[11],[14],[19]
Investment owned, at cost	15,668	[12],[13]			15,686	[11],[14]
Investments at fair value	$ 15,903	[12],[13]			$ 15,944	[11],[14]
Investment, Identifier [Axis]: Acquia Inc, First Lien Revolver
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[6],[7],[8],[9],[10],[11],[12]	7%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	12.18%	[12],[13],[16]	12.18%	[12],[13],[16]	10.64%	[11],[14],[21]	10.64%	[11],[14],[21]
Investment owned, balance, principal amount	$ 1,317	[12],[13],[16],[18]			$ 914	[11],[14],[19],[21]
Investment owned, at cost	1,296	[12],[13],[16]			890	[11],[14],[21]
Investments at fair value	$ 1,308	[12],[13],[16]			$ 898	[11],[14],[21]
Investment, Identifier [Axis]: Acquia Inc, First Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[12]	7%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	10.74%	[12],[13]	10.74%	[12],[13]	9.63%	[11],[14]	9.63%	[11],[14]
Investment owned, balance, principal amount	$ 27,349	[12],[13],[18]			$ 27,349	[11],[14],[19]
Investment owned, at cost	27,064	[12],[13]			27,038	[11],[14]
Investments at fair value	$ 27,240	[12],[13]			$ 27,158	[11],[14]
Investment, Identifier [Axis]: Aden & Anais Merger Sub Inc, Common Units in Aden & Anais Holdings, Inc.
Investment owned, balance (in shares) | shares	51,645	[1],[2],[3],[4],[5],[13]	51,645	[1],[2],[3],[4],[5],[13]	51,645	[6],[7],[8],[9],[10],[11]	51,645	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 5,165	[13]			$ 5,165	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: AirStrip Technologies Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	5,715	[1],[2],[3],[4],[5],[13]	5,715	[1],[2],[3],[4],[5],[13]	5,715	[6],[7],[8],[9],[10],[11]	5,715	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 139.99	[1],[2],[3],[4],[5],[13]			$ 139.99	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 90	[13]			$ 90	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: All Web Leads Inc, First Lien Term Loan
Investment, basis spread, variable rate	1%	[1],[2],[3],[4],[5],[12],[13]	1%	[1],[2],[3],[4],[5],[12],[13]
Investment, interest rate, paid in kind	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[12]	8.50%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	5.73%	[12],[13]	5.73%	[12],[13]
Investment owned, balance, principal amount	$ 23,562	[12],[13],[18]			$ 23,338	[11],[14],[19]
Investment owned, at cost	22,547	[12],[13]			22,057	[11],[14]
Investments at fair value	$ 22,354	[12],[13]			$ 22,141	[11],[14]
Investment, Identifier [Axis]: Altice France SA, Fixed Rate Bond
Investment, basis spread, variable rate					5.50%	[6],[7],[8],[9],[10],[15]	5.50%	[6],[7],[8],[9],[10],[15]
Investment interest rate	5.50%	[1],[2],[3],[4],[5],[13],[20]	5.50%	[1],[2],[3],[4],[5],[13],[20]
Investment owned, balance, principal amount	$ 4,050	[18],[20]			$ 4,050	[15],[19]
Investment owned, at cost	3,533	[20]			3,518	[15]
Investments at fair value	$ 3,095	[20]			$ 3,057	[15]
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	166,414	[1],[2],[3],[4],[5],[13]	166,414	[1],[2],[3],[4],[5],[13]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 15.46	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 642	[13]
Investments at fair value	$ 629	[13]
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, First Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[12],[13]	3.50%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	12.68%	[12],[13]	12.68%	[12],[13]
Investment owned, balance, principal amount	$ 8,640	[12],[13],[18]
Investment owned, at cost	7,904	[12],[13]
Investments at fair value	$ 7,930	[12],[13]
Investment, Identifier [Axis]: Alvogen Pharma US Inc, First Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[6],[7],[8],[9],[10],[11],[12]	7.50%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	12.23%	[12],[13]	12.23%	[12],[13]	11.20%	[11],[14]	11.20%	[11],[14]
Investment owned, balance, principal amount	$ 12,968	[12],[13],[18]			$ 13,134	[11],[14],[19]
Investment owned, at cost	12,711	[12],[13]			12,847	[11],[14]
Investments at fair value	$ 12,903	[12],[13]			$ 13,068	[11],[14]
Investment, Identifier [Axis]: Alvotech Holdings SA, Common Shares in Alvotech SA
Investment owned, balance (in shares) | shares	587,930	[1],[2],[3],[4],[5],[20]	587,930	[1],[2],[3],[4],[5],[20]	587,930	[6],[7],[8],[9],[10],[15]	587,930	[6],[7],[8],[9],[10],[15]
Investment owned, at cost	$ 5,308	[20]			$ 5,308	[15]
Investments at fair value	$ 5,879	[20]			$ 3,974	[15]
Investment, Identifier [Axis]: Alvotech Holdings SA, Seller Earn Out Shares in Alvotech SA
Investment owned, balance (in shares) | shares					124,780	[6],[7],[8],[9],[10],[11],[15]	124,780	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost					$ 485	[11],[15]
Investments at fair value					$ 212	[11],[15]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche A Fixed Rate Bond
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[13],[20]	3.50%	[1],[2],[3],[4],[5],[13],[20]
Investment interest rate	8.50%	[1],[2],[3],[4],[5],[13],[20]	8.50%	[1],[2],[3],[4],[5],[13],[20]	10%	[6],[7],[8],[9],[10],[11],[15]	10%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 26,179	[13],[18],[20]			$ 24,043	[11],[15],[19]
Investment owned, at cost	25,798	[13],[20]			23,747	[11],[15]
Investments at fair value	$ 25,684	[13],[20]			$ 23,923	[11],[15]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche B Fixed Rate Bond
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[13],[20]	3.50%	[1],[2],[3],[4],[5],[13],[20]
Investment interest rate	8.50%	[1],[2],[3],[4],[5],[13],[20]	8.50%	[1],[2],[3],[4],[5],[13],[20]	10%	[6],[7],[8],[9],[10],[11],[15]	10%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 25,612	[13],[18],[20]			$ 23,522	[11],[15],[19]
Investment owned, at cost	25,264	[13],[20]			23,264	[11],[15]
Investments at fair value	$ 25,128	[13],[20]			$ 23,404	[11],[15]
Investment, Identifier [Axis]: American Auto Auction Group LLC, Second Lien Term Loan
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[12],[13]	8.75%	[1],[2],[3],[4],[5],[12],[13]	8.75%	[6],[7],[8],[9],[10],[11],[12]	8.75%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	13.33%	[12],[13]	13.33%	[12],[13]	12.30%	[11],[14]	12.30%	[11],[14]
Investment owned, balance, principal amount	$ 14,760	[12],[13],[18]			$ 14,760	[11],[14],[19]
Investment owned, at cost	14,503	[12],[13]			14,492	[11],[14]
Investments at fair value	$ 11,439	[12],[13]			$ 13,284	[11],[14]
Investment, Identifier [Axis]: American Tire Distributors Inc, First Lien Term Loan
Investment, basis spread, variable rate	6.25%	[1],[2],[3],[4],[5],[12]	6.25%	[1],[2],[3],[4],[5],[12]	6.25%	[6],[7],[8],[9],[10],[12]	6.25%	[6],[7],[8],[9],[10],[12]
Investment interest rate	10.61%	[12]	10.61%	[12]	9.03%	[14]	9.03%	[14]
Investment owned, balance, principal amount	$ 9,870	[12],[18]			$ 9,895	[14],[19]
Investment owned, at cost	9,747	[12]			9,772	[14]
Investments at fair value	$ 9,081	[12]			$ 9,293	[14]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, First Lien Term Loan
Investment, basis spread, variable rate	4.25%	[1],[2],[3],[4],[5],[12],[13],[20]	4.25%	[1],[2],[3],[4],[5],[12],[13],[20]	4.25%	[6],[7],[8],[9],[10],[11],[12],[15]	4.25%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	8.98%	[12],[13],[20]	8.98%	[12],[13],[20]	7.92%	[11],[14],[15]	7.92%	[11],[14],[15]
Investment owned, balance, principal amount	$ 15,181	[12],[13],[18],[20]			$ 15,220	[11],[14],[15],[19]
Investment owned, at cost	14,014	[12],[13],[20]			13,973	[11],[14],[15]
Investments at fair value	$ 14,637	[12],[13],[20]			$ 14,687	[11],[14],[15]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, Second Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13],[20]	8%	[1],[2],[3],[4],[5],[12],[13],[20]	8%	[6],[7],[8],[9],[10],[11],[12],[15]	8%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	12.73%	[12],[13],[20]	12.73%	[12],[13],[20]	11.67%	[11],[14],[15]	11.67%	[11],[14],[15]
Investment owned, balance, principal amount	$ 12,500	[12],[13],[18],[20]			$ 12,500	[11],[14],[15],[19]
Investment owned, at cost	12,188	[12],[13],[20]			12,188	[11],[14],[15]
Investments at fair value	$ 11,833	[12],[13],[20]			$ 11,958	[11],[14],[15]
Investment, Identifier [Axis]: Anastasia Parent LLC, First Lien Term Loan
Investment, basis spread, variable rate	3.75%	[1],[2],[3],[4],[5],[12]	3.75%	[1],[2],[3],[4],[5],[12]	3.75%	[6],[7],[8],[9],[10],[12]	3.75%	[6],[7],[8],[9],[10],[12]
Investment interest rate	8.48%	[12]	8.48%	[12]	7.42%	[14]	7.42%	[14]
Investment owned, balance, principal amount	$ 2,729	[12],[18]			$ 2,736	[14],[19]
Investment owned, at cost	2,254	[12]			2,260	[14]
Investments at fair value	$ 2,043	[12]			$ 2,189	[14]
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Second Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[6],[7],[8],[9],[10],[11],[12]	8%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	12.36%	[12],[13]	12.36%	[12],[13]	10.78%	[11],[14]	10.78%	[11],[14]
Investment owned, balance, principal amount	$ 2,996	[12],[13],[18]			$ 4,346	[11],[14],[19]
Investment owned, at cost	2,951	[12],[13]			4,281	[11],[14]
Investments at fair value	$ 2,558	[12],[13]			$ 3,813	[11],[14]
Investment, Identifier [Axis]: Apptio Inc, First Lien Revolver
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[16]	6%	[1],[2],[3],[4],[5],[12],[13],[16]	6%	[6],[7],[8],[9],[10],[11],[12],[21]	6%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment interest rate	9.94%	[12],[13],[16]	9.94%	[12],[13],[16]	8.46%	[11],[14],[21]	8.46%	[11],[14],[21]
Investment owned, balance, principal amount	$ 1,338	[12],[13],[16],[18]			$ 892	[11],[14],[19],[21]
Investment owned, at cost	1,312	[12],[13],[16]			863	[11],[14],[21]
Investments at fair value	$ 1,294	[12],[13],[16]			$ 846	[11],[14],[21]
Investment, Identifier [Axis]: Apptio Inc, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[12]	6%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	9.94%	[12],[13]	9.94%	[12],[13]	8.46%	[11],[14]	8.46%	[11],[14]
Investment owned, balance, principal amount	$ 34,458	[12],[13],[18]			$ 34,458	[11],[14],[19]
Investment owned, at cost	33,818	[12],[13]			33,737	[11],[14]
Investments at fair value	$ 33,769	[12],[13]			$ 33,738	[11],[14]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[12],[13],[20]	5.75%	[1],[2],[3],[4],[5],[12],[13],[20]	5.75%	[6],[7],[8],[9],[10],[11],[12],[15],[21]	5.75%	[6],[7],[8],[9],[10],[11],[12],[15],[21]
Investment interest rate	7.48%	[12],[13],[20]	7.48%	[12],[13],[20]
Investment owned, balance, principal amount	$ 3,649	[12],[13],[16],[18],[20]			$ 0	[11],[14],[15],[19],[21]
Investment owned, at cost	3,666	[12],[13],[16],[20]			(44)	[11],[14],[15],[21]
Investments at fair value	$ 3,908	[12],[13],[16],[20]			$ 0	[11],[14],[15],[21]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 1
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[20]	7%	[1],[2],[3],[4],[5],[12],[13],[20]	7%	[6],[7],[8],[9],[10],[11],[12],[15]	7%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	8%	[12],[13],[20]	8%	[12],[13],[20]	8%	[11],[14],[15]	8%	[11],[14],[15]
Investment owned, balance, principal amount	$ 1,964	[12],[13],[18],[20]			$ 1,964	[11],[14],[15],[19]
Investment owned, at cost	2,176	[12],[13],[20]			2,176	[11],[14],[15]
Investments at fair value	$ 2,103	[12],[13],[20]			$ 1,927	[11],[14],[15]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 2
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[20]	7%	[1],[2],[3],[4],[5],[12],[13],[20]	7%	[6],[7],[8],[9],[10],[11],[12],[15]	7%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	10.43%	[12],[13],[20]	10.43%	[12],[13],[20]	9.19%	[11],[14],[15]	9.19%	[11],[14],[15]
Investment owned, balance, principal amount	$ 18,636	[12],[13],[18],[20]			$ 18,636	[11],[14],[15],[19]
Investment owned, at cost	23,058	[12],[13],[20]			23,139	[11],[14],[15]
Investments at fair value	$ 22,485	[12],[13],[20]			$ 20,826	[11],[14],[15]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 3
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[12],[13],[20]	5.75%	[1],[2],[3],[4],[5],[12],[13],[20]	5.75%	[6],[7],[8],[9],[10],[11],[12],[15]	5.75%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate	8.81%	[12],[13],[20]	8.81%	[12],[13],[20]	8.81%	[11],[14],[15]	8.81%	[11],[14],[15]
Investment owned, balance, principal amount	$ 10,519	[12],[13],[18],[20]			$ 10,519	[11],[14],[15],[19]
Investment owned, at cost	10,368	[12],[13],[20]			10,357	[11],[14],[15]
Investments at fair value	$ 10,561	[12],[13],[20]			$ 10,328	[11],[14],[15]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Units
Investment owned, balance (in shares) | shares	1,609,201	[1],[2],[3],[4],[5],[13]	1,609,201	[1],[2],[3],[4],[5],[13]					1,609,201
Investment owned, at cost	$ 764	[13]
Investments at fair value	$ 354	[13]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Units
Investment owned, balance (in shares) | shares					1,609,201	[6],[7],[8],[9],[10],[11]	1,609,201	[6],[7],[8],[9],[10],[11]
Investment owned, at cost					$ 764	[11]
Investments at fair value					$ 370	[11]
% of Total Net Assets	0%		0%						0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Warrants
Investment owned, balance (in shares) | shares	70,424.5641	[1],[2],[3],[4],[5],[13]	70,424.5641	[1],[2],[3],[4],[5],[13]	70,424.5641	[6],[7],[8],[9],[10],[11]	70,424.5641	[6],[7],[8],[9],[10],[11]	70,424.5641
Investment owned, exercise price (in dollars per share) | $ / shares	$ 3.3778	[1],[2],[3],[4],[5],[13]			$ 3.3778	[6],[7],[8],[9],[10],[11]			$ 3.3778
Investment owned, at cost	$ 0	[13]			$ 0	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
% of Total Net Assets	0%		0%						0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[6],[7],[8],[9],[10],[11],[12],[21]	6.75%	[6],[7],[8],[9],[10],[11],[12],[21]	6.75%
Investment interest rate	11.48%	[12],[13],[16]	11.48%	[12],[13],[16]	10.42%	[11],[14],[21]	10.42%	[11],[14],[21]	7.75%
Investment owned, balance, principal amount	$ 21,464	[12],[13],[16],[18]			$ 24,490	[11],[14],[19],[21]
Investment owned, at cost	21,464	[12],[13],[16]			24,490	[11],[14],[21]
Investments at fair value	$ 21,252	[12],[13],[16]			$ 24,225	[11],[14],[21]
% of Total Net Assets	1.80%		1.80%						1.20%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units
Investment owned, balance (in shares) | shares					1,019,168.8	[6],[7],[8],[9],[10],[11]	1,019,168.8	[6],[7],[8],[9],[10],[11]
Investment interest rate					6%	[6],[7],[8],[9],[10],[11]	6%	[6],[7],[8],[9],[10],[11]
Investment owned, at cost					$ 1,019	[11]
Investments at fair value					$ 1,223	[11]
% of Total Net Assets	0.10%		0.10%						0.10%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units,
Investment owned, balance (in shares) | shares	1,019,168.8	[1],[2],[3],[4],[5],[13]	1,019,168.8	[1],[2],[3],[4],[5],[13]					1,019,168.8
Investment interest rate	6%	[1],[2],[3],[4],[5],[13]	6%	[1],[2],[3],[4],[5],[13]					6%
Investment owned, at cost	$ 1,019	[13]
Investments at fair value	$ 1,243	[13]
Investment, Identifier [Axis]: Associated Asphalt Partners LLC, First Lien Term Loan
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[12]	5.25%	[1],[2],[3],[4],[5],[12]	5.25%	[6],[7],[8],[9],[10],[12]	5.25%	[6],[7],[8],[9],[10],[12]
Investment interest rate	9.63%	[12]	9.63%	[12]	8.06%	[14]	8.06%	[14]
Investment owned, balance, principal amount	$ 2,493	[12],[18]			$ 2,501	[14],[19]
Investment owned, at cost	2,353	[12]			2,331	[14]
Investments at fair value	$ 1,928	[12]			$ 1,934	[14]
Investment, Identifier [Axis]: Astra Acquisition Corp, First Lien Term Loan
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[12]	5.25%	[1],[2],[3],[4],[5],[12]	5.25%	[6],[7],[8],[9],[10],[12]	5.25%	[6],[7],[8],[9],[10],[12]
Investment interest rate	9.63%	[12]	9.63%	[12]	8.37%	[14]	8.37%	[14]
Investment owned, balance, principal amount	$ 5,640	[12],[18]			$ 5,640	[14],[19]
Investment owned, at cost	5,489	[12]			5,482	[14]
Investments at fair value	$ 5,006	[12]			$ 4,822	[14]
Investment, Identifier [Axis]: Athenex Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	328,149	[1],[2],[3],[4],[5],[13],[20]	328,149	[1],[2],[3],[4],[5],[13],[20]	328,149	[6],[7],[8],[9],[10],[11],[15]	328,149	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 0.4955	[1],[2],[3],[4],[5],[13],[20]			$ 0.4955	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 973	[13],[20]			$ 973	[11],[15]
Investments at fair value	7	[13],[20]			16	[11],[15]
Investment, Identifier [Axis]: Athenex Inc, First Lien Revenue Interest Financing Term Loan
Investment owned, balance, principal amount	8,649	[13],[18],[20]			8,309	[11],[15],[19]
Investment owned, at cost	8,604	[13],[20]			8,264	[11],[15]
Investments at fair value	$ 8,649	[13],[20]			$ 8,309	[11],[15]
Investment, Identifier [Axis]: Athenex Inc, First Lien Term Loan
Investment, basis spread, variable rate					11%	[6],[7],[8],[9],[10],[11],[15]	11%	[6],[7],[8],[9],[10],[11],[15]
Investment interest rate	11%	[1],[2],[3],[4],[5],[13],[20]	11%	[1],[2],[3],[4],[5],[13],[20]
Investment owned, balance, principal amount	$ 12,556	[13],[18],[20]			$ 13,346	[11],[15],[19]
Investment owned, at cost	12,191	[13],[20]			12,929	[11],[15]
Investments at fair value	$ 12,036	[13],[20]			$ 12,812	[11],[15]
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan
Investment, basis spread, variable rate					6%	[6],[7],[8],[9],[10],[11],[12],[15]	6%	[6],[7],[8],[9],[10],[11],[12],[15]
Investment interest rate					8.78%	[11],[14],[15]	8.78%	[11],[14],[15]
Investment owned, balance, principal amount					$ 22,425	[11],[14],[15],[19]
Investment owned, at cost					22,086	[11],[14],[15]
Investments at fair value					$ 21,326	[11],[14],[15]
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan,
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[20]	6%	[1],[2],[3],[4],[5],[12],[13],[20]
Investment interest rate	10.32%	[12],[13],[20]	10.32%	[12],[13],[20]
Investment owned, balance, principal amount	$ 22,368	[12],[13],[18],[20]
Investment owned, at cost	22,050	[12],[13],[20]
Investments at fair value	$ 21,274	[12],[13],[20]
Investment, Identifier [Axis]: Avalara Inc, First Lien Revolver
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12],[13],[16]	7.25%	[1],[2],[3],[4],[5],[12],[13],[16]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]
Investment owned, at cost	(100)	[12],[13],[16]
Investments at fair value	$ (104)	[12],[13],[16]
Investment, Identifier [Axis]: Avalara Inc, First Lien Term Loan
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12],[13]	7.25%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	11.83%	[12]	11.83%	[12]
Investment owned, balance, principal amount	$ 41,467	[12],[13],[18]
Investment owned, at cost	40,466	[12],[13]
Investments at fair value	$ 40,430	[12],[13]
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate					5%	[6],[7],[8],[9],[10],[11],[12],[21]	5%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment interest rate					8.12%	[11],[14],[21]	8.12%	[11],[14],[21]
Investment owned, balance, principal amount					$ 2,546	[11],[14],[19],[21]
Investment owned, at cost					2,503	[11],[14],[21]
Investments at fair value					$ 2,395	[11],[14],[21]
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12],[13],[16]	5%	[1],[2],[3],[4],[5],[12],[13],[16]
Investment interest rate	9.73%	[12],[13],[16]	9.73%	[12],[13],[16]
Investment owned, balance, principal amount	$ 2,541	[12],[13],[16],[18]
Investment owned, at cost	2,497	[12],[13],[16]
Investments at fair value	$ 2,420	[12],[13],[16]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13],[16]	8.50%	[1],[2],[3],[4],[5],[12],[13],[16]	8.50%	[6],[7],[8],[9],[10],[11],[12],[21]	8.50%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment interest rate	13.23%	[12],[13],[16]	13.23%	[12],[13],[16]	11.62%	[11],[14],[21]	11.62%	[11],[14],[21]
Investment owned, balance, principal amount	$ 5,197	[12],[13],[16],[18]			$ 4,227	[11],[14],[19],[21]
Investment owned, at cost	5,042	[12],[13],[16]			4,070	[11],[14],[21]
Investments at fair value	$ 4,854	[12],[13],[16]			$ 3,839	[11],[14],[21]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[12]	8.50%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	13.23%	[12],[13]	13.23%	[12],[13]	11.62%	[11],[14]	11.62%	[11],[14]
Investment owned, balance, principal amount	$ 7,166	[12],[13],[18]			$ 7,166	[11],[14],[19]
Investment owned, at cost	7,059	[12],[13]			7,059	[11],[14]
Investments at fair value	$ 6,944	[12],[13]			$ 6,915	[11],[14]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Revolver
Investment, basis spread, variable rate	4.50%	[1],[2],[3],[4],[5],[12],[13],[16]	4.50%	[1],[2],[3],[4],[5],[12],[13],[16]	4.50%	[6],[7],[8],[9],[10],[11],[14],[21]	4.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	12%	[12],[13],[16]	12%	[12],[13],[16]	10.75%	[11],[14],[21]	10.75%	[11],[14],[21]
Investment owned, balance, principal amount	$ 897	[12],[13],[16],[18]			$ 1,702	[11],[14],[19],[21]
Investment owned, at cost	859	[12],[13],[16]			1,660	[11],[14],[21]
Investments at fair value	$ 857	[12],[13],[16]			$ 1,617	[11],[14],[21]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Term Loan
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[6],[7],[8],[9],[10],[11],[14]	5.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.91%	[12],[13]	9.91%	[12],[13]	8.31%	[11],[14]	8.31%	[11],[14]
Investment owned, balance, principal amount	$ 32,995	[12],[13],[18]			$ 33,078	[11],[14],[19]
Investment owned, at cost	32,555	[12],[13]			32,612	[11],[14]
Investments at fair value	$ 32,533	[12],[13]			$ 32,053	[11],[14]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	21,177	[1],[2],[3],[4],[5],[13],[20]	21,177	[1],[2],[3],[4],[5],[13],[20]	21,177	[6],[7],[8],[9],[10],[11],[15]	21,177	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 20.04	[1],[2],[3],[4],[5],[13],[20]			$ 20.04	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 125	[13],[20]			$ 125	[11],[15]
Investments at fair value	$ 275	[13],[20]			$ 98	[11],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Delayed Draw Term Loan
Investment, interest rate, paid in kind	2.25%	[1],[2],[3],[4],[5],[13],[16],[20]	2.25%	[1],[2],[3],[4],[5],[13],[16],[20]
Investment interest rate	8%	[1],[2],[3],[4],[5],[13],[16],[20]	8%	[1],[2],[3],[4],[5],[13],[16],[20]	10.25%	[6],[7],[8],[9],[10],[11],[15],[21]	10.25%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, balance, principal amount	$ 0	[13],[16],[18],[20]			$ 0	[11],[15],[19],[21]
Investment owned, at cost	0	[13],[16],[20]			0	[11],[15],[21]
Investments at fair value	0	[13],[16],[20]			0	[11],[15],[21]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Revenue Interest Financing Delayed Draw Term Loan
Investment owned, balance, principal amount	0	[13],[16],[18],[20]			0	[11],[15],[19],[21]
Investment owned, at cost	0	[13],[16],[20]			0	[11],[15],[21]
Investments at fair value	0	[13],[16],[20]			0	[11],[15],[21]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Revenue Interest Financing Term Loan
Investment owned, balance, principal amount	2,432	[13],[18],[20]			2,353	[11],[15],[19]
Investment owned, at cost	2,432	[13],[20]			2,353	[11],[15]
Investments at fair value	$ 2,432	[13],[20]			$ 2,353	[11],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Term Loan
Investment, interest rate, paid in kind	2.25%	[1],[2],[3],[4],[5],[13],[20]	2.25%	[1],[2],[3],[4],[5],[13],[20]
Investment interest rate	8%	[1],[2],[3],[4],[5],[13],[20]	8%	[1],[2],[3],[4],[5],[13],[20]	10.25%	[6],[7],[8],[9],[10],[11],[15]	10.25%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 5,383	[13],[18],[20]			$ 5,322	[11],[15],[19]
Investment owned, at cost	5,184	[13],[20]			5,111	[11],[15]
Investments at fair value	$ 5,028	[13],[20]			$ 5,114	[11],[15]
Investment, Identifier [Axis]: Blackhawk Network Holdings Inc, Second Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12]	7%	[1],[2],[3],[4],[5],[12]	7%	[6],[7],[8],[9],[10],[14]	7%	[6],[7],[8],[9],[10],[14]
Investment interest rate	10.94%	[12]	10.94%	[12]	9.50%	[14]	9.50%	[14]
Investment owned, balance, principal amount	$ 30,625	[12],[18]			$ 30,625	[14],[19]
Investment owned, at cost	30,300	[12]			30,276	[14]
Investments at fair value	$ 26,391	[12]			$ 29,017	[14]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Common Units in Unstoppable Automotive AMV, LLC
Investment owned, balance (in shares) | shares	298,460	[1],[2],[3],[4],[5],[13]	298,460	[1],[2],[3],[4],[5],[13]	298,460	[6],[7],[8],[9],[10],[11]	298,460	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 298	[13]			$ 298	[11]
Investments at fair value	$ 379	[13]			$ 349	[11]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, First Lien Term Loan
Investment, basis spread, variable rate					9%	[6],[7],[8],[9],[10],[11]	9%	[6],[7],[8],[9],[10],[11]
Investment interest rate	9%	[1],[2],[3],[4],[5],[13]	9%	[1],[2],[3],[4],[5],[13]
Investment owned, balance, principal amount	$ 3,979	[13],[18]			$ 3,979	[11],[19]
Investment owned, at cost	3,980	[13]			3,980	[11]
Investments at fair value	$ 3,960	[13]			$ 3,960	[11]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Preferred Units in Unstoppable Automotive AMV, LLC
Investment owned, balance (in shares) | shares	1,293,324	[1],[2],[3],[4],[5],[13]	1,293,324	[1],[2],[3],[4],[5],[13]	1,293,324	[6],[7],[8],[9],[10],[11]	1,293,324	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 1,293	[13]			$ 1,293	[11]
Investments at fair value	$ 1,267	[13]			$ 1,280	[11]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Preferred Units in Unstoppable Automotive VMV, LLC
Investment owned, balance (in shares) | shares	298,460	[1],[2],[3],[4],[5],[13]	298,460	[1],[2],[3],[4],[5],[13]	298,460	[6],[7],[8],[9],[10],[11]	298,460	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 298	[13]			$ 298	[11]
Investments at fair value	$ 292	[13]			$ 295	[11]
Investment, Identifier [Axis]: C Technology Holdings LLC, Common Units
Investment owned, balance (in shares) | shares	829	[1],[2],[3],[4],[5],[13]	829	[1],[2],[3],[4],[5],[13]	829	[6],[7],[8],[9],[10],[11],[12]	829	[6],[7],[8],[9],[10],[11],[12]	829
Investment owned, at cost	$ 0	[13]			$ 0	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: C Technology Holdings LLC, Preferred Units
Investment owned, balance (in shares) | shares	34,984,460.37	[1],[2],[3],[4],[5],[13]	34,984,460.37	[1],[2],[3],[4],[5],[13]	34,984,460.37	[6],[7],[8],[9],[10],[11],[12]	34,984,460.37	[6],[7],[8],[9],[10],[11],[12]	34,984,460.37
Investment owned, at cost	$ 34,984	[13]			$ 34,984	[11]
Investments at fair value	$ 27,638	[13]			$ 27,638	[11]
Investment, Identifier [Axis]: C5 Technology Holding, LLC, Common Units
% of Total Net Assets	0%		0%						0%
Investment, Identifier [Axis]: C5 Technology Holding, LLC, Preferred Units
% of Total Net Assets	2.30%		2.30%						2.10%
Investment, Identifier [Axis]: CCO Holdings LLC, Fixed Rate Bond
Investment interest rate					4.50%	[6],[7],[8],[9],[10],[15]	4.50%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount					$ 2,097	[15],[19]
Investment owned, at cost					1,746	[15]
Investments at fair value					$ 1,603	[15]
Investment, Identifier [Axis]: CITGO Holding Inc, Fixed Rate Bond
Investment interest rate					9.25%	[6],[7],[8],[9],[10],[11],[14]	9.25%	[6],[7],[8],[9],[10],[11],[14]
Investment owned, balance, principal amount					$ 7,857	[19]
Investment owned, at cost					7,857
Investments at fair value					$ 7,807
Investment, Identifier [Axis]: CITGO Petroleum Corp, First Lien Term Loan
Investment, basis spread, variable rate					6.25%	[6],[7],[8],[9],[10],[14]	6.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate					9.37%	[14]	9.37%	[14]
Investment owned, balance, principal amount					$ 795	[14],[19]
Investment owned, at cost					770	[14]
Investments at fair value					$ 797	[14]
Investment, Identifier [Axis]: Cadence Aerospace LLC, First Lien Term Loan
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[6],[7],[8],[9],[10],[11],[14]	6.50%	[6],[7],[8],[9],[10],[11],[14]
Investment, interest rate, paid in kind	2%	[1],[2],[3],[4],[5],[12],[13]	2%	[1],[2],[3],[4],[5],[12],[13]	2%	[6],[7],[8],[9],[10],[11],[14]	2%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.92%	[12],[13]	10.92%	[12],[13]	9.31%	[11],[14]	9.31%	[11],[14]
Investment owned, balance, principal amount	$ 14,332	[12],[13],[18]			$ 14,294	[11],[14],[19]
Investment owned, at cost	13,700	[12],[13]			13,471	[11],[14]
Investments at fair value	$ 13,178	[12],[13]			$ 13,143	[11],[14]
Investment, Identifier [Axis]: Caregiver Services Inc, Series A Preferred Stock
Investment owned, balance (in shares) | shares	1,080,399		1,080,399		1,080,399	[6],[7],[8],[9],[10],[11]	1,080,399	[6],[7],[8],[9],[10],[11]	1,080,399
Investment interest rate	10%	[1],[2],[3],[4],[5],[13]	10%	[1],[2],[3],[4],[5],[13]	10%	[6],[7],[8],[9],[10],[11]	10%	[6],[7],[8],[9],[10],[11]	10%
Investment owned, at cost	$ 1,080	[13]			$ 1,080	[11]
Investments at fair value	$ 324	[13]			$ 378	[11]
Investment, Identifier [Axis]: Caregiver Services, Inc., Series A Preferred Stock
% of Total Net Assets	0%		0%						0.10%
Investment, Identifier [Axis]: Carvana Co, Fixed Rate Bond
Investment interest rate					5.625%	[6],[7],[8],[9],[10],[15]	5.625%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount					$ 6,700	[15],[19]
Investment owned, at cost					5,825	[15]
Investments at fair value					4,724	[15]
Investment, Identifier [Axis]: Cash and Cash Equivalents and Restricted Cash, JP Morgan Prime Money Market Fund, Institutional Shares
Money market funds, at carrying value					$ 5,261
Investment, Identifier [Axis]: CircusTrix Holdings LLC, First Lien Term Loan
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[6],[7],[8],[9],[10],[11],[14]	5.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.57%	[12],[13]	9.57%	[12],[13]	8.62%	[11],[14]	8.62%	[11],[14]
Investment owned, balance, principal amount	$ 10,668	[12],[13],[18]			$ 10,692	[11],[14],[19]
Investment owned, at cost	10,201	[12],[13]			10,004	[11],[14]
Investments at fair value	$ 10,465	[12],[13]			$ 10,209	[11],[14]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 1
Investment interest rate	7.50%	[1],[2],[3],[4],[5],[20]	7.50%	[1],[2],[3],[4],[5],[20]	7.50%	[6],[7],[8],[9],[10],[15]	7.50%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount	$ 4,311	[18],[20]			$ 4,311	[15],[19]
Investment owned, at cost	4,311	[20]			4,311	[15]
Investments at fair value	$ 3,174	[20]			$ 3,132	[15]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 2
Investment interest rate	7.75%	[1],[2],[3],[4],[5],[20]	7.75%	[1],[2],[3],[4],[5],[20]	5.125%	[6],[7],[8],[9],[10],[15]	5.125%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount	$ 676	[18],[20]			$ 1,374	[15],[19]
Investment owned, at cost	649	[20]			1,229	[15]
Investments at fair value	$ 494	[20]			$ 1,163	[15]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 3
Investment interest rate					7.75%	[6],[7],[8],[9],[10],[15]	7.75%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount					$ 676	[15],[19]
Investment owned, at cost					648	[15]
Investments at fair value					$ 512	[15]
Investment, Identifier [Axis]: Condor Merger Sub Inc, Fixed Rate Bond
Investment interest rate	7.375%	[1],[2],[3],[4],[5]	7.375%	[1],[2],[3],[4],[5]	7.375%	[6],[7],[8],[9],[10],[11],[14]	7.375%	[6],[7],[8],[9],[10],[11],[14]
Investment owned, balance, principal amount	$ 8,420	[18]			$ 8,420	[19]
Investment owned, at cost	8,248				8,243
Investments at fair value	6,785				6,900
Investment, Identifier [Axis]: Continental Intermodal Group LP, Common Stock Warrants
Investment owned, at cost	648	[13]			648	[11]
Investments at fair value	$ 220	[13]			$ 457	[11]
Investment, Identifier [Axis]: Continental Intermodal Group LP, First Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[14]	8.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.88%	[12],[13]	12.88%	[12],[13]	11.62%	[11],[14]	11.62%	[11],[14]
Investment owned, balance, principal amount	$ 19,992	[12],[13],[18]			$ 22,537	[11],[14],[19]
Investment owned, at cost	19,286	[12],[13]			21,642	[11],[14]
Investments at fair value	$ 17,893	[12],[13]			$ 20,396	[11],[14]
Investment, Identifier [Axis]: Convergeone Holdings Inc, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12]	5%	[1],[2],[3],[4],[5],[12]	5%	[6],[7],[8],[9],[10],[14]	5%	[6],[7],[8],[9],[10],[14]
Investment interest rate	9.38%	[12]	9.38%	[12]	8.12%	[14]	8.12%	[14]
Investment owned, balance, principal amount	$ 11,882	[12],[18]			$ 11,913	[14],[19]
Investment owned, at cost	11,684	[12]			11,697	[14]
Investments at fair value	$ 6,963	[12]			$ 8,596	[14]
Investment, Identifier [Axis]: Conviva Inc, Shares of Series D Preferred Stock
Investment owned, balance (in shares) | shares	517,851	[1],[2],[3],[4],[5],[13]	517,851	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 605	[13]
Investments at fair value	$ 894	[13]
Investment, Identifier [Axis]: Conviva Inc,Shares of Series D Preferred Stock
Investment owned, balance (in shares) | shares					517,851	[6],[7],[8],[9],[10],[11]	517,851	[6],[7],[8],[9],[10],[11]
Investment owned, at cost					$ 605	[11]
Investments at fair value					$ 894	[11]
Investment, Identifier [Axis]: CorEvitas LLC, Class A2 Common Units in CorEvitas Holdings, L.P.
Investment owned, balance (in shares) | shares	1,099	[1],[2],[3],[4],[5],[13]	1,099	[1],[2],[3],[4],[5],[13]	1,099	[6],[7],[8],[9],[10],[11]	1,099	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 690	[13]			$ 690	[11]
Investments at fair value	$ 2,340	[13]			$ 2,340	[11]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Revolver
Investment, basis spread, variable rate	4.75%	[1],[2],[3],[4],[5],[12],[13],[16]	4.75%	[1],[2],[3],[4],[5],[12],[13],[16]	4.75%	[6],[7],[8],[9],[10],[11],[14],[21]	4.75%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	12.25%	[12],[13],[16]	12.25%	[12],[13],[16]	11%	[11],[14],[21]	11%	[11],[14],[21]
Investment owned, balance, principal amount	$ 305	[12],[13],[16],[18]			$ 916	[11],[14],[19],[21]
Investment owned, at cost	289	[12],[13],[16]			898	[11],[14],[21]
Investments at fair value	$ 261	[12],[13],[16]			$ 898	[11],[14],[21]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Term Loan
Investment, basis spread, variable rate	6.125%	[1],[2],[3],[4],[5],[12],[13]	6.125%	[1],[2],[3],[4],[5],[12],[13]	5.75%	[6],[7],[8],[9],[10],[11],[14]	5.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.55%	[12],[13]	10.55%	[12],[13]	8.88%	[11],[14]	8.88%	[11],[14]
Investment owned, balance, principal amount	$ 13,677	[12],[13],[18]			$ 13,712	[11],[14],[19]
Investment owned, at cost	13,527	[12],[13]			13,554	[11],[14]
Investments at fair value	$ 13,344	[12],[13]			$ 13,583	[11],[14]
Investment, Identifier [Axis]: Covetrus Inc, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12]	5%	[1],[2],[3],[4],[5],[12]	5%	[6],[7],[8],[9],[10],[14]	5%	[6],[7],[8],[9],[10],[14]
Investment interest rate	9.58%	[12]	9.58%	[12]	7.65%	[14]	7.65%	[14]
Investment owned, balance, principal amount	$ 10,336	[12],[18]			$ 10,336	[14],[19]
Investment owned, at cost	9,733	[12]			9,716	[14]
Investments at fair value	$ 9,711	[12]			$ 9,681	[14]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Revolver
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[16]	6%	[1],[2],[3],[4],[5],[12],[13],[16]	6%	[6],[7],[8],[9],[10],[11],[14],[21]	6%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(13)	[12],[13],[16]			(13)	[11],[14],[21]
Investments at fair value	$ (26)	[12],[13],[16]			$ (26)	[11],[14],[21]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.41%	[12],[13]	10.41%	[12],[13]	8.81%	[11],[14]	8.81%	[11],[14]
Investment owned, balance, principal amount	$ 18,153	[12],[13],[18]			$ 18,200	[11],[14],[19]
Investment owned, at cost	17,766	[12],[13]			17,790	[11],[14]
Investments at fair value	$ 17,798	[12],[13]			$ 17,843	[11],[14]
Investment, Identifier [Axis]: Cuppa Bidco BV, First Lien Term Loan
Investment, basis spread, variable rate	4.75%	[1],[2],[3],[4],[5],[12]	4.75%	[1],[2],[3],[4],[5],[12]
Investment interest rate	7.50%	[12],[20]	7.50%	[12],[20]
Investment owned, balance, principal amount	$ 12,340	[12],[18],[20]
Investment owned, at cost	10,521	[12],[20]
Investments at fair value	$ 10,997	[12],[20]
Investment, Identifier [Axis]: DTI Holdco Inc, First Lien Term Loan
Investment, basis spread, variable rate	4.75%	[1],[2],[3],[4],[5],[12]	4.75%	[1],[2],[3],[4],[5],[12]	4.75%	[6],[7],[8],[9],[10],[14]	4.75%	[6],[7],[8],[9],[10],[14]
Investment interest rate	8.84%	[12]	8.84%	[12]	7.33%	[14]	7.33%	[14]
Investment owned, balance, principal amount	$ 4,988	[12],[18]			$ 5,000	[14],[19]
Investment owned, at cost	4,897	[12]			4,906	[14]
Investments at fair value	$ 4,607	[12]			$ 4,760	[14]
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan
Investment, basis spread, variable rate					5.75%	[6],[7],[8],[9],[10],[14],[15]	5.75%	[6],[7],[8],[9],[10],[14],[15]
Investment interest rate					8.49%	[14],[15]	8.49%	[14],[15]
Investment owned, balance, principal amount					$ 4,988	[14],[15],[19]
Investment owned, at cost					4,882	[14],[15]
Investments at fair value					$ 4,757	[14],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Units in Delta Financial Holdings LLC
Investment owned, balance (in shares) | shares	2.09	[1],[2],[3],[4],[5],[13]	2.09	[1],[2],[3],[4],[5],[13]	2.09	[6],[7],[8],[9],[10],[11],[15]	2.09	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 2	[13],[20]			$ 2	[11],[15]
Investments at fair value	$ 2	[13],[20]			$ 2	[11],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Warrants
Investment owned, balance (in shares) | shares	31.37	[1],[2],[3],[4],[5],[13]	31.37	[1],[2],[3],[4],[5],[13]	31.37	[6],[7],[8],[9],[10],[11],[15]	31.37	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 1	[1],[2],[3],[4],[5],[13]			$ 1	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 0	[13],[20]			$ 0	[11],[15]
Investments at fair value	$ 0	[13],[20]			$ 0	[11],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Series C Preferred Units in Delta Financial Holdings LLC
Investment owned, balance (in shares) | shares	419	[1],[2],[3],[4],[5],[13]	419	[1],[2],[3],[4],[5],[13]	419	[6],[7],[8],[9],[10],[11],[15]	419	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 419	[13],[20]			$ 419	[11],[15]
Investments at fair value	$ 419	[13],[20]			$ 419	[11],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Subordinated Delayed Draw Term Loan
Investment interest rate	10%	[1],[2],[3],[4],[5],[13],[16]	10%	[1],[2],[3],[4],[5],[13],[16]	10%	[6],[7],[8],[9],[10],[11],[15],[21]	10%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, balance, principal amount	$ 8,365	[13],[16],[18],[20]			$ 4,183	[11],[15],[19],[21]
Investment owned, at cost	8,365	[13],[16],[20]			4,183	[11],[15],[21]
Investments at fair value	$ 8,365	[13],[16],[20]			$ 4,183	[11],[15],[21]
Investment, Identifier [Axis]: Delta Topco Inc, Second Lien Term Loan
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12]	7.25%	[1],[2],[3],[4],[5],[12]	7.25%	[6],[7],[8],[9],[10],[14]	7.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate	11.65%	[12]	11.65%	[12]	9.34%	[14]	9.34%	[14]
Investment owned, balance, principal amount	$ 6,680	[12],[18]			$ 6,680	[14],[19]
Investment owned, at cost	6,647	[12]			6,647	[14]
Investments at fair value	$ 5,319	[12]			$ 5,934	[14]
Investment, Identifier [Axis]: Dialyze Holdings LLC, Class A Warrants
Investment owned, balance (in shares) | shares	5,403,823	[1],[2],[3],[4],[5],[13]	5,403,823	[1],[2],[3],[4],[5],[13]	5,403,823	[6],[7],[8],[9],[10],[11]	5,403,823	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 1	[1],[2],[3],[4],[5],[13]			$ 1	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 1,405	[13]			$ 1,405	[11]
Investments at fair value	$ 1,297	[13]			$ 1,297	[11]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate					9%	[6],[7],[8],[9],[10],[11],[14],[21]	9%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment, interest rate, paid in kind					2%	[6],[7],[8],[9],[10],[11],[14],[21]	2%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount					$ 0	[11],[14],[19],[21]
Investment owned, at cost					(135)	[11],[14],[21]
Investments at fair value					$ (129)	[11],[14],[21]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Term Loan
Investment, basis spread, variable rate	9%	[1],[2],[3],[4],[5],[12],[13]	9%	[1],[2],[3],[4],[5],[12],[13]	9%	[6],[7],[8],[9],[10],[11],[14]	9%	[6],[7],[8],[9],[10],[11],[14]
Investment, interest rate, paid in kind					2%	[6],[7],[8],[9],[10],[11],[14]	2%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	13.73%	[12],[13]	13.73%	[12],[13]	12.67%	[11],[14]	12.67%	[11],[14]
Investment owned, balance, principal amount	$ 20,965	[12],[13],[18]			$ 24,396	[11],[14],[19]
Investment owned, at cost	19,913	[12],[13]			23,083	[11],[14]
Investments at fair value	$ 20,912	[12],[13]			$ 22,993	[11],[14]
Investment, Identifier [Axis]: Dialyze Holdings LLC, Subordinated Term Loan
Investment, interest rate, paid in kind	8%	[1],[2],[3],[4],[5],[13]	8%	[1],[2],[3],[4],[5],[13]
Investment owned, balance, principal amount	$ 520	[12],[13],[16],[18]
Investment owned, at cost	520	[12],[13],[16]
Investments at fair value	$ 494	[12],[13],[16]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Revolver
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[1],[2],[3],[4],[5],[12],[13],[16]	6.50%	[6],[7],[8],[9],[10],[11],[14],[21]	6.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	11.59%	[12],[13],[16]	11.59%	[12],[13],[16]	9.41%	[11],[14],[21]	9.41%	[11],[14],[21]
Investment owned, balance, principal amount	$ 251	[12],[13],[16],[18]			$ 251	[11],[14],[19],[21]
Investment owned, at cost	229	[12],[13],[16]			228	[11],[14],[21]
Investments at fair value	$ 239	[12],[13],[16]			$ 239	[11],[14],[21]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Term Loan
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.09%	[12],[13]	11.09%	[12],[13]	9.91%	[11],[14]	9.91%	[11],[14]
Investment owned, balance, principal amount	$ 9,877	[12],[13],[18]			$ 9,902	[11],[14],[19]
Investment owned, at cost	9,593	[12],[13]			9,599	[11],[14]
Investments at fair value	$ 9,768	[12],[13]			$ 9,793	[11],[14]
Investment, Identifier [Axis]: DirecTV Financing LLC, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12]	5%	[1],[2],[3],[4],[5],[12]	5%	[6],[7],[8],[9],[10],[14]	5%	[6],[7],[8],[9],[10],[14]
Investment interest rate	9.38%	[12]	9.38%	[12]	8.12%	[14]	8.12%	[14]
Investment owned, balance, principal amount	$ 8,166	[12],[18]			$ 19,242	[14],[19]
Investment owned, at cost	8,012	[12]			18,970	[14]
Investments at fair value	$ 7,968	[12]			$ 17,973	[14]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, Common Units in DD Healthcare Services Holdings, LLC
Investment owned, balance (in shares) | shares	30,030.8	[1],[2],[3],[4],[5],[13]	30,030.8	[1],[2],[3],[4],[5],[13]	30,030.8	[6],[7],[8],[9],[10],[11]	30,030.8	[6],[7],[8],[9],[10],[11]	30,030.8
Investment owned, at cost	$ 15,222	[13]			$ 15,222	[11]
Investments at fair value	$ 4,227	[13]			$ 4,946	[11]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Revolver
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12],[13],[16]	5%	[1],[2],[3],[4],[5],[12],[13],[16]	5%	[6],[7],[8],[9],[10],[11],[12],[21]	5%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	0	[12],[13],[16]			0	[11],[14],[21]
Investments at fair value	$ 0	[12],[13],[16]			$ 0	[11],[14],[21]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12],[13]	5%	[1],[2],[3],[4],[5],[12],[13]	5%	[6],[7],[8],[9],[10],[11],[12]	5%	[6],[7],[8],[9],[10],[11],[12]	5%
Investment interest rate	9.73%	[12],[13]	9.73%	[12],[13]	8.68%	[11],[14]	8.68%	[11],[14]
Investment owned, balance, principal amount	$ 14,297	[12],[13],[18]			$ 14,333	[11],[14],[19]
Investment owned, at cost	14,297	[12],[13]			14,333	[11],[14]
Investments at fair value	$ 14,297	[12],[13]			$ 14,333	[11],[14]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Units In DD Healthcare Services Holdings, LLC
% of Total Net Assets	0.40%		0.40%						1.40%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Loan
Investment interest rate	9.73%		9.73%						6%
% of Total Net Assets	1.20%		1.20%						1.80%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver
% of Total Net Assets	0%		0%						0%
Investment, Identifier [Axis]: Dryden 66 Euro CLO 2018, Class DR Notes, Class DR Notes
Investment, basis spread, variable rate	3.35%	[1],[2],[3],[4],[5],[12],[20]	3.35%	[1],[2],[3],[4],[5],[12],[20]
Investment interest rate	4.75%	[12],[20]	4.75%	[12],[20]
Investment owned, balance, principal amount	$ 1,500	[12],[18],[20]
Investment owned, at cost	1,335	[12],[20]
Investments at fair value	$ 1,389	[12],[20]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units, 12%
Investment owned, balance (in shares) | shares	487.5	[1],[2],[3],[4],[5],[13]	487.5	[1],[2],[3],[4],[5],[13]
Investment interest rate	12%	[1],[2],[3],[4],[5],[13]	12%	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 488	[13]
Investments at fair value	$ 1,067	[13]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units
Investment owned, balance (in shares) | shares					487.5	[6],[7],[8],[9],[10],[11]	487.5	[6],[7],[8],[9],[10],[11]
Investment interest rate					12%	[6],[7],[8],[9],[10],[11]	12%	[6],[7],[8],[9],[10],[11]
Investment owned, at cost					$ 488	[11]
Investments at fair value					$ 966	[11]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class B Common Units
Investment owned, balance (in shares) | shares	12,500	[1],[2],[3],[4],[5],[13]	12,500	[1],[2],[3],[4],[5],[13]	12,500	[6],[7],[8],[9],[10],[11]	12,500	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 0	[13]			$ 0	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: Eagleview Technology Corporation, Second Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[6],[7],[8],[9],[10],[11],[14]	7.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.23%	[12],[13]	12.23%	[12],[13]	11.17%	[11],[14]	11.17%	[11],[14]
Investment owned, balance, principal amount	$ 8,974	[12],[13],[18]			$ 8,974	[11],[19]
Investment owned, at cost	8,884	[12],[13]			8,884	[11]
Investments at fair value	$ 7,897	[12],[13]			$ 8,503	[11]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Delayed Draw Term Loan
Investment, interest rate, paid in kind	6%	[1],[2],[3],[4],[5],[13],[16],[20]	6%	[1],[2],[3],[4],[5],[13],[16],[20]	6%	[6],[7],[8],[9],[10],[11],[15],[21]	6%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment interest rate	3%	[1],[2],[3],[4],[5],[13],[16],[20]	3%	[1],[2],[3],[4],[5],[13],[16],[20]	3%	[6],[7],[8],[9],[10],[11],[15],[21]	3%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, balance, principal amount	$ 1,694	[13],[16],[18],[20]
Investment owned, at cost	1,667	[13],[16],[20]			$ 3	[11],[15],[21]
Investments at fair value	$ 1,694	[13],[16],[20]			$ 0	[11],[15],[21]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Term Loan
Investment, interest rate, paid in kind	6%	[1],[2],[3],[4],[5],[13],[20]	6%	[1],[2],[3],[4],[5],[13],[20]	6%	[6],[7],[8],[9],[10],[11],[15]	6%	[6],[7],[8],[9],[10],[11],[15]
Investment interest rate	3%	[1],[2],[3],[4],[5],[13],[20]	3%	[1],[2],[3],[4],[5],[13],[20]	3%	[6],[7],[8],[9],[10],[11],[15]	3%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 10,576	[13],[18],[20]			$ 10,418	[11],[15],[19]
Investment owned, at cost	10,441	[13],[20]			10,275	[11],[15]
Investments at fair value	$ 10,100	[13],[20]			$ 10,231	[11],[15]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings Inc, Second Lien Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12]	6.75%	[1],[2],[3],[4],[5],[12]	6.75%	[6],[7],[8],[9],[10],[14]	6.75%	[6],[7],[8],[9],[10],[14]
Investment interest rate	11.13%	[12]	11.13%	[12]	9.87%	[14]	9.87%	[14]
Investment owned, balance, principal amount	$ 25,061	[12],[18]			$ 25,061	[14],[19]
Investment owned, at cost	24,685	[12]			24,685	[14]
Investments at fair value	$ 19,273	[12]			$ 21,646	[14]
Investment, Identifier [Axis]: Fair Street LLC, First Lien Delayed Draw Term Loan
Investment interest rate	12.50%	[1],[2],[3],[4],[5],[13],[16],[17]	12.50%	[1],[2],[3],[4],[5],[13],[16],[17]
Investment owned, balance, principal amount	$ 1,174	[13],[16],[17],[18]
Investment owned, at cost	1,111	[13],[16],[17]
Investments at fair value	$ 1,108	[13],[16],[17]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, First Lien Delayed Draw Term Loan
Investment interest rate	9%	[1],[2],[3],[4],[5],[13],[16],[20]	9%	[1],[2],[3],[4],[5],[13],[16],[20]	9%	[6],[7],[8],[9],[10],[11],[21]	9%	[6],[7],[8],[9],[10],[11],[21]
Investment owned, balance, principal amount	$ 31,000	[13],[16],[18]			$ 27,850	[11],[19],[21]
Investment owned, at cost	31,000	[13],[16]			27,850	[11],[21]
Investments at fair value	$ 31,000	[13],[16]			$ 27,850	[11],[21]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Warrant Units
Investment owned, balance (in shares) | shares	2,500	[1],[2],[3],[4],[5],[13],[16],[20]	2,500	[1],[2],[3],[4],[5],[13],[16],[20]	2,500	[6],[7],[8],[9],[10],[11],[15],[21]	2,500	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 0.01	[1],[2],[3],[4],[5],[13],[16],[20]			$ 0.01	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, at cost	$ 0	[13],[16],[20]			$ 0	[11],[15]
Investments at fair value	$ 3	[13],[16],[20]			$ 3	[11],[15]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Equity Interest
% of Total Net Assets									0%
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Investment, basis spread, variable rate									9%
Investment owned, ownership percentage									100%
% of Total Net Assets									0%
Investment, Identifier [Axis]: Fortress Biotech Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	331,200	[1],[2],[3],[4],[5],[13],[20]	331,200	[1],[2],[3],[4],[5],[13],[20]	331,200	[6],[7],[8],[9],[10],[11],[15]	331,200	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 3.20	[1],[2],[3],[4],[5],[13],[20]			$ 3.20	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 405	[13],[20]			$ 405	[11],[15]
Investments at fair value	$ 26	[13],[20]			$ 66	[11],[15]
Investment, Identifier [Axis]: Fortress Biotech Inc, First Lien Term Loan
Investment interest rate	11%	[1],[2],[3],[4],[5],[13],[20]	11%	[1],[2],[3],[4],[5],[13],[20]	11%	[6],[7],[8],[9],[10],[11],[15]	11%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 9,466	[13],[18],[20]			$ 9,466	[11],[15],[19]
Investment owned, at cost	9,106	[13],[20]			9,071	[11],[15]
Investments at fair value	$ 8,922	[13],[20]			$ 9,008	[11],[15]
Investment, Identifier [Axis]: Frontier Communications Holdings LLC, Fixed Rate Bond
Investment interest rate	6%	[1],[2],[3],[4],[5],[20]	6%	[1],[2],[3],[4],[5],[20]	6%	[6],[7],[8],[9],[10],[15]	6%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount	$ 4,881	[18],[20]			$ 4,881	[15],[19]
Investment owned, at cost	4,432	[20]			4,420	[15]
Investments at fair value	$ 3,841	[20]			$ 3,845	[15]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Revolver
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[6],[7],[8],[9],[10],[11],[14],[21]	7%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	11.75%	[12],[13],[16]	11.75%	[12],[13],[16]	10.60%	[11],[14],[21]	10.60%	[11],[14],[21]
Investment owned, balance, principal amount	$ 1,280	[12],[13],[16],[18]			$ 1,280	[11],[14],[19],[21]
Investment owned, at cost	1,272	[12],[13],[16]			1,268	[11],[14],[21]
Investments at fair value	$ 1,268	[12],[13],[16]			$ 1,262	[11],[14],[21]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.73%	[12],[13]	11.73%	[12],[13]	10.67%	[11],[14]	10.67%	[11],[14]
Investment owned, balance, principal amount	$ 24,819	[12],[13],[18]			$ 25,128	[11],[14],[19]
Investment owned, at cost	24,682	[12],[13]			24,915	[11],[14]
Investments at fair value	$ 24,641	[12],[13]			$ 24,851	[11],[14]
Investment, Identifier [Axis]: Global Medical Response Inc, First Lien Term Loan
Investment, basis spread, variable rate					4.25%	[6],[7],[8],[9],[10],[14]	4.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate					7.37%	[14]	7.37%	[14]
Investment owned, balance, principal amount					$ 5,572	[14],[19]
Investment owned, at cost					5,435	[14]
Investments at fair value					$ 4,848	[14]
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2, Class D Notes, Class D Notes
Investment, basis spread, variable rate	2.85%	[1],[2],[3],[4],[5],[12],[20]	2.85%	[1],[2],[3],[4],[5],[12],[20]
Investment interest rate	4.31%	[12],[20]	4.31%	[12],[20]
Investment owned, balance, principal amount	$ 1,000	[12],[18]
Investment owned, at cost	865	[12]
Investments at fair value	$ 899	[12]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[6],[7],[8],[9],[10],[11],[14],[21]	8%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(51)	[12],[13],[16]			(54)	[11],[14],[21]
Investments at fair value	$ (57)	[12],[13],[16]			$ (50)	[11],[14],[21]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Revolver
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[6],[7],[8],[9],[10],[11],[14],[21]	8%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(26)	[12],[13],[16]			(27)	[11],[14],[21]
Investments at fair value	$ (29)	[12],[13],[16]			$ (25)	[11],[14],[21]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12]	8%	[1],[2],[3],[4],[5],[12]	8%	[6],[7],[8],[9],[10],[11],[14]	8%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.33%	[12],[13]	12.33%	[12],[13]	11.04%	[11],[14]	11.04%	[11],[14]
Investment owned, balance, principal amount	$ 14,275	[12],[13],[18]			$ 14,311	[11],[14],[19]
Investment owned, at cost	14,020	[12],[13]			14,041	[11],[14]
Investments at fair value	$ 13,990	[12],[13]			$ 14,060	[11],[14]
Investment, Identifier [Axis]: Harbor Purchaser Inc, First Lien Term Loan
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[12]	5.25%	[1],[2],[3],[4],[5],[12]	5.25%	[6],[7],[8],[9],[10],[14]	5.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate	9.67%	[12]	9.67%	[12]	8.38%	[14]	8.38%	[14]
Investment owned, balance, principal amount	$ 9,369	[12],[18]			$ 9,392	[14],[19]
Investment owned, at cost	9,070	[12]			9,080	[14]
Investments at fair value	$ 8,938	[12]			$ 8,582	[14]
Investment, Identifier [Axis]: Hayfin Emerald CLO XI, Class E Notes, Class E Notes
Investment, basis spread, variable rate	8.12%	[1],[2],[3],[4],[5],[12],[20]	8.12%	[1],[2],[3],[4],[5],[12],[20]
Investment interest rate	10.11%	[12],[20]	10.11%	[12],[20]
Investment owned, balance, principal amount	$ 2,250	[12],[20]
Investment owned, at cost	2,041	[12],[20]
Investments at fair value	$ 2,079	[12],[20]
Investment, Identifier [Axis]: Horizon Aircraft Finance I, Class A Notes
Investment interest rate	4.458%	[1],[2],[3],[4],[5],[12],[20]	4.458%	[1],[2],[3],[4],[5],[12],[20]
Investment owned, balance, principal amount	$ 7,112	[12],[20]
Investment owned, at cost	5,697	[12],[20]
Investments at fair value	$ 5,838	[12],[20]
Investment, Identifier [Axis]: INW Manufacturing LLC, First Lien Term Loan
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[12],[13]	5.75%	[1],[2],[3],[4],[5],[12],[13]	5.75%	[6],[7],[8],[9],[10],[11],[14]	5.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.48%	[12],[13]	10.48%	[12],[13]	9.42%	[11],[14]	9.42%	[11],[14]
Investment owned, balance, principal amount	$ 35,156	[12],[13],[18]			$ 35,625	[11],[14],[19]
Investment owned, at cost	34,394	[12],[13]			34,806	[11],[14]
Investments at fair value	$ 30,059	[12],[13]			$ 31,528	[11],[14]
Investment, Identifier [Axis]: IPC Corp, First Lien Term Loan
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[6],[7],[8],[9],[10],[11],[14]	6.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.44%	[12],[13]	9.44%	[12],[13]	9.44%	[11],[14]	9.44%	[11],[14]
Investment owned, balance, principal amount	$ 34,357	[12],[13],[18]			$ 34,357	[11],[14],[19]
Investment owned, at cost	33,660	[12],[13]			33,612	[11],[14]
Investments at fair value	$ 32,553	[12],[13]			$ 32,639	[11],[14]
Investment, Identifier [Axis]: Immucor Inc, First Lien Term Loan
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[12],[13]	5.75%	[1],[2],[3],[4],[5],[12],[13]	5.75%	[6],[7],[8],[9],[10],[11],[14]	5.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.48%	[12],[13]	10.48%	[12],[13]	9.42%	[11],[14]	9.42%	[11],[14]
Investment owned, balance, principal amount	$ 8,547	[12],[13],[18]			$ 8,569	[11],[14],[19]
Investment owned, at cost	8,395	[12],[13]			8,401	[11],[14]
Investments at fair value	$ 8,635	[12],[13]			$ 8,407	[11],[14]
Investment, Identifier [Axis]: Immucor Inc, Second Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[6],[7],[8],[9],[10],[11],[14]	8%	[6],[7],[8],[9],[10],[11],[14]
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[12],[13]	3.50%	[1],[2],[3],[4],[5],[12],[13]	3.50%	[6],[7],[8],[9],[10],[11],[14]	3.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.73%	[12],[13]	12.73%	[12],[13]	11.67%	[11],[14]	11.67%	[11],[14]
Investment owned, balance, principal amount	$ 22,819	[12],[13],[18]			$ 22,619	[11],[14],[19]
Investment owned, at cost	22,401	[12],[13]			22,162	[11],[14]
Investments at fair value	23,275	[12],[13]			22,275	[11],[14]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Revenue Interest Financing Term
Investment owned, balance, principal amount	13,482	[13],[18]
Investment owned, at cost	13,482	[13]
Investments at fair value	$ 13,428	[13]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Revenue Interest Financing Term Loan
Investment owned, balance, principal amount					13,083	[11],[19]
Investment owned, at cost					13,083	[11]
Investments at fair value					$ 13,083	[11]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Term Loan
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[12],[13]	8.75%	[1],[2],[3],[4],[5],[12],[13]	8.75%	[6],[7],[8],[9],[10],[11],[14]	8.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	13.20%	[12],[13]	13.20%	[12],[13]	12.45%	[11],[14]	12.45%	[11],[14]
Investment owned, balance, principal amount	$ 12,161	[12],[13],[18]			$ 12,161	[11],[14],[19]
Investment owned, at cost	11,956	[12],[13]			11,944	[11],[14]
Investments at fair value	$ 11,876	[12],[13]			$ 11,942	[11],[14]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Delayed Draw Term Loan
Investment interest rate	11%	[1],[2],[3],[4],[5],[13],[16],[20]	11%	[1],[2],[3],[4],[5],[13],[16],[20]	11%	[6],[7],[8],[9],[10],[11],[15],[21]	11%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, balance, principal amount	$ 0	[13],[16],[18],[20]			$ 0	[11],[15],[19],[21]
Investment owned, at cost	0	[13],[16],[20]			0	[11],[15],[21]
Investments at fair value	$ 0	[13],[16],[20]			$ 0	[11],[15],[21]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan
Investment interest rate	11%	[1],[2],[3],[4],[5],[13],[20]	11%	[1],[2],[3],[4],[5],[13],[20]	11%	[6],[7],[8],[9],[10],[11],[15]	11%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 6,817	[13],[18],[20]			$ 6,817	[11],[15],[19]
Investment owned, at cost	6,569	[13],[20]			6,553	[11],[15]
Investments at fair value	$ 6,336	[13],[20]			$ 6,408	[11],[15]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Tranche A Warrant Shares
Investment owned, balance (in shares) | shares					56,999	[6],[7],[8],[9],[10],[11],[15]	56,999	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares					$ 4.23	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost					$ 135	[11],[15]
Investments at fair value					$ 609	[11],[15]
Investment, Identifier [Axis]: Integral Development Corporation, Common Stock Warrants
Investment owned, balance (in shares) | shares	1,078,284	[1],[2],[3],[4],[5],[13]	1,078,284	[1],[2],[3],[4],[5],[13]	1,078,284	[6],[7],[8],[9],[10],[11]	1,078,284	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 0.9274	[1],[2],[3],[4],[5],[13]			$ 0.9274	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 113	[13]			$ 113	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: Inventus Power Inc, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12],[13]	5%	[1],[2],[3],[4],[5],[12],[13]	5%	[6],[7],[8],[9],[10],[11],[14]	5%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.84%	[12],[13]	9.84%	[12],[13]	8.55%	[11],[14]	8.55%	[11],[14]
Investment owned, balance, principal amount	$ 18,612	[12],[13],[18]			$ 18,660	[11],[14],[19]
Investment owned, at cost	18,536	[12],[13]			18,567	[11],[14]
Investments at fair value	$ 18,054	[12],[13]			$ 18,134	[11],[14]
Investment, Identifier [Axis]: Inventus Power Inc, Second Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[14]	8.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	13.23%	[12],[13]	13.23%	[12],[13]	12.17%	[11],[14]	12.17%	[11],[14]
Investment owned, balance, principal amount	$ 13,674	[12],[13],[18]			$ 13,674	[11],[14],[19]
Investment owned, at cost	13,535	[12],[13]			13,514	[11],[14]
Investments at fair value	$ 13,195	[12],[13]			$ 13,154	[11],[14]
Investment, Identifier [Axis]: Ivanti Software Inc, Second Lien Term Loan
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12]	7.25%	[1],[2],[3],[4],[5],[12]	7.25%	[6],[7],[8],[9],[10],[14]	7.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate	12.01%	[12]	12.01%	[12]	10.33%	[14]	10.33%	[14]
Investment owned, balance, principal amount	$ 10,247	[12],[18]			$ 10,247	[14],[19]
Investment owned, at cost	10,196	[12]			10,196	[14]
Investments at fair value	5,994	[12]			7,702	[14]
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund Institutional Shares, JP Morgan Prime Money Market Fund, Institutional Shares
Money market funds, at carrying value	$ 3,421
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund Institutional Shares, Other cash accounts
Money market funds, at carrying value					$ 21,103
Investment, Identifier [Axis]: Jazz Acquisition Inc, First Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[6],[7],[8],[9],[10],[11],[14]	7.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.88%	[12],[13]	11.88%	[12],[13]	10.62%	[11],[14]	10.62%	[11],[14]
Investment owned, balance, principal amount	$ 35,912	[12],[13],[18]			$ 36,234	[11],[14],[19]
Investment owned, at cost	34,918	[12],[13]			35,170	[11],[14]
Investments at fair value	$ 36,176	[12],[13]			$ 36,392	[11],[14]
Investment, Identifier [Axis]: Jazz Acquisition Inc, Second Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12]	8%	[1],[2],[3],[4],[5],[12]	8%	[6],[7],[8],[9],[10],[14]	8%	[6],[7],[8],[9],[10],[14]
Investment interest rate	12.38%	[12]	12.38%	[12]	11.12%	[14]	11.12%	[14]
Investment owned, balance, principal amount	$ 528	[12],[18]			$ 528	[14],[19]
Investment owned, at cost	480	[12]			478	[14]
Investments at fair value	$ 483	[12]			$ 481	[14]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Revolver
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[12],[13],[16]	6.50%	[1],[2],[3],[4],[5],[12],[13],[16]	6.50%	[6],[7],[8],[9],[10],[11],[14],[21]	6.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	11.75%	[12],[13],[16]	11.75%	[12],[13],[16]	10.17%	[11],[14],[21]	10.17%	[11],[14],[21]
Investment owned, balance, principal amount	$ 659	[12],[13],[16],[18]			$ 329	[11],[14],[19],[21]
Investment owned, at cost	640	[12],[13],[16]			311	[11],[14],[21]
Investments at fair value	$ 599	[12],[13],[16]			$ 292	[11],[14],[21]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Term Loan
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[1],[2],[3],[4],[5],[12],[13]	6.50%	[6],[7],[8],[9],[10],[11],[14]	6.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.23%	[12],[13]	11.23%	[12],[13]	10.17%	[11],[14]	10.17%	[11],[14]
Investment owned, balance, principal amount	$ 13,589	[12],[13],[18]			$ 13,623	[11],[14],[19]
Investment owned, at cost	13,453	[12],[13]			13,487	[11],[14]
Investments at fair value	$ 13,153	[12],[13]			$ 13,351	[11],[14]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Revolver
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14],[21]	6%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	10.38%	[12],[13]	10.38%	[12],[13]	9.12%	[11],[14],[21]	9.12%	[11],[14],[21]
Investment owned, balance, principal amount	$ 2,137	[12],[13],[18]			$ 1,710	[11],[14],[19],[21]
Investment owned, at cost	2,101	[12],[13]			1,672	[11],[14],[21]
Investments at fair value	$ 2,014	[12],[13]			$ 1,651	[11],[14],[21]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.38%	[12],[13]	10.38%	[12],[13]	9.12%	[11],[14]	9.12%	[11],[14]
Investment owned, balance, principal amount	$ 21,315	[12],[13],[18]			$ 19,236	[11],[14],[19]
Investment owned, at cost	20,839	[12],[13]			18,894	[11],[14]
Investments at fair value	$ 20,089	[12],[13]			$ 18,707	[11],[14]
Investment, Identifier [Axis]: LTI Holdings Inc, Second Lien Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12]	6.75%	[1],[2],[3],[4],[5],[12]	6.75%	[6],[7],[8],[9],[10],[14]	6.75%	[6],[7],[8],[9],[10],[14]
Investment interest rate	11.13%	[12]	11.13%	[12]	9.87%	[14]	9.87%	[14]
Investment owned, balance, principal amount	$ 2,140	[12],[18]			$ 2,140	[14],[19]
Investment owned, at cost	2,095	[12]			2,092	[14]
Investments at fair value	$ 1,712	[12]			$ 1,890	[14]
Investment, Identifier [Axis]: LaserShip Inc, Second Lien Term Loan
Investment, basis spread, variable rate					7.50%	[6],[7],[8],[9],[10],[11],[14]	7.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate					10.38%	[11],[14]	10.38%	[11],[14]
Investment owned, balance, principal amount					$ 2,394	[11],[14],[19]
Investment owned, at cost					2,370	[11],[14]
Investments at fair value					$ 1,867	[11],[14]
Investment, Identifier [Axis]: Latam Airlines Group SA, First Lien Term Loan
Investment, basis spread, variable rate	9.50%	[1],[2],[3],[4],[5],[12],[20]	9.50%	[1],[2],[3],[4],[5],[12],[20]
Investment interest rate	13.99%	[12],[13]	13.99%	[12],[13]
Investment owned, balance, principal amount	$ 26,205	[12],[13],[18]
Investment owned, at cost	24,034	[12],[13]
Investments at fair value	$ 25,864	[12],[13]
Investment, Identifier [Axis]: Lift Brands Holdings Inc, Class A Common Units in Snap Investments, LLC
Investment owned, balance (in shares) | shares	2,000,000	[1],[2],[3],[4],[5],[13]	2,000,000	[1],[2],[3],[4],[5],[13]	2,000,000	[6],[7],[8],[9],[10],[11]	2,000,000	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 1,399	[13]			$ 1,399	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: Lightbox Intermediate LP, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12],[13]	5%	[1],[2],[3],[4],[5],[12],[13]	5%	[6],[7],[8],[9],[10],[11],[14]	5%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.73%	[12],[13]	9.73%	[12],[13]	8.67%	[11],[14]	8.67%	[11],[14]
Investment owned, balance, principal amount	$ 36,913	[12],[13],[18]			$ 41,008	[11],[14],[19]
Investment owned, at cost	36,233	[12],[13]			40,243	[11],[14]
Investments at fair value	$ 35,621	[12],[13]			$ 39,573	[11],[14]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Class A2 Units in LES Group Holdings, L.P.
Investment owned, balance (in shares) | shares	450.75	[1],[2],[3],[4],[5],[13]	450.75	[1],[2],[3],[4],[5],[13]	450.75	[6],[7],[8],[9],[10],[11]	450.75	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 451	[13]			$ 451	[11]
Investments at fair value	$ 451	[13]			$ 451	[11]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13],[16]	8.50%	[1],[2],[3],[4],[5],[12],[13],[16]	8.50%	[6],[7],[8],[9],[10],[11],[14],[21]	8.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	12.94%	[12],[13],[16]	12.94%	[12],[13],[16]	11.38%	[11],[14],[21]	11.38%	[11],[14],[21]
Investment owned, balance, principal amount	$ 2,370	[12],[13],[16],[18]			$ 2,370	[11],[14],[19],[21]
Investment owned, at cost	2,323	[12],[13],[16]			2,323	[11],[14],[21]
Investments at fair value	$ 2,257	[12],[13],[16]			$ 2,265	[11],[14],[21]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[14]	8.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.88%	[12],[13]	12.88%	[12],[13]	11.38%	[11],[14]	11.38%	[11],[14]
Investment owned, balance, principal amount	$ 4,357	[12],[13],[18]			$ 4,357	[11],[14],[19]
Investment owned, at cost	4,289	[12],[13]			4,285	[11],[14]
Investments at fair value	$ 4,215	[12],[13]			$ 4,226	[11],[14]
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Revolver
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[16]	6%	[1],[2],[3],[4],[5],[12],[13],[16]	6%	[6],[7],[8],[9],[10],[11],[14],[21]	6%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	10.94%	[12],[13],[16]	10.94%	[12],[13],[16]
Investment owned, balance, principal amount	$ 200	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	178	[12],[13],[16]			(23)	[11],[14],[21]
Investments at fair value	$ 148	[12],[13],[16]			$ (54)	[11],[14],[21]
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.50%	[12],[13]	9.50%	[12],[13]	9.50%	[11],[14]	9.50%	[11],[14]
Investment owned, balance, principal amount	$ 18,344	[12],[13],[18]			$ 18,390	[11],[14],[19]
Investment owned, at cost	18,057	[12],[13]			18,088	[11],[14]
Investments at fair value	$ 17,678	[12],[13]			$ 17,691	[11],[14]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[6],[7],[8],[9],[10],[11],[14],[21]	5.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(11)	[12],[13],[16]			(12)	[11],[14],[21]
Investments at fair value	$ (95)	[12],[13],[16]			$ (96)	[11],[14],[21]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[1],[2],[3],[4],[5],[12],[13],[16]	5.50%	[6],[7],[8],[9],[10],[11],[14],[21]	5.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(13)	[12],[13],[16]			(13)	[11],[14],[21]
Investments at fair value	$ (65)	[12],[13],[16]			$ (51)	[11],[14],[21]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[1],[2],[3],[4],[5],[12],[13]	5.50%	[6],[7],[8],[9],[10],[11],[14]	5.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.23%	[12],[13]	10.23%	[12],[13]	9.17%	[11],[14]	9.17%	[11],[14]
Investment owned, balance, principal amount	$ 25,768	[12],[13],[18]			$ 29,565	[11],[14],[19]
Investment owned, at cost	25,392	[12],[13]			29,128	[11],[14]
Investments at fair value	$ 24,833	[12],[13]			$ 28,734	[11],[14]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Delayed Draw Term Loan
Investment interest rate	11.50%	[1],[2],[3],[4],[5],[13],[16],[20]	11.50%	[1],[2],[3],[4],[5],[13],[16],[20]	11.50%	[6],[7],[8],[9],[10],[11],[15],[21]	11.50%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, balance, principal amount	$ 0	[13],[16],[18],[20]			$ 0	[11],[15],[19],[21]
Investment owned, at cost	0	[13],[16],[20]			0	[11],[15],[21]
Investments at fair value	$ 0	[13],[16],[20]			$ 0	[11],[15],[21]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Term Loan
Investment interest rate	11.50%	[1],[2],[3],[4],[5],[13],[20]	11.50%	[1],[2],[3],[4],[5],[13],[20]	11.50%	[6],[7],[8],[9],[10],[11],[15]	11.50%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 17,203	[13],[18],[20]			$ 17,203	[11],[15],[19]
Investment owned, at cost	16,972	[13],[20]			16,954	[11],[15]
Investments at fair value	$ 16,573	[13],[20]			$ 16,644	[11],[15]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Delayed Draw Term Loan
Investment, interest rate, paid in kind	1.75%	[1],[2],[3],[4],[5],[13],[16],[20]	1.75%	[1],[2],[3],[4],[5],[13],[16],[20]	1.75%	[6],[7],[8],[9],[10],[11],[15],[21]	1.75%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment interest rate	8%	[1],[2],[3],[4],[5],[13],[16],[20]	8%	[1],[2],[3],[4],[5],[13],[16],[20]	8%	[6],[7],[8],[9],[10],[11],[15],[21]	8%	[6],[7],[8],[9],[10],[11],[15],[21]
Investment owned, balance, principal amount	$ 0	[13],[16],[18],[20]			$ 0	[11],[15],[19],[21]
Investment owned, at cost	1	[13],[16],[20]			1	[11],[15],[21]
Investments at fair value	$ 0	[13],[16],[20]			$ 0	[11],[15],[21]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Term Loan
Investment, interest rate, paid in kind	1.75%	[1],[2],[3],[4],[5],[13],[20]	1.75%	[1],[2],[3],[4],[5],[13],[20]	1.75%	[6],[7],[8],[9],[10],[11],[15]	1.75%	[6],[7],[8],[9],[10],[11],[15]
Investment interest rate	8%	[1],[2],[3],[4],[5],[13],[20]	8%	[1],[2],[3],[4],[5],[13],[20]	8%	[6],[7],[8],[9],[10],[11],[15]	8%	[6],[7],[8],[9],[10],[11],[15]
Investment owned, balance, principal amount	$ 7,247	[13],[18],[20]			$ 7,215	[11],[15],[19]
Investment owned, at cost	6,717	[13],[20]			6,650	[11],[15]
Investments at fair value	$ 6,474	[13],[20]			$ 6,440	[11],[15]
Investment, Identifier [Axis]: Mesoblast Inc, Warrant Shares
Investment owned, balance (in shares) | shares					209,588	[6],[7],[8],[9],[10],[11],[15]	209,588	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares					$ 7.26	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost					$ 480	[11],[15]
Investments at fair value					$ 170	[11],[15]
Investment, Identifier [Axis]: Mesoblast, Inc, Warrant Shares 1
Investment owned, balance (in shares) | shares	209,588	[1],[2],[3],[4],[5],[13],[20]	209,588	[1],[2],[3],[4],[5],[13],[20]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 7.26	[1],[2],[3],[4],[5],[13],[20]
Investment owned, at cost	$ 480	[13],[20]
Investments at fair value	$ 222	[13],[20]
Investment, Identifier [Axis]: Mesoblast, Inc, Warrant Shares 2
Investment owned, balance (in shares) | shares	53,887	[1],[2],[3],[4],[5],[13],[20]	53,887	[1],[2],[3],[4],[5],[13],[20]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 3.70	[1],[2],[3],[4],[5],[13],[20]
Investment owned, at cost	$ 0
Investments at fair value	$ 81
Investment, Identifier [Axis]: Mindbody Inc, First Lien Revolver
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[6],[7],[8],[9],[10],[11],[14],[21]	8%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(48)	[12],[13],[16]			(54)	[11],[14],[21]
Investments at fair value	$ (88)	[12],[13],[16]			$ (100)	[11],[14],[21]
Investment, Identifier [Axis]: Mindbody Inc, First Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment, interest rate, paid in kind					1.50%	[6],[7],[8],[9],[10],[11],[14]	1.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.72%	[12],[13]	11.72%	[12],[13]	10.64%	[11],[14]	10.64%	[11],[14]
Investment owned, balance, principal amount	$ 45,487	[12],[13],[18]			$ 45,665	[11],[14],[19]
Investment owned, at cost	44,616	[12],[13]			44,689	[11],[14]
Investments at fair value	$ 44,486	[12],[13]			$ 44,523	[11],[14]
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate					7%	[6],[7],[8],[9],[10],[11],[12],[21]	7%	[6],[7],[8],[9],[10],[11],[12],[21]
Investment owned, balance, principal amount					$ 0	[11],[14],[19],[21]
Investment owned, at cost					(31)	[11],[14],[21]
Investments at fair value					$ 0	[11],[14],[21]
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Term Loan
Investment, basis spread, variable rate					7%	[6],[7],[8],[9],[10],[11],[12]	7%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate					9.80%	[11],[14]	9.80%	[11],[14]
Investment owned, balance, principal amount					$ 389	[11],[14],[19]
Investment owned, at cost					387	[11],[14]
Investments at fair value					$ 727	[11],[14]
Investment, Identifier [Axis]: Mosaic Companies LLC, First Lien Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[6],[7],[8],[9],[10],[11],[14]	6.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.93%	[12],[13]	10.93%	[12],[13]	9.89%	[11],[14]	9.89%	[11],[14]
Investment owned, balance, principal amount	$ 45,907	[12],[13],[18]			$ 46,499	[11],[14],[19]
Investment owned, at cost	45,266	[12],[13]			45,802	[11],[14]
Investments at fair value	$ 45,127	[12],[13]			$ 45,421	[11],[14]
Investment, Identifier [Axis]: NFP Corp, Fixed Rate Bond
Investment interest rate	6.875%	[1],[2],[3],[4],[5]	6.875%	[1],[2],[3],[4],[5]	6.875%	[6],[7],[8],[9],[10]	6.875%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount	$ 10,191	[18]			$ 10,191	[19]
Investment owned, at cost	9,787				9,773
Investments at fair value	$ 8,423				$ 7,966
Investment, Identifier [Axis]: NN Inc, First Lien Term Loan
Investment, basis spread, variable rate	6.88%	[1],[2],[3],[4],[5],[12],[13]	6.88%	[1],[2],[3],[4],[5],[12],[13]	6.88%	[6],[7],[8],[9],[10],[11],[14],[15]	6.88%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment interest rate	11.26%	[12],[13],[20]	11.26%	[12],[13],[20]	9.99%	[11],[14],[15]	9.99%	[11],[14],[15]
Investment owned, balance, principal amount	$ 58,564	[12],[13],[18],[20]			$ 58,713	[11],[14],[15],[19]
Investment owned, at cost	57,577	[12],[13],[20]			57,655	[11],[14],[15]
Investments at fair value	$ 55,958	[12],[13],[20]			$ 56,805	[11],[14],[15]
Investment, Identifier [Axis]: Navisite LLC, Second Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[14]	8.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	13.23%	[12],[13]	13.23%	[12],[13]	12.17%	[11],[14]	12.17%	[11],[14]
Investment owned, balance, principal amount	$ 22,560	[12],[13],[18]			$ 22,560	[11],[14],[19]
Investment owned, at cost	22,260	[12],[13]			22,241	[11],[14]
Investments at fair value	$ 21,545	[12],[13]			$ 21,524	[11],[14]
Investment, Identifier [Axis]: NeuAG LLC, First Lien Term Loan
Investment, basis spread, variable rate	10.50%	[1],[2],[3],[4],[5],[12],[13]	10.50%	[1],[2],[3],[4],[5],[12],[13]	10.50%	[6],[7],[8],[9],[10],[11],[14]	10.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	15.23%	[12],[13]	15.23%	[12],[13]	14.17%	[11],[14]	14.17%	[11],[14]
Investment owned, balance, principal amount	$ 50,276	[12],[13],[18]			$ 50,459	[11],[14],[19]
Investment owned, at cost	49,271	[12],[13]			49,301	[11],[14]
Investments at fair value	$ 52,292	[12],[13]			$ 51,972	[11],[14]
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class D Notes, Class D Notes
Investment, basis spread, variable rate	6.06%	[1],[2],[3],[4],[5],[12]	6.06%	[1],[2],[3],[4],[5],[12]
Investment interest rate	8.05%	[12],[20]	8.05%	[12],[20]
Investment owned, balance, principal amount | €			€ 2,500	[12],[20]
Investment owned, at cost	$ 2,503	[12],[20]
Investments at fair value	$ 2,576	[12],[20]
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class E Notes, Class E Notes
Investment, basis spread, variable rate	6.87%	[1],[2],[3],[4],[5],[12]	6.87%	[1],[2],[3],[4],[5],[12]
Investment interest rate	8.86%	[12],[20]	8.86%	[12],[20]
Investment owned, balance, principal amount | €			€ 3,000	[12],[20]
Investment owned, at cost	$ 2,677	[12],[20]
Investments at fair value	$ 2,728	[12],[20]
Investment, Identifier [Axis]: OCSI Glick JV LLC, LLC Equity Interest
Investment owned, ownership percentage	87.50%	[1],[2],[3],[4],[5],[13],[16],[20],[22]	87.50%	[1],[2],[3],[4],[5],[13],[16],[20],[22]					87.50%
Investment owned, at cost	$ 54,791	[16],[20],[22],[23]
Investments at fair value	$ 24,108	[16],[20],[22],[23]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Equity Interest
Investment owned, ownership percentage	87.50%	[1],[2],[3],[4],[5],[13],[16],[20],[22]	87.50%	[1],[2],[3],[4],[5],[13],[16],[20],[22]	87.50%	[6],[7],[8],[9],[10],[15],[16],[24]	87.50%	[6],[7],[8],[9],[10],[15],[16],[24]	87.50%
Investment owned, at cost	$ 0	[16],[20],[22]			$ 0	[15],[21],[24]
Investments at fair value	$ 0	[16],[20],[22]			$ 0	[15],[21],[24]
% of Total Net Assets	0%		0%						0%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Investment, basis spread, variable rate	4.50%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	4.50%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	4.50%	[6],[7],[8],[9],[10],[11],[12],[15],[16]	4.50%	[6],[7],[8],[9],[10],[11],[12],[15],[16]	4.50%
Investment interest rate	7.67%	[12],[13],[16],[20]	7.67%	[12],[13],[16],[20]	6.30%	[11],[14],[15],[21]	6.30%	[11],[14],[15],[21]	4.58%
Investment owned, balance, principal amount	$ 59,049	[12],[13],[16],[18],[20]			$ 59,662	[11],[14],[15],[19],[21]
Investment owned, at cost	49,961	[12],[13],[16],[20]			50,194	[11],[14],[15],[21]
Investments at fair value	$ 49,536	[12],[13],[16],[20]			$ 50,283	[11],[14],[15],[21]
% of Total Net Assets	4.10%		4.10%						4.20%
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment, basis spread, variable rate	4%	[1],[2],[3],[4],[5],[12]	4%	[1],[2],[3],[4],[5],[12]	4%	[6],[7],[8],[9],[10],[14]	4%	[6],[7],[8],[9],[10],[14]
Investment interest rate	8.42%	[12]	8.42%	[12]	7.12%	[14]	7.12%	[14]
Investment owned, balance, principal amount	$ 3,315	[12],[18]			$ 3,323	[14],[19]
Investment owned, at cost	3,165	[12]			3,162	[14]
Investments at fair value	$ 3,167	[12]			$ 3,207	[14]
Investment, Identifier [Axis]: OEConnection LLC, Second Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.42%	[12],[13]	11.42%	[12],[13]	10.05%	[11],[14]	10.05%	[11],[14]
Investment owned, balance, principal amount	$ 7,519	[12],[13],[18]			$ 7,519	[11],[14],[19]
Investment owned, at cost	7,396	[12],[13]			7,389	[11],[14]
Investments at fair value	$ 7,221	[12],[13]			$ 7,237	[11],[14]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	2%	[1],[2],[3],[4],[5],[12],[13],[16]	2%	[1],[2],[3],[4],[5],[12],[13],[16]	2%	[6],[7],[8],[9],[10],[11],[14],[21]	2%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment, interest rate, paid in kind	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[6],[7],[8],[9],[10],[11],[14],[21]	8%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(30)	[12],[13],[16]			(31)	[11],[14],[21]
Investments at fair value	$ 0	[12],[13],[16]			$ 0	[11],[14],[21]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Term Loan
Investment, basis spread, variable rate	2%	[1],[2],[3],[4],[5],[12],[13]	2%	[1],[2],[3],[4],[5],[12],[13]	2%	[6],[7],[8],[9],[10],[11],[14]	2%	[6],[7],[8],[9],[10],[11],[14]
Investment, interest rate, paid in kind	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[6],[7],[8],[9],[10],[11],[14]	8%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	6.76%	[12],[13]	6.76%	[12],[13]	5.08%	[11],[14]	5.08%	[11],[14]
Investment owned, balance, principal amount	$ 21,993	[12],[13],[18]			$ 21,557	[11],[14],[19]
Investment owned, at cost	21,728	[12],[13]			21,267	[11],[14]
Investments at fair value	21,993	[12],[13]			$ 21,557	[11],[14]
Investment, Identifier [Axis]: Other accounts, Other cash accounts
Money market funds, at carrying value	$ 15,824
Investment, Identifier [Axis]: P & L Development LLC, Fixed Rate Bond
Investment interest rate	7.75%	[1],[2],[3],[4],[5]	7.75%	[1],[2],[3],[4],[5]	7.75%	[6],[7],[8],[9],[10]	7.75%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount	$ 7,776	[18]			$ 7,776	[19]
Investment owned, at cost	7,817				7,820
Investments at fair value	$ 6,318				$ 5,846
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[1],[2],[3],[4],[5],[12],[13],[16]	7%	[6],[7],[8],[9],[10],[11],[14],[21]	7%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	10.74%	[12],[13],[16]	10.74%	[12],[13],[16]	9.25%	[11],[14],[21]	9.25%	[11],[14],[21]
Investment owned, balance, principal amount	$ 2,228	[12],[13],[16],[18]			$ 2,228	[11],[14],[19],[21]
Investment owned, at cost	2,188	[12],[13],[16]			2,186	[11],[14],[21]
Investments at fair value	$ 2,184	[12],[13],[16]			$ 2,203	[11],[14],[21]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Revolver
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14],[21]	7%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	11.76%	[12],[13]	11.76%	[12],[13]
Investment owned, balance, principal amount	$ 1,252	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	1,232	[12],[13],[16]			(21)	[11],[14],[21]
Investments at fair value	$ 1,230	[12],[13],[16]			$ (13)	[11],[14],[21]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.74%	[12],[13]	10.74%	[12],[13]	9.28%	[11],[14]	9.28%	[11],[14]
Investment owned, balance, principal amount	$ 26,088	[12],[13],[18]			$ 26,154	[11],[14],[19]
Investment owned, at cost	25,674	[12],[13]			25,712	[11],[14]
Investments at fair value	$ 25,632	[12],[13]			$ 25,893	[11],[14]
Investment, Identifier [Axis]: PRGX Global Inc, Class B Common Units
Investment owned, balance (in shares) | shares	80,515	[1],[2],[3],[4],[5],[13]	80,515	[1],[2],[3],[4],[5],[13]	80,515	[6],[7],[8],[9],[10],[11]	80,515	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 79	[12],[13]			$ 79	[11]
Investments at fair value	$ 121	[12],[13]			$ 89	[11]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Revolver
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[6],[7],[8],[9],[10],[11],[14]	6.75%	[6],[7],[8],[9],[10],[11],[14]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(31)	[12],[13],[16]			(34)	[11],[14],[21]
Investments at fair value	$ (49)	[12],[13],[16]			$ (49)	[11],[14],[21]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[6],[7],[8],[9],[10],[11],[14]	6.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.50%	[12],[13]	11.50%	[12],[13]	10.42%	[11],[14]	10.42%	[11],[14]
Investment owned, balance, principal amount	$ 31,186	[12],[13],[18]			$ 33,775	[11],[14],[19]
Investment owned, at cost	30,466	[12],[13]			32,931	[11],[14]
Investments at fair value	$ 30,578	[12],[13]			$ 33,116	[11],[14]
Investment, Identifier [Axis]: Park Place Technologies LLC, First Lien Term Loan
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[12]	5%	[1],[2],[3],[4],[5],[12]	5%	[6],[7],[8],[9],[10],[14]	5%	[6],[7],[8],[9],[10],[14]
Investment interest rate	9.42%	[12]	9.42%	[12]	8.13%	[14]	8.13%	[14]
Investment owned, balance, principal amount	$ 4,838	[12],[18]			$ 9,850	[14],[19]
Investment owned, at cost	4,703	[12]			9,460	[14]
Investments at fair value	$ 4,575	[12]			$ 9,374	[14]
Investment, Identifier [Axis]: Performance Health Holdings Inc, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.73%	[12],[13]	10.73%	[12],[13]	8.88%	[11],[14]	8.88%	[11],[14]
Investment owned, balance, principal amount	$ 17,976	[12],[13],[18]			$ 17,976	[11],[14],[19]
Investment owned, at cost	17,705	[12],[13]			17,690	[11],[14]
Investments at fair value	$ 17,537	[12],[13]			$ 17,537	[11],[14]
Investment, Identifier [Axis]: Planview Parent Inc, Second Lien Term Loan
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12],[13]	7.25%	[1],[2],[3],[4],[5],[12],[13]	7.25%	[6],[7],[8],[9],[10],[11],[14]	7.25%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.98%	[12],[13]	11.98%	[12],[13]	10.92%	[11],[14]	10.92%	[11],[14]
Investment owned, balance, principal amount	$ 28,627	[12],[13],[18]			$ 28,627	[11],[14],[19]
Investment owned, at cost	28,198	[12],[13]			28,198	[11],[14]
Investments at fair value	$ 25,693	[12],[13]			$ 27,482	[11],[14]
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Revolver
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[1],[2],[3],[4],[5],[12],[13],[16]	8%	[6],[7],[8],[9],[10],[11],[14],[21]	8%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	12.36%	[12],[13],[16]	12.36%	[12],[13],[16]
Investment owned, balance, principal amount	$ 1,766	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	1,716	[12],[13],[16]			(53)	[11],[14],[21]
Investments at fair value	$ 1,678	[12],[13],[16]			$ (111)	[11],[14],[21]
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[6],[7],[8],[9],[10],[11],[14]	8%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.83%	[12],[13]	11.83%	[12],[13]	10.68%	[11],[14]	10.68%	[11],[14]
Investment owned, balance, principal amount	$ 48,689	[12],[13],[18]			$ 48,689	[11],[14],[19]
Investment owned, at cost	47,993	[12],[13]			47,951	[11],[14]
Investments at fair value	$ 47,471	[12],[13]			$ 47,155	[11],[14]
Investment, Identifier [Axis]: Profrac Holdings II LLC, First Lien Term Loan
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12],[13]	7.25%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[14]	8.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.10%	[12],[13]	11.10%	[12],[13]	10.01%	[11],[14]	10.01%	[11],[14]
Investment owned, balance, principal amount	$ 22,984	[12],[13],[18]			$ 23,275	[11],[14],[19]
Investment owned, at cost	22,496	[12],[13]			22,722	[11],[14]
Investments at fair value	$ 22,432	[12],[13]			$ 22,810	[11],[14]
Investment, Identifier [Axis]: Project Boost Purchaser LLC, Second Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[6],[7],[8],[9],[10],[11],[14]	8%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.38%	[12],[13]	12.38%	[12],[13]	11.12%	[11],[14]	11.12%	[11],[14]
Investment owned, balance, principal amount	$ 5,250	[12],[13],[18]			$ 5,250	[11],[14],[19]
Investment owned, at cost	5,173	[12],[13]			5,168	[11],[14]
Investments at fair value	$ 4,955	[12],[13]			$ 5,047	[11],[14]
Investment, Identifier [Axis]: Quantum Bidco Limited, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[20]	6%	[1],[2],[3],[4],[5],[12],[13],[20]	6%	[6],[7],[8],[9],[10],[11],[14],[15]	6%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment interest rate	9.63%	[12],[13],[20]	9.63%	[12],[13],[20]	8.39%	[11],[14],[15]	8.39%	[11],[14],[15]
Investment owned, balance, principal amount	$ 3,501	[12],[13],[18],[20]			$ 3,501	[11],[14],[15],[19]
Investment owned, at cost	4,655	[12],[13],[20]			4,646	[11],[14],[15]
Investments at fair value	$ 3,599	[12],[13],[20]			$ 3,367	[11],[14],[15]
Investment, Identifier [Axis]: QuorumLabs Inc, Junior-2 Preferred Stock
Investment owned, balance (in shares) | shares	64,887,669	[1],[2],[3],[4],[5],[13]	64,887,669	[1],[2],[3],[4],[5],[13]	64,887,669	[6],[7],[8],[9],[10],[11]	64,887,669	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 375	[13]			$ 375	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Fixed Rate Bond
Investment interest rate					5.25%	[6],[7],[8],[9],[10]	5.25%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount					$ 1,325	[19]
Investment owned, at cost					1,218
Investments at fair value					$ 1,097
Investment, Identifier [Axis]: Radiology Partners Inc, First Lien Term Loan
Investment, basis spread, variable rate	4.25%	[1],[2],[3],[4],[5],[12]	4.25%	[1],[2],[3],[4],[5],[12]	4.25%	[6],[7],[8],[9],[10],[14]	4.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate	8.64%	[12]	8.64%	[12]	7.33%	[14]	7.33%	[14]
Investment owned, balance, principal amount	$ 3,400	[12],[18]			$ 3,400	[14],[19]
Investment owned, at cost	3,221	[12]			3,202	[14]
Investments at fair value	$ 2,870	[12]			$ 2,880	[14]
Investment, Identifier [Axis]: Radiology Partners Inc, Fixed Rate Bond
Investment interest rate	9.25%	[1],[2],[3],[4],[5]	9.25%	[1],[2],[3],[4],[5]	9.25%	[6],[7],[8],[9],[10]	9.25%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount	$ 4,755	[18]			$ 4,755	[19]
Investment owned, at cost	4,721				4,720
Investments at fair value	$ 2,677				$ 3,109
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Revolver
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[12],[13],[16]	6.50%	[1],[2],[3],[4],[5],[12],[13],[16]	6.50%	[6],[7],[8],[9],[10],[11],[14],[21]	6.50%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(40)	[12],[13],[16]			(43)	[11],[14],[21]
Investments at fair value	$ (47)	[12],[13],[16]			$ (64)	[11],[14],[21]
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[1],[2],[3],[4],[5],[12],[13]
Investment, interest rate, paid in kind					7.50%	[6],[7],[8],[9],[10],[11],[14]	7.50%	[6],[7],[8],[9],[10],[11],[14]
Investment owned, balance, principal amount	$ 25,405	[12],[13],[18]			$ 24,692	[11],[14],[19]
Investment owned, at cost	25,002	[12],[13]			24,265	[11],[14]
Investments at fair value	$ 24,846	[12],[13]			$ 24,101	[11],[14]
Investment, Identifier [Axis]: Renaissance Holding Corp, Second Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12]	7%	[1],[2],[3],[4],[5],[12]	7%	[6],[7],[8],[9],[10],[14]	7%	[6],[7],[8],[9],[10],[14]
Investment interest rate	11.38%	[12]	11.38%	[12]	10.12%	[14]	10.12%	[14]
Investment owned, balance, principal amount	$ 3,542	[12],[18]			$ 3,542	[14],[19]
Investment owned, at cost	3,515	[12]			3,515	[14]
Investments at fair value	$ 3,315	[12]			$ 3,402	[14]
Investment, Identifier [Axis]: RumbleOn Inc, Class B Common Stock Warrants
Investment owned, balance (in shares) | shares	164,660	[1],[2],[3],[4],[5],[13],[20]	164,660	[1],[2],[3],[4],[5],[13],[20]	164,660	[6],[7],[8],[9],[10],[11],[15]	164,660	[6],[7],[8],[9],[10],[11],[15]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 31.50	[1],[2],[3],[4],[5],[13],[20]			$ 33	[6],[7],[8],[9],[10],[11],[15]
Investment owned, at cost	$ 1,202	[13],[20]			$ 1,202	[11],[15]
Investments at fair value	$ 0	[13],[20]			$ 74	[11],[15]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	8.25%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	8.25%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	8.25%	[6],[7],[8],[9],[10],[11],[14],[15],[21]	8.25%	[6],[7],[8],[9],[10],[11],[14],[15],[21]
Investment interest rate	12.98%	[12],[13],[16],[20]	12.98%	[12],[13],[16],[20]	11.92%	[11],[14],[15],[21]	11.92%	[11],[14],[15],[21]
Investment owned, balance, principal amount	$ 10,920	[12],[13],[16],[18],[20]			$ 11,393	[11],[14],[15],[19],[21]
Investment owned, at cost	10,185	[12],[13],[16],[20]			10,583	[11],[14],[15],[21]
Investments at fair value	$ 10,243	[12],[13],[16],[20]			$ 10,760	[11],[14],[15],[21]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Term Loan
Investment, basis spread, variable rate	8.25%	[1],[2],[3],[4],[5],[12],[13],[20]	8.25%	[1],[2],[3],[4],[5],[12],[13],[20]	8.25%	[6],[7],[8],[9],[10],[11],[14],[15]	8.25%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment interest rate	12.98%	[12],[13],[20]	12.98%	[12],[13],[20]	11.92%	[11],[14],[15]	11.92%	[11],[14],[15]
Investment owned, balance, principal amount	$ 36,092	[12],[13],[18],[20]			$ 37,656	[11],[14],[15],[19]
Investment owned, at cost	34,407	[12],[13],[20]			35,775	[11],[14],[15]
Investments at fair value	$ 34,540	[12],[13],[20]			$ 36,187	[11],[14],[15]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Units in Eyesouth Co-Investor FT Aggregator LLC
Investment owned, balance (in shares) | shares	1,037	[1],[2],[3],[4],[5],[13]	1,037	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 1,037
Investments at fair value	$ 1,113
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[12],[13],[16]	8.75%	[1],[2],[3],[4],[5],[12],[13],[16]
Investment owned, balance, principal amount	$ 0	[12],[13],[16]
Investment owned, at cost	(35)	[12],[16]
Investments at fair value	$ (68)	[12],[16]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Term Loan
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[12],[13]	8.75%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	12.52%	[12]	12.52%	[12]
Investment owned, balance, principal amount	$ 8,010	[12],[18]
Investment owned, at cost	7,777	[12]
Investments at fair value	$ 7,778	[12]
Investment, Identifier [Axis]: SM Wellness Holdings Inc, First Lien Term Loan
Investment, basis spread, variable rate	4.75%	[1],[2],[3],[4],[5],[12],[13]	4.75%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	9.42%	[12]	9.42%	[12]
Investment owned, balance, principal amount	$ 3,395	[12],[13]
Investment owned, at cost	2,784	[12],[13]
Investments at fair value	$ 2,767	[12],[13]
Investment, Identifier [Axis]: SM Wellness Holdings Inc, Second Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[6],[7],[8],[9],[10],[11],[14]	8%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.67%	[12],[13]	12.67%	[12],[13]	10.74%	[11],[14]	10.74%	[11],[14]
Investment owned, balance, principal amount	$ 9,109	[12],[13],[18]			$ 9,109	[11],[14],[19]
Investment owned, at cost	8,972	[12],[13]			8,972	[11],[14]
Investments at fair value	$ 6,604	[12],[13]			$ 8,289	[11],[14]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan
Investment, basis spread, variable rate	4.50%	[1],[2],[3],[4],[5],[12]	4.50%	[1],[2],[3],[4],[5],[12]
Investment interest rate	8.92%	[12]	8.92%	[12]
Investment owned, balance, principal amount	$ 1,496	[12],[18]
Investment owned, at cost	1,410	[12]
Investments at fair value	$ 1,401	[12]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan,
Investment, basis spread, variable rate					4.50%	[6],[7],[8],[9],[10],[14]	4.50%	[6],[7],[8],[9],[10],[14]
Investment interest rate					7.63%	[14]	7.63%	[14]
Investment owned, balance, principal amount					$ 1,500	[14],[19]
Investment owned, at cost					1,410	[14]
Investments at fair value					$ 1,393	[14]
Investment, Identifier [Axis]: SVP-Singer Holdings Inc, First Lien Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[6],[7],[8],[9],[10],[11],[14]	6.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.48%	[12],[13]	11.48%	[12],[13]	10.42%	[11],[14]	10.42%	[11],[14]
Investment owned, balance, principal amount	$ 20,714	[12],[13],[18]			$ 20,766	[11],[14],[19]
Investment owned, at cost	19,554	[12],[13]			19,550	[11],[14]
Investments at fair value	$ 17,917	[12],[13]			$ 18,188	[11],[14]
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan, LIBOR+4.50% cash due 12/10/2026
Investment, basis spread, variable rate					4.50%	[6],[7],[8],[9],[10],[14]	4.50%	[6],[7],[8],[9],[10],[14]
Investment interest rate					7.63%	[14]	7.63%	[14]
Investment owned, balance, principal amount					$ 1,691	[14],[19]
Investment owned, at cost					1,610	[14]
Investments at fair value					$ 1,623	[14]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, Common Stock Warrants
Investment owned, balance (in shares) | shares	991,019	[1],[2],[3],[4],[5],[13]	991,019	[1],[2],[3],[4],[5],[13]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 4.83	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 327	[13]
Investments at fair value	$ 307	[13]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Revolver
Investment, basis spread, variable rate	10%	[1],[2],[3],[4],[5],[12],[13],[16]	10%	[1],[2],[3],[4],[5],[12],[13],[16]
Investment interest rate	14.32%	[12],[13],[16]	14.32%	[12],[13],[16]
Investment owned, balance, principal amount	$ 931	[12],[13],[16],[18]
Investment owned, at cost	812	[12],[13],[16]
Investments at fair value	$ 814	[12],[13],[16]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Term Loan
Investment, basis spread, variable rate	10%	[1],[2],[3],[4],[5],[12],[13]	10%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	14.32%	[12]	14.32%	[12]
Investment owned, balance, principal amount	$ 27,848	[12],[18]
Investment owned, at cost	26,787	[12]
Investments at fair value	$ 26,804	[12]
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Common Stock Warrants
Investment owned, balance (in shares) | shares	408,508	[1],[2],[3],[4],[5],[13],[20]	408,508	[1],[2],[3],[4],[5],[13],[20]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 0.01	[1],[2],[3],[4],[5],[13],[20]
Investment owned, at cost	$ 0	[13],[20]
Investments at fair value	$ 4,081	[13],[20]
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Put Options on Common Shares in Alvotech SA
Investment owned, balance (in shares) | shares	293,082	[1],[2],[3],[4],[5],[13],[20]	293,082	[1],[2],[3],[4],[5],[13],[20]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 10	[1],[2],[3],[4],[5],[13],[20]
Investment owned, at cost	$ 0	[13],[20]
Investments at fair value	$ 580	[13],[20]
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Seller Earn Out Shares in Alvotech SA
Investment owned, balance (in shares) | shares	124,780	[1],[2],[3],[4],[5],[13],[20]	124,780	[1],[2],[3],[4],[5],[13],[20]
Investment owned, at cost	$ 485	[13],[20]
Investments at fair value	$ 418	[13],[20]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Equity Interest
% of Total Net Assets	2%		2%						2.90%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, LLC Equity Interest
Investment owned, ownership percentage					87.50%	[6],[7],[8],[9],[10],[12],[15],[16],[25]	87.50%	[6],[7],[8],[9],[10],[12],[15],[16],[25]
Investment owned, at cost					$ 49,322	[15],[21],[24],[25]
Investments at fair value					$ 20,715	[15],[21],[24],[25]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	7%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	7%	[6],[7],[8],[9],[10],[11],[12],[15],[16]	7%	[6],[7],[8],[9],[10],[11],[12],[15],[16]	7%
Investment interest rate	10.17%	[12],[13],[16],[20]	10.17%	[12],[13],[16],[20]	8.80%	[11],[14],[15],[21]	8.80%	[11],[14],[15],[21]	8%
Investment owned, balance, principal amount	$ 112,656	[12],[13],[16],[18],[20]			$ 96,250	[11],[14],[15],[19],[21]
Investment owned, at cost	112,656	[12],[13],[16],[20]			96,250	[11],[14],[15],[21]
Investments at fair value	$ 112,656	[12],[13],[16],[20]			$ 96,250	[11],[14],[15],[21]
% of Total Net Assets	9.40%		9.40%						7.30%
Investment, Identifier [Axis]: ShareThis Inc, Series C Preferred Stock Warrants
Investment owned, balance (in shares) | shares	345,452	[1],[2],[3],[4],[5],[13]	345,452	[1],[2],[3],[4],[5],[13]	345,452	[6],[7],[8],[9],[10],[11]	345,452	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 3.0395	[1],[2],[3],[4],[5],[13]			$ 3.0395	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 367	[13]			$ 367	[11]
Investments at fair value	$ 0	[13]			$ 0	[11]
Investment, Identifier [Axis]: SiO Medical Products Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	415.34	[1],[2],[3],[4],[5],[13]	415.34	[1],[2],[3],[4],[5],[13]	415.34	[6],[7],[8],[9],[10],[11]	415.34	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 4,920.75	[1],[2],[3],[4],[5],[13]			$ 4,920.75	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 681	[13]			$ 681	[11]
Investments at fair value	$ 243	[13]			$ 681	[11]
Investment, Identifier [Axis]: SiO Medical Products Inc, First Lien Term Loan
Investment, interest rate, paid in kind	8.50%	[1],[2],[3],[4],[5],[13]	8.50%	[1],[2],[3],[4],[5],[13]	8.50%	[6],[7],[8],[9],[10],[11]	8.50%	[6],[7],[8],[9],[10],[11]
Investment interest rate	5.50%	[1],[2],[3],[4],[5],[13]	5.50%	[1],[2],[3],[4],[5],[13]	5.50%	[6],[7],[8],[9],[10],[11]	5.50%	[6],[7],[8],[9],[10],[11]
Investment owned, balance, principal amount	$ 47,112	[13],[18]			$ 46,121	[11],[19]
Investment owned, at cost	46,447	[13]			45,413	[11]
Investments at fair value	$ 44,520	[13]			$ 45,295	[11]
Investment, Identifier [Axis]: SonicWall US Holdings Inc, Second Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[1],[2],[3],[4],[5],[12],[13]	7.50%	[6],[7],[8],[9],[10],[11],[14]	7.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.20%	[12],[13]	12.20%	[12],[13]	10.48%	[11],[14]	10.48%	[11],[14]
Investment owned, balance, principal amount	$ 3,195	[12],[13],[18]			$ 3,195	[11],[14],[19]
Investment owned, at cost	3,163	[12],[13]			3,163	[11],[14]
Investments at fair value	$ 2,971	[12],[13]			$ 2,997	[11],[14]
Investment, Identifier [Axis]: Sorrento Therapeutics Inc, Common Stock Units
Investment owned, balance (in shares) | shares	50,000	[1],[2],[3],[4],[5],[20]	50,000	[1],[2],[3],[4],[5],[20]	50,000	[6],[7],[8],[9],[10],[15]	50,000	[6],[7],[8],[9],[10],[15]
Investment owned, at cost	$ 197	[20]			$ 197	[15]
Investments at fair value	$ 44	[20]			$ 79	[15]
Investment, Identifier [Axis]: Spanx LLC, First Lien Revolver
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[12],[13],[16]	5.25%	[1],[2],[3],[4],[5],[12],[13],[16]	5.25%	[6],[7],[8],[9],[10],[11],[14],[21]	5.25%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	9.29%	[12],[13],[16]	9.29%	[12],[13],[16]	8.03%	[11],[14],[21]	8.03%	[11],[14],[21]
Investment owned, balance, principal amount	$ 330	[12],[13],[16],[18]			$ 866	[11],[14],[19],[21]
Investment owned, at cost	280	[12],[13],[16]			813	[11],[14],[21]
Investments at fair value	$ 260	[12],[13],[16]			$ 796	[11],[14],[21]
Investment, Identifier [Axis]: Spanx LLC, First Lien Term Loan
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[12],[13]	5.25%	[1],[2],[3],[4],[5],[12],[13]	5.25%	[6],[7],[8],[9],[10],[11],[14]	5.25%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	9.64%	[12],[13]	9.64%	[12],[13]	8.30%	[11],[14]	8.30%	[11],[14]
Investment owned, balance, principal amount	$ 4,523	[12],[13],[18]			$ 4,534	[11],[14],[19]
Investment owned, at cost	4,447	[12],[13]			4,455	[11],[14]
Investments at fair value	$ 4,415	[12],[13]			$ 4,427	[11],[14]
Investment, Identifier [Axis]: SumUp Holdings Luxembourg SÀRL, First Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13],[20]	8.50%	[1],[2],[3],[4],[5],[12],[13],[20]	8.50%	[6],[7],[8],[9],[10],[11],[14],[15]	8.50%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment interest rate	10.49%	[12],[13],[20]	10.49%	[12],[13],[20]	10%	[11],[14],[15]	10%	[11],[14],[15]
Investment owned, balance, principal amount	$ 16,911	[12],[13],[18],[20]					€ 16,911	[11],[14],[15],[19]
Investment owned, at cost	19,415	[12],[13],[20]			$ 19,414	[11],[14],[15]
Investments at fair value	$ 17,732	[12],[13],[20]			$ 16,360	[11],[14],[15]
Investment, Identifier [Axis]: Sunland Asphalt & Construction LLC, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.15%	[12],[13]	11.15%	[12],[13]	8.88%	[11],[14]	8.88%	[11],[14]
Investment owned, balance, principal amount	$ 42,510	[12],[13],[18]			$ 42,618	[11],[14],[19]
Investment owned, at cost	41,624	[12],[13]			41,654	[11],[14]
Investments at fair value	$ 41,702	[12],[13]			$ 41,723	[11],[14]
Investment, Identifier [Axis]: Superior Industries International Inc, First Lien Term Loan
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[12],[13]	8%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	12.32%	[12]	12.32%	[12]
Investment owned, balance, principal amount	$ 39,774	[12]
Investment owned, at cost	38,591	[12],[13]
Investments at fair value	$ 38,581	[12],[13]
Investment, Identifier [Axis]: Supermoose Borrower LLC, First Lien Term Loan
Investment, basis spread, variable rate	3.75%	[1],[2],[3],[4],[5],[12]	3.75%	[1],[2],[3],[4],[5],[12]	3.75%	[6],[7],[8],[9],[10],[14]	3.75%	[6],[7],[8],[9],[10],[14]
Investment interest rate	8.48%	[12]	8.48%	[12]	7.42%	[14]	7.42%	[14]
Investment owned, balance, principal amount	$ 3,457	[12],[18]			$ 3,466	[14],[19]
Investment owned, at cost	3,162	[12]			3,141	[14]
Investments at fair value	$ 2,994	[12]			$ 3,056	[14]
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Second Lien Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[1],[2],[3],[4],[5],[12],[13]	6.75%	[6],[7],[8],[9],[10],[11],[14]	6.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.14%	[12],[13]	11.14%	[12],[13]	9.81%	[11],[14]	9.81%	[11],[14]
Investment owned, balance, principal amount	$ 12,500	[12],[13],[18]			$ 12,500	[11],[14],[19]
Investment owned, at cost	12,476	[12],[13]			12,474	[11],[14]
Investments at fair value	$ 11,434	[12],[13]			$ 11,469	[11],[14]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Subordinated Debt
Investment interest rate	11.50%	[1],[2],[3],[4],[5],[13],[17],[20]	11.50%	[1],[2],[3],[4],[5],[13],[17],[20]	11.50%	[6],[7],[8],[9],[10],[11],[14],[15]	11.50%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment owned, balance, principal amount	$ 4,984	[13],[17],[18],[20]			$ 4,984	[11],[15],[19],[26]
Investment owned, at cost	4,873	[13],[17],[20]			4,866	[11],[15],[26]
Investments at fair value	$ 4,847	[13],[17],[20]			$ 4,872	[11],[15],[26]
Investment, Identifier [Axis]: TIBCO Software Inc, First Lien Term Loan
Investment, basis spread, variable rate	4.50%	[1],[2],[3],[4],[5],[12]	4.50%	[1],[2],[3],[4],[5],[12]	4.50%	[6],[7],[8],[9],[10],[14]	4.50%	[6],[7],[8],[9],[10],[14]
Investment interest rate	9.18%	[12]	9.18%	[12]	8.15%	[14]	8.15%	[14]
Investment owned, balance, principal amount	$ 12,032	[12],[18]			$ 12,032	[14],[19]
Investment owned, at cost	10,986	[12]			10,949	[14]
Investments at fair value	$ 10,775	[12]			$ 10,827	[14]
Investment, Identifier [Axis]: Tacala LLC, Second Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[12]	7.50%	[1],[2],[3],[4],[5],[12]	7.50%	[6],[7],[8],[9],[10],[14]	7.50%	[6],[7],[8],[9],[10],[14]
Investment interest rate	11.88%	[12]	11.88%	[12]	10.62%	[14]	10.62%	[14]
Investment owned, balance, principal amount	$ 9,448	[12],[18]			$ 9,448	[14],[19]
Investment owned, at cost	9,343	[12]			9,338	[14]
Investments at fair value	$ 8,610	[12]			$ 8,692	[14]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Revolver
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	6%	[1],[2],[3],[4],[5],[12],[13],[16],[20]	6%	[6],[7],[8],[9],[10],[11],[14],[15],[21]	6%	[6],[7],[8],[9],[10],[11],[14],[15],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18],[20]			$ 0	[11],[14],[15],[19],[21]
Investment owned, at cost	(28)	[12],[13],[16],[20]			(29)	[11],[14],[15],[21]
Investments at fair value	$ (26)	[12],[13],[16],[20]			$ (28)	[11],[14],[15],[21]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13],[20]	6%	[1],[2],[3],[4],[5],[12],[13],[20]	6%	[6],[7],[8],[9],[10],[11],[14],[15]	6%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment interest rate	10.29%	[12],[13],[20]	10.29%	[12],[13],[20]	8.68%	[11],[14],[15]	8.68%	[11],[14],[15]
Investment owned, balance, principal amount	$ 23,215	[12],[13],[18],[20]			$ 23,215	[11],[14],[15],[19]
Investment owned, at cost	22,833	[12],[13],[20]			22,815	[11],[14],[15]
Investments at fair value	$ 22,866	[12],[13],[20]			$ 22,843	[11],[14],[15]
Investment, Identifier [Axis]: Tecta America Corp, Second Lien Term Loan
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[1],[2],[3],[4],[5],[12],[13]	8.50%	[6],[7],[8],[9],[10],[11],[14]	8.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.94%	[12],[13]	12.94%	[12],[13]	11.62%	[11],[14]	11.62%	[11],[14]
Investment owned, balance, principal amount	$ 5,203	[12],[13],[18]			$ 5,203	[11],[14],[19]
Investment owned, at cost	5,125	[12],[13]			5,125	[11],[14]
Investments at fair value	$ 4,982	[12],[13]			$ 5,034	[11],[14]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Revolver
Investment, basis spread, variable rate	9.75%	[1],[2],[3],[4],[5],[12],[13],[16]	9.75%	[1],[2],[3],[4],[5],[12],[13],[16]	9.25%	[6],[7],[8],[9],[10],[11],[14],[21]	9.25%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment interest rate	13.67%	[12],[13],[16]	13.67%	[12],[13],[16]	12.20%	[11],[14]	12.20%	[11],[14]
Investment owned, balance, principal amount	$ 1,231	[12],[13],[16],[18]			$ 1,231	[11],[14],[19]
Investment owned, at cost	1,212	[12],[13],[16]			1,210	[11],[14]
Investments at fair value	$ 1,182	[12],[13],[16]			$ 1,187	[11],[14]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Term Loan
Investment, basis spread, variable rate	9.75%	[1],[2],[3],[4],[5],[12],[13]	9.75%	[1],[2],[3],[4],[5],[12],[13]	9.25%	[6],[7],[8],[9],[10],[11],[14]	9.25%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	13.67%	[12],[13]	13.67%	[12],[13]	12.11%	[11],[14]	12.11%	[11],[14]
Investment owned, balance, principal amount	$ 18,276	[12],[13],[18]			$ 18,323	[11],[14],[19]
Investment owned, at cost	17,941	[12],[13]			17,956	[11],[14]
Investments at fair value	$ 17,765	[12],[13]			$ 17,865	[11],[14]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Common Units of TerSera Holdings LLC
Investment owned, balance (in shares) | shares	668,879	[1],[2],[3],[4],[5],[13]	668,879	[1],[2],[3],[4],[5],[13]	668,879	[6],[7],[8],[9],[10],[11]	668,879	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 2,028	[13]			$ 2,028	[11]
Investments at fair value	$ 4,662	[13]			$ 4,077	[11]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Second Lien Term Loan
Investment, basis spread, variable rate	9.50%	[1],[2],[3],[4],[5],[12],[13]	9.50%	[1],[2],[3],[4],[5],[12],[13]	9.50%	[6],[7],[8],[9],[10],[11],[14]	9.50%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	13.88%	[12],[13]	13.88%	[12],[13]	13.17%	[11],[14]	13.17%	[11],[14]
Investment owned, balance, principal amount	$ 29,663	[12],[13],[18]			$ 29,663	[11],[14],[19]
Investment owned, at cost	29,375	[12],[13]			29,352	[11],[14]
Investments at fair value	$ 29,057	[12],[13]			$ 29,031	[11],[14]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner
Investment, basis spread, variable rate					7.30%	[6],[7],[8],[9],[10],[11],[12]	7.30%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate					10.44%	[11],[14]	10.44%	[11],[14]
Investment owned, balance, principal amount					$ 15,674	[11],[14],[19]
Investment owned, at cost					15,605	[11],[14]
Investments at fair value					$ 15,682	[11],[14]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner, LLC
Investment, basis spread, variable rate	7.30%	[1],[2],[3],[4],[5],[12],[13]	7.30%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	11.69%	[12],[13]	11.69%	[12],[13]
Investment owned, balance, principal amount	$ 15,301	[12],[13],[18]
Investment owned, at cost	15,279	[12],[13]
Investments at fair value	$ 15,391	[12],[13]
Investment, Identifier [Axis]: The Avery, Subordinated Debt in T8 Senior Mezz LLC
Investment, basis spread, variable rate	12.50%	[1],[2],[3],[4],[5],[12],[13]	12.50%	[1],[2],[3],[4],[5],[12],[13]	12.50%	[6],[7],[8],[9],[10],[11],[12]	12.50%	[6],[7],[8],[9],[10],[11],[12]
Investment interest rate	17.24%	[12],[13]	17.24%	[12],[13]	16.17%	[11],[14]	16.17%	[11],[14]
Investment owned, balance, principal amount	$ 3,706	[12],[13],[18]			$ 3,789	[11],[14],[19]
Investment owned, at cost	3,701	[12],[13]			3,774	[11],[14]
Investments at fair value	$ 3,733	[12],[13]			$ 3,800	[11],[14]
Investment, Identifier [Axis]: Thrasio LLC, First Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	11.17%	[12],[13]	11.17%	[12],[13]	11.17%	[11],[14]	11.17%	[11],[14]
Investment owned, balance, principal amount	$ 37,399	[12],[13],[18]			$ 37,494	[11],[14],[19]
Investment owned, at cost	36,532	[12],[13]			36,569	[11],[14]
Investments at fair value	$ 34,126	[12],[13]			$ 35,807	[11],[14]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.
Investment owned, balance (in shares) | shares	284,650.32	[1],[2],[3],[4],[5],[13]	284,650.32	[1],[2],[3],[4],[5],[13]	284,650.32	[6],[7],[8],[9],[10],[11]	284,650.32	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 2,409	[13]			$ 2,409	[11]
Investments at fair value	$ 1,882	[13]			$ 2,320	[11]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.
Investment owned, balance (in shares) | shares	8,434	[1],[2],[3],[4],[5],[13]	8,434	[1],[2],[3],[4],[5],[13]	8,434	[6],[7],[8],[9],[10],[11]	8,434	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 101	[13]			$ 101	[11]
Investments at fair value	$ 71	[13]			$ 69	[11]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series D Preferred Stock in Thrasio Holdings, Inc.
Investment owned, balance (in shares) | shares	48,352	[1],[2],[3],[4],[5],[13]	48,352	[1],[2],[3],[4],[5],[13]	48,352	[6],[7],[8],[9],[10],[11]	48,352	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 979	[13]			$ 979	[11]
Investments at fair value	$ 852	[13]			$ 979	[11]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series X Preferred Stock in Thrasio Holdings, Inc.
Investment owned, balance (in shares) | shares	25,780	[1],[2],[3],[4],[5],[13]	25,780	[1],[2],[3],[4],[5],[13]	23,201	[6],[7],[8],[9],[10],[11],[21]	23,201	[6],[7],[8],[9],[10],[11],[21]
Investment owned, at cost	$ 25,564	[13],[16]			$ 22,986	[11],[21]
Investments at fair value	$ 29,070	[13],[16]			$ 26,487	[11],[21]
Investment, Identifier [Axis]: Touchstone Acquisition Inc, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12]	6%	[1],[2],[3],[4],[5],[12]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.38%	[12],[13]	10.38%	[12],[13]	9.12%	[11],[14]	9.12%	[11],[14]
Investment owned, balance, principal amount	$ 6,001	[12],[13],[18]			$ 6,016	[11],[14],[19]
Investment owned, at cost	5,897	[12],[13]			5,908	[11],[14]
Investments at fair value	$ 5,866	[12],[13]			$ 5,895	[11],[14]
Investment, Identifier [Axis]: Tranche A Warrant Shares, Tranche A Warrant Shares
Investment owned, balance (in shares) | shares	56,999	[1],[2],[3],[4],[5],[13],[20]	56,999	[1],[2],[3],[4],[5],[13],[20]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 4.23	[1],[2],[3],[4],[5],[13],[20]
Investment owned, at cost	$ 135	[13],[20]
Investments at fair value	$ 662	[13],[20]
Investment, Identifier [Axis]: Trinitas CLO XV, Class E Notes, Class E Notes
Investment, basis spread, variable rate	7.45%	[1],[2],[3],[4],[5],[12],[20]	7.45%	[1],[2],[3],[4],[5],[12],[20]
Investment interest rate	11.77%	[12],[20]	11.77%	[12],[20]
Investment owned, balance, principal amount	$ 1,000	[12],[20]
Investment owned, at cost	810	[12],[20]
Investments at fair value	$ 846	[12],[20]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 1
Investment interest rate	6.50%	[1],[2],[3],[4],[5],[20]	6.50%	[1],[2],[3],[4],[5],[20]	6.50%	[6],[7],[8],[9],[10],[15]	6.50%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount	$ 4,500	[18],[20]			$ 4,500	[15],[19]
Investment owned, at cost	4,074	[20]			4,060	[15]
Investments at fair value	$ 2,990	[20]			$ 3,026	[15]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 2
Investment interest rate	4.75%	[1],[2],[3],[4],[5],[20]	4.75%	[1],[2],[3],[4],[5],[20]	4.75%	[6],[7],[8],[9],[10],[15]	4.75%	[6],[7],[8],[9],[10],[15]
Investment owned, balance, principal amount	$ 300	[18],[20]			$ 300	[15],[19]
Investment owned, at cost	260	[20]			258	[15]
Investments at fair value	$ 240	[20]			$ 238	[15]
Investment, Identifier [Axis]: WP CPP Holdings LLC, First Lien Term Loan
Investment, basis spread, variable rate	3.75%	[1],[2],[3],[4],[5],[12],[13]	3.75%	[1],[2],[3],[4],[5],[12],[13]	3.75%	[6],[7],[8],[9],[10],[14]	3.75%	[6],[7],[8],[9],[10],[14]
Investment interest rate	8.17%	[12]	8.17%	[12]	6.56%	[14]	6.56%	[14]
Investment owned, balance, principal amount	$ 7,545	[12],[18]			$ 7,564	[14],[19]
Investment owned, at cost	7,029	[12]			6,989	[14]
Investments at fair value	$ 6,598	[12]			$ 6,795	[14]
Investment, Identifier [Axis]: WP CPP Holdings LLC, Second Lien Term Loan
Investment, basis spread, variable rate	7.75%	[1],[2],[3],[4],[5],[12],[13]	7.75%	[1],[2],[3],[4],[5],[12],[13]	7.75%	[6],[7],[8],[9],[10],[11],[14]	7.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.17%	[12],[13]	12.17%	[12],[13]	10.56%	[11],[14]	10.56%	[11],[14]
Investment owned, balance, principal amount	$ 6,000	[12],[13],[18]			$ 6,000	[11],[14],[19]
Investment owned, at cost	5,866	[12],[13]			5,855	[11],[14]
Investments at fair value	$ 5,055	[12],[13]			$ 5,070	[11],[14]
Investment, Identifier [Axis]: WPEngine Inc, First Lien Term Loan
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[1],[2],[3],[4],[5],[12],[13]	6%	[6],[7],[8],[9],[10],[11],[14]	6%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	10.19%	[12],[13]	10.19%	[12],[13]	10.19%	[11],[14]	10.19%	[11],[14]
Investment owned, balance, principal amount	$ 40,536	[12],[13],[18]			$ 40,536	[11],[14],[19]
Investment owned, at cost	39,991	[12],[13]			39,947	[11],[14]
Investments at fair value	$ 40,131	[12],[13]			$ 40,131	[11],[14]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC
Investment, basis spread, variable rate					7%	[6],[7],[8],[9],[10],[11],[14]	7%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate					10.67%	[11],[14]	10.67%	[11],[14]
Investment owned, balance, principal amount					$ 5,000	[11],[14],[19]
Investment owned, at cost					4,925	[11],[14]
Investments at fair value					$ 4,538	[11],[14]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC, Second Lien Term Loan
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[12],[13]	7%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	11.73%	[12],[13]	11.73%	[12],[13]
Investment owned, balance, principal amount	$ 5,000	[12],[13],[18]
Investment owned, at cost	4,925	[12],[13]
Investments at fair value	$ 4,191	[12],[13]
Investment, Identifier [Axis]: Win Brands Group LLC, Class F Warrants in Brand Value Growth LLC
Investment owned, balance (in shares) | shares	3,621	[1],[2],[3],[4],[5],[13]	3,621	[1],[2],[3],[4],[5],[13]	3,621	[6],[7],[8],[9],[10],[11]	3,621	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 0.01	[1],[2],[3],[4],[5],[13]			$ 0.01	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 0	[13]			$ 0	[11]
Investments at fair value	$ 128	[13]			$ 192	[11]
Investment, Identifier [Axis]: Win Brands Group LLC, First Lien Term Loan
Investment, basis spread, variable rate	15%	[1],[2],[3],[4],[5],[12],[13]	15%	[1],[2],[3],[4],[5],[12],[13]	15%	[6],[7],[8],[9],[10],[11],[14]	15%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	20.75%	[12],[13]	20.75%	[12],[13]	19.64%	[11],[14]	19.64%	[11],[14]
Investment owned, balance, principal amount	$ 2,238	[12],[13],[18]			$ 2,316	[11],[14],[19]
Investment owned, at cost	2,217	[12],[13]			2,293	[11],[14]
Investments at fair value	$ 2,137	[12],[13]			$ 2,264	[11],[14]
Investment, Identifier [Axis]: Windstream Services II LLC, First Lien Term Loan
Investment, basis spread, variable rate	6.25%	[1],[2],[3],[4],[5],[12]	6.25%	[1],[2],[3],[4],[5],[12]	6.25%	[6],[7],[8],[9],[10],[14]	6.25%	[6],[7],[8],[9],[10],[14]
Investment interest rate	10.67%	[12]	10.67%	[12]	9.37%	[14]	9.37%	[14]
Investment owned, balance, principal amount	$ 25,432	[12],[18]			$ 25,499	[14],[19]
Investment owned, at cost	24,612	[12]			24,632	[14]
Investments at fair value	$ 23,131	[12]			$ 23,204	[14]
Investment, Identifier [Axis]: Windstream Services II LLC, Shares of Common Stock in Windstream Holdings II, LLC
Investment owned, balance (in shares) | shares	18,032	[1],[2],[3],[4],[5],[13]	18,032	[1],[2],[3],[4],[5],[13]	18,032	[6],[7],[8],[9],[10],[11]	18,032	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 216	[13]			$ 216	[11]
Investments at fair value	$ 279	[13]			$ 296	[11]
Investment, Identifier [Axis]: Windstream Services II LLC, Warrants in Windstream Holdings II, LLC
Investment owned, balance (in shares) | shares	109,420	[1],[2],[3],[4],[5],[13]	109,420	[1],[2],[3],[4],[5],[13]	109,420	[6],[7],[8],[9],[10],[11]	109,420	[6],[7],[8],[9],[10],[11]
Investment owned, at cost	$ 1,842	[13]			$ 1,842	[11]
Investments at fair value	$ 1,695	[13]			$ 1,799	[11]
Investment, Identifier [Axis]: Zayo Group Holdings Inc, Fixed Rate Bond
Investment interest rate	4%	[1],[2],[3],[4],[5]	4%	[1],[2],[3],[4],[5]	4%	[6],[7],[8],[9],[10]	4%	[6],[7],[8],[9],[10]
Investment owned, balance, principal amount	$ 250	[18]			$ 250	[19]
Investment owned, at cost	214				212
Investments at fair value	$ 185				$ 201
Investment, Identifier [Axis]: Zep Inc, Second Lien Term Loan
Investment, basis spread, variable rate	8.25%	[1],[2],[3],[4],[5],[13],[14]	8.25%	[1],[2],[3],[4],[5],[13],[14]	8.25%	[6],[7],[8],[9],[10],[11],[14]	8.25%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate	12.98%	[12],[13]	12.98%	[12],[13]	11.92%	[11],[14]	11.92%	[11],[14]
Investment owned, balance, principal amount	$ 19,578	[12],[13],[14],[18]			$ 19,578	[11],[14],[19]
Investment owned, at cost	19,545	[12],[13],[14]			19,542	[11],[14]
Investments at fair value	$ 13,704	[12],[13],[14]			$ 16,152	[11],[14]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Second Lien Term Loan
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[13],[14],[20]	7.50%	[1],[2],[3],[4],[5],[13],[14],[20]	7.50%	[6],[7],[8],[9],[10],[11],[14],[15]	7.50%	[6],[7],[8],[9],[10],[11],[14],[15]
Investment interest rate	10.96%	[12],[13],[20]	10.96%	[12],[13],[20]	9.72%	[11],[14],[15]	9.72%	[11],[14],[15]
Investment owned, balance, principal amount	$ 18,000	[12],[13],[14],[18],[20]			$ 18,000	[11],[14],[15],[19]
Investment owned, at cost	23,839	[12],[13],[14],[20]			23,804	[11],[14],[15]
Investments at fair value	$ 16,369	[12],[13],[14],[20]			$ 16,552	[11],[14],[15]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc.,
Investment owned, balance (in shares) | shares					18,635	[6],[7],[8],[9],[10],[11]	18,635	[6],[7],[8],[9],[10],[11]
Investment interest rate					10.75%	[6],[7],[8],[9],[10],[11]	10.75%	[6],[7],[8],[9],[10],[11]
Investment owned, at cost					$ 18,264	[11]
Investments at fair value					$ 16,575	[11]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%
Investment owned, balance (in shares) | shares	18,635	[1],[2],[3],[4],[5],[13]	18,635	[1],[2],[3],[4],[5],[13]
Investment interest rate	10.75%	[1],[2],[3],[4],[5],[13]	10.75%	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 18,264	[13]
Investments at fair value	$ 15,606	[13]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[6],[7],[8],[9],[10],[11],[14],[21]	6.75%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	0	[12],[13],[16]			0	[11],[14],[21]
Investments at fair value	$ 0	[12],[13],[16]			$ 0	[11],[14],[21]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Revolver
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[1],[2],[3],[4],[5],[12],[13],[16]	6.75%	[6],[7],[8],[9],[10],[11],[14],[21]	6.75%	[6],[7],[8],[9],[10],[11],[14],[21]
Investment owned, balance, principal amount	$ 0	[12],[13],[16],[18]			$ 0	[11],[14],[19],[21]
Investment owned, at cost	(30)	[12],[13],[16]			(31)	[11],[14],[21]
Investments at fair value	$ (75)	[12],[13],[16]			$ (32)	[11],[14],[21]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan
Investment, basis spread, variable rate					6.75%	[6],[7],[8],[9],[10],[11],[14]	6.75%	[6],[7],[8],[9],[10],[11],[14]
Investment interest rate					9.49%	[11],[14]	9.49%	[11],[14]
Investment owned, balance, principal amount					$ 19,203	[11],[14],[19]
Investment owned, at cost					18,874	[11],[14]
Investments at fair value					$ 18,867	[11],[14]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 1
Investment, basis spread, variable rate	3.375%	[1],[2],[3],[4],[5],[12],[13]	3.375%	[1],[2],[3],[4],[5],[12],[13]
Investment, interest rate, paid in kind	3.875%	[1],[2],[3],[4],[5],[12],[13]	3.875%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	7.14%	[12],[13]	7.14%	[12],[13]
Investment owned, balance, principal amount	$ 19,203	[12],[13],[18]
Investment owned, at cost	18,888	[12],[13]
Investments at fair value	$ 18,420	[12],[13]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 2
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[12],[13]	7.25%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	11.52%	[12],[13]	11.52%	[12],[13]
Investment owned, balance, principal amount	$ 2,944	[12],[13]
Investment owned, at cost	2,895	[12],[13]
Investments at fair value	$ 2,885	[12],[13]
Investment, Identifier [Axis]: scPharmaceuticals Inc, Common Stock Warrants
Investment owned, balance (in shares) | shares	53,700	[1],[2],[3],[4],[5],[13]	53,700	[1],[2],[3],[4],[5],[13]
Investment owned, exercise price (in dollars per share) | $ / shares	$ 5.40	[1],[2],[3],[4],[5],[13]
Investment owned, at cost	$ 175	[13]
Investments at fair value	$ 262	[13]
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Delayed Draw Term Loan
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[12],[13],[16]	8.75%	[1],[2],[3],[4],[5],[12],[13],[16]
Investment owned, balance, principal amount	$ 0	[12],[13],[16]
Investment owned, at cost	0	[12],[13],[16]
Investments at fair value	$ 0	[12],[13],[16]
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Term Loan
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[12],[13]	8.75%	[1],[2],[3],[4],[5],[12],[13]
Investment interest rate	11.75%	[12],[13]	11.75%	[12],[13]
Investment owned, balance, principal amount	$ 5,212	[12],[13],[18]
Investment owned, at cost	4,945	[12],[13]
Investments at fair value	$ 4,957	[12],[13]
[1]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[2]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[3]Equity ownership may be held in shares or units of companies related to the portfolio companies.[4]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[5]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[6]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[7]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[8]Equity ownership may be held in shares or units of companies related to the portfolio companies.[9]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[10]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[11]As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.[12]The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the London Interbank Offered Rate ("LIBOR") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to the secured overnight financing rate ("SOFR") or the sterling overnight index average ("SONIA"). The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of December 31, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 4.38%, the 90-day LIBOR at 4.73%, the 180-day LIBOR at 5.15%, the PRIME at 7.50%, the 30-day SOFR at 4.32%, the 90-day SOFR at 4.58%, the 180-day SOFR at 4.79%, the SONIA at 3.43%, the 30-day EURIBOR at 1.90%, the 90-day EURIBOR at 1.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.[13] As of December 31, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments - Derivatives - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Schedule of Investments [Line Items]
Derivative liability at fair value	$ (44,139)	$ (41,969)
Foreign currency forward contracts
Schedule of Investments [Line Items]
Gross Amount of Recognized Liabilities	(4,211)	6,789
Interest rate swap
Schedule of Investments [Line Items]
Gross Amount of Recognized Liabilities	$ 39,928	$ 41,969
Interest rate	2.70%	2.70%
Floating interest rate	1.658%	1.658%
Notional amount	$ 350,000	$ 350,000
Derivative liability at fair value	(39,928)	(41,969)
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 9, 2023 | Foreign currency forward contracts
Schedule of Investments [Line Items]
Notional Amount to be Purchased	46,412
Notional Amount to be Sold	39,965
Gross Amount of Recognized Liabilities	(1,712)
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022 | Foreign currency forward contracts
Schedule of Investments [Line Items]
Notional Amount to be Purchased		45,692
Notional Amount to be Sold		37,033
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 19, 2022, 2 | Foreign currency forward contracts
Schedule of Investments [Line Items]
Notional Amount to be Purchased		45,692
Notional Amount to be Sold		37,033
Gross Amount of Recognized Liabilities		4,323
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 9, 2023 | Foreign currency forward contracts
Schedule of Investments [Line Items]
Notional Amount to be Purchased	44,825
Notional Amount to be Sold	44,224
Gross Amount of Recognized Liabilities	$ (2,499)
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022 | Foreign currency forward contracts
Schedule of Investments [Line Items]
Notional Amount to be Purchased		43,179
Notional Amount to be Sold		41,444
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022, 1 | Foreign currency forward contracts
Schedule of Investments [Line Items]
Notional Amount to be Purchased		43,179
Notional Amount to be Sold		41,444
Gross Amount of Recognized Liabilities		$ 2,466

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022
Schedule of Investments [Line Items]
Percentage of total assets representing qualifying assets	73.80%	75.70%
Percentage of total assets representing non-qualifying assets	26.20%	24.30%
Share-Based Payment Arrangement, Tranche One
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)	$ 15	$ 15
Investment owned, balance, shares, VWAP number of trading days	10 days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days	20 days
Share-Based Payment Arrangement, Tranche Two
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)	$ 20	$ 20
Investment owned, balance, shares, VWAP number of trading days	10 days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days	20 days

Organization

Organization	3 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams. On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”). On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Company as the surviving company (the “OSI2 Merger”). See Note 14.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 and all prior periods reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Use of Estimates: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value. Fair Value Measurements: The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2022 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable" and "payables from unsettled transactions" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of December 31, 2022 and September 30, 2022, there were no investments on non-accrual status. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. The Company has also structured exit fees across certain of its portfolio investments to be received upon the future exit of those investments. These fees are typically paid to the Company upon the earliest to occur of (i) a sale of the borrower or substantially all of the assets of the borrower, (ii) the maturity date of the loan or (iii) the date when full prepayment of the loan occurs. The receipt of such fees is contingent upon the occurrence of one of the events listed above for each of the investments. These fees are included in net investment income over the life of the loan. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of December 31, 2022 and September 30, 2022, included in restricted cash was $1.9 million and $2.8 million, respectively, that was held at Wells Fargo Bank, N.A. in connection with the Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the Citibank Facility, the Company was restricted in terms of access to $1.9 million and $2.8 million as of December 31, 2022 and September 30, 2022, respectively, until t he occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility. Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date). Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2019, 2020 and 2021. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months. Recently Adopted Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting if certain criteria are met. The guidance is effective from March 12, 2020 through December 31, 2022. As of December 31, 2022, the adoption of this guidance did not have an impact on the Company's Consolidated Financial Statements.

Portfolio Investments

Portfolio Investments	3 Months Ended
	Dec. 31, 2022
Schedule of Investments [Abstract]
Portfolio Investments	Portfolio Investments As of December 31, 2022, 219.9% of net assets at fair value, or $2.6 billion, was invested in 156 portfolio companies, including (i) $136.8 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $49.5 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of December 31, 2022, 1.6% of net assets at fair value, or $19.2 million, was invested in cash and cash equivalents (including $1.9 million of restricted cash). In comparison, as of September 30, 2022, 200.2% of net assets at fair value, or $2.5 billion, was invested in 149 portfolio investments, including (i) $117.0 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.3 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2022, 2.1% of net assets at fair value, or $26.4 million, was invested in cash and cash equivalents (including $2.8 million of restricted cash). As of December 31, 2022, 86.3% of the Company's portfolio at fair value consisted of senior secured debt investments and 8.5% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2022, 86.9% of the Company's portfolio at fair value consisted of senior secured debt investments and 8.1% consisted of subordinated debt investments, including the debt investments in the JVs. The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants, limited partnership interests or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain. During the three months ended December 31, 2022 and 2021, the Company recorded net realized gains (losses) of $(3.2) million and $9.3 million, respectively. During the three months ended December 31, 2022 and 2021, the Company recorded net unrealized depreciation of $23.0 million and $4.6 million, respectively. The composition of the Company's investments as of December 31, 2022 and September 30, 2022 at cost and fair value was as follows: December 31, 2022 September 30, 2022 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,428,251 $ 2,343,380 $ 2,294,392 $ 2,223,329 Investments in equity securities 132,355 113,190 127,596 103,534 Debt investments in the JVs 162,617 162,192 146,444 146,533 Equity investments in the JVs 54,791 24,108 49,322 20,715 Total $ 2,778,014 $ 2,642,870 $ 2,617,754 $ 2,494,111 The following table presents the composition of the Company's debt investments as of December 31, 2022 and September 30, 2022 at fixed rates and floating rates: December 31, 2022 September 30, 2022 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,188,193 87.33 % $ 2,049,644 86.49 % Fixed rate debt securities 317,379 12.67 320,218 13.51 Total $ 2,505,572 100.00 % $ 2,369,862 100.00 % The following table presents the financial instruments carried at fair value as of December 31, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 233,393 $ 2,047,842 $ — $ 2,281,235 Investments in debt securities (subordinated, including the debt investments in the JVs) — 44,706 179,631 — 224,337 Investments in equity securities (preferred) — — 80,625 — 80,625 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 5,923 — 26,642 24,108 56,673 Total investments at fair value 5,923 278,099 2,334,740 24,108 2,642,870 Cash equivalents 3,421 — — — 3,421 Total assets at fair value $ 9,344 $ 278,099 $ 2,334,740 $ 24,108 $ 2,646,291 Derivative liability $ — $ 44,139 $ — $ — $ 44,139 Total liabilities at fair value $ — $ 44,139 $ — $ — $ 44,139 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 255,803 $ 1,910,606 $ — $ 2,166,409 Investments in debt securities (subordinated, including the debt investments in the JVs) — 44,065 159,388 — 203,453 Investments in equity securities (preferred) — — 79,523 — 79,523 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,053 — 19,958 20,715 44,726 Total investments at fair value 4,053 299,868 2,169,475 20,715 2,494,111 Cash equivalents 5,261 — — — 5,261 Derivative assets — 6,789 — — 6,789 Total assets at fair value $ 9,314 $ 306,657 $ 2,169,475 $ 20,715 $ 2,506,161 Derivative liability $ — $ 41,969 $ — $ — $ 41,969 Total liabilities at fair value $ — $ 41,969 $ — $ — $ 41,969 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period. The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases 177,599 21,104 2,579 2,181 203,463 Sales and repayments (55,885) (699) — (48) (56,632) Transfers in (a) 19,075 — — — 19,075 Capitalized PIK interest income 5,763 6 — — 5,769 Accretion of OID 4,114 398 — — 4,512 Net unrealized appreciation (depreciation) (12,271) (566) (1,477) 4,505 (9,809) Net realized gains (losses) (1,159) — — 46 (1,113) Fair value as of December 31, 2022 $ 2,047,842 $ 179,631 $ 80,625 $ 26,642 $ 2,334,740 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022 $ (12,398) $ (566) $ (1,477) $ 4,505 $ (9,936) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward in the changes in fair value from September 30, 2021 to December 31, 2021 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2021 $ 1,878,536 $ 176,317 $ 63,565 $ 43,163 $ 2,161,581 Purchases 191,087 3,589 979 1,441 197,096 Sales and repayments (131,946) (20,185) — (6,503) (158,634) Transfers in (a) 3,178 — — — 3,178 Transfers out (a) (17,070) — — — (17,070) Capitalized PIK interest income 6,172 313 — — 6,485 Accretion of OID 5,378 819 — — 6,197 Net unrealized appreciation (depreciation) (9,877) 516 1,006 6,636 (1,719) Net realized gains (losses) 8,638 — — (2,795) 5,843 Fair value as of December 31, 2021 $ 1,934,096 $ 161,369 $ 65,550 $ 41,942 $ 2,202,957 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2021 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2021 $ (717) $ 368 $ 1,006 $ 1,139 $ 1,796 __________ (a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the three months ended December 31, 2021 as a result of a change in the number of market quotes available and/or a change in market liquidity. Significant Unobservable Inputs for Level 3 Investments The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2022: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,692,264 Market Yield Market Yield (b) 9.0% - 33.0% 14.0% 14,297 Enterprise Value EBITDA Multiple (c) 5.0x - 7.0x 6.0x 38,581 Transaction Precedent Transaction Price (d) N/A - N/A N/A 302,700 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 13,706 Market Yield Market Yield (b) 10.0% - 20.0% 11.4% 3,733 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,192 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 30,226 Enterprise Value Revenue Multiple (c) 0.1x - 4.3x 0.5x 73,822 Enterprise Value EBITDA Multiple (c) 3.0x - 20.0x 14.6x 1,600 Enterprise Value Asset Multiple (c) 0.9x - 1.1x 1.0x 1,619 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,334,740 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,599,148 Market Yield Market Yield (b) 9.0% - 30.0% 13.7% 14,333 Enterprise Value EBITDA Multiple (c) 5.0x - 7.0x 6.0x 297,125 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 12,855 Market Yield Market Yield (b) 10.0% - 19.0% 13.8% Debt Investments in the JVs 146,533 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 61,693 Enterprise Value Revenue Multiple (c) 0.4x - 10.1x 4.3x 36,913 Enterprise Value EBITDA Multiple (c) 3.0x - 20.0x 11.4x 3 Enterprise Value Asset Multiple (c) 0.9x - 1.1x 1.0x 872 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,169,475 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively. Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. Financial Instruments Disclosed, But Not Carried, At Fair Value The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2022 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 695,000 $ 695,000 $ — $ — $ 695,000 Citibank Facility payable 165,000 165,000 — — 165,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 297,303 286,734 — 286,734 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 306,321 296,835 — 296,835 — Total $ 1,463,624 $ 1,443,569 $ — $ 583,569 $ 860,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 540,000 $ 540,000 $ — $ — $ 540,000 Citibank Facility payable 160,000 160,000 — — 160,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 296,991 283,077 — 283,077 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 304,052 294,028 — 294,028 — Total $ 1,301,043 $ 1,277,105 $ — $ 577,105 $ 700,000 The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes") and 2.700% notes due 2027 (the "2027 Notes"), which are included in Level 2 of the hierarchy. Portfolio Composition Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,359,295 84.94 % $ 2,227,245 85.08 % Debt investments in the JVs 162,617 5.85 % 146,444 5.59 % Preferred equity 87,878 3.16 % 85,300 3.26 % Subordinated debt 68,956 2.48 % 67,147 2.57 % LLC equity interests of the JVs 54,791 1.97 % 49,322 1.88 % Common equity and warrants 44,477 1.60 % 42,296 1.62 % Total $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,281,235 86.32 % 189.78 % $ 2,166,409 86.86 % 173.93 % Debt investments in the JVs 162,192 6.14 % 13.49 % 146,533 5.88 % 11.77 % Preferred equity 80,625 3.05 % 6.71 % 79,523 3.19 % 6.38 % Subordinated debt 62,145 2.35 % 5.17 % 56,920 2.28 % 4.57 % Common equity and warrants 32,565 1.23 % 2.71 % 24,011 0.96 % 1.93 % LLC equity interests of the JVs 24,108 0.91 % 2.01 % 20,715 0.83 % 1.66 % Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Northeast $ 772,197 27.78 % $ 747,420 28.55 % Midwest 403,393 14.52 % 373,236 14.26 % Southeast 397,717 14.32 % 356,041 13.60 % West 351,871 12.67 % 358,306 13.69 % International 350,510 12.62 % 301,242 11.51 % Southwest 204,143 7.35 % 221,308 8.45 % South 164,094 5.91 % 168,819 6.45 % Northwest 134,089 4.83 % 91,382 3.49 % Total $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 716,827 27.12 % 59.63 % $ 696,368 27.93 % 55.90 % Midwest 384,219 14.54 % 31.97 % 356,934 14.31 % 28.66 % Southeast 380,276 14.39 % 31.64 % 344,567 13.82 % 27.66 % International 342,447 12.96 % 28.49 % 279,646 11.21 % 22.45 % West 330,698 12.51 % 27.51 % 345,251 13.84 % 27.72 % Southwest 195,818 7.41 % 16.29 % 214,984 8.62 % 17.26 % South 160,150 6.06 % 13.32 % 166,230 6.66 % 13.35 % Northwest 132,435 5.01 % 11.02 % 90,131 3.61 % 7.24 % Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2022 and September 30, 2022: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Application Software $ 435,165 15.66 % $ 391,938 14.98 % Multi-Sector Holdings (1) 229,676 8.27 195,766 7.48 Pharmaceuticals 131,307 4.73 126,508 4.83 Data Processing & Outsourced Services 118,058 4.25 120,477 4.60 Biotechnology 111,745 4.02 109,960 4.20 Health Care Technology 110,251 3.97 100,084 3.82 Specialized Finance 87,523 3.15 80,864 3.09 Industrial Machinery 81,483 2.93 81,787 3.12 Health Care Services 65,732 2.37 58,674 2.24 Internet & Direct Marketing Retail 65,585 2.36 67,926 2.59 Aerospace & Defense 61,993 2.23 61,963 2.37 Construction & Engineering 60,828 2.19 60,996 2.33 Health Care Distributors 58,320 2.10 57,112 2.18 Other Diversified Financial Services 57,241 2.06 29,300 1.12 Personal Products 53,190 1.91 53,214 2.03 Automotive Retail 51,663 1.86 59,254 2.26 Auto Parts & Equipment 51,067 1.84 12,474 0.48 Real Estate Operating Companies 49,980 1.80 47,585 1.82 Fertilizers & Agricultural Chemicals 49,271 1.77 49,301 1.88 Internet Services & Infrastructure 49,271 1.77 54,095 2.07 Metal & Glass Containers 47,128 1.70 47,704 1.82 Home Improvement Retail 45,266 1.63 45,802 1.75 Soft Drinks 43,935 1.58 34,272 1.31 Airport Services 43,748 1.57 43,322 1.65 Leisure Facilities 41,182 1.48 39,768 1.52 Insurance Brokers 39,268 1.41 35,628 1.36 Diversified Support Services 38,167 1.37 37,992 1.45 Specialty Chemicals 37,298 1.34 37,319 1.43 Health Care Supplies 36,693 1.32 36,471 1.39 Real Estate Services 36,233 1.30 40,243 1.54 Integrated Telecommunication Services 34,635 1.25 34,628 1.32 Electrical Components & Equipment 33,813 1.22 33,814 1.29 Advertising 27,507 0.99 28,245 1.08 Movies & Entertainment 26,202 0.94 26,161 1.00 Distributors 25,262 0.91 25,278 0.97 Airlines 24,034 0.87 — — Health Care Equipment 21,838 0.79 24,353 0.93 Environmental & Facilities Services 21,156 0.76 20,857 0.80 Oil & Gas Storage & Transportation 19,934 0.72 22,290 0.85 Home Furnishings 19,554 0.70 19,550 0.75 Systems Software 14,895 0.54 14,890 0.57 Consumer Finance 14,503 0.52 14,492 0.55 Hotels, Resorts & Cruise Lines 13,943 0.50 13,960 0.53 IT Consulting & Other Services 11,684 0.42 11,697 0.45 Restaurants 9,343 0.34 9,338 0.36 Education Services 9,070 0.33 9,080 0.35 Cable & Satellite 8,012 0.29 20,716 0.79 Research & Consulting Services 7,848 0.28 9,187 0.35 Apparel, Accessories & Luxury Goods 5,165 0.19 5,165 0.20 Air Freight & Logistics 4,925 0.18 7,295 0.28 Integrated Oil & Gas 4,873 0.18 4,866 0.19 Apparel Retail 4,727 0.17 5,268 0.20 Food Distributors 4,655 0.17 4,646 0.18 Specialized REITs 4,334 0.16 4,318 0.16 Real Estate Development 4,278 0.15 — — Diversified Banks 3,515 0.13 3,515 0.13 Technology Distributors 3,163 0.11 3,163 0.12 Construction Materials 2,353 0.08 2,331 0.09 Housewares & Specialties 2,217 0.08 2,293 0.09 Electronic Components 2,095 0.08 2,092 0.08 Alternative Carriers 214 0.01 212 0.01 Oil & Gas Refining & Marketing — — 8,627 0.33 Trading Companies & Distributors — — 7,628 0.29 $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 422,862 15.95 % 35.18 % $ 384,589 15.43 % 30.87 % Multi-Sector Holdings (1) 198,904 7.53 16.55 167,248 6.71 13.43 Pharmaceuticals 127,414 4.82 10.60 119,511 4.79 9.59 Biotechnology 115,489 4.37 9.61 108,465 4.35 8.71 Data Processing & Outsourced Services 106,224 4.02 8.84 111,335 4.46 8.94 Health Care Technology 103,479 3.92 8.61 97,315 3.90 7.81 Industrial Machinery 79,791 3.02 6.64 81,008 3.25 6.50 Specialized Finance 79,751 3.02 6.63 73,087 2.93 5.87 Internet & Direct Marketing Retail 66,001 2.50 5.49 70,419 2.82 5.65 Aerospace & Defense 61,490 2.33 5.12 61,881 2.48 4.97 Construction & Engineering 60,938 2.31 5.07 61,188 2.45 4.91 Health Care Distributors 54,898 2.08 4.57 54,662 2.19 4.39 Other Diversified Financial Services 54,080 2.05 4.50 24,326 0.98 1.95 Fertilizers & Agricultural Chemicals 52,292 1.98 4.35 51,972 2.08 4.17 Health Care Services 51,260 1.94 4.26 45,943 1.84 3.69 Automotive Retail 50,681 1.92 4.22 57,629 2.31 4.63 Real Estate Operating Companies 50,127 1.90 4.17 48,062 1.93 3.86 Auto Parts & Equipment 50,015 1.89 4.16 11,469 0.46 0.92 Internet Services & Infrastructure 48,973 1.85 4.07 53,797 2.16 4.32 Personal Products 48,903 1.85 4.07 50,150 2.01 4.03 Home Improvement Retail 45,127 1.71 3.75 45,421 1.82 3.65 Metal & Glass Containers 44,763 1.69 3.72 47,599 1.91 3.82 Soft Drinks 44,387 1.68 3.69 33,670 1.35 2.70 Airport Services 43,267 1.64 3.60 42,883 1.72 3.44 Leisure Facilities 40,578 1.54 3.38 39,258 1.57 3.15 Insurance Brokers 39,057 1.48 3.25 33,081 1.33 2.66 Health Care Supplies 37,776 1.43 3.14 36,577 1.47 2.94 Diversified Support Services 35,626 1.35 2.96 36,712 1.47 2.95 Real Estate Services 35,621 1.35 2.96 39,573 1.59 3.18 Electrical Components & Equipment 32,970 1.25 2.74 32,933 1.32 2.64 Integrated Telecommunication Services 32,041 1.21 2.67 32,201 1.29 2.59 Specialty Chemicals 31,476 1.19 2.62 33,969 1.36 2.73 Movies & Entertainment 26,470 1.00 2.20 26,645 1.07 2.14 Advertising 26,022 0.98 2.16 26,948 1.08 2.16 Airlines 25,864 0.98 2.15 — — — Distributors 24,569 0.93 2.04 24,494 0.98 1.97 Health Care Equipment 22,703 0.86 1.89 24,161 0.97 1.94 Environmental & Facilities Services 20,675 0.78 1.72 20,585 0.83 1.65 Oil & Gas Storage & Transportation 18,113 0.69 1.51 20,853 0.84 1.67 Home Furnishings 17,917 0.68 1.49 18,188 0.73 1.46 Hotels, Resorts & Cruise Lines 13,904 0.53 1.16 13,985 0.56 1.12 Systems Software 12,104 0.46 1.01 12,834 0.51 1.03 Consumer Finance 11,439 0.43 0.95 13,284 0.53 1.07 Education Services 8,938 0.34 0.74 8,582 0.34 0.69 Restaurants 8,610 0.33 0.72 8,692 0.35 0.70 Cable & Satellite 7,968 0.30 0.66 19,576 0.78 1.57 Research & Consulting Services 7,165 0.27 0.60 8,573 0.34 0.69 IT Consulting & Other Services 6,963 0.26 0.58 8,596 0.34 0.69 Integrated Oil & Gas 4,847 0.18 0.40 4,872 0.20 0.39 Apparel Retail 4,675 0.18 0.39 5,223 0.21 0.42 Real Estate Development 4,267 0.16 0.35 — — — Air Freight & Logistics 4,191 0.16 0.35 6,405 0.26 0.51 Food Distributors 3,599 0.14 0.30 3,367 0.13 0.27 Diversified Banks 3,315 0.13 0.28 3,402 0.14 0.27 Specialized REITs 3,230 0.12 0.27 3,264 0.13 0.26 Technology Distributors 2,971 0.11 0.25 2,997 0.12 0.24 Housewares & Specialties 2,265 0.09 0.19 2,456 0.10 0.20 Construction Materials 1,928 0.07 0.16 1,934 0.08 0.16 Electronic Components 1,712 0.06 0.14 1,890 0.08 0.15 Alternative Carriers 185 0.01 0.02 201 0.01 0.02 Oil & Gas Refining & Marketing — — — 8,604 0.34 0.69 Trading Companies & Distributors — — — 5,567 0.22 0.45 Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % ___________________ (1) This industry includes the Company's investments in the JVs. As of December 31, 2022 and September 30, 2022, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments. Senior Loan Fund JV I, LLC In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of December 31, 2022 and September 30, 2022, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I has a senior revolving credit facility with Deutsche Bank AG, New York Branch (as amended, the "SLF JV I Deutsche Bank Facility"), which permitted up to $260.0 million of borrowings (subject to borrowing base and other limitations) as of each of December 31, 2022 and September 30, 2022. Borrowings under the SLF JV I Deutsche Bank Facility are secured by all of the assets of SLF JV I Funding LLC, a special purpose financing subsidiary of SLF JV I. As of December 31, 2022, the reinvestment period of the SLF JV I Deutsche Bank Facility was scheduled to expire May 3, 2023 and the maturity date was May 3, 2028. As of December 31, 2022, borrowings under the SLF JV I Deutsche Bank Facility accrued interest at a rate equal to 3-month LIBOR plus 2.00% per annum during the reinvestment period, 3-month LIBOR plus 2.15% per annum for the first year after the reinvestment period, 3-month LIBOR plus 2.25% for the following year and 3-month LIBOR plus 2.50% thereafter, in each case with a 0.125% LIBOR floor. $226.0 million and $230.0 million of borrowings were outstanding under the SLF JV I Deutsche Bank Facility as of December 31, 2022 and September 30, 2022, respectively. As of December 31, 2022 and September 30, 2022, SLF JV I had total assets of $409.4 million and $385.2 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 59 and 60 portfolio companies as of December 31, 2022 and September 30, 2022, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of December 31, 2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $136.8 million in aggregate, at fair value. As of September 30, 2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $117.0 million in aggregate, at fair value. As of December 31, 2022, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of September 30, 2022, the Company and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from the Company. As of December 31, 2022, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the three months ended December 31, 2022, the Company contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2022, the Company had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I. Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2022 and September 30, 2022: December 31, 2022 September 30, 2022 Senior secured loans (1) $382,148 $383,194 Weighted average interest rate on senior secured loans (2) 9.55% 8.33% Number of borrowers in SLF JV I 59 60 Largest exposure to a single borrower (1) $11,337 $10,093 Total of five largest loan exposures to borrowers (1) $51,990 $48,139 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. SLF JV I Portfolio as of December 31, 2022 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes Access CIG, LLC First Lien Term Loan, LIBOR+3.75% cash due 2/27/2025 7.82 % Diversified Support Services $ 10,067 $ 10,008 $ 9,883 ADB Companies, LLC First Lien Term Loan, SOFR+6.25% cash due 12/18/2025 11.34 % Construction & Engineering 8,413 8,296 8,267 (4) Altice France S.A. First Lien Term Loan, LIBOR+4.00% cash due 8/14/2026 8.65 % Integra

Fee Income

Fee Income	3 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Fee Income	Fee IncomeFor the three months ended December 31, 2022 and 2021, the Company recorded total fee income of $2.0 million and $0.9 million, respectively, of which $0.2 million and $0.2 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees and certain exit fees.

Share Data and Net Assets

Share Data and Net Assets	3 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Share Data and Net Assets	Share Data and Net Assets The share and per share information disclosed in Note 5 have been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Earnings per Share The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three months ended December 31, 2022 and 2021: (Share amounts in thousands) Three months ended Three months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 13,172 $ 39,408 Weighted average common shares outstanding — basic and diluted 61,142 60,127 Earnings (loss) per common share — basic and diluted $ 0.22 $ 0.66 Changes in Net Assets The following table presents the changes in net assets for the three months ended December 31, 2022: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 The following table presents the changes in net assets for the three months ended December 31, 2021: Common Stock Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2021 60,120 $ 601 $ 1,805,557 $ (493,335) $ 1,312,823 Net investment income — — — 32,295 32,295 Net unrealized appreciation (depreciation) — — — (4,586) (4,586) Net realized gains (losses) — — — 9,321 9,321 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 2,378 2,378 Distributions to stockholders — — — (27,956) (27,956) Issuance of common stock under dividend reinvestment plan 36 1 785 — 786 Balance as of December 31, 2021 60,156 $ 602 $ 1,806,342 $ (481,883) $ 1,325,061 Distributions Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment. The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP. For income tax purposes, the Company estimated its distributions for the 2022 calendar year will be composed primarily of ordinary income. The character of such distributions will be appropriately reported to the Internal Revenue Service and stockholders for the 2022 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders. The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2022 and 2021: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 $ 0.42 $ 24.8 million 41,510 (1) $ 0.8 million Total for the three months ended December 31, 2022 $ 0.96 $ 56.8 million 94,879 $ 1.9 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly October 13, 2021 December 15, 2021 December 31, 2021 $ 0.465 $ 27.2 million 35,990 (1) $ 0.8 million Total for the three months ended December 31, 2021 $ 0.465 $ 27.2 million 35,990 $ 0.8 million __________ (1) New shares were issued and distributed. Common Stock Issuances During the three months ended December 31, 2022 and 2021, the Company issued of 94,879 and 35,990, respectively, of shares of common stock as part of the DRIP. On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices. In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the three months ended December 31, 2022.

Borrowings

Borrowings	3 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Borrowings	Borrowings Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2022, the size of the Syndicated Facility was $1.0 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2022, (i) the period during which the Company may make drawings will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at the Company’s option) was 2.00% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OCSL Senior Funding II LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of December 31, 2022, except for assets that were held by OCSL Senior Funding II LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2022, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of December 31, 2022 and September 30, 2022, the Company had $695.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $695.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 5.849% and 2.174% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $10.0 million and $3.8 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. As of December 31, 2022, the Company was able to borrow up to $200 million under the Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024. As of December 31, 2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions. As of December 31, 2022 and September 30, 2022, the Company had $165.0 million and $160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $165.0 million and $160.0 million, respectively. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% and 1.830% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $2.7 million and $0.8 million, respectively, related to the Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of December 31, 2022 and September 30, 2022: As of December 31, 2022 As of September 30, 2022 ($ in millions) 2025 Notes 2027 Notes 2025 Notes 2027 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 350.0 Unamortized financing costs (1.6) (3.1) (1.8) (3.2) Unaccreted discount (1.1) (0.7) (1.2) (0.7) Interest rate swap fair value adjustment — (39.9) — (42.0) Net carrying value $ 297.3 $ 306.3 $ 297.0 $ 304.1 Fair Value $ 286.7 $ 296.8 $ 283.1 $ 294.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — 2.5 Total interest expense $ 2.9 $ 5.1 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 5.586 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2021: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — (0.7) Total interest expense $ 2.9 $ 1.9 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 1.782 %

Taxable_Distributable Income an

Taxable/Distributable Income and Dividend Distributions	3 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Taxable/Distributable Income and Dividend Distributions	Taxable/Distributable Income and Dividend Distributions Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans. As of September 30, 2022, the Company had net capital loss carryforwards of $523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $64.5 million are available to offset future short-term capital gains and $459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations. Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2022 and 2021. Three months ended Three months ended Net increase (decrease) in net assets resulting from operations $ 13,172 $ 39,408 Net unrealized (appreciation) depreciation 22,982 4,586 Book/tax difference due to organizational costs — (22) Book/tax difference due to capital losses utilized 8,013 (10,531) Other book/tax differences (12,910) (11,171) Taxable/Distributable Income (1) $ 31,257 $ 22,270 __________ (1) The Company's taxable income for the three months ended December 31, 2022 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. Therefore, the final taxable income may be different than the estimate. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2022, $11.4 million of the $13.1 million deferred tax assets would not more likely than not be realized in future periods. As of December 31, 2022, the Company recorded a net deferred tax asset of $1.7 million on the Consolidated Statements of Assets and Liabilities. For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit. For the three months ended December 31, 2021, the Company recognized a total benefit for income tax related to realized and unrealized losses of $2.4 million, which was composed of (i) a current income tax benefit of approximately $1.4 million, and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. For the three months ended December 31, 2021, the Company recognized a provision for income tax related to net investment income of $3.3 million, which was all current income tax expense. As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ (43,624) Net realized capital losses 473,274 Unrealized losses, net 153,119 Accumulated overdistributed earnings $ 582,769 The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was

Realized Gains or Losses and Ne

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation	3 Months Ended
	Dec. 31, 2022
Investment Company [Abstract]
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation	Realized Gains or Losses and Net Unrealized Appreciation or Depreciation Realized Gains or Losses Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules. During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 4.4 Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) Global Medical Response Inc. (1.0) Other, net (1.7) Total, net $ (3.2) During the three months ended December 31, 2021, the Company recorded an aggregate net realized gain of $9.3 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 3.0 OmniSYS Acquisition Corporation 2.0 First Star Speir Aviation Limited 1.9 Other, net 2.4 Total, net $ 9.3 Net Unrealized Appreciation or Depreciation Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation. During the three months ended December 31, 2022 and 2021, the Company recorded net unrealized depreciation of $23.0 million and $4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments.

Concentration of Credit Risk

Concentration of Credit Risk	3 Months Ended
	Dec. 31, 2022
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances may be in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of December 31, 2022 and September 30, 2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $16.9 million and $15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree. Investment Advisory Agreement The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company. From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM. Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company. Base Management Fee Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger. For the three months ended December 31, 2022 and 2021, the base management fee incurred under the Investment Advisory Agreement was $9.2 million (net of waiver) and $9.2 million (net of waiver), respectively. Incentive Fee The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows: • No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets; • 100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and • For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved. There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle. For the three months ended December 31, 2022 and 2021, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $7.7 million and $6.5 million, respectively. Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2022, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2022 under the Investment Advisory Agreement, no Part II incentive fees would be payable. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2022, there were no accrued capital gains incentive fees. For the three months ended December 31, 2021, $1.8 million of accrued capital gains incentive fees were expensed. As of December 31, 2022, the total accrued capital gains incentive fee liability was zero. Indemnification The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser. Administrative Services The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation. Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies. For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non- investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities. For the three months ended December 31, 2022 and 2021, the Company accrued administrative expenses of $0.4 million and $0.5 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. As of December 31, 2022 and September 30, 2022, $3.3 million and $3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

Financial Highlights

Financial Highlights	3 Months Ended
	Dec. 31, 2022
Investment Company [Abstract]
Financial Highlights	Financial Highlights (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $20.38 $21.84 Net investment income (1) 0.63 0.54 Net unrealized appreciation (depreciation) (1) (0.38) (0.08) Net realized gains (losses) (1) (0.05) 0.16 (Provision) benefit for taxes on realized and unrealized gains (losses) (1) 0.01 0.04 Distributions of net investment income to stockholders (0.96) (0.47) Net asset value per share at end of period $19.63 $22.03 Per share market value at beginning of period (7) $18.00 $21.18 Per share market value at end of period (7) $20.61 $22.38 Total return (2) 19.90% 7.92% Common shares outstanding at beginning of period 61,125 60,120 Common shares outstanding at end of period 61,220 60,156 Net assets at beginning of period $1,245,563 $1,312,823 Net assets at end of period $1,201,989 $1,325,061 Average net assets (3) $1,241,806 $1,327,934 Ratio of net investment income to average net assets (4) 12.40% 9.65% Ratio of total expenses to average net assets (4) 13.11% 8.99% Ratio of net expenses to average net assets (4) 12.87% 8.77% Ratio of portfolio turnover to average investments at fair value 4.24% 9.14% Weighted average outstanding debt (5) $1,441,326 $1,331,141 Average debt per share (1) $23.57 $22.14 Asset coverage ratio at end of period (6) 176.31% 200.81% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Interim periods are annualized. (5) Calculated based upon the weighted average of principal debt outstanding for the period. (6) Based on outstanding senior securities of $1,514.4 million and $1,300.0 million as of December 31, 2022 and 2021, respectively. (7) Per share market values are adjusted to reflect the 1-for-3 reverse stock split of the Company's common stock completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (8) The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Derivative Instruments

Derivative Instruments	3 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2022, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts. In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of December 31, 2022, the Company paid $39.8 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities. Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2022. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 44,825 € 44,224 2/9/2023 $ — $ (2,499) Derivative liability Foreign currency forward contract $ 46,412 £ 39,965 2/9/2023 $ — $ (1,712) Derivative liability $ — $ (4,211) Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 43,179 € 41,444 11/10/2022 $ 2,466 $ — Derivative asset Foreign currency forward contract $ 45,692 £ 37,033 11/10/2022 $ 4,323 $ — Derivative asset $ 6,789 $ — Certain information related to the Company’s interest rate swap is presented below as of December 31, 2022. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 39,928 Derivative liability $ — $ 39,928 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 41,969 Derivative liability $ — $ 41,969

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Off-Balance Sheet Arrangements The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2022, the Company's only off-balance sheet arrangements consisted of $198.9 million of unfunded commitments, which was comprised of $171.8 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities. A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of December 31, 2022 and September 30, 2022 is shown in the table below: December 31, 2022 September 30, 2022 Delta Leasing SPV II LLC $ 23,004 $ 27,187 Fairbridge Strategic Capital Funding LLC 15,995 22,150 OCSI Glick JV LLC 13,998 13,998 Senior Loan Fund JV I, LLC 13,125 35,000 BioXcel Therapeutics, Inc. 11,785 11,785 Dominion Diagnostics, LLC 11,148 11,148 BAART Programs, Inc. 7,675 8,645 iCIMs, Inc. 6,930 6,930 Marinus Pharmaceuticals, Inc. 5,734 5,734 scPharmaceuticals Inc. 5,212 — Assembled Brands Capital LLC 5,035 2,008 RumbleOn, Inc. 4,822 4,822 MRI Software LLC 4,427 5,196 107 Fair Street LLC 4,322 — Grove Hotel Parcel Owner, LLC 4,293 4,293 Accupac, Inc. 4,197 4,605 Innocoll Pharmaceuticals Limited 4,195 4,195 Avalara, Inc. 4,147 — Mindbody, Inc. 4,000 4,000 OTG Management, LLC 3,789 3,789 Mesoblast, Inc. 3,553 3,553 Establishment Labs Holdings Inc. 3,384 5,075 112-126 Van Houten Real22 LLC 3,174 — ADC Therapeutics SA 3,020 3,020 Spanx, LLC 2,762 2,226 PRGX Global, Inc. 2,518 2,518 SCP Eye Care Services, LLC 2,356 — Relativity ODA LLC 2,218 2,218 Berner Food & Beverage, LLC 2,197 1,392 Salus Workers' Compensation, LLC 2,171 — Pluralsight, LLC 1,766 3,532 Tahoe Bidco B.V. 1,741 1,741 CorEvitas, LLC 1,526 915 Coyote Buyer, LLC 1,333 1,333 MHE Intermediate Holdings, LLC 1,229 1,429 Kings Buyer, LLC 1,208 1,537 Liquid Environmental Solutions Corporation 1,115 1,115 Acquia Inc. 923 1,326 Apptio, Inc. 892 1,338 Digital.AI Software Holdings, Inc. 826 826 Telestream Holdings Corporation 528 528 GKD Index Partners, LLC 320 320 PFNY Holdings, LLC 275 1,527 Ardonagh Midco 3 PLC — 4,372 Dialyze Holdings, LLC — 3,431 Thrasio, LLC — 2,578 109 Montgomery Owner LLC — 477 LSL Holdco, LLC — 427 Total $ 198,868 $ 224,239

Schedule_12-14

Schedule 12-14	3 Months Ended
	Dec. 31, 2022
Investments in and Advances to Affiliates [Abstract]
Schedule 12-14	Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Three months ended December 31, 2022 (unaudited) Portfolio Company/Type of Investment (1) Cash Interest Rate Industry Principal Net Realized Gain (Loss) Amount of Fair Value Gross Gross Fair Value % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services 829 Common Units $ — $ — $ — $ — $ — $ — — % 34,984,460.37 Preferred Units — — 27,638 — — 27,638 2.3 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan, LIBOR+5.00% cash due 2/28/2024 9.73 % $ 14,297 — 331 14,333 — (36) 14,297 1.2 % First Lien Revolver, LIBOR+5.00% cash due 2/28/2024 — — 14 — — — — — % 30,030.8 Common Units in DD Healthcare Services Holdings, LLC — — 4,946 — (719) 4,227 0.4 % OCSI Glick JV LLC (5) Multi-Sector Holdings Subordinated Debt, LIBOR+4.50% cash due 10/20/2028 7.67 % 59,049 — 1,624 50,283 380 (1,127) 49,536 4.1 % 87.5% equity interest — — — — — — — % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Subordinated Debt, LIBOR+7.00% cash due 12/29/2028 10.17 % 112,656 — 2,611 96,250 16,406 — 112,656 9.4 % 87.5% LLC equity interest — 1,050 20,715 5,469 (2,076) 24,108 2.0 % Total Control Investments $ 186,002 $ — $ 5,630 $ 214,165 $ 22,255 $ (3,958) $ 232,462 19.3 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver, LIBOR+6.75% cash due 10/17/2023 11.48 % $ 21,464 $ — $ 646 $ 24,225 $ 55 $ (3,028) $ 21,252 1.8 % 1,609,201 Class A Units — — 370 — (16) 354 — % 1,019,168.80 Preferred Units, 6% — — 1,223 20 — 1,243 0.1 % 70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029 — — — — — — — % Caregiver Services, Inc. Health Care Services 1,080,399 shares of Series A Preferred Stock, 10% — — — 378 — (54) 324 — % Total Affiliate Investments $ 21,464 $ — $ 646 $ 26,196 $ 75 $ (3,098) $ 23,173 1.9 % Total Control & Affiliate Investments $ 207,466 $ — $ 6,276 $ 240,361 $ 22,330 $ (7,056) $ 255,635 21.2 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (6) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required). Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Three months ended December 31, 2021 (unaudited) Portfolio Company/Type of Investment (1) Cash Interest Rate Industry Principal Net Realized Gain (Loss) Amount of Fair Value Gross Gross Fair Value % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services 829 Common Units $ — $ — $ — $ — $ — $ — — % 34,984,460.37 Preferred Units — — 27,638 — — 27,638 2.1 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan, LIBOR+5.00% cash due 2/28/2024 6.00 % $ 23,201 — 430 27,381 — (4,180) 23,201 1.8 % First Lien Revolver, LIBOR+5.00% cash due 2/28/2024 — — 14 — — — — — % 30,030.8 Common Units in DD Healthcare Services Holdings, LLC — 3,308 18,065 — — 18,065 1.4 % First Star Speir Aviation Limited (5) Airlines First Lien Term Loan, 9.00% cash due 12/15/2025 — 7,500 — 7,500 — (7,500) — — % 100% equity interest (5,632) 158 698 — (698) — — % OCSI Glick JV LLC (6) Multi-Sector Holdings Subordinated Debt, LIBOR+4.50% cash due 10/20/2028 4.58 % 61,237 — 1,081 55,582 745 (473) 55,854 4.2 % 87.5% equity interest — — — — — — — % Senior Loan Fund JV I, LLC (7) Multi-Sector Holdings Subordinated Debt, LIBOR+7.00% cash due 12/29/2028 8.00 % 96,250 — 1,967 96,250 — — 96,250 7.3 % 87.5% LLC equity interest — 451 37,651 810 — 38,461 2.9 % Total Control Investments $ 180,688 $ 1,868 $ 7,409 $ 270,765 $ 1,555 $ (12,851) $ 259,469 19.6 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver, LIBOR+6.75% cash due 10/17/2023 7.75 % $ 15,982 $ — $ 339 $ 15,712 $ 3,499 $ (3,487) $ 15,724 1.2 % 1,609,201 Class A Units — — 587 — (201) 386 — % 1,019,168.80 Preferred Units, 6% — — 1,152 20 — 1,172 0.1 % 70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029 — — — — — — — % Caregiver Services, Inc. Health Care Services 1,080,399 shares of Series A Preferred Stock, 10% — — — 838 — — 838 0.1 % Total Affiliate Investments $ 15,982 $ — $ 339 $ 18,289 $ 3,519 $ (3,688) $ 18,120 1.4 % Total Control & Affiliate Investments $ 196,670 $ 1,868 $ 7,748 $ 289,054 $ 5,074 $ (16,539) $ 277,589 21.0 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2021. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities. (6) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (7) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

N-2

N-2 - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cover [Abstract]
Entity Central Index Key	0001414932
Amendment Flag	false
Securities Act File Number	1-33901
Document Type	10-Q
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Entity Emerging Growth Company	false
Financial Highlights [Abstract]
Senior Securities [Table Text Block]
Senior Securities Amount	$ 1,514.4	$ 1,300
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt [Table Text Block]	Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2022, the size of the Syndicated Facility was $1.0 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2022, (i) the period during which the Company may make drawings will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at the Company’s option) was 2.00% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OCSL Senior Funding II LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of December 31, 2022, except for assets that were held by OCSL Senior Funding II LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2022, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of December 31, 2022 and September 30, 2022, the Company had $695.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $695.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 5.849% and 2.174% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $10.0 million and $3.8 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. As of December 31, 2022, the Company was able to borrow up to $200 million under the Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024. As of December 31, 2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions. As of December 31, 2022 and September 30, 2022, the Company had $165.0 million and $160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $165.0 million and $160.0 million, respectively. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% and 1.830% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $2.7 million and $0.8 million, respectively, related to the Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.
Syndicated Facility [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	Syndicated Facility
Long Term Debt, Structuring [Text Block]	On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2022, the size of the Syndicated Facility was $1.0 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2022, (i) the period during which the Company may make drawings will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at the Company’s option) was 2.00% and (b) alternate base rate loans was 1.00%.
Long Term Debt, Dividends and Covenants [Text Block]	The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2022, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.
Citibank Facility [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	Citibank Facility
Long Term Debt, Structuring [Text Block]	On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. As of December 31, 2022, the Company was able to borrow up to $200 million under the Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024.
Long Term Debt, Dividends and Covenants [Text Block]	As of December 31, 2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
2025 Notes [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	2025 Notes
Long Term Debt, Structuring [Text Block]	On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Long Term Debt, Dividends and Covenants [Text Block]	The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.
2027 Notes [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	2027 Notes
Long Term Debt, Structuring [Text Block]	On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Long Term Debt, Dividends and Covenants [Text Block]	The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 and all prior periods reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Use of Estimates	Use of Estimates: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
Consolidation	Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.
Fair Value Measurements	Fair Value Measurements: The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2022 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.
Foreign Currency Translation	Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Derivative Instruments	Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.
Investment Income	Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of December 31, 2022 and September 30, 2022, there were no investments on non-accrual status. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. The Company has also structured exit fees across certain of its portfolio investments to be received upon the future exit of those investments. These fees are typically paid to the Company upon the earliest to occur of (i) a sale of the borrower or substantially all of the assets of the borrower, (ii) the maturity date of the loan or (iii) the date when full prepayment of the loan occurs. The receipt of such fees is contingent upon the occurrence of one of the events listed above for each of the investments. These fees are included in net investment income over the life of the loan. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
Cash and Cash Equivalents and Restricted Cash	Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.
Due From Portfolio Companies	Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date).
Receivables/Payables from Unsettled Transactions	Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
Deferred Financing Costs	Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.
Deferred Offering Costs	Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.
Income Taxes	Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2019, 2020 and 2021. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting PronouncementsIn March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting if certain criteria are met. The guidance is effective from March 12, 2020 through December 31, 2022. As of December 31, 2022, the adoption of this guidance did not have an impact on the Company's Consolidated Financial Statements

Portfolio Investments (Tables)

Portfolio Investments (Tables)	3 Months Ended
	Dec. 31, 2022
Schedule of Investments [Abstract]
Composition of Investments	Below is certain summarized financial information for SLF JV I as of December 31, 2022 and September 30, 2022 and for the three months ended December 31, 2022 and 2021: December 31, 2022 September 30, 2022 Selected Balance Sheet Information: Investments at fair value (cost December 31, 2022: $380,682; cost September 30, 2022: $382,673) $ 355,427 $ 359,625 Cash and cash equivalents 39,259 14,274 Restricted cash 6,612 5,642 Other assets 8,106 5,686 Total assets $ 409,404 $ 385,227 Senior credit facility payable $ 226,000 $ 230,000 SLF JV I Notes payable at fair value (proceeds December 31, 2022: $128,750; proceeds September 30, 2022: $110,000) 128,750 110,000 Other liabilities 27,094 21,539 Total liabilities $ 381,844 $ 361,539 Members' equity 27,560 23,688 Total liabilities and members' equity $ 409,404 $ 385,227 Three months ended December 31, 2022 Three months ended December 31, 2021 Selected Statements of Operations Information: Interest income $ 8,781 $ 5,423 Other income — 11 Total investment income 8,781 5,434 Senior credit facility interest expense 3,709 1,514 SLF JV I Notes interest expense 2,982 2,249 Other expenses 69 79 Total expenses (1) 6,760 3,842 Net investment income 2,021 1,592 Net unrealized appreciation (depreciation) (2,207) (525) Net realized gains (losses) (992) 374 Net income (loss) $ (1,178) $ 1,441 __________ (1) There are no management fees or incentive fees charged at SLF JV I. Below is certain summarized financial information for the Glick JV as of December 31, 2022 and September 30, 2022 and for the three months ended December 31, 2022 and December 31, 2021: December 31, 2022 September 30, 2022 Selected Balance Sheet Information: Investments at fair value (cost December 31, 2022: $131,077; September 30, 2022: $140,083) $ 123,339 $ 133,144 Cash and cash equivalents 9,777 7,021 Restricted cash 1,747 1,788 Other assets 2,592 4,855 Total assets $ 137,455 $ 146,808 Senior credit facility payable $ 76,082 $ 82,082 Glick JV Notes payable at fair value (proceeds December 31, 2022: $67,485; September 30, 2022: $68,185) 56,614 57,463 Other liabilities 4,759 7,263 Total liabilities $ 137,455 $ 146,808 Members' equity — — Total liabilities and members' equity $ 137,455 $ 146,808 For the three months ended December 31, 2022 For the three months ended December 31, 2021 Selected Statements of Operations Information: Interest income $ 3,403 $ 2,160 Fee income — — Total investment income 3,403 2,160 Senior credit facility interest expense 1,285 510 Glick JV Notes interest expense 1,324 818 Other expenses 53 39 Total expenses (1) 2,662 1,367 Net investment income 741 793 Net unrealized appreciation (depreciation) (651) (882) Realized gain (loss) (90) 89 Net income (loss) $ — $ — __________ (1) There are no management fees or incentive fees charged at the Glick JV.
Investment Holdings, Schedule of Investments	The composition of the Company's investments as of December 31, 2022 and September 30, 2022 at cost and fair value was as follows: December 31, 2022 September 30, 2022 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,428,251 $ 2,343,380 $ 2,294,392 $ 2,223,329 Investments in equity securities 132,355 113,190 127,596 103,534 Debt investments in the JVs 162,617 162,192 146,444 146,533 Equity investments in the JVs 54,791 24,108 49,322 20,715 Total $ 2,778,014 $ 2,642,870 $ 2,617,754 $ 2,494,111 The following table presents the composition of the Company's debt investments as of December 31, 2022 and September 30, 2022 at fixed rates and floating rates: December 31, 2022 September 30, 2022 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,188,193 87.33 % $ 2,049,644 86.49 % Fixed rate debt securities 317,379 12.67 320,218 13.51 Total $ 2,505,572 100.00 % $ 2,369,862 100.00 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2022 and September 30, 2022: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Application Software $ 435,165 15.66 % $ 391,938 14.98 % Multi-Sector Holdings (1) 229,676 8.27 195,766 7.48 Pharmaceuticals 131,307 4.73 126,508 4.83 Data Processing & Outsourced Services 118,058 4.25 120,477 4.60 Biotechnology 111,745 4.02 109,960 4.20 Health Care Technology 110,251 3.97 100,084 3.82 Specialized Finance 87,523 3.15 80,864 3.09 Industrial Machinery 81,483 2.93 81,787 3.12 Health Care Services 65,732 2.37 58,674 2.24 Internet & Direct Marketing Retail 65,585 2.36 67,926 2.59 Aerospace & Defense 61,993 2.23 61,963 2.37 Construction & Engineering 60,828 2.19 60,996 2.33 Health Care Distributors 58,320 2.10 57,112 2.18 Other Diversified Financial Services 57,241 2.06 29,300 1.12 Personal Products 53,190 1.91 53,214 2.03 Automotive Retail 51,663 1.86 59,254 2.26 Auto Parts & Equipment 51,067 1.84 12,474 0.48 Real Estate Operating Companies 49,980 1.80 47,585 1.82 Fertilizers & Agricultural Chemicals 49,271 1.77 49,301 1.88 Internet Services & Infrastructure 49,271 1.77 54,095 2.07 Metal & Glass Containers 47,128 1.70 47,704 1.82 Home Improvement Retail 45,266 1.63 45,802 1.75 Soft Drinks 43,935 1.58 34,272 1.31 Airport Services 43,748 1.57 43,322 1.65 Leisure Facilities 41,182 1.48 39,768 1.52 Insurance Brokers 39,268 1.41 35,628 1.36 Diversified Support Services 38,167 1.37 37,992 1.45 Specialty Chemicals 37,298 1.34 37,319 1.43 Health Care Supplies 36,693 1.32 36,471 1.39 Real Estate Services 36,233 1.30 40,243 1.54 Integrated Telecommunication Services 34,635 1.25 34,628 1.32 Electrical Components & Equipment 33,813 1.22 33,814 1.29 Advertising 27,507 0.99 28,245 1.08 Movies & Entertainment 26,202 0.94 26,161 1.00 Distributors 25,262 0.91 25,278 0.97 Airlines 24,034 0.87 — — Health Care Equipment 21,838 0.79 24,353 0.93 Environmental & Facilities Services 21,156 0.76 20,857 0.80 Oil & Gas Storage & Transportation 19,934 0.72 22,290 0.85 Home Furnishings 19,554 0.70 19,550 0.75 Systems Software 14,895 0.54 14,890 0.57 Consumer Finance 14,503 0.52 14,492 0.55 Hotels, Resorts & Cruise Lines 13,943 0.50 13,960 0.53 IT Consulting & Other Services 11,684 0.42 11,697 0.45 Restaurants 9,343 0.34 9,338 0.36 Education Services 9,070 0.33 9,080 0.35 Cable & Satellite 8,012 0.29 20,716 0.79 Research & Consulting Services 7,848 0.28 9,187 0.35 Apparel, Accessories & Luxury Goods 5,165 0.19 5,165 0.20 Air Freight & Logistics 4,925 0.18 7,295 0.28 Integrated Oil & Gas 4,873 0.18 4,866 0.19 Apparel Retail 4,727 0.17 5,268 0.20 Food Distributors 4,655 0.17 4,646 0.18 Specialized REITs 4,334 0.16 4,318 0.16 Real Estate Development 4,278 0.15 — — Diversified Banks 3,515 0.13 3,515 0.13 Technology Distributors 3,163 0.11 3,163 0.12 Construction Materials 2,353 0.08 2,331 0.09 Housewares & Specialties 2,217 0.08 2,293 0.09 Electronic Components 2,095 0.08 2,092 0.08 Alternative Carriers 214 0.01 212 0.01 Oil & Gas Refining & Marketing — — 8,627 0.33 Trading Companies & Distributors — — 7,628 0.29 $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 422,862 15.95 % 35.18 % $ 384,589 15.43 % 30.87 % Multi-Sector Holdings (1) 198,904 7.53 16.55 167,248 6.71 13.43 Pharmaceuticals 127,414 4.82 10.60 119,511 4.79 9.59 Biotechnology 115,489 4.37 9.61 108,465 4.35 8.71 Data Processing & Outsourced Services 106,224 4.02 8.84 111,335 4.46 8.94 Health Care Technology 103,479 3.92 8.61 97,315 3.90 7.81 Industrial Machinery 79,791 3.02 6.64 81,008 3.25 6.50 Specialized Finance 79,751 3.02 6.63 73,087 2.93 5.87 Internet & Direct Marketing Retail 66,001 2.50 5.49 70,419 2.82 5.65 Aerospace & Defense 61,490 2.33 5.12 61,881 2.48 4.97 Construction & Engineering 60,938 2.31 5.07 61,188 2.45 4.91 Health Care Distributors 54,898 2.08 4.57 54,662 2.19 4.39 Other Diversified Financial Services 54,080 2.05 4.50 24,326 0.98 1.95 Fertilizers & Agricultural Chemicals 52,292 1.98 4.35 51,972 2.08 4.17 Health Care Services 51,260 1.94 4.26 45,943 1.84 3.69 Automotive Retail 50,681 1.92 4.22 57,629 2.31 4.63 Real Estate Operating Companies 50,127 1.90 4.17 48,062 1.93 3.86 Auto Parts & Equipment 50,015 1.89 4.16 11,469 0.46 0.92 Internet Services & Infrastructure 48,973 1.85 4.07 53,797 2.16 4.32 Personal Products 48,903 1.85 4.07 50,150 2.01 4.03 Home Improvement Retail 45,127 1.71 3.75 45,421 1.82 3.65 Metal & Glass Containers 44,763 1.69 3.72 47,599 1.91 3.82 Soft Drinks 44,387 1.68 3.69 33,670 1.35 2.70 Airport Services 43,267 1.64 3.60 42,883 1.72 3.44 Leisure Facilities 40,578 1.54 3.38 39,258 1.57 3.15 Insurance Brokers 39,057 1.48 3.25 33,081 1.33 2.66 Health Care Supplies 37,776 1.43 3.14 36,577 1.47 2.94 Diversified Support Services 35,626 1.35 2.96 36,712 1.47 2.95 Real Estate Services 35,621 1.35 2.96 39,573 1.59 3.18 Electrical Components & Equipment 32,970 1.25 2.74 32,933 1.32 2.64 Integrated Telecommunication Services 32,041 1.21 2.67 32,201 1.29 2.59 Specialty Chemicals 31,476 1.19 2.62 33,969 1.36 2.73 Movies & Entertainment 26,470 1.00 2.20 26,645 1.07 2.14 Advertising 26,022 0.98 2.16 26,948 1.08 2.16 Airlines 25,864 0.98 2.15 — — — Distributors 24,569 0.93 2.04 24,494 0.98 1.97 Health Care Equipment 22,703 0.86 1.89 24,161 0.97 1.94 Environmental & Facilities Services 20,675 0.78 1.72 20,585 0.83 1.65 Oil & Gas Storage & Transportation 18,113 0.69 1.51 20,853 0.84 1.67 Home Furnishings 17,917 0.68 1.49 18,188 0.73 1.46 Hotels, Resorts & Cruise Lines 13,904 0.53 1.16 13,985 0.56 1.12 Systems Software 12,104 0.46 1.01 12,834 0.51 1.03 Consumer Finance 11,439 0.43 0.95 13,284 0.53 1.07 Education Services 8,938 0.34 0.74 8,582 0.34 0.69 Restaurants 8,610 0.33 0.72 8,692 0.35 0.70 Cable & Satellite 7,968 0.30 0.66 19,576 0.78 1.57 Research & Consulting Services 7,165 0.27 0.60 8,573 0.34 0.69 IT Consulting & Other Services 6,963 0.26 0.58 8,596 0.34 0.69 Integrated Oil & Gas 4,847 0.18 0.40 4,872 0.20 0.39 Apparel Retail 4,675 0.18 0.39 5,223 0.21 0.42 Real Estate Development 4,267 0.16 0.35 — — — Air Freight & Logistics 4,191 0.16 0.35 6,405 0.26 0.51 Food Distributors 3,599 0.14 0.30 3,367 0.13 0.27 Diversified Banks 3,315 0.13 0.28 3,402 0.14 0.27 Specialized REITs 3,230 0.12 0.27 3,264 0.13 0.26 Technology Distributors 2,971 0.11 0.25 2,997 0.12 0.24 Housewares & Specialties 2,265 0.09 0.19 2,456 0.10 0.20 Construction Materials 1,928 0.07 0.16 1,934 0.08 0.16 Electronic Components 1,712 0.06 0.14 1,890 0.08 0.15 Alternative Carriers 185 0.01 0.02 201 0.01 0.02 Oil & Gas Refining & Marketing — — — 8,604 0.34 0.69 Trading Companies & Distributors — — — 5,567 0.22 0.45 Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % SLF JV I Portfolio as of December 31, 2022 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes Access CIG, LLC First Lien Term Loan, LIBOR+3.75% cash due 2/27/2025 7.82 % Diversified Support Services $ 10,067 $ 10,008 $ 9,883 ADB Companies, LLC First Lien Term Loan, SOFR+6.25% cash due 12/18/2025 11.34 % Construction & Engineering 8,413 8,296 8,267 (4) Altice France S.A. First Lien Term Loan, LIBOR+4.00% cash due 8/14/2026 8.65 % Integrated Telecommunication Services 2,992 2,844 2,791 Alvogen Pharma US, Inc. First Lien Term Loan, SOFR+7.50% cash due 6/30/2025 12.23 % Pharmaceuticals 9,150 9,060 9,104 (4) American Rock Salt Company LLC First Lien Term Loan, LIBOR+4.00% cash due 6/9/2028 8.38 % Diversified Metals & Mining 1,995 1,836 1,883 American Tire Distributors, Inc. First Lien Term Loan, LIBOR+6.25% cash due 10/20/2028 10.61 % Distributors 4,860 4,800 4,471 (4) Amplify Finco Pty Ltd. First Lien Term Loan, LIBOR+4.25% cash due 11/26/2026 8.98 % Movies & Entertainment 7,780 7,702 7,501 (4) Anastasia Parent, LLC First Lien Term Loan, LIBOR+3.75% cash due 8/11/2025 8.48 % Personal Products 1,535 1,200 1,149 (4) Apptio, Inc. First Lien Term Loan, LIBOR+6.00% cash due 1/10/2025 9.94 % Application Software 4,615 4,584 4,523 (4) Apptio, Inc. First Lien Revolver, LIBOR+6.00% cash due 1/10/2025 9.94 % Application Software 231 228 223 (4)(5) Total Apptio, Inc. 4,846 4,812 4,746 ASP-R-PAC Acquisition Co LLC First Lien Term Loan, LIBOR+6.00% cash due 12/29/2027 10.38 % Paper Packaging 4,166 4,097 4,012 ASP-R-PAC Acquisition Co LLC First Lien Revolver, LIBOR+6.00% cash due 12/29/2027 Paper Packaging — (8) (18) (5) Total ASP-R-PAC Acquisition Co LLC 4,166 4,089 3,994 Astra Acquisition Corp. First Lien Term Loan, LIBOR+5.25% cash due 10/25/2028 9.63 % Application Software 5,052 4,866 4,484 (4) Asurion, LLC First Lien Term Loan, SOFR+4.00% cash due 8/19/2028 8.68 % Property & Casualty Insurance 4,988 4,752 4,463 Asurion, LLC Second Lien Term Loan, LIBOR+5.25% cash due 1/20/2029 9.63 % Property & Casualty Insurance 4,346 3,995 3,404 Total Asurion, LLC 9,334 8,747 7,867 athenahealth Group Inc. First Lien Term Loan, SOFR+3.50% cash due 2/15/2029 7.82 % Health Care Technology 2,558 2,353 2,316 athenahealth Group Inc. First Lien Delayed Draw Term Loan, SOFR+3.50% cash due 2/15/2029 7.82 % Health Care Technology 109 74 68 (5) Total athenahealth Group Inc. 2,667 2,427 2,384 Aurora Lux Finco S.À.R.L. First Lien Term Loan, LIBOR+6.00% cash due 12/24/2026 10.32 % Airport Services 6,321 6,232 6,012 (4) BAART Programs, Inc. First Lien Term Loan, LIBOR+5.00% cash due 6/11/2027 9.07 % Health Care Services 6,354 6,295 6,176 BAART Programs, Inc. First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/2027 9.73 % Health Care Services 1,767 1,747 1,682 (4)(5) Total BAART Programs, Inc. 8,121 8,042 7,858 Blackhawk Network Holdings, Inc. First Lien Term Loan, LIBOR+3.00% cash due 6/15/2025 7.08 % Data Processing & Outsourced Services 9,550 9,542 9,331 Boxer Parent Company Inc. First Lien Term Loan, LIBOR+3.75% cash due 10/2/2025 8.13 % Systems Software 1,994 1,917 1,914 BYJU's Alpha, Inc. First Lien Term Loan, LIBOR+6.00% cash due 11/24/2026 10.70 % Application Software 7,425 7,335 5,988 C5 Technology Holdings, LLC 171 Common Units Data Processing & Outsourced Services — — (4) C5 Technology Holdings, LLC 7,193,539.63 Preferred Units Data Processing & Outsourced Services 7,194 5,683 (4) Total C5 Technology Holdings, LLC 7,194 5,683 Cengage Learning, Inc. First Lien Term Loan, LIBOR+4.75% cash due 7/14/2026 7.81 % Education Services 2,992 2,734 2,698 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes Centerline Communications, LLC First Lien Term Loan, SOFR+5.50% cash due 8/10/2023 10.43 % Wireless Telecommunication Services $ 6,345 $ 6,242 $ 6,231 Centerline Communications, LLC First Lien Revolver, SOFR+5.50% cash due 8/10/2027 Wireless Telecommunication Services — (10) (10) (5) Total Centerline Communications, LLC 6,345 6,232 6,221 Convergeone Holdings, Inc. First Lien Term Loan, LIBOR+5.00% cash due 1/4/2026 9.38 % IT Consulting & Other Services 7,354 7,200 4,309 (4) Covetrus, Inc. First Lien Term Loan, SOFR+5.00% cash due 9/20/2029 9.58 % Health Care Distributors 5,375 5,053 5,050 (4) Curium Bidco S.à.r.l. First Lien Term Loan, LIBOR+4.00% cash due 7/9/2026 8.73 % Biotechnology 7,800 7,726 7,644 Curium Bidco S.à.r.l. First Lien Term Loan, LIBOR+4.25% cash due 12/2/2027 8.98 % Biotechnology 997 978 975 Total Curium Bidco S.à.r.l. 8,797 8,704 8,619 DirecTV Financing, LLC First Lien Term Loan, LIBOR+5.00% cash due 8/2/2027 9.38 % Cable & Satellite 6,277 6,178 6,124 (4) Domtar Corporation First Lien Term Loan, LIBOR+5.50% cash due 11/30/2028 9.79 % Paper Products 4,090 4,055 3,926 DTI Holdco, Inc. First Lien Term Loan, SOFR+4.75% cash due 4/26/2029 8.84 % Research & Consulting Services 7,980 7,835 7,372 (4) eResearch Technology, Inc. First Lien Term Loan, LIBOR+4.50% cash due 2/4/2027 8.88 % Application Software 7,811 7,681 6,915 Gibson Brands, Inc. First Lien Term Loan, LIBOR+5.00% cash due 8/11/2028 9.13 % Leisure Products 7,425 7,351 5,495 Global Medical Response, Inc. First Lien Term Loan, LIBOR+4.25% cash due 10/2/2025 8.42 % Health Care Services 1,260 1,246 891 Harbor Purchaser Inc. First Lien Term Loan, SOFR+5.25% cash due 4/9/2029 9.67 % Education Services 7,980 7,764 7,613 (4) Indivior Finance S.À.R.L. First Lien Term Loan, SOFR+5.25% cash due 6/30/2026 10.09 % Pharmaceuticals 7,388 7,282 7,277 INW Manufacturing, LLC First Lien Term Loan, LIBOR+5.75% cash due 3/25/2027 10.48 % Personal Products 9,375 9,172 8,016 (4) Iris Holding, Inc. First Lien Term Loan, SOFR+4.75% cash due 6/28/2028 8.94 % Metal & Glass Containers 4,988 4,630 4,548 LABL, Inc. First Lien Term Loan, LIBOR+5.00% cash due 10/29/2028 9.38 % Office Services & Supplies 2,992 2,858 2,848 LaserAway Intermediate Holdings II, LLC First Lien Term Loan, LIBOR+5.75% cash due 10/14/2027 9.76 % Health Care Services 7,425 7,306 7,295 Lightbox Intermediate, L.P. First Lien Term Loan, LIBOR+5.00% cash due 5/9/2026 9.73 % Real Estate Services 11,337 11,152 10,941 (4) LogMeIn, Inc. First Lien Term Loan, LIBOR+4.75% cash due 8/31/2027 9.14 % Application Software 7,840 7,736 5,080 LTI Holdings, Inc. First Lien Term Loan, LIBOR+3.50% cash due 9/6/2025 7.88 % Electronic Components 7,347 7,270 7,050 McAfee Corp. First Lien Term Loan, SOFR+3.75% cash due 3/1/2029 7.97 % Systems Software 1,995 1,876 1,862 Mindbody, Inc. First Lien Term Loan, LIBOR+7.00% cash due 2/14/2025 11.72 % Internet Services & Infrastructure 4,668 4,636 4,566 (4) Mindbody, Inc. First Lien Revolver, LIBOR+8.00% cash due 2/14/2025 Internet Services & Infrastructure — (3) (10) (4)(5) Total Mindbody, Inc. 4,668 4,633 4,556 MRI Software LLC First Lien Term Loan, LIBOR+5.50% cash due 2/10/2026 10.23 % Application Software 10,611 10,416 10,227 (4) MRI Software LLC First Lien Revolver, LIBOR+5.50% cash due 2/10/2026 Application Software — (3) (12) (4)(5) Total MRI Software LLC 10,611 10,413 10,215 Northern Star Industries Inc. First Lien Term Loan, LIBOR+4.50% cash due 3/31/2025 9.23 % Electrical Components & Equipment 6,668 6,657 6,467 OEConnection LLC First Lien Term Loan, SOFR+4.00% cash due 9/25/2026 8.42 % Application Software 7,757 7,721 7,411 (4) Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes Park Place Technologies, LLC First Lien Term Loan, SOFR+5.00% cash due 11/10/2027 9.42 % Internet Services & Infrastructure $ 9,900 $ 9,504 $ 9,362 (4) Planview Parent, Inc. First Lien Term Loan, LIBOR+4.00% cash due 12/17/2027 8.73 % Application Software 2,435 2,294 2,274 Planview Parent, Inc. Second Lien Term Loan, LIBOR+7.25% cash due 12/18/2028 11.98 % Application Software 4,503 4,435 4,041 (4) Total Planview Parent, Inc. 6,938 6,729 6,315 Pluralsight, LLC First Lien Term Loan, LIBOR+8.00% cash due 4/6/2027 11.83 % Application Software 6,796 6,698 6,626 (4) Pluralsight, LLC First Lien Revolver, LIBOR+8.00% cash due 4/6/2027 Application Software 212 206 201 (4)(5) Total Pluralsight, LLC 7,008 6,904 6,827 RevSpring, Inc. First Lien Term Loan, LIBOR+4.00% cash due 10/11/2025 8.73 % Commercial Printing 9,600 9,583 9,288 SHO Holding I Corporation First Lien Term Loan, LIBOR+5.25% cash due 4/27/2024 9.66 % Footwear 8,179 8,173 6,339 SHO Holding I Corporation First Lien Term Loan, LIBOR+5.23% cash due 4/27/2024 9.64 % Footwear 138 138 120 Total SHO Holding I Corporation 8,317 8,311 6,459 Sorenson Communications, LLC First Lien Term Loan, LIBOR+5.50% cash due 3/17/2026 10.23 % Communications Equipment 2,478 2,454 2,374 Spanx, LLC First Lien Term Loan, LIBOR+5.25% cash due 11/20/2028 9.64 % Apparel Retail 8,910 8,760 8,699 (4) SPX Flow, Inc. First Lien Term Loan, SOFR+4.50% cash due 4/5/2029 8.92 % Industrial Machinery 10,075 9,610 9,436 (4) Supermoose Borrower, LLC First Lien Term Loan, LIBOR+3.75% cash due 8/29/2025 8.48 % Application Software 7,723 7,482 6,688 (4) Surgery Center Holdings, Inc. First Lien Term Loan, LIBOR+3.75% cash due 8/31/2026 8.05 % Health Care Facilities 3,044 3,034 3,014 TIBCO Software Inc. First Lien Term Loan, SOFR+4.50% cash due 3/20/2029 9.18 % Application Software 6,256 5,712 5,602 (4) Touchstone Acquisition, Inc. First Lien Term Loan, LIBOR+6.00% cash due 12/29/2028 10.38 % Health Care Supplies 7,267 7,142 7,104 (4) Veritas US Inc. First Lien Term Loan, LIBOR+5.00% cash due 9/1/2025 9.73 % Application Software 6,354 6,286 4,515 Windstream Services II, LLC First Lien Term Loan, SOFR+6.25% cash due 9/21/2027 10.67 % Integrated Telecommunication Services 7,798 7,587 7,092 (4) WP CPP Holdings, LLC Second Lien Term Loan, LIBOR+7.75% cash due 4/30/2026 12.17 % Aerospace & Defense 6,000 5,974 5,055 (4) WP CPP Holdings, LLC First Lien Term Loan, LIBOR+3.75% cash due 4/30/2025 8.17 % Aerospace & Defense 1,980 1,913 1,732 (4) Total WP CPP Holdings, LLC 7,980 7,887 6,787 Zayo Group Holdings, Inc. First Lien Term Loan, LIBOR+3.00% cash due 3/9/2027 7.38 % Alternative Carriers 2,155 2,009 1,756 Total Portfolio Investments $ 382,148 $ 380,682 $ 355,427 _________ (1) Represents the interest rate as of December 31, 2022. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of December 31, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 4.38%, the 90-day LIBOR at 4.73%, the 30-day SOFR at 4.32%, the 90-day SOFR at 4.58% and the 180-day SOFR at 4.79%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of December 31, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of December 31, 2022. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. SLF JV I Portfolio as of September 30, 2022 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes Access CIG, LLC First Lien Term Loan, LIBOR+3.75% cash due 2/27/2025 6.82 % Diversified Support Services $ 10,093 $ 10,028 $ 9,692 ADB Companies, LLC First Lien Term Loan, SOFR+6.25% cash due 12/18/2025 9.80 % Construction & Engineering 8,518 8,389 8,371 (4) Altice France S.A. First Lien Term Loan, LIBOR+4.00% cash due 8/14/2026 6.91 % Integrated Telecommunication Services 3,000 2,841 2,730 Alvogen Pharma US, Inc. First Lien Term Loan, SOFR+7.50% cash due 6/30/2025 11.20 % Pharmaceuticals 9,267 9,166 9,221 (4) American Tire Distributors, Inc. First Lien Term Loan, LIBOR+6.25% cash due 10/20/2028 9.03 % Distributors 4,873 4,812 4,576 (4) Amplify Finco Pty Ltd. First Lien Term Loan, LIBOR+4.25% cash due 11/26/2026 7.92 % Movies & Entertainment 7,800 7,722 7,527 (4) Anastasia Parent, LLC First Lien Term Loan, LIBOR+3.75% cash due 8/11/2025 7.42 % Personal Products 1,539 1,203 1,232 (4) Apptio, Inc. First Lien Term Loan, LIBOR+6.00% cash due 1/10/2025 8.46 % Application Software 4,615 4,580 4,519 (4) Apptio, Inc. First Lien Revolver, LIBOR+6.00% cash due 1/10/2025 8.46 % Application Software 154 151 146 (4)(5) Total Apptio, Inc. 4,769 4,731 4,665 ASP-R-PAC Acquisition Co LLC First Lien Term Loan, LIBOR+6.00% cash due 12/29/2027 9.67 % Paper Packaging 4,176 4,103 4,080 ASP-R-PAC Acquisition Co LLC First Lien Revolver, LIBOR+6.00% cash due 12/29/2027 Paper Packaging — (9) (11) (5) Total ASP-R-PAC Acquisition Co LLC 4,176 4,094 4,069 Astra Acquisition Corp. First Lien Term Loan, LIBOR+5.25% cash due 10/25/2028 8.37 % Application Software 5,052 4,858 4,319 (4) Asurion, LLC First Lien Term Loan, SOFR+4.00% cash due 8/19/2028 7.70 % Property & Casualty Insurance 5,000 4,753 4,276 Asurion, LLC Second Lien Term Loan, LIBOR+5.25% cash due 1/20/2029 8.37 % Property & Casualty Insurance 4,346 3,981 3,347 Total Asurion, LLC 9,346 8,734 7,623 Aurora Lux Finco S.À.R.L. First Lien Term Loan, LIBOR+6.00% cash due 12/24/2026 8.78 % Airport Services 6,338 6,242 6,027 (4) BAART Programs, Inc. First Lien Term Loan, LIBOR+5.00% cash due 6/11/2027 8.12 % Health Care Services 6,371 6,311 6,148 BAART Programs, Inc. First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/2027 8.12 % Health Care Services 1,771 1,751 1,664 (4)(5) Total BAART Programs, Inc. 8,142 8,062 7,812 Blackhawk Network Holdings, Inc. First Lien Term Loan, LIBOR+3.00% cash due 6/15/2025 6.03 % Data Processing & Outsourced Services 9,575 9,566 8,977 BYJU's Alpha, Inc. First Lien Term Loan, LIBOR+6.00% cash due 11/24/2026 8.98 % Application Software 7,444 7,347 5,455 C5 Technology Holdings, LLC 171 Common Units Data Processing & Outsourced Services — — (4) C5 Technology Holdings, LLC 7,193,539.63 Preferred Units Data Processing & Outsourced Services 7,194 5,683 (4) Total C5 Technology Holdings, LLC 7,194 5,683 Centerline Communications, LLC First Lien Term Loan, SOFR+5.50% cash due 8/10/2027 9.12 % Wireless Telecommunication Services 4,358 4,286 4,280 Centerline Communications, LLC First Lien Delayed Draw Term Loan, SOFR+5.50% cash due 8/10/2027 9.12 % Wireless Telecommunication Services 449 432 413 (5) Centerline Communications, LLC First Lien Revolver, SOFR+5.50% cash due 8/10/2027 Wireless Telecommunication Services — (10) (11) (5) Total Centerline Communications, LLC 4,807 4,708 4,682 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes CITGO Petroleum Corp. First Lien Term Loan, LIBOR+6.25% cash due 3/28/2024 9.37 % Oil & Gas Refining & Marketing $ 7,038 $ 6,967 $ 7,057 (4) City Football Group Limited First Lien Term Loan, LIBOR+3.50% cash due 7/21/2028 6.48 % Movies & Entertainment 6,451 6,419 6,166 Convergeone Holdings, Inc. First Lien Term Loan, LIBOR+5.00% cash due 1/4/2026 8.12 % IT Consulting & Other Services 7,373 7,206 5,320 (4) Covetrus, Inc. First Lien Term Loan, SOFR+5.00% cash due 9/20/2029 7.65 % Health Care Distributors 5,375 5,053 5,035 (4) Curium Bidco S.à.r.l. First Lien Term Loan, LIBOR+4.00% cash due 7/9/2026 7.67 % Biotechnology 5,820 5,776 5,587 Dealer Tire, LLC First Lien Term Loan, LIBOR+4.25% cash due 12/12/2025 7.37 % Distributors 2,992 2,935 2,924 Delivery Hero FinCo LLC First Lien Term Loan, SOFR+5.75% cash due 8/12/2027 8.49 % Internet & Direct Marketing Retail 6,035 5,876 5,756 (4) DirecTV Financing, LLC First Lien Term Loan, LIBOR+5.00% cash due 8/2/2027 8.12 % Cable & Satellite 6,436 6,332 6,012 (4) Domtar Corporation First Lien Term Loan, LIBOR+5.50% cash due 11/30/2028 8.26 % Paper Products 4,100 4,065 3,921 DTI Holdco, Inc. First Lien Term Loan, SOFR+4.75% cash due 4/26/2029 7.33 % Research & Consulting Services 8,000 7,849 7,616 (4) Eagle Parent Corp. First Lien Term Loan, SOFR+4.25% cash due 4/1/2029 7.80 % Industrial Machinery 4,478 4,373 4,367 eResearch Technology, Inc. First Lien Term Loan, LIBOR+4.50% cash due 2/4/2027 7.62 % Application Software 7,331 7,258 6,859 Gibson Brands, Inc. First Lien Term Loan, LIBOR+5.00% cash due 8/11/2028 7.94 % Leisure Products 7,444 7,369 6,029 Global Medical Response, Inc. First Lien Term Loan, LIBOR+4.25% cash due 3/14/2025 7.37 % Health Care Services 1,979 1,979 1,722 (4) Global Medical Response, Inc. First Lien Term Loan, LIBOR+4.25% cash due 10/2/2025 6.81 % Health Care Services 2,192 2,165 1,912 Total Global Medical Response, Inc. 4,171 4,144 3,634 Harbor Purchaser Inc. First Lien Term Loan, SOFR+5.25% cash due 4/9/2029 8.38 % Education Services 8,000 7,774 7,310 (4) Indivior Finance S.À.R.L. First Lien Term Loan, SOFR+5.25% cash due 6/30/2026 8.80 % Pharmaceuticals 7,406 7,293 7,286 INW Manufacturing, LLC First Lien Term Loan, LIBOR+5.75% cash due 3/25/2027 9.42 % Personal Products 9,500 9,282 8,408 (4) Iris Holding, Inc. First Lien Term Loan, SOFR+4.75% cash due 6/28/2028 7.89 % Metal & Glass Containers 5,000 4,624 4,610 LaserAway Intermediate Holdings II, LLC First Lien Term Loan, LIBOR+5.75% cash due 10/14/2027 8.23 % Health Care Services 7,444 7,318 7,323 Lightbox Intermediate, L.P. First Lien Term Loan, LIBOR+5.00% cash due 5/9/2026 8.67 % Real Estate Services 7,367 7,315 7,109 (4) LogMeIn, Inc. First Lien Term Loan, LIBOR+4.75% cash due 8/31/2027 7.80 % Application Software 7,860 7,751 5,494 LTI Holdings, Inc. First Lien Term Loan, LIBOR+3.25% cash due 9/6/2025 6.37 % Electronic Components 7,366 7,282 6,835 Mindbody, Inc. First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/2025 10.64 % Internet Services & Infrastructure 4,687 4,651 4,570 (4) Mindbody, Inc. First Lien Revolver, LIBOR+8.00% cash due 2/14/2025 Internet Services & Infrastructure — (4) (12) (4)(5) Total Mindbody, Inc. 4,687 4,647 4,558 MRI Software LLC First Lien Term Loan, LIBOR+5.50% cash due 2/10/2026 9.17 % Application Software 6,139 6,104 5,966 (4) MRI Software LLC First Lien Revolver, LIBOR+5.50% cash due 2/10/2026 Application Software — (3) (10) (4)(5) Total MRI Software LLC 6,139 6,101 5,956 Northern Star Industries Inc. First Lien Term Loan, LIBOR+4.75% cash due 3/31/2025 7.87 % Electrical Components & Equipment 6,685 6,673 6,484 OEConnection LLC First Lien Term Loan, LIBOR+4.00% cash due 9/25/2026 7.12 % Application Software 7,777 7,741 7,505 (4) Park Place Technologies, LLC First Lien Term Loan, SOFR+5.00% cash due 11/10/2027 8.13 % Internet Services & Infrastructure 4,925 4,781 4,687 (4) Peloton Interactive, Inc. First Lien Term Loan, SOFR+6.50% cash due 5/25/2027 8.35 % Leisure Products 5,486 5,251 5,371 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes Planview Parent, Inc. Second Lien Term Loan, LIBOR+7.25% cash due 12/18/2028 10.92 % Application Software $ 4,503 $ 4,435 $ 4,323 (4) Pluralsight, LLC First Lien Term Loan, LIBOR+8.00% cash due 4/6/2027 10.68 % Application Software 6,796 6,694 6,582 (4) Pluralsight, LLC First Lien Revolver, LIBOR+8.00% cash due 4/6/2027 Application Software — (6) (13) (4)(5) Total Pluralsight, LLC 6,796 6,688 6,569 RevSpring, Inc. First Lien Term Loan, LIBOR+4.00% cash due 10/11/2025 7.67 % Commercial Printing 9,625 9,607 9,304 Sabert Corporation First Lien Term Loan, LIBOR+4.50% cash due 12/10/2026 7.63 % Metal & Glass Containers 2,536 2,511 2,435 (4) SHO Holding I Corporation First Lien Term Loan, LIBOR+5.25% cash due 4/27/2024 8.06 % Footwear 8,201 8,194 7,176 SHO Holding I Corporation First Lien Term Loan, LIBOR+5.23% cash due 4/27/2024 8.04 % Footwear 138 138 121 Total SHO Holding I Corporation 8,339 8,332 7,297 Sorenson Communications, LLC First Lien Term Loan, LIBOR+5.50% cash due 3/17/2026 9.17 % Communications Equipment 2,553 2,528 2,454 Spanx, LLC First Lien Term Loan, LIBOR+5.25% cash due 11/20/2028 8.30 % Apparel Retail 8,933 8,776 8,721 (4) SPX Flow, Inc. First Lien Term Loan, SOFR+4.50% cash due 4/5/2029 7.63 % Industrial Machinery 7,500 7,184 6,966 (4) Supermoose Borrower, LLC First Lien Term Loan, LIBOR+3.75% cash due 8/29/2025 7.42 % Application Software 7,743 7,479 6,827 (4) Surgery Center Holdings, Inc. First Lien Term Loan, LIBOR+3.75% cash due 8/31/2026 6.51 % Health Care Facilities 3,377 3,365 3,213 TIBCO Software Inc. First Lien Term Loan, SOFR+4.50% cash due 3/20/2029 8.15 % Application Software 6,256 5,693 5,629 (4) Touchstone Acquisition, Inc. First Lien Term Loan, LIBOR+6.00% cash due 12/29/2028 9.12 % Health Care Supplies 7,285 7,155 7,140 (4) Veritas US Inc. First Lien Term Loan, LIBOR+5.00% cash due 9/1/2025 8.67 % Application Software 6,365 6,290 5,087 Windstream Services II, LLC First Lien Term Loan, LIBOR+6.25% cash due 9/21/2027 9.37 % Integrated Telecommunication Services 7,818 7,596 7,115 (4) WP CPP Holdings, LLC Second Lien Term Loan, LIBOR+7.75% cash due 4/30/2026 10.56 % Aerospace & Defense 6,000 5,972 5,070 (4) WP CPP Holdings, LLC First Lien Term Loan, LIBOR+3.75% cash due 4/30/2025 6.56 % Aerospace & Defense 1,985 1,910 1,783 (4) Total WP CPP Holdings, LLC 7,985 7,882 6,853 Zayo Group Holdings, Inc. First Lien Term Loan, LIBOR+3.00% cash due 3/9/2027 6.12 % Alternative Carriers 2,155 2,000 1,812 Total Portfolio Investments $ 383,194 $ 382,673 $ 359,625 _________ (1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55% and the 180-day SOFR at 3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of September 30, 2022. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. Glick JV Portfolio as of December 31, 2022 Portfolio Company Investment Type Cash Interest Rate (1)(2) Industry Principal Cost Fair Value (3) Notes ADB Companies, LLC First Lien Term Loan, SOFR+6.25% cash due 12/18/2025 11.34% Construction & Engineering $ 4,589 $ 4,528 $ 4,510 (4) Alvogen Pharma Inc First Lien Term Loan, SOFR+7.50% cash due 6/30/2025 12.23% Pharmaceuticals 6,479 6,413 6,447 (4) Alvogen Pharma Inc First Lien Term Loan, LIBOR+4.00% cash due 6/9/2028 8.38% Diversified Metals & Mining 997 918 941 Total Alvogen Pharma Inc 7,476 7,331 7,388 American Tire Distributors, Inc. First Lien Term Loan, LIBOR+6.25% cash due 10/20/2028 10.61% Distributors 2,882 2,846 2,652 (4) Amplify Finco Pty Ltd. First Lien Term Loan, LIBOR+4.25% cash due 11/26/2026 8.98% Movies & Entertainment 2,918 2,888 2,813 (4) Anastasia Parent, LLC First Lien Term Loan, L
Schedule of Financial Instruments Carried at Fair Value	The following table presents the financial instruments carried at fair value as of December 31, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 233,393 $ 2,047,842 $ — $ 2,281,235 Investments in debt securities (subordinated, including the debt investments in the JVs) — 44,706 179,631 — 224,337 Investments in equity securities (preferred) — — 80,625 — 80,625 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 5,923 — 26,642 24,108 56,673 Total investments at fair value 5,923 278,099 2,334,740 24,108 2,642,870 Cash equivalents 3,421 — — — 3,421 Total assets at fair value $ 9,344 $ 278,099 $ 2,334,740 $ 24,108 $ 2,646,291 Derivative liability $ — $ 44,139 $ — $ — $ 44,139 Total liabilities at fair value $ — $ 44,139 $ — $ — $ 44,139 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 255,803 $ 1,910,606 $ — $ 2,166,409 Investments in debt securities (subordinated, including the debt investments in the JVs) — 44,065 159,388 — 203,453 Investments in equity securities (preferred) — — 79,523 — 79,523 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,053 — 19,958 20,715 44,726 Total investments at fair value 4,053 299,868 2,169,475 20,715 2,494,111 Cash equivalents 5,261 — — — 5,261 Derivative assets — 6,789 — — 6,789 Total assets at fair value $ 9,314 $ 306,657 $ 2,169,475 $ 20,715 $ 2,506,161 Derivative liability $ — $ 41,969 $ — $ — $ 41,969 Total liabilities at fair value $ — $ 41,969 $ — $ — $ 41,969 __________
Roll-Forward in the Changes in Fair Value	The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases 177,599 21,104 2,579 2,181 203,463 Sales and repayments (55,885) (699) — (48) (56,632) Transfers in (a) 19,075 — — — 19,075 Capitalized PIK interest income 5,763 6 — — 5,769 Accretion of OID 4,114 398 — — 4,512 Net unrealized appreciation (depreciation) (12,271) (566) (1,477) 4,505 (9,809) Net realized gains (losses) (1,159) — — 46 (1,113) Fair value as of December 31, 2022 $ 2,047,842 $ 179,631 $ 80,625 $ 26,642 $ 2,334,740 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022 $ (12,398) $ (566) $ (1,477) $ 4,505 $ (9,936) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward in the changes in fair value from September 30, 2021 to December 31, 2021 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2021 $ 1,878,536 $ 176,317 $ 63,565 $ 43,163 $ 2,161,581 Purchases 191,087 3,589 979 1,441 197,096 Sales and repayments (131,946) (20,185) — (6,503) (158,634) Transfers in (a) 3,178 — — — 3,178 Transfers out (a) (17,070) — — — (17,070) Capitalized PIK interest income 6,172 313 — — 6,485 Accretion of OID 5,378 819 — — 6,197 Net unrealized appreciation (depreciation) (9,877) 516 1,006 6,636 (1,719) Net realized gains (losses) 8,638 — — (2,795) 5,843 Fair value as of December 31, 2021 $ 1,934,096 $ 161,369 $ 65,550 $ 41,942 $ 2,202,957 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2021 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2021 $ (717) $ 368 $ 1,006 $ 1,139 $ 1,796 __________ (a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the three months ended December 31, 2021 as a result of a change in the number of market quotes available and/or a change in market liquidity.
Schedule of Significant Unobservable Inputs for Level 3 Investments	The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2022: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,692,264 Market Yield Market Yield (b) 9.0% - 33.0% 14.0% 14,297 Enterprise Value EBITDA Multiple (c) 5.0x - 7.0x 6.0x 38,581 Transaction Precedent Transaction Price (d) N/A - N/A N/A 302,700 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 13,706 Market Yield Market Yield (b) 10.0% - 20.0% 11.4% 3,733 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,192 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 30,226 Enterprise Value Revenue Multiple (c) 0.1x - 4.3x 0.5x 73,822 Enterprise Value EBITDA Multiple (c) 3.0x - 20.0x 14.6x 1,600 Enterprise Value Asset Multiple (c) 0.9x - 1.1x 1.0x 1,619 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,334,740 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,599,148 Market Yield Market Yield (b) 9.0% - 30.0% 13.7% 14,333 Enterprise Value EBITDA Multiple (c) 5.0x - 7.0x 6.0x 297,125 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 12,855 Market Yield Market Yield (b) 10.0% - 19.0% 13.8% Debt Investments in the JVs 146,533 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 61,693 Enterprise Value Revenue Multiple (c) 0.4x - 10.1x 4.3x 36,913 Enterprise Value EBITDA Multiple (c) 3.0x - 20.0x 11.4x 3 Enterprise Value Asset Multiple (c) 0.9x - 1.1x 1.0x 872 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,169,475 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.
Fair Value Disclosure of Asset and Liability Not Measured at Fair Value	The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2022 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 695,000 $ 695,000 $ — $ — $ 695,000 Citibank Facility payable 165,000 165,000 — — 165,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 297,303 286,734 — 286,734 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 306,321 296,835 — 296,835 — Total $ 1,463,624 $ 1,443,569 $ — $ 583,569 $ 860,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 540,000 $ 540,000 $ — $ — $ 540,000 Citibank Facility payable 160,000 160,000 — — 160,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 296,991 283,077 — 283,077 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 304,052 294,028 — 294,028 — Total $ 1,301,043 $ 1,277,105 $ — $ 577,105 $ 700,000
Portfolio Composition	Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,359,295 84.94 % $ 2,227,245 85.08 % Debt investments in the JVs 162,617 5.85 % 146,444 5.59 % Preferred equity 87,878 3.16 % 85,300 3.26 % Subordinated debt 68,956 2.48 % 67,147 2.57 % LLC equity interests of the JVs 54,791 1.97 % 49,322 1.88 % Common equity and warrants 44,477 1.60 % 42,296 1.62 % Total $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,281,235 86.32 % 189.78 % $ 2,166,409 86.86 % 173.93 % Debt investments in the JVs 162,192 6.14 % 13.49 % 146,533 5.88 % 11.77 % Preferred equity 80,625 3.05 % 6.71 % 79,523 3.19 % 6.38 % Subordinated debt 62,145 2.35 % 5.17 % 56,920 2.28 % 4.57 % Common equity and warrants 32,565 1.23 % 2.71 % 24,011 0.96 % 1.93 % LLC equity interests of the JVs 24,108 0.91 % 2.01 % 20,715 0.83 % 1.66 % Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Northeast $ 772,197 27.78 % $ 747,420 28.55 % Midwest 403,393 14.52 % 373,236 14.26 % Southeast 397,717 14.32 % 356,041 13.60 % West 351,871 12.67 % 358,306 13.69 % International 350,510 12.62 % 301,242 11.51 % Southwest 204,143 7.35 % 221,308 8.45 % South 164,094 5.91 % 168,819 6.45 % Northwest 134,089 4.83 % 91,382 3.49 % Total $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 716,827 27.12 % 59.63 % $ 696,368 27.93 % 55.90 % Midwest 384,219 14.54 % 31.97 % 356,934 14.31 % 28.66 % Southeast 380,276 14.39 % 31.64 % 344,567 13.82 % 27.66 % International 342,447 12.96 % 28.49 % 279,646 11.21 % 22.45 % West 330,698 12.51 % 27.51 % 345,251 13.84 % 27.72 % Southwest 195,818 7.41 % 16.29 % 214,984 8.62 % 17.26 % South 160,150 6.06 % 13.32 % 166,230 6.66 % 13.35 % Northwest 132,435 5.01 % 11.02 % 90,131 3.61 % 7.24 % Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $20.38 $21.84 Net investment income (1) 0.63 0.54 Net unrealized appreciation (depreciation) (1) (0.38) (0.08) Net realized gains (losses) (1) (0.05) 0.16 (Provision) benefit for taxes on realized and unrealized gains (losses) (1) 0.01 0.04 Distributions of net investment income to stockholders (0.96) (0.47) Net asset value per share at end of period $19.63 $22.03 Per share market value at beginning of period (7) $18.00 $21.18 Per share market value at end of period (7) $20.61 $22.38 Total return (2) 19.90% 7.92% Common shares outstanding at beginning of period 61,125 60,120 Common shares outstanding at end of period 61,220 60,156 Net assets at beginning of period $1,245,563 $1,312,823 Net assets at end of period $1,201,989 $1,325,061 Average net assets (3) $1,241,806 $1,327,934 Ratio of net investment income to average net assets (4) 12.40% 9.65% Ratio of total expenses to average net assets (4) 13.11% 8.99% Ratio of net expenses to average net assets (4) 12.87% 8.77% Ratio of portfolio turnover to average investments at fair value 4.24% 9.14% Weighted average outstanding debt (5) $1,441,326 $1,331,141 Average debt per share (1) $23.57 $22.14 Asset coverage ratio at end of period (6) 176.31% 200.81% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Interim periods are annualized. (5) Calculated based upon the weighted average of principal debt outstanding for the period. (6) Based on outstanding senior securities of $1,514.4 million and $1,300.0 million as of December 31, 2022 and 2021, respectively. (7) Per share market values are adjusted to reflect the 1-for-3 reverse stock split of the Company's common stock completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (8) The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Share Data and Net Assets (Tabl

Share Data and Net Assets (Tables)	3 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three months ended December 31, 2022 and 2021: (Share amounts in thousands) Three months ended Three months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 13,172 $ 39,408 Weighted average common shares outstanding — basic and diluted 61,142 60,127 Earnings (loss) per common share — basic and diluted $ 0.22 $ 0.66
Schedule of Changes in Net Assets	The following table presents the changes in net assets for the three months ended December 31, 2022: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 The following table presents the changes in net assets for the three months ended December 31, 2021: Common Stock Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2021 60,120 $ 601 $ 1,805,557 $ (493,335) $ 1,312,823 Net investment income — — — 32,295 32,295 Net unrealized appreciation (depreciation) — — — (4,586) (4,586) Net realized gains (losses) — — — 9,321 9,321 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 2,378 2,378 Distributions to stockholders — — — (27,956) (27,956) Issuance of common stock under dividend reinvestment plan 36 1 785 — 786 Balance as of December 31, 2021 60,156 $ 602 $ 1,806,342 $ (481,883) $ 1,325,061
Schedule of Distributions	The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2022 and 2021: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 $ 0.42 $ 24.8 million 41,510 (1) $ 0.8 million Total for the three months ended December 31, 2022 $ 0.96 $ 56.8 million 94,879 $ 1.9 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly October 13, 2021 December 15, 2021 December 31, 2021 $ 0.465 $ 27.2 million 35,990 (1) $ 0.8 million Total for the three months ended December 31, 2021 $ 0.465 $ 27.2 million 35,990 $ 0.8 million __________ (1) New shares were issued and distributed.

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Components of Debt	The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of December 31, 2022 and September 30, 2022: As of December 31, 2022 As of September 30, 2022 ($ in millions) 2025 Notes 2027 Notes 2025 Notes 2027 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 350.0 Unamortized financing costs (1.6) (3.1) (1.8) (3.2) Unaccreted discount (1.1) (0.7) (1.2) (0.7) Interest rate swap fair value adjustment — (39.9) — (42.0) Net carrying value $ 297.3 $ 306.3 $ 297.0 $ 304.1 Fair Value $ 286.7 $ 296.8 $ 283.1 $ 294.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — 2.5 Total interest expense $ 2.9 $ 5.1 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 5.586 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2021: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — (0.7) Total interest expense $ 2.9 $ 1.9 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 1.782 %

Taxable_Distributable Income _2

Taxable/Distributable Income and Dividend Distributions (Tables)	3 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations	Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2022 and 2021. Three months ended Three months ended Net increase (decrease) in net assets resulting from operations $ 13,172 $ 39,408 Net unrealized (appreciation) depreciation 22,982 4,586 Book/tax difference due to organizational costs — (22) Book/tax difference due to capital losses utilized 8,013 (10,531) Other book/tax differences (12,910) (11,171) Taxable/Distributable Income (1) $ 31,257 $ 22,270
Components of Accumulated Overdistributed Earnings	As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ (43,624) Net realized capital losses 473,274 Unrealized losses, net 153,119 Accumulated overdistributed earnings $ 582,769

Realized Gains or Losses and _2

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables)	3 Months Ended
	Dec. 31, 2022
Investment Company [Abstract]
Schedule of Aggregate Net Realized Gains	During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 4.4 Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) Global Medical Response Inc. (1.0) Other, net (1.7) Total, net $ (3.2) During the three months ended December 31, 2021, the Company recorded an aggregate net realized gain of $9.3 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 3.0 OmniSYS Acquisition Corporation 2.0 First Star Speir Aviation Limited 1.9 Other, net 2.4 Total, net $ 9.3

Financial Highlights (Tables)

Financial Highlights (Tables)	3 Months Ended
	Dec. 31, 2022
Investment Company [Abstract]
Portfolio Composition	Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,359,295 84.94 % $ 2,227,245 85.08 % Debt investments in the JVs 162,617 5.85 % 146,444 5.59 % Preferred equity 87,878 3.16 % 85,300 3.26 % Subordinated debt 68,956 2.48 % 67,147 2.57 % LLC equity interests of the JVs 54,791 1.97 % 49,322 1.88 % Common equity and warrants 44,477 1.60 % 42,296 1.62 % Total $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,281,235 86.32 % 189.78 % $ 2,166,409 86.86 % 173.93 % Debt investments in the JVs 162,192 6.14 % 13.49 % 146,533 5.88 % 11.77 % Preferred equity 80,625 3.05 % 6.71 % 79,523 3.19 % 6.38 % Subordinated debt 62,145 2.35 % 5.17 % 56,920 2.28 % 4.57 % Common equity and warrants 32,565 1.23 % 2.71 % 24,011 0.96 % 1.93 % LLC equity interests of the JVs 24,108 0.91 % 2.01 % 20,715 0.83 % 1.66 % Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2022 September 30, 2022 Cost: % of Total Investments % of Total Investments Northeast $ 772,197 27.78 % $ 747,420 28.55 % Midwest 403,393 14.52 % 373,236 14.26 % Southeast 397,717 14.32 % 356,041 13.60 % West 351,871 12.67 % 358,306 13.69 % International 350,510 12.62 % 301,242 11.51 % Southwest 204,143 7.35 % 221,308 8.45 % South 164,094 5.91 % 168,819 6.45 % Northwest 134,089 4.83 % 91,382 3.49 % Total $ 2,778,014 100.00 % $ 2,617,754 100.00 % December 31, 2022 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 716,827 27.12 % 59.63 % $ 696,368 27.93 % 55.90 % Midwest 384,219 14.54 % 31.97 % 356,934 14.31 % 28.66 % Southeast 380,276 14.39 % 31.64 % 344,567 13.82 % 27.66 % International 342,447 12.96 % 28.49 % 279,646 11.21 % 22.45 % West 330,698 12.51 % 27.51 % 345,251 13.84 % 27.72 % Southwest 195,818 7.41 % 16.29 % 214,984 8.62 % 17.26 % South 160,150 6.06 % 13.32 % 166,230 6.66 % 13.35 % Northwest 132,435 5.01 % 11.02 % 90,131 3.61 % 7.24 % Total $ 2,642,870 100.00 % 219.87 % $ 2,494,111 100.00 % 200.24 % (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $20.38 $21.84 Net investment income (1) 0.63 0.54 Net unrealized appreciation (depreciation) (1) (0.38) (0.08) Net realized gains (losses) (1) (0.05) 0.16 (Provision) benefit for taxes on realized and unrealized gains (losses) (1) 0.01 0.04 Distributions of net investment income to stockholders (0.96) (0.47) Net asset value per share at end of period $19.63 $22.03 Per share market value at beginning of period (7) $18.00 $21.18 Per share market value at end of period (7) $20.61 $22.38 Total return (2) 19.90% 7.92% Common shares outstanding at beginning of period 61,125 60,120 Common shares outstanding at end of period 61,220 60,156 Net assets at beginning of period $1,245,563 $1,312,823 Net assets at end of period $1,201,989 $1,325,061 Average net assets (3) $1,241,806 $1,327,934 Ratio of net investment income to average net assets (4) 12.40% 9.65% Ratio of total expenses to average net assets (4) 13.11% 8.99% Ratio of net expenses to average net assets (4) 12.87% 8.77% Ratio of portfolio turnover to average investments at fair value 4.24% 9.14% Weighted average outstanding debt (5) $1,441,326 $1,331,141 Average debt per share (1) $23.57 $22.14 Asset coverage ratio at end of period (6) 176.31% 200.81% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Interim periods are annualized. (5) Calculated based upon the weighted average of principal debt outstanding for the period. (6) Based on outstanding senior securities of $1,514.4 million and $1,300.0 million as of December 31, 2022 and 2021, respectively. (7) Per share market values are adjusted to reflect the 1-for-3 reverse stock split of the Company's common stock completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (8) The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Foreign Currency Forward Contracts and Interest Rate Swap	Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2022. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 44,825 € 44,224 2/9/2023 $ — $ (2,499) Derivative liability Foreign currency forward contract $ 46,412 £ 39,965 2/9/2023 $ — $ (1,712) Derivative liability $ — $ (4,211) Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 43,179 € 41,444 11/10/2022 $ 2,466 $ — Derivative asset Foreign currency forward contract $ 45,692 £ 37,033 11/10/2022 $ 4,323 $ — Derivative asset $ 6,789 $ — Certain information related to the Company’s interest rate swap is presented below as of December 31, 2022. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 39,928 Derivative liability $ — $ 39,928 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 41,969 Derivative liability $ — $ 41,969

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Unfunded Commitments	A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of December 31, 2022 and September 30, 2022 is shown in the table below: December 31, 2022 September 30, 2022 Delta Leasing SPV II LLC $ 23,004 $ 27,187 Fairbridge Strategic Capital Funding LLC 15,995 22,150 OCSI Glick JV LLC 13,998 13,998 Senior Loan Fund JV I, LLC 13,125 35,000 BioXcel Therapeutics, Inc. 11,785 11,785 Dominion Diagnostics, LLC 11,148 11,148 BAART Programs, Inc. 7,675 8,645 iCIMs, Inc. 6,930 6,930 Marinus Pharmaceuticals, Inc. 5,734 5,734 scPharmaceuticals Inc. 5,212 — Assembled Brands Capital LLC 5,035 2,008 RumbleOn, Inc. 4,822 4,822 MRI Software LLC 4,427 5,196 107 Fair Street LLC 4,322 — Grove Hotel Parcel Owner, LLC 4,293 4,293 Accupac, Inc. 4,197 4,605 Innocoll Pharmaceuticals Limited 4,195 4,195 Avalara, Inc. 4,147 — Mindbody, Inc. 4,000 4,000 OTG Management, LLC 3,789 3,789 Mesoblast, Inc. 3,553 3,553 Establishment Labs Holdings Inc. 3,384 5,075 112-126 Van Houten Real22 LLC 3,174 — ADC Therapeutics SA 3,020 3,020 Spanx, LLC 2,762 2,226 PRGX Global, Inc. 2,518 2,518 SCP Eye Care Services, LLC 2,356 — Relativity ODA LLC 2,218 2,218 Berner Food & Beverage, LLC 2,197 1,392 Salus Workers' Compensation, LLC 2,171 — Pluralsight, LLC 1,766 3,532 Tahoe Bidco B.V. 1,741 1,741 CorEvitas, LLC 1,526 915 Coyote Buyer, LLC 1,333 1,333 MHE Intermediate Holdings, LLC 1,229 1,429 Kings Buyer, LLC 1,208 1,537 Liquid Environmental Solutions Corporation 1,115 1,115 Acquia Inc. 923 1,326 Apptio, Inc. 892 1,338 Digital.AI Software Holdings, Inc. 826 826 Telestream Holdings Corporation 528 528 GKD Index Partners, LLC 320 320 PFNY Holdings, LLC 275 1,527 Ardonagh Midco 3 PLC — 4,372 Dialyze Holdings, LLC — 3,431 Thrasio, LLC — 2,578 109 Montgomery Owner LLC — 477 LSL Holdco, LLC — 427 Total $ 198,868 $ 224,239

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022
Accounting Policies [Abstract]
Restricted cash	$ 1,863		$ 2,836
Excise tax	$ 78	$ 0	$ 100

Portfolio Investments - Narrati

Portfolio Investments - Narrative (Details)	3 Months Ended			12 Months Ended
	Dec. 31, 2022 USD ($) member borrower		Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) borrower		Sep. 30, 2021 USD ($)	May 18, 2021	Feb. 25, 2020
Investment Company, Nonconsolidated Subsidiary [Line Items]
% of Total Net Assets	219.87%	[1],[2],[3],[4],[5]		200.24%	[6],[7],[8],[9],[10]
Investments at fair value	$ 2,642,870,000			$ 2,494,111,000
Number of borrowers | borrower	156			149
Money market funds, percent of net assets	1.60%	[1],[2],[3],[4],[5]		2.10%	[6],[7],[8],[9],[10]
Cash, cash equivalents and restricted cash	$ 19,245,000		$ 46,057,000	$ 26,364,000		$ 31,635,000
Restricted cash	1,863,000			2,836,000
Net realized gains (losses)	(3,203,000)		9,321,000
Net unrealized appreciation (depreciation)	(22,982,000)		(4,586,000)
Credit facilities payable	860,000,000			700,000,000
Assets	2,767,260,000			2,646,313,000
Unfunded commitments	198,868,000			224,239,000
Investment owned, at cost	2,778,014,000			2,617,754,000
Senior Loan Fund JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	136,764,000			116,965,000
Investment owned, at cost	167,447,000			145,572,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	49,536,000			50,283,000
Investment owned, at cost	$ 49,961,000			$ 50,194,000
Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	100%			100%
Debt Securities, Senior Secured
Investment Company, Nonconsolidated Subsidiary [Line Items]
% of Total Net Assets	189.78%			173.93%
Investments at fair value	$ 2,281,235,000			$ 2,166,409,000
Investment owned, at cost	$ 2,359,295,000			$ 2,227,245,000
Debt Securities, Senior Secured | Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	86.32%			86.86%
Debt Securities, Subordinated, Including JV Debt Instruments
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 224,337,000			$ 203,453,000
Debt Securities, Subordinated, Including JV Debt Instruments | Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	8.50%			8.10%
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 136,800,000			$ 117,000,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	49,500,000			50,300,000
Investment owned, at cost	$ 50,000,000			50,200,000
2025 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	3.50%							3.50%
2027 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	2.70%						2.70%
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 355,427,000			$ 359,625,000
Number of borrowers | borrower	59			60
Restricted cash	$ 6,612,000			$ 5,642,000
Number of board of directors | member	4
Number of board of directors selected by company | member	2
Number of board of directors selected by counterparty | member	2
Number of investment committee members selected by company | member	1
Number of investment committee members selected by counterparty | member	1
Investment owned, ownership percentage	87.50%			87.50%
Credit facilities payable	$ 226,000,000			$ 230,000,000
Assets	409,404,000			385,227,000
Financial support funded by company and counterparty	190,500,000			165,500,000
Financial support funded by company for investee	166,700,000			144,800,000
Unfunded commitments	13,100,000			35,000,000
Investment owned, at cost	380,682,000			382,673,000
Interest income	8,781,000		5,423,000
Investments sold	13,500,000		9,700,000
Proceeds from sale of investments	12,900,000		9,700,000
Gain (loss) on sale of investments	(100,000)		500,000
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	260,000,000			260,000,000
Credit facilities payable	$ 226,000,000			$ 230,000,000
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | London Interbank Offered Rate, Floor
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	0.125%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | During The Reinvestment Period | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | First Year After Reinvestment Period | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.15%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Second Year After Reinvestment Period | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.25%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Third Year After Reinvestment Period, And There After | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.50%
SLF JV I | Kemper
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, ownership percentage	12.50%			12.50%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 123,339,000			$ 133,144,000
Number of borrowers | borrower	40			43
Restricted cash	$ 1,747,000			$ 1,788,000
Number of board of directors | member	4
Number of board of directors selected by company | member	2
Number of board of directors selected by counterparty | member	2
Number of investment committee members selected by company | member	1
Number of investment committee members selected by counterparty | member	1
Credit facilities payable	$ 76,082,000			82,082,000
Assets	137,455,000			146,808,000
Financial support funded by company and counterparty	84,000,000			84,000,000
Financial support funded by company for investee	73,500,000			73,500,000
Investment owned, at cost	131,077,000			140,083,000
Interest income	3,403,000		$ 2,160,000
Financial commitment to investee by company and counterparty, aggregate amount	100,000,000			100,000,000
Financial commitment to investee, aggregate amount	87,500,000			87,500,000
Financial commitment to investee by counterparty, aggregate amount	12,500,000			12,500,000
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	90,000,000
Credit facilities payable	$ 76,100,000			$ 82,100,000
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | London Interbank Offered Rate, Floor
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	0.125%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | During The Reinvestment Period | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.25%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | First Year After Reinvestment Period | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.40%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Second Year After Reinvestment Period | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.50%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Third Year After Reinvestment Period, And There After | London Interbank Offered Rate (LIBOR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.75%
[1]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[2]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[3]Equity ownership may be held in shares or units of companies related to the portfolio companies.[4]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[5]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[6]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[7]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[8]Equity ownership may be held in shares or units of companies related to the portfolio companies.[9]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[10]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

Portfolio Investments - Composi

Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,778,014	$ 2,617,754
Investments at fair value	2,642,870	2,494,111
Debt investments, fair value	$ 2,505,572	$ 2,369,862
% of Debt Portfolio	100%	100%
Investments in debt securities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,428,251	$ 2,294,392
Investments at fair value	2,343,380	2,223,329
Investments in equity securities
Schedule of Investments [Line Items]
Investment owned, at cost	132,355	127,596
Investments at fair value	113,190	103,534
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	162,617	146,444
Investments at fair value	162,192	146,533
Equity investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	54,791	49,322
Investments at fair value	24,108	20,715
Floating rate debt securities, including the debt investments in the JVs
Schedule of Investments [Line Items]
Debt investments, fair value	$ 317,379	$ 2,049,644
% of Debt Portfolio	87.33%	86.49%
Fixed rate debt securities
Schedule of Investments [Line Items]
Debt investments, fair value	$ 2,188,193	$ 320,218
% of Debt Portfolio	12.67%	13.51%

Portfolio Investments - Schedul

Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Schedule of Investments [Line Items]
Investments at fair value	$ 2,642,870	$ 2,494,111
Cash equivalents	3,421	5,261
Derivative assets at fair value	0	6,789
Total assets at fair value	2,646,291	2,506,161
Derivative liability at fair value	44,139	41,969
Total liabilities at fair value	44,139	41,969
Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	2,281,235	2,166,409
Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	224,337	203,453
Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	80,625	79,523
Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	56,673	44,726
Level 1
Schedule of Investments [Line Items]
Investments at fair value	5,923	4,053
Cash equivalents	3,421	5,261
Derivative assets at fair value		0
Total assets at fair value	9,344	9,314
Derivative liability at fair value	0	0
Total liabilities at fair value	0	0
Level 1 | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	5,923	4,053
Level 2
Schedule of Investments [Line Items]
Investments at fair value	278,099	299,868
Cash equivalents	0	0
Derivative assets at fair value		6,789
Total assets at fair value	278,099	306,657
Derivative liability at fair value	44,139	41,969
Total liabilities at fair value	44,139	41,969
Level 2 | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	233,393	255,803
Level 2 | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	44,706	44,065
Level 2 | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 2 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 3
Schedule of Investments [Line Items]
Investments at fair value	2,334,740	2,169,475
Cash equivalents	0	0
Derivative assets at fair value		0
Total assets at fair value	2,334,740	2,169,475
Derivative liability at fair value	0	0
Total liabilities at fair value	0	0
Level 3 | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	2,047,842	1,910,606
Level 3 | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	179,631	159,388
Level 3 | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	80,625	79,523
Level 3 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	26,642	19,958
Fair Value Measured at Net Asset Value Per Share
Schedule of Investments [Line Items]
Investments at fair value	24,108	20,715
Cash equivalents	0	0
Derivative assets at fair value		0
Total assets at fair value	24,108	20,715
Derivative liability at fair value	0	0
Total liabilities at fair value	0
Fair Value Measured at Net Asset Value Per Share | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	0	0
Total liabilities at fair value		0
Fair Value Measured at Net Asset Value Per Share | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	$ 24,108	$ 20,715

Portfolio Investments - Roll-Fo

Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	$ 2,169,475	$ 2,161,581
Purchases	203,463	197,096
Sales and repayments	(56,632)	(158,634)
Transfers in	19,075	3,178
Transfers out		(17,070)
Capitalized PIK interest income	5,769	6,485
Accretion of OID	4,512	6,197
Fair value, ending balance	2,334,740	2,202,957
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022	(9,936)	1,796
Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(9,809)	(1,719)
Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,113)	5,843
Debt Securities, Senior Secured
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	1,910,606	1,878,536
Purchases	177,599	191,087
Sales and repayments	(55,885)	(131,946)
Transfers in	19,075	3,178
Transfers out		(17,070)
Capitalized PIK interest income	5,763	6,172
Accretion of OID	4,114	5,378
Fair value, ending balance	2,047,842	1,934,096
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022	(12,398)	(717)
Debt Securities, Senior Secured | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(12,271)	(9,877)
Debt Securities, Senior Secured | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,159)	8,638
Debt Securities, Subordinated
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	159,388	176,317
Purchases	21,104	3,589
Sales and repayments	(699)	(20,185)
Transfers in	0	0
Transfers out		0
Capitalized PIK interest income	6	313
Accretion of OID	398	819
Fair value, ending balance	179,631	161,369
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022	(566)	368
Debt Securities, Subordinated | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(566)	516
Debt Securities, Subordinated | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0
Equity Securities, Preferred
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	79,523	63,565
Purchases	2,579	979
Sales and repayments	0	0
Transfers in	0	0
Transfers out		0
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	80,625	65,550
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022	(1,477)	1,006
Equity Securities, Preferred | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,477)	1,006
Equity Securities, Preferred | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0
Equity Securities, Common And Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	19,958	43,163
Purchases	2,181	1,441
Sales and repayments	(48)	(6,503)
Transfers in	0	0
Transfers out		0
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	26,642	41,942
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022	4,505	1,139
Equity Securities, Common And Warrants | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	4,505	6,636
Equity Securities, Common And Warrants | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 46	$ (2,795)

Portfolio Investments - Signifi

Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 2,642,870	$ 2,494,111
Debt Securities, Senior Secured
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,281,235	2,166,409
Debt investments in the JVs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	162,192	146,533
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,334,740	2,169,475
Level 3 | Debt Securities, Senior Secured
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,047,842	1,910,606
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,692,264	$ 1,599,148
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.090	0.090
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.330	0.300
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.140	0.137
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 14,297	$ 14,333
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	5	5
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7	7
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	6	6
Level 3 | Debt Securities, Senior Secured | Valuation, Transaction Precedent | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 38,581
Level 3 | Debt Securities, Senior Secured | Valuation, Broker Quotations | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value		$ 297,125
Level 3 | Debt Securities, Senior Secured | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	302,700
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 13,706	$ 12,855
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.100	0.100
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.200	0.190
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.114	0.138
Level 3 | Subordinated Debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 3,733
Level 3 | Debt investments in the JVs | Valuation, Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	162,192	$ 146,533
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 73,822	$ 36,913
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3	3
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	20	20
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	14.6	11.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 30,226	$ 61,693
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1	0.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	4.3	10.1
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.5	4.3
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,600	$ 3
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.9	0.9
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.1	1.1
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1	1
Level 3 | Equity Securities, Preferred & Common | Valuation, Transaction Precedent | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,619	$ 872

Portfolio Investments - Sched_2

Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Schedule of Investments [Line Items]
Carrying Value	$ 1,463,624	$ 1,301,043
Fair Value	1,443,569	1,277,105
Syndicated Facility
Schedule of Investments [Line Items]
Carrying Value	695,000	540,000
Fair Value	695,000	540,000
Citibank Facility
Schedule of Investments [Line Items]
Carrying Value	165,000	160,000
Fair Value	165,000	160,000
2025 Notes
Schedule of Investments [Line Items]
Carrying Value	297,303	296,991
Fair Value	286,734	283,077
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	306,321	304,052
Fair Value	296,835	294,028
Level 1
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Fair Value	583,569	577,105
Level 2 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	286,734	283,077
Level 2 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	296,835	294,028
Level 3
Schedule of Investments [Line Items]
Fair Value	860,000	700,000
Level 3 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	695,000	540,000
Level 3 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value	165,000	160,000
Level 3 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	$ 0	$ 0

Portfolio Investments - Portfol

Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2022		Sep. 30, 2022
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,778,014		$ 2,617,754
Investments at fair value	$ 2,642,870		$ 2,494,111
% of Total Net Assets	219.87%	[1],[2],[3],[4],[5]	200.24%	[6],[7],[8],[9],[10]
Northeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 772,197		$ 747,420
Investments at fair value	$ 716,827		$ 696,368
% of Total Net Assets	59.63%		55.90%
Midwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 403,393		$ 373,236
Investments at fair value	$ 384,219		$ 356,934
% of Total Net Assets	31.97%		28.66%
Southeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 397,717		$ 356,041
Investments at fair value	$ 380,276		$ 344,567
% of Total Net Assets	31.64%		27.66%
West
Schedule of Investments [Line Items]
Investment owned, at cost	$ 351,871		$ 358,306
Investments at fair value	$ 342,447		$ 279,646
% of Total Net Assets	28.49%		22.45%
International
Schedule of Investments [Line Items]
Investment owned, at cost	$ 350,510		$ 301,242
Investments at fair value	$ 330,698		$ 345,251
% of Total Net Assets	27.51%		27.72%
Southwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 204,143		$ 221,308
Investments at fair value	$ 195,818		$ 214,984
% of Total Net Assets	16.29%		17.26%
South
Schedule of Investments [Line Items]
Investment owned, at cost	$ 164,094		$ 168,819
Investments at fair value	$ 160,150		$ 166,230
% of Total Net Assets	13.32%		13.35%
Northwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 134,089		$ 91,382
Investments at fair value	$ 132,435		$ 90,131
% of Total Net Assets	11.02%		7.24%
Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%		100%
Investment Owned, At Cost | Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%		100%
Investment Owned, At Cost | Geographic Concentration Risk | Northeast
Schedule of Investments [Line Items]
Concentration risk	27.78%		28.55%
Investment Owned, At Cost | Geographic Concentration Risk | Midwest
Schedule of Investments [Line Items]
Concentration risk	14.52%		14.26%
Investment Owned, At Cost | Geographic Concentration Risk | Southeast
Schedule of Investments [Line Items]
Concentration risk	14.32%		13.60%
Investment Owned, At Cost | Geographic Concentration Risk | West
Schedule of Investments [Line Items]
Concentration risk	12.67%		13.69%
Investment Owned, At Cost | Geographic Concentration Risk | International
Schedule of Investments [Line Items]
Concentration risk	12.62%		11.51%
Investment Owned, At Cost | Geographic Concentration Risk | Southwest
Schedule of Investments [Line Items]
Concentration risk	7.35%		8.45%
Investment Owned, At Cost | Geographic Concentration Risk | South
Schedule of Investments [Line Items]
Concentration risk	5.91%		6.45%
Investment Owned, At Cost | Geographic Concentration Risk | Northwest
Schedule of Investments [Line Items]
Concentration risk	4.83%		3.49%
Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%		100%
Investment Owned, At Fair Value | Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%		100%
Investment Owned, At Fair Value | Geographic Concentration Risk | Northeast
Schedule of Investments [Line Items]
Concentration risk	27.12%		27.93%
Investment Owned, At Fair Value | Geographic Concentration Risk | Midwest
Schedule of Investments [Line Items]
Concentration risk	14.54%		14.31%
Investment Owned, At Fair Value | Geographic Concentration Risk | Southeast
Schedule of Investments [Line Items]
Concentration risk	14.39%		13.82%
Investment Owned, At Fair Value | Geographic Concentration Risk | West
Schedule of Investments [Line Items]
Concentration risk	12.96%		11.21%
Investment Owned, At Fair Value | Geographic Concentration Risk | International
Schedule of Investments [Line Items]
Concentration risk	12.51%		13.84%
Investment Owned, At Fair Value | Geographic Concentration Risk | Southwest
Schedule of Investments [Line Items]
Concentration risk	7.41%		8.62%
Investment Owned, At Fair Value | Geographic Concentration Risk | South
Schedule of Investments [Line Items]
Concentration risk	6.06%		6.66%
Investment Owned, At Fair Value | Geographic Concentration Risk | Northwest
Schedule of Investments [Line Items]
Concentration risk	5.01%		3.61%
Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,359,295		$ 2,227,245
Investments at fair value	$ 2,281,235		$ 2,166,409
% of Total Net Assets	189.78%		173.93%
Debt Securities, Senior Secured | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	84.94%		85.08%
Debt Securities, Senior Secured | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	86.32%		86.86%
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 162,617		$ 146,444
Investments at fair value	$ 162,192		$ 146,533
% of Total Net Assets	13.49%		11.77%
Debt investments in the JVs | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	5.85%		5.59%
Debt investments in the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.14%		5.88%
Equity Securities, Preferred
Schedule of Investments [Line Items]
Investment owned, at cost	$ 87,878		$ 85,300
Investments at fair value	$ 80,625		$ 79,523
% of Total Net Assets	6.71%		6.38%
Equity Securities, Preferred | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.16%		3.26%
Equity Securities, Preferred | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.05%		3.19%
Debt Securities, Subordinated
Schedule of Investments [Line Items]
Investment owned, at cost	$ 68,956		$ 67,147
Investments at fair value	$ 62,145		$ 56,920
% of Total Net Assets	5.17%		4.57%
Debt Securities, Subordinated | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.48%		2.57%
Debt Securities, Subordinated | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.35%		2.28%
Equity Securities, JV LLC
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,791		$ 49,322
Investments at fair value	$ 32,565		$ 24,011
% of Total Net Assets	2.71%		1.93%
Equity Securities, JV LLC | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.97%		1.88%
Equity Securities, JV LLC | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.23%		0.96%
Equity Securities, Common And Warrants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 44,477		$ 42,296
Investments at fair value	$ 24,108		$ 20,715
% of Total Net Assets	2.01%		1.66%
Equity Securities, Common And Warrants | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.60%		1.62%
Equity Securities, Common And Warrants | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.91%		0.83%
[1]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[2]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[3]Equity ownership may be held in shares or units of companies related to the portfolio companies.[4]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[5]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[6]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[7]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[8]Equity ownership may be held in shares or units of companies related to the portfolio companies.[9]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[10]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

Portfolio Investments - Portf_2

Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2022		Sep. 30, 2022
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,778,014		$ 2,617,754
Investments at fair value	$ 2,642,870		$ 2,494,111
% of Total Net Assets	219.87%	[1],[2],[3],[4],[5]	200.24%	[6],[7],[8],[9],[10]
Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%		100%
Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%		100%
Application Software Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 435,165		$ 391,938
Investments at fair value	$ 422,862		$ 384,589
% of Total Net Assets	35.18%		30.87%
Application Software Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	15.95%		15.43%
Application Software Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	15.66%		14.98%
Multi-Sector Holdings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 229,676		$ 195,766
Investments at fair value	$ 198,904		$ 167,248
% of Total Net Assets	16.55%		13.43%
Multi-Sector Holdings | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	7.53%		6.71%
Multi-Sector Holdings | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	8.27%		7.48%
Pharmaceuticals Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 131,307		$ 126,508
Investments at fair value	$ 127,414		$ 119,511
% of Total Net Assets	10.60%		9.59%
Pharmaceuticals Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.82%		4.79%
Pharmaceuticals Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.73%		4.83%
Data Processing & Outsourced Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 118,058		$ 120,477
Investments at fair value	$ 115,489		$ 108,465
% of Total Net Assets	9.61%		8.71%
Data Processing & Outsourced Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.37%		4.35%
Data Processing & Outsourced Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.25%		4.60%
Biotechnology Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 111,745		$ 109,960
Investments at fair value	$ 106,224		$ 111,335
% of Total Net Assets	8.84%		8.94%
Biotechnology Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.02%		4.46%
Biotechnology Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.02%		4.20%
Health Care Technology Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 110,251		$ 100,084
Investments at fair value	$ 103,479		$ 97,315
% of Total Net Assets	8.61%		7.81%
Health Care Technology Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.92%		3.90%
Health Care Technology Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.97%		3.82%
Specialized Finance Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 87,523		$ 80,864
Investments at fair value	$ 79,791		$ 81,008
% of Total Net Assets	6.64%		6.50%
Specialized Finance Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.02%		3.25%
Specialized Finance Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.15%		3.09%
Industrial Machinery Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 81,483		$ 81,787
Investments at fair value	$ 79,751		$ 73,087
% of Total Net Assets	6.63%		5.87%
Industrial Machinery Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.02%		2.93%
Industrial Machinery Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.93%		3.12%
Health Care Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 65,732		$ 58,674
Investments at fair value	$ 66,001		$ 70,419
% of Total Net Assets	5.49%		5.65%
Health Care Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.50%		2.82%
Health Care Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.37%		2.24%
Internet & Direct Marketing Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 65,585		$ 67,926
Investments at fair value	$ 61,490		$ 61,881
% of Total Net Assets	5.12%		4.97%
Internet & Direct Marketing Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.33%		2.48%
Internet & Direct Marketing Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.36%		2.59%
Aerospace & Defense Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,993		$ 61,963
Investments at fair value	$ 60,938		$ 61,188
% of Total Net Assets	5.07%		4.91%
Aerospace & Defense Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.31%		2.45%
Aerospace & Defense Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.23%		2.37%
Construction & Engineering Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 60,828		$ 60,996
Investments at fair value	$ 54,898		$ 54,662
% of Total Net Assets	4.57%		4.39%
Construction & Engineering Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.08%		2.19%
Construction & Engineering Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.19%		2.33%
Health Care Distributors Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 58,320		$ 57,112
Investments at fair value	$ 54,080		$ 24,326
% of Total Net Assets	4.50%		1.95%
Health Care Distributors Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.05%		0.98%
Health Care Distributors Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.10%		2.18%
Other Diversified Financial Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 57,241		$ 29,300
Investments at fair value	$ 52,292		$ 51,972
% of Total Net Assets	4.35%		4.17%
Other Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.98%		2.08%
Other Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.06%		1.12%
Personal Products Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 53,190		$ 53,214
Investments at fair value	$ 51,260		$ 45,943
% of Total Net Assets	4.26%		3.69%
Personal Products Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.94%		1.84%
Personal Products Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.91%		2.03%
Automotive Retail Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 51,663		$ 59,254
Investments at fair value	$ 50,681		$ 57,629
% of Total Net Assets	4.22%		4.63%
Automotive Retail Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.92%		2.31%
Automotive Retail Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.86%		2.26%
Auto Parts & Equipment Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 51,067		$ 12,474
Investments at fair value	$ 50,127		$ 48,062
% of Total Net Assets	4.17%		3.86%
Auto Parts & Equipment Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.90%		1.93%
Auto Parts & Equipment Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.84%		0.48%
Real Estate Operating Companies Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,980		$ 47,585
Investments at fair value	$ 50,015		$ 11,469
% of Total Net Assets	4.16%		0.92%
Real Estate Operating Companies Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.89%		0.46%
Real Estate Operating Companies Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.80%		1.82%
Fertilizers & Agricultural Chemicals Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,271		$ 49,301
Investments at fair value	$ 48,973		$ 53,797
% of Total Net Assets	4.07%		4.32%
Fertilizers & Agricultural Chemicals Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.85%		2.16%
Fertilizers & Agricultural Chemicals Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.77%		1.88%
Internet Services & Infrastructure Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,271		$ 54,095
Investments at fair value	$ 48,903		$ 50,150
% of Total Net Assets	4.07%		4.03%
Internet Services & Infrastructure Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.85%		2.01%
Internet Services & Infrastructure Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.77%		2.07%
Metal & Glass Containers Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 47,128		$ 47,704
Investments at fair value	$ 45,127		$ 45,421
% of Total Net Assets	3.75%		3.65%
Metal & Glass Containers Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.71%		1.82%
Metal & Glass Containers Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.70%		1.82%
Home Improvement Retail Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 45,266		$ 45,802
Investments at fair value	$ 44,763		$ 47,599
% of Total Net Assets	3.72%		3.82%
Home Improvement Retail Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.69%		1.91%
Home Improvement Retail Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.63%		1.75%
Soft Drinks Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 43,935		$ 34,272
Investments at fair value	$ 44,387		$ 33,670
% of Total Net Assets	3.69%		2.70%
Soft Drinks Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.68%		1.35%
Soft Drinks Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.58%		1.31%
Airport Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 43,748		$ 43,322
Investments at fair value	$ 43,267		$ 42,883
% of Total Net Assets	3.60%		3.44%
Airport Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.64%		1.72%
Airport Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.57%		1.65%
Leisure Facilities Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 41,182		$ 39,768
Investments at fair value	$ 40,578		$ 39,258
% of Total Net Assets	3.38%		3.15%
Leisure Facilities Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.54%		1.57%
Leisure Facilities Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.48%		1.52%
Insurance Brokers Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 39,268		$ 35,628
Investments at fair value	$ 39,057		$ 33,081
% of Total Net Assets	3.25%		2.66%
Insurance Brokers Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.48%		1.33%
Insurance Brokers Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.41%		1.36%
Diversified Support Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 38,167		$ 37,992
Investments at fair value	$ 37,776		$ 36,577
% of Total Net Assets	3.14%		2.94%
Diversified Support Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.43%		1.47%
Diversified Support Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.37%		1.45%
Specialty Chemicals Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 37,298		$ 37,319
Investments at fair value	$ 35,626		$ 36,712
% of Total Net Assets	2.96%		2.95%
Specialty Chemicals Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.35%		1.47%
Specialty Chemicals Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.34%		1.43%
Health Care Supplies Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 36,693		$ 36,471
Investments at fair value	$ 35,621		$ 39,573
% of Total Net Assets	2.96%		3.18%
Health Care Supplies Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.35%		1.59%
Health Care Supplies Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.32%		1.39%
Real Estate Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 36,233		$ 40,243
Investments at fair value	$ 32,970		$ 32,933
% of Total Net Assets	2.74%		2.64%
Real Estate Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.25%		1.32%
Real Estate Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.30%		1.54%
Integrated Telecommunication Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 34,635		$ 34,628
Investments at fair value	$ 32,041		$ 32,201
% of Total Net Assets	2.67%		2.59%
Integrated Telecommunication Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.21%		1.29%
Integrated Telecommunication Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.25%		1.32%
Electrical Components & Equipment Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 33,813		$ 33,814
Investments at fair value	$ 31,476		$ 33,969
% of Total Net Assets	2.62%		2.73%
Electrical Components & Equipment Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.19%		1.36%
Electrical Components & Equipment Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.22%		1.29%
Advertising Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 27,507		$ 28,245
Investments at fair value	$ 26,470		$ 26,645
% of Total Net Assets	2.20%		2.14%
Advertising Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1%		1.07%
Advertising Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.99%		1.08%
Movies & Entertainment Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 26,202		$ 26,161
Investments at fair value	$ 26,022		$ 26,948
% of Total Net Assets	2.16%		2.16%
Movies & Entertainment Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.98%		1.08%
Movies & Entertainment Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.94%		1%
Distributors Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,262		$ 25,278
Investments at fair value	$ 25,864		$ 0
% of Total Net Assets	2.15%		0%
Distributors Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.98%		0%
Distributors Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.91%		0.97%
Airlines Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,034		$ 0
Investments at fair value	$ 24,569		$ 24,494
% of Total Net Assets	2.04%		1.97%
Airlines Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.93%		0.98%
Airlines Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.87%		0%
Health Care Equipment Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 21,838		$ 24,353
Investments at fair value	$ 22,703		$ 24,161
% of Total Net Assets	1.89%		1.94%
Health Care Equipment Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.86%		0.97%
Health Care Equipment Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.79%		0.93%
Environmental & Facilities Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 21,156		$ 20,857
Investments at fair value	$ 20,675		$ 20,585
% of Total Net Assets	1.72%		1.65%
Environmental & Facilities Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.78%		0.83%
Environmental & Facilities Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.76%		0.80%
Oil & Gas Storage & Transportation Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,934		$ 22,290
Investments at fair value	$ 18,113		$ 20,853
% of Total Net Assets	1.51%		1.67%
Oil & Gas Storage & Transportation Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.69%		0.84%
Oil & Gas Storage & Transportation Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.72%		0.85%
Home Furnishings Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,554		$ 19,550
Investments at fair value	$ 17,917		$ 18,188
% of Total Net Assets	1.49%		1.46%
Home Furnishings Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.68%		0.73%
Home Furnishings Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.70%		0.75%
System Software Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 14,895		$ 14,890
Investments at fair value	$ 13,904		$ 13,985
% of Total Net Assets	1.16%		1.12%
System Software Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.53%		0.56%
System Software Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.54%		0.57%
Consumer Finance Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 14,503		$ 14,492
Investments at fair value	$ 12,104		$ 12,834
% of Total Net Assets	1.01%		1.03%
Consumer Finance Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.46%		0.51%
Consumer Finance Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.52%		0.55%
Hotels, Resorts & Cruise Lines Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 13,943		$ 13,960
Investments at fair value	$ 11,439		$ 13,284
% of Total Net Assets	0.95%		1.07%
Hotels, Resorts & Cruise Lines Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.43%		0.53%
Hotels, Resorts & Cruise Lines Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.50%		0.53%
IT Consulting & Other Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 11,684		$ 11,697
Investments at fair value	$ 8,938		$ 8,582
% of Total Net Assets	0.74%		0.69%
IT Consulting & Other Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.34%		0.34%
IT Consulting & Other Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.42%		0.45%
Restaurants Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 9,343		$ 9,338
Investments at fair value	$ 8,610		$ 8,692
% of Total Net Assets	0.72%		0.70%
Restaurants Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.33%		0.35%
Restaurants Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.34%		0.36%
Education Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 9,070		$ 9,080
Investments at fair value	$ 7,968		$ 19,576
% of Total Net Assets	0.66%		1.57%
Education Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.30%		0.78%
Education Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.33%		0.35%
Cable & Satellite Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,012		$ 20,716
Investments at fair value	$ 7,165		$ 8,573
% of Total Net Assets	0.60%		0.69%
Cable & Satellite Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.27%		0.34%
Cable & Satellite Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.29%		0.79%
Research & Consulting Services Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 7,848		$ 9,187
Investments at fair value	$ 6,963		$ 8,596
% of Total Net Assets	0.58%		0.69%
Research & Consulting Services Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.26%		0.34%
Research & Consulting Services Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.28%		0.35%
Apparel, Accessories & Luxury Goods Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 5,165		$ 5,165
Investments at fair value	$ 4,847		$ 4,872
% of Total Net Assets	0.40%		0.39%
Apparel, Accessories & Luxury Goods Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.18%		0.20%
Apparel, Accessories & Luxury Goods Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.19%		0.20%
Air Freight & Logistics Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,925		$ 7,295
Investments at fair value	$ 4,675		$ 5,223
% of Total Net Assets	0.39%		0.42%
Air Freight & Logistics Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.18%		0.21%
Air Freight & Logistics Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.18%		0.28%
Integrated Oil & Gas Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,873		$ 4,866
Investments at fair value	$ 4,267		$ 0
% of Total Net Assets	0.35%		0%
Integrated Oil & Gas Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.16%		0%
Integrated Oil & Gas Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.18%		0.19%
Apparel Retail Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,727		$ 5,268
Investments at fair value	$ 4,191		$ 6,405
% of Total Net Assets	0.35%		0.51%
Apparel Retail Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.16%		0.26%
Apparel Retail Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.17%		0.20%
Food Distributors Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,655		$ 4,646
Investments at fair value	$ 3,599		$ 3,367
% of Total Net Assets	0.30%		0.27%
Food Distributors Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.14%		0.13%
Food Distributors Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.17%		0.18%
Specialized REITs Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,334		$ 4,318
Investments at fair value	$ 3,315		$ 3,402
% of Total Net Assets	0.28%		0.27%
Specialized REITs Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.13%		0.14%
Specialized REITs Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.16%		0.16%
Real Estate Development Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,278		$ 0
Investments at fair value	$ 3,230		$ 3,264
% of Total Net Assets	0.27%		0.26%
Real Estate Development Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.12%		0.13%
Real Estate Development Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%		0%
Diversified Banks Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,515		$ 3,515
Investments at fair value	$ 2,971		$ 2,997
% of Total Net Assets	0.25%		0.24%
Diversified Banks Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.11%		0.12%
Diversified Banks Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.13%		0.13%
Technology Distributors Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,163		$ 3,163
Investments at fair value	$ 2,265		$ 2,456
% of Total Net Assets	0.19%		0.20%
Technology Distributors Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%		0.10%
Technology Distributors Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.11%		0.12%
Construction Materials Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,353		$ 2,331
Investments at fair value	$ 1,928		$ 1,934
% of Total Net Assets	0.16%		0.16%
Construction Materials Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.07%		0.08%
Construction Materials Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.08%		0.09%
Housewares & Specialties Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,217		$ 2,293
Investments at fair value	$ 1,712		$ 1,890
% of Total Net Assets	0.14%		0.15%
Housewares & Specialties Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%		0.08%
Housewares & Specialties Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.08%		0.09%
Electronic Components Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,095		$ 2,092
Investments at fair value	$ 185		$ 201
% of Total Net Assets	0.02%		0.02%
Electronic Components Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.01%		0.01%
Electronic Components Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.08%		0.08%
Alternative Carriers Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 214		$ 212
Investments at fair value	$ 0		$ 8,604
% of Total Net Assets	0%		0.69%
Alternative Carriers Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%		0.34%
Alternative Carriers Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.01%		0.01%
Oil & Gas Refining & Marketing Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0		$ 8,627
Investments at fair value	$ 0		$ 5,567
% of Total Net Assets	0%		0.45%
Oil & Gas Refining & Marketing Sector | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%		0.22%
Oil & Gas Refining & Marketing Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%		0.33%
Trading Companies & Distributors Sector
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0		$ 7,628
Trading Companies & Distributors Sector | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%		0.29%
[1]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[2]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[3]Equity ownership may be held in shares or units of companies related to the portfolio companies.[4]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[5]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[6]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[7]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[8]Equity ownership may be held in shares or units of companies related to the portfolio companies.[9]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[10]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

Portfolio Investments - Summary

Portfolio Investments - Summary of Portfolio (Details) € in Thousands, $ in Thousands	Dec. 31, 2022 USD ($) borrower		Dec. 31, 2022 EUR (€) borrower		Sep. 30, 2022 USD ($) borrower		Sep. 30, 2022 EUR (€) borrower		Dec. 31, 2021
Investment Company, Nonconsolidated Subsidiary [Line Items]
Number of borrowers in the Glick JV | borrower	156		156		149		149
Investment, Identifier [Axis]: - Van Houten Real LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,239	[1],[2],[3],[4]
Investment interest rate	12%	[1],[2],[4],[5],[6],[7],[8],[9]	12%	[1],[2],[4],[5],[6],[7],[8],[9]
Investment, Identifier [Axis]: ADB Companies LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 14,505	[1],[3],[10]			$ 14,685	[11],[12],[13]
Investment interest rate	11.34%	[1],[10]	11.34%	[1],[10]	9.80%	[11],[13]	9.80%	[11],[13]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10],[14]			$ 0	[11],[12],[13],[15],[16]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,589	[1],[3],[10],[14]			$ 6,589	[11],[12],[13],[16]
Investment interest rate	12.23%	[1],[10],[14]	12.23%	[1],[10],[14]	11.20%	[11],[13],[16]	11.20%	[11],[13],[16]
Investment, Identifier [Axis]: AI Sirona Luxembourg Acquisition Sarl, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 24,838	[1],[3],[10],[14]			$ 24,838	[11],[12],[13],[16]
Investment interest rate	9.15%	[1],[10],[14]	9.15%	[1],[10],[14]	7.94%	[11],[13],[16]	7.94%	[11],[13],[16]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 14,414	[1],[3],[10]			$ 14,414	[11],[12],[13]
Investment interest rate	12.17%	[1],[10]	12.17%	[1],[10]	10.88%	[11],[13]	10.88%	[11],[13]
Investment, Identifier [Axis]: AMMC CLO 27, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,275	[10]
Investment interest rate	13.49%	[10]	13.49%	[10]
Investment, Identifier [Axis]: APX Group Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,075	[3],[14]			$ 2,075	[12],[16]
Investment interest rate	5.75%	[5],[6],[7],[8],[9],[14]	5.75%	[5],[6],[7],[8],[9],[14]	5.75%	[16],[17],[18],[19],[20],[21]	5.75%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 5,500	[12]
Investment interest rate					7.50%	[17],[18],[19],[20],[21]	7.50%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,500	[12]
Investment interest rate					5.25%	[17],[18],[19],[20],[21]	5.25%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: AT Holdings II Ltd, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 15,939	[1],[3],[14]
Investment interest rate	14.25%	[1],[5],[6],[7],[8],[9],[14]	14.25%	[1],[5],[6],[7],[8],[9],[14]
Investment, Identifier [Axis]: AT Holdings II SÀRL, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 15,643	[1],[3],[14]			$ 33,997	[11],[12],[16]
Investment, Identifier [Axis]: Access CIG LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 20,000	[3],[10]			$ 20,000	[12],[13]
Investment interest rate	11.82%	[10]	11.82%	[10]	10.82%	[13]	10.82%	[13]
Investment, Identifier [Axis]: Accupac Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Accupac Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 908	[1],[2],[3],[10]			$ 500	[11],[12],[13],[15]
Investment interest rate	10.17%	[1],[2],[10]	10.17%	[1],[2],[10]	9.14%	[11],[13],[15]	9.14%	[11],[13],[15]
Investment, Identifier [Axis]: Accupac Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 15,935	[1],[3],[10]			$ 15,976	[11],[12],[13]
Investment interest rate	10.16%	[1],[10]	10.16%	[1],[10]	9.12%	[11],[13]	9.12%	[11],[13]
Investment, Identifier [Axis]: Acquia Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,317	[1],[2],[3],[10]			$ 914	[11],[12],[13],[15]
Investment interest rate	12.18%	[1],[2],[10]	12.18%	[1],[2],[10]	10.64%	[11],[13],[15]	10.64%	[11],[13],[15]
Investment, Identifier [Axis]: Acquia Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 27,349	[1],[3],[10]			$ 27,349	[11],[12],[13]
Investment interest rate	10.74%	[1],[10]	10.74%	[1],[10]	9.63%	[11],[13]	9.63%	[11],[13]
Investment, Identifier [Axis]: All Web Leads Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 23,562	[1],[3],[10]			$ 23,338	[11],[12],[13]
Investment interest rate	5.73%	[1],[10]	5.73%	[1],[10]
Investment, Identifier [Axis]: Altice France SA, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,050	[3],[14]			4,050	[12],[16]
Investment interest rate	5.50%	[1],[5],[6],[7],[8],[9],[14]	5.50%	[1],[5],[6],[7],[8],[9],[14]
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,640	[1],[3],[10]
Investment interest rate	12.68%	[1],[10]	12.68%	[1],[10]
Investment, Identifier [Axis]: Alvogen Pharma US Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,968	[1],[3],[10]			$ 13,134	[11],[12],[13]
Investment interest rate	12.23%	[1],[10]	12.23%	[1],[10]	11.20%	[11],[13]	11.20%	[11],[13]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche A Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 26,179	[1],[3],[14]			$ 24,043	[11],[12],[16]
Investment interest rate	8.50%	[1],[5],[6],[7],[8],[9],[14]	8.50%	[1],[5],[6],[7],[8],[9],[14]	10%	[11],[16],[17],[18],[19],[20],[21]	10%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche B Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 25,612	[1],[3],[14]			$ 23,522	[11],[12],[16]
Investment interest rate	8.50%	[1],[5],[6],[7],[8],[9],[14]	8.50%	[1],[5],[6],[7],[8],[9],[14]	10%	[11],[16],[17],[18],[19],[20],[21]	10%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: American Auto Auction Group LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 14,760	[1],[3],[10]			$ 14,760	[11],[12],[13]
Investment interest rate	13.33%	[1],[10]	13.33%	[1],[10]	12.30%	[11],[13]	12.30%	[11],[13]
Investment, Identifier [Axis]: American Tire Distributors Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,870	[3],[10]			$ 9,895	[12],[13]
Investment interest rate	10.61%	[10]	10.61%	[10]	9.03%	[13]	9.03%	[13]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 15,181	[1],[3],[10],[14]			$ 15,220	[11],[12],[13],[16]
Investment interest rate	8.98%	[1],[10],[14]	8.98%	[1],[10],[14]	7.92%	[11],[13],[16]	7.92%	[11],[13],[16]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,500	[1],[3],[10],[14]			$ 12,500	[11],[12],[13],[16]
Investment interest rate	12.73%	[1],[10],[14]	12.73%	[1],[10],[14]	11.67%	[11],[13],[16]	11.67%	[11],[13],[16]
Investment, Identifier [Axis]: Anastasia Parent LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,729	[3],[10]			$ 2,736	[12],[13]
Investment interest rate	8.48%	[10]	8.48%	[10]	7.42%	[13]	7.42%	[13]
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,996	[1],[3],[10]			$ 4,346	[11],[12],[13]
Investment interest rate	12.36%	[1],[10]	12.36%	[1],[10]	10.78%	[11],[13]	10.78%	[11],[13]
Investment, Identifier [Axis]: Apptio Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,338	[1],[2],[3],[10]			$ 892	[11],[12],[13],[15]
Investment interest rate	9.94%	[1],[2],[10]	9.94%	[1],[2],[10]	8.46%	[11],[13],[15]	8.46%	[11],[13],[15]
Investment, Identifier [Axis]: Apptio Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 34,458	[1],[3],[10]			$ 34,458	[11],[12],[13]
Investment interest rate	9.94%	[1],[10]	9.94%	[1],[10]	8.46%	[11],[13]	8.46%	[11],[13]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,649	[1],[2],[3],[10],[14]			$ 0	[11],[12],[13],[15],[16]
Investment interest rate	7.48%	[1],[10],[14]	7.48%	[1],[10],[14]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,964	[1],[3],[10],[14]			$ 1,964	[11],[12],[13],[16]
Investment interest rate	8%	[1],[10],[14]	8%	[1],[10],[14]	8%	[11],[13],[16]	8%	[11],[13],[16]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 18,636	[1],[3],[10],[14]			$ 18,636	[11],[12],[13],[16]
Investment interest rate	10.43%	[1],[10],[14]	10.43%	[1],[10],[14]	9.19%	[11],[13],[16]	9.19%	[11],[13],[16]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,519	[1],[3],[10],[14]			$ 10,519	[11],[12],[13],[16]
Investment interest rate	8.81%	[1],[10],[14]	8.81%	[1],[10],[14]	8.81%	[11],[13],[16]	8.81%	[11],[13],[16]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 21,464	[1],[2],[3],[10]			$ 24,490	[11],[12],[13],[15]
Investment interest rate	11.48%	[1],[2],[10]	11.48%	[1],[2],[10]	10.42%	[11],[13],[15]	10.42%	[11],[13],[15]	7.75%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate					6%	[11],[17],[18],[19],[20],[21]	6%	[11],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	6%	[1],[5],[6],[7],[8],[9]	6%	[1],[5],[6],[7],[8],[9]					6%
Investment, Identifier [Axis]: Associated Asphalt Partners LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,493	[3],[10]			$ 2,501	[12],[13]
Investment interest rate	9.63%	[10]	9.63%	[10]	8.06%	[13]	8.06%	[13]
Investment, Identifier [Axis]: Astra Acquisition Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,640	[3],[10]			$ 5,640	[12],[13]
Investment interest rate	9.63%	[10]	9.63%	[10]	8.37%	[13]	8.37%	[13]
Investment, Identifier [Axis]: Athenex Inc, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,649	[1],[3],[14]			$ 8,309	[11],[12],[16]
Investment, Identifier [Axis]: Athenex Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,556	[1],[3],[14]			13,346	[11],[12],[16]
Investment interest rate	11%	[1],[5],[6],[7],[8],[9],[14]	11%	[1],[5],[6],[7],[8],[9],[14]
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 22,425	[11],[12],[13],[16]
Investment interest rate					8.78%	[11],[13],[16]	8.78%	[11],[13],[16]
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 22,368	[1],[3],[10],[14]
Investment interest rate	10.32%	[1],[10],[14]	10.32%	[1],[10],[14]
Investment, Identifier [Axis]: Avalara Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]
Investment, Identifier [Axis]: Avalara Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 41,467	[1],[3],[10]
Investment interest rate	11.83%	[10]	11.83%	[10]
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,546	[11],[12],[13],[15]
Investment interest rate					8.12%	[11],[13],[15]	8.12%	[11],[13],[15]
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,541	[1],[2],[3],[10]
Investment interest rate	9.73%	[1],[2],[10]	9.73%	[1],[2],[10]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,197	[1],[2],[3],[10]			$ 4,227	[11],[12],[13],[15]
Investment interest rate	13.23%	[1],[2],[10]	13.23%	[1],[2],[10]	11.62%	[11],[13],[15]	11.62%	[11],[13],[15]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,166	[1],[3],[10]			$ 7,166	[11],[12],[13]
Investment interest rate	13.23%	[1],[10]	13.23%	[1],[10]	11.62%	[11],[13]	11.62%	[11],[13]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 897	[1],[2],[3],[10]			$ 1,702	[11],[12],[13],[15]
Investment interest rate	12%	[1],[2],[10]	12%	[1],[2],[10]	10.75%	[11],[13],[15]	10.75%	[11],[13],[15]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 32,995	[1],[3],[10]			$ 33,078	[11],[12],[13]
Investment interest rate	9.91%	[1],[10]	9.91%	[1],[10]	8.31%	[11],[13]	8.31%	[11],[13]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[14]			$ 0	[11],[12],[15],[16]
Investment interest rate	8%	[1],[2],[5],[6],[7],[8],[9],[14]	8%	[1],[2],[5],[6],[7],[8],[9],[14]	10.25%	[11],[15],[16],[17],[18],[19],[20],[21]	10.25%	[11],[15],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Revenue Interest Financing Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[14]			$ 0	[11],[12],[15],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	2,432	[1],[3],[14]			2,353	[11],[12],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,383	[1],[3],[14]			$ 5,322	[11],[12],[16]
Investment interest rate	8%	[1],[5],[6],[7],[8],[9],[14]	8%	[1],[5],[6],[7],[8],[9],[14]	10.25%	[11],[16],[17],[18],[19],[20],[21]	10.25%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Blackhawk Network Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 30,625	[3],[10]			$ 30,625	[12],[13]
Investment interest rate	10.94%	[10]	10.94%	[10]	9.50%	[13]	9.50%	[13]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,979	[1],[3]			$ 3,979	[11],[12]
Investment interest rate	9%	[1],[5],[6],[7],[8],[9]	9%	[1],[5],[6],[7],[8],[9]
Investment, Identifier [Axis]: CCO Holdings LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,097	[12],[16]
Investment interest rate					4.50%	[16],[17],[18],[19],[20],[21]	4.50%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: CITGO Holding Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 7,857	[12]
Investment interest rate					9.25%	[11],[13],[17],[18],[19],[20],[21]	9.25%	[11],[13],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: CITGO Petroleum Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 795	[12],[13]
Investment interest rate					9.37%	[13]	9.37%	[13]
Investment, Identifier [Axis]: Cadence Aerospace LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 14,332	[1],[3],[10]			$ 14,294	[11],[12],[13]
Investment interest rate	10.92%	[1],[10]	10.92%	[1],[10]	9.31%	[11],[13]	9.31%	[11],[13]
Investment, Identifier [Axis]: Caregiver Services Inc, Series A Preferred Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	10%	[1],[5],[6],[7],[8],[9]	10%	[1],[5],[6],[7],[8],[9]	10%	[11],[17],[18],[19],[20],[21]	10%	[11],[17],[18],[19],[20],[21]	10%
Investment, Identifier [Axis]: Carvana Co, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 6,700	[12],[16]
Investment interest rate					5.625%	[16],[17],[18],[19],[20],[21]	5.625%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: CircusTrix Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,668	[1],[3],[10]			$ 10,692	[11],[12],[13]
Investment interest rate	9.57%	[1],[10]	9.57%	[1],[10]	8.62%	[11],[13]	8.62%	[11],[13]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,311	[3],[14]			$ 4,311	[12],[16]
Investment interest rate	7.50%	[5],[6],[7],[8],[9],[14]	7.50%	[5],[6],[7],[8],[9],[14]	7.50%	[16],[17],[18],[19],[20],[21]	7.50%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 676	[3],[14]			$ 1,374	[12],[16]
Investment interest rate	7.75%	[5],[6],[7],[8],[9],[14]	7.75%	[5],[6],[7],[8],[9],[14]	5.125%	[16],[17],[18],[19],[20],[21]	5.125%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 676	[12],[16]
Investment interest rate					7.75%	[16],[17],[18],[19],[20],[21]	7.75%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Condor Merger Sub Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,420	[3]			$ 8,420	[12]
Investment interest rate	7.375%	[5],[6],[7],[8],[9]	7.375%	[5],[6],[7],[8],[9]	7.375%	[11],[13],[17],[18],[19],[20],[21]	7.375%	[11],[13],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Continental Intermodal Group LP, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 19,992	[1],[3],[10]			$ 22,537	[11],[12],[13]
Investment interest rate	12.88%	[1],[10]	12.88%	[1],[10]	11.62%	[11],[13]	11.62%	[11],[13]
Investment, Identifier [Axis]: Convergeone Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 11,882	[3],[10]			$ 11,913	[12],[13]
Investment interest rate	9.38%	[10]	9.38%	[10]	8.12%	[13]	8.12%	[13]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 305	[1],[2],[3],[10]			$ 916	[11],[12],[13],[15]
Investment interest rate	12.25%	[1],[2],[10]	12.25%	[1],[2],[10]	11%	[11],[13],[15]	11%	[11],[13],[15]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 13,677	[1],[3],[10]			$ 13,712	[11],[12],[13]
Investment interest rate	10.55%	[1],[10]	10.55%	[1],[10]	8.88%	[11],[13]	8.88%	[11],[13]
Investment, Identifier [Axis]: Covetrus Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,336	[3],[10]			$ 10,336	[12],[13]
Investment interest rate	9.58%	[10]	9.58%	[10]	7.65%	[13]	7.65%	[13]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 18,153	[1],[3],[10]			$ 18,200	[11],[12],[13]
Investment interest rate	10.41%	[1],[10]	10.41%	[1],[10]	8.81%	[11],[13]	8.81%	[11],[13]
Investment, Identifier [Axis]: Cuppa Bidco BV, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,340	[3],[10],[14]
Investment interest rate	7.50%	[10],[14]	7.50%	[10],[14]
Investment, Identifier [Axis]: DTI Holdco Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,988	[3],[10]			$ 5,000	[12],[13]
Investment interest rate	8.84%	[10]	8.84%	[10]	7.33%	[13]	7.33%	[13]
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 4,988	[12],[13],[16]
Investment interest rate					8.49%	[13],[16]	8.49%	[13],[16]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Subordinated Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,365	[1],[2],[3],[14]			$ 4,183	[11],[12],[15],[16]
Investment interest rate	10%	[1],[2],[5],[6],[7],[8],[9]	10%	[1],[2],[5],[6],[7],[8],[9]	10%	[11],[15],[16],[17],[18],[19],[20],[21]	10%	[11],[15],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Delta Topco Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,680	[3],[10]			$ 6,680	[12],[13]
Investment interest rate	11.65%	[10]	11.65%	[10]	9.34%	[13]	9.34%	[13]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 20,965	[1],[3],[10]			$ 24,396	[11],[12],[13]
Investment interest rate	13.73%	[1],[10]	13.73%	[1],[10]	12.67%	[11],[13]	12.67%	[11],[13]
Investment, Identifier [Axis]: Dialyze Holdings LLC, Subordinated Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 520	[1],[2],[3],[10]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 251	[1],[2],[3],[10]			$ 251	[11],[12],[13],[15]
Investment interest rate	11.59%	[1],[2],[10]	11.59%	[1],[2],[10]	9.41%	[11],[13],[15]	9.41%	[11],[13],[15]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,877	[1],[3],[10]			$ 9,902	[11],[12],[13]
Investment interest rate	11.09%	[1],[10]	11.09%	[1],[10]	9.91%	[11],[13]	9.91%	[11],[13]
Investment, Identifier [Axis]: DirecTV Financing LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,166	[3],[10]			$ 19,242	[12],[13]
Investment interest rate	9.38%	[10]	9.38%	[10]	8.12%	[13]	8.12%	[13]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 14,297	[1],[3],[10]			$ 14,333	[11],[12],[13]
Investment interest rate	9.73%	[1],[10]	9.73%	[1],[10]	8.68%	[11],[13]	8.68%	[11],[13]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	9.73%		9.73%						6%
Investment, Identifier [Axis]: Dryden 66 Euro CLO 2018, Class DR Notes, Class DR Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,500	[3],[10],[14]
Investment interest rate	4.75%	[10],[14]	4.75%	[10],[14]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units, 12%
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	12%	[1],[5],[6],[7],[8],[9]	12%	[1],[5],[6],[7],[8],[9]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate					12%	[11],[17],[18],[19],[20],[21]	12%	[11],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Eagleview Technology Corporation, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,974	[1],[3],[10]			$ 8,974	[11],[12]
Investment interest rate	12.23%	[1],[10]	12.23%	[1],[10]	11.17%	[11],[13]	11.17%	[11],[13]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,694	[1],[2],[3],[14]
Investment interest rate	3%	[1],[2],[5],[6],[7],[8],[9],[14]	3%	[1],[2],[5],[6],[7],[8],[9],[14]	3%	[11],[15],[16],[17],[18],[19],[20],[21]	3%	[11],[15],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,576	[1],[3],[14]			$ 10,418	[11],[12],[16]
Investment interest rate	3%	[1],[5],[6],[7],[8],[9],[14]	3%	[1],[5],[6],[7],[8],[9],[14]	3%	[11],[16],[17],[18],[19],[20],[21]	3%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 25,061	[3],[10]			$ 25,061	[12],[13]
Investment interest rate	11.13%	[10]	11.13%	[10]	9.87%	[13]	9.87%	[13]
Investment, Identifier [Axis]: Fair Street LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,174	[1],[2],[3],[4]
Investment interest rate	12.50%	[1],[2],[4],[5],[6],[7],[8],[9]	12.50%	[1],[2],[4],[5],[6],[7],[8],[9]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 31,000	[1],[2],[3]			$ 27,850	[11],[12],[15]
Investment interest rate	9%	[1],[2],[5],[6],[7],[8],[9],[14]	9%	[1],[2],[5],[6],[7],[8],[9],[14]	9%	[11],[15],[17],[18],[19],[20],[21]	9%	[11],[15],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Fortress Biotech Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,466	[1],[3],[14]			$ 9,466	[11],[12],[16]
Investment interest rate	11%	[1],[5],[6],[7],[8],[9],[14]	11%	[1],[5],[6],[7],[8],[9],[14]	11%	[11],[16],[17],[18],[19],[20],[21]	11%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Frontier Communications Holdings LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,881	[3],[14]			$ 4,881	[12],[16]
Investment interest rate	6%	[5],[6],[7],[8],[9],[14]	6%	[5],[6],[7],[8],[9],[14]	6%	[16],[17],[18],[19],[20],[21]	6%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,280	[1],[2],[3],[10]			$ 1,280	[11],[12],[13],[15]
Investment interest rate	11.75%	[1],[2],[10]	11.75%	[1],[2],[10]	10.60%	[11],[13],[15]	10.60%	[11],[13],[15]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 24,819	[1],[3],[10]			$ 25,128	[11],[12],[13]
Investment interest rate	11.73%	[1],[10]	11.73%	[1],[10]	10.67%	[11],[13]	10.67%	[11],[13]
Investment, Identifier [Axis]: Global Medical Response Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 5,572	[12],[13]
Investment interest rate					7.37%	[13]	7.37%	[13]
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2, Class D Notes, Class D Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,000	[3],[10]
Investment interest rate	4.31%	[10],[14]	4.31%	[10],[14]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	0	[1],[2],[3],[10]			0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 14,275	[1],[3],[10]			$ 14,311	[11],[12],[13]
Investment interest rate	12.33%	[1],[10]	12.33%	[1],[10]	11.04%	[11],[13]	11.04%	[11],[13]
Investment, Identifier [Axis]: Harbor Purchaser Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,369	[3],[10]			$ 9,392	[12],[13]
Investment interest rate	9.67%	[10]	9.67%	[10]	8.38%	[13]	8.38%	[13]
Investment, Identifier [Axis]: Hayfin Emerald CLO XI, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,250	[10],[14]
Investment interest rate	10.11%	[10],[14]	10.11%	[10],[14]
Investment, Identifier [Axis]: Horizon Aircraft Finance I, Class A Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,112	[10],[14]
Investment interest rate	4.458%	[5],[6],[7],[8],[9],[10],[14]	4.458%	[5],[6],[7],[8],[9],[10],[14]
Investment, Identifier [Axis]: INW Manufacturing LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 35,156	[1],[3],[10]			$ 35,625	[11],[12],[13]
Investment interest rate	10.48%	[1],[10]	10.48%	[1],[10]	9.42%	[11],[13]	9.42%	[11],[13]
Investment, Identifier [Axis]: IPC Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 34,357	[1],[3],[10]			$ 34,357	[11],[12],[13]
Investment interest rate	9.44%	[1],[10]	9.44%	[1],[10]	9.44%	[11],[13]	9.44%	[11],[13]
Investment, Identifier [Axis]: Immucor Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,547	[1],[3],[10]			$ 8,569	[11],[12],[13]
Investment interest rate	10.48%	[1],[10]	10.48%	[1],[10]	9.42%	[11],[13]	9.42%	[11],[13]
Investment, Identifier [Axis]: Immucor Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 22,819	[1],[3],[10]			$ 22,619	[11],[12],[13]
Investment interest rate	12.73%	[1],[10]	12.73%	[1],[10]	11.67%	[11],[13]	11.67%	[11],[13]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Revenue Interest Financing Term
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 13,482	[1],[3]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 13,083	[11],[12]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,161	[1],[3],[10]			$ 12,161	[11],[12],[13]
Investment interest rate	13.20%	[1],[10]	13.20%	[1],[10]	12.45%	[11],[13]	12.45%	[11],[13]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[14]			$ 0	[11],[12],[15],[16]
Investment interest rate	11%	[1],[2],[5],[6],[7],[8],[9],[14]	11%	[1],[2],[5],[6],[7],[8],[9],[14]	11%	[11],[15],[16],[17],[18],[19],[20],[21]	11%	[11],[15],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,817	[1],[3],[14]			$ 6,817	[11],[12],[16]
Investment interest rate	11%	[1],[5],[6],[7],[8],[9],[14]	11%	[1],[5],[6],[7],[8],[9],[14]	11%	[11],[16],[17],[18],[19],[20],[21]	11%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Inventus Power Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 18,612	[1],[3],[10]			$ 18,660	[11],[12],[13]
Investment interest rate	9.84%	[1],[10]	9.84%	[1],[10]	8.55%	[11],[13]	8.55%	[11],[13]
Investment, Identifier [Axis]: Inventus Power Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 13,674	[1],[3],[10]			$ 13,674	[11],[12],[13]
Investment interest rate	13.23%	[1],[10]	13.23%	[1],[10]	12.17%	[11],[13]	12.17%	[11],[13]
Investment, Identifier [Axis]: Ivanti Software Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,247	[3],[10]			$ 10,247	[12],[13]
Investment interest rate	12.01%	[10]	12.01%	[10]	10.33%	[13]	10.33%	[13]
Investment, Identifier [Axis]: Jazz Acquisition Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 35,912	[1],[3],[10]			$ 36,234	[11],[12],[13]
Investment interest rate	11.88%	[1],[10]	11.88%	[1],[10]	10.62%	[11],[13]	10.62%	[11],[13]
Investment, Identifier [Axis]: Jazz Acquisition Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 528	[3],[10]			$ 528	[12],[13]
Investment interest rate	12.38%	[10]	12.38%	[10]	11.12%	[13]	11.12%	[13]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 659	[1],[2],[3],[10]			$ 329	[11],[12],[13],[15]
Investment interest rate	11.75%	[1],[2],[10]	11.75%	[1],[2],[10]	10.17%	[11],[13],[15]	10.17%	[11],[13],[15]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 13,589	[1],[3],[10]			$ 13,623	[11],[12],[13]
Investment interest rate	11.23%	[1],[10]	11.23%	[1],[10]	10.17%	[11],[13]	10.17%	[11],[13]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,137	[1],[3],[10]			$ 1,710	[11],[12],[13],[15]
Investment interest rate	10.38%	[1],[10]	10.38%	[1],[10]	9.12%	[11],[13],[15]	9.12%	[11],[13],[15]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 21,315	[1],[3],[10]			$ 19,236	[11],[12],[13]
Investment interest rate	10.38%	[1],[10]	10.38%	[1],[10]	9.12%	[11],[13]	9.12%	[11],[13]
Investment, Identifier [Axis]: LTI Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,140	[3],[10]			$ 2,140	[12],[13]
Investment interest rate	11.13%	[10]	11.13%	[10]	9.87%	[13]	9.87%	[13]
Investment, Identifier [Axis]: LaserShip Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,394	[11],[12],[13]
Investment interest rate					10.38%	[11],[13]	10.38%	[11],[13]
Investment, Identifier [Axis]: Latam Airlines Group SA, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 26,205	[1],[3],[10]
Investment interest rate	13.99%	[1],[10]	13.99%	[1],[10]
Investment, Identifier [Axis]: Lightbox Intermediate LP, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 36,913	[1],[3],[10]			$ 41,008	[11],[12],[13]
Investment interest rate	9.73%	[1],[10]	9.73%	[1],[10]	8.67%	[11],[13]	8.67%	[11],[13]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,370	[1],[2],[3],[10]			$ 2,370	[11],[12],[13],[15]
Investment interest rate	12.94%	[1],[2],[10]	12.94%	[1],[2],[10]	11.38%	[11],[13],[15]	11.38%	[11],[13],[15]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,357	[1],[3],[10]			$ 4,357	[11],[12],[13]
Investment interest rate	12.88%	[1],[10]	12.88%	[1],[10]	11.38%	[11],[13]	11.38%	[11],[13]
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 200	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment interest rate	10.94%	[1],[2],[10]	10.94%	[1],[2],[10]
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 18,344	[1],[3],[10]			$ 18,390	[11],[12],[13]
Investment interest rate	9.50%	[1],[10]	9.50%	[1],[10]	9.50%	[11],[13]	9.50%	[11],[13]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	0	[1],[2],[3],[10]			0	[11],[12],[13],[15]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 25,768	[1],[3],[10]			$ 29,565	[11],[12],[13]
Investment interest rate	10.23%	[1],[10]	10.23%	[1],[10]	9.17%	[11],[13]	9.17%	[11],[13]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[14]			$ 0	[11],[12],[15],[16]
Investment interest rate	11.50%	[1],[2],[5],[6],[7],[8],[9],[14]	11.50%	[1],[2],[5],[6],[7],[8],[9],[14]	11.50%	[11],[15],[16],[17],[18],[19],[20],[21]	11.50%	[11],[15],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 17,203	[1],[3],[14]			$ 17,203	[11],[12],[16]
Investment interest rate	11.50%	[1],[5],[6],[7],[8],[9],[14]	11.50%	[1],[5],[6],[7],[8],[9],[14]	11.50%	[11],[16],[17],[18],[19],[20],[21]	11.50%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[14]			$ 0	[11],[12],[15],[16]
Investment interest rate	8%	[1],[2],[5],[6],[7],[8],[9],[14]	8%	[1],[2],[5],[6],[7],[8],[9],[14]	8%	[11],[15],[16],[17],[18],[19],[20],[21]	8%	[11],[15],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,247	[1],[3],[14]			$ 7,215	[11],[12],[16]
Investment interest rate	8%	[1],[5],[6],[7],[8],[9],[14]	8%	[1],[5],[6],[7],[8],[9],[14]	8%	[11],[16],[17],[18],[19],[20],[21]	8%	[11],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Mindbody Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Mindbody Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 45,487	[1],[3],[10]			$ 45,665	[11],[12],[13]
Investment interest rate	11.72%	[1],[10]	11.72%	[1],[10]	10.64%	[11],[13]	10.64%	[11],[13]
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 389	[11],[12],[13]
Investment interest rate					9.80%	[11],[13]	9.80%	[11],[13]
Investment, Identifier [Axis]: Mosaic Companies LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 45,907	[1],[3],[10]			$ 46,499	[11],[12],[13]
Investment interest rate	10.93%	[1],[10]	10.93%	[1],[10]	9.89%	[11],[13]	9.89%	[11],[13]
Investment, Identifier [Axis]: NFP Corp, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,191	[3]			$ 10,191	[12]
Investment interest rate	6.875%	[5],[6],[7],[8],[9]	6.875%	[5],[6],[7],[8],[9]	6.875%	[17],[18],[19],[20],[21]	6.875%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: NN Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 58,564	[1],[3],[10],[14]			$ 58,713	[11],[12],[13],[16]
Investment interest rate	11.26%	[1],[10],[14]	11.26%	[1],[10],[14]	9.99%	[11],[13],[16]	9.99%	[11],[13],[16]
Investment, Identifier [Axis]: Navisite LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 22,560	[1],[3],[10]			$ 22,560	[11],[12],[13]
Investment interest rate	13.23%	[1],[10]	13.23%	[1],[10]	12.17%	[11],[13]	12.17%	[11],[13]
Investment, Identifier [Axis]: NeuAG LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 50,276	[1],[3],[10]			$ 50,459	[11],[12],[13]
Investment interest rate	15.23%	[1],[10]	15.23%	[1],[10]	14.17%	[11],[13]	14.17%	[11],[13]
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class D Notes, Class D Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal | €			€ 2,500	[10],[14]
Investment interest rate	8.05%	[10],[14]	8.05%	[10],[14]
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal | €			€ 3,000	[10],[14]
Investment interest rate	8.86%	[10],[14]	8.86%	[10],[14]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 59,049	[1],[2],[3],[10],[14]			$ 59,662	[11],[12],[13],[15],[16]
Investment interest rate	7.67%	[1],[2],[10],[14]	7.67%	[1],[2],[10],[14]	6.30%	[11],[13],[15],[16]	6.30%	[11],[13],[15],[16]	4.58%
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,315	[3],[10]			$ 3,323	[12],[13]
Investment interest rate	8.42%	[10]	8.42%	[10]	7.12%	[13]	7.12%	[13]
Investment, Identifier [Axis]: OEConnection LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,519	[1],[3],[10]			$ 7,519	[11],[12],[13]
Investment interest rate	11.42%	[1],[10]	11.42%	[1],[10]	10.05%	[11],[13]	10.05%	[11],[13]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 21,993	[1],[3],[10]			$ 21,557	[11],[12],[13]
Investment interest rate	6.76%	[1],[10]	6.76%	[1],[10]	5.08%	[11],[13]	5.08%	[11],[13]
Investment, Identifier [Axis]: P & L Development LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,776	[3]			$ 7,776	[12]
Investment interest rate	7.75%	[5],[6],[7],[8],[9]	7.75%	[5],[6],[7],[8],[9]	7.75%	[17],[18],[19],[20],[21]	7.75%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,228	[1],[2],[3],[10]			$ 2,228	[11],[12],[13],[15]
Investment interest rate	10.74%	[1],[2],[10]	10.74%	[1],[2],[10]	9.25%	[11],[13],[15]	9.25%	[11],[13],[15]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,252	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment interest rate	11.76%	[1],[10]	11.76%	[1],[10]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 26,088	[1],[3],[10]			$ 26,154	[11],[12],[13]
Investment interest rate	10.74%	[1],[10]	10.74%	[1],[10]	9.28%	[11],[13]	9.28%	[11],[13]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 31,186	[1],[3],[10]			$ 33,775	[11],[12],[13]
Investment interest rate	11.50%	[1],[10]	11.50%	[1],[10]	10.42%	[11],[13]	10.42%	[11],[13]
Investment, Identifier [Axis]: Park Place Technologies LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,838	[3],[10]			$ 9,850	[12],[13]
Investment interest rate	9.42%	[10]	9.42%	[10]	8.13%	[13]	8.13%	[13]
Investment, Identifier [Axis]: Performance Health Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 17,976	[1],[3],[10]			$ 17,976	[11],[12],[13]
Investment interest rate	10.73%	[1],[10]	10.73%	[1],[10]	8.88%	[11],[13]	8.88%	[11],[13]
Investment, Identifier [Axis]: Planview Parent Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 28,627	[1],[3],[10]			$ 28,627	[11],[12],[13]
Investment interest rate	11.98%	[1],[10]	11.98%	[1],[10]	10.92%	[11],[13]	10.92%	[11],[13]
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,766	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment interest rate	12.36%	[1],[2],[10]	12.36%	[1],[2],[10]
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 48,689	[1],[3],[10]			$ 48,689	[11],[12],[13]
Investment interest rate	11.83%	[1],[10]	11.83%	[1],[10]	10.68%	[11],[13]	10.68%	[11],[13]
Investment, Identifier [Axis]: Profrac Holdings II LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 22,984	[1],[3],[10]			$ 23,275	[11],[12],[13]
Investment interest rate	11.10%	[1],[10]	11.10%	[1],[10]	10.01%	[11],[13]	10.01%	[11],[13]
Investment, Identifier [Axis]: Project Boost Purchaser LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,250	[1],[3],[10]			$ 5,250	[11],[12],[13]
Investment interest rate	12.38%	[1],[10]	12.38%	[1],[10]	11.12%	[11],[13]	11.12%	[11],[13]
Investment, Identifier [Axis]: Quantum Bidco Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,501	[1],[3],[10],[14]			$ 3,501	[11],[12],[13],[16]
Investment interest rate	9.63%	[1],[10],[14]	9.63%	[1],[10],[14]	8.39%	[11],[13],[16]	8.39%	[11],[13],[16]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 1,325	[12]
Investment interest rate					5.25%	[17],[18],[19],[20],[21]	5.25%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Radiology Partners Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,400	[3],[10]			$ 3,400	[12],[13]
Investment interest rate	8.64%	[10]	8.64%	[10]	7.33%	[13]	7.33%	[13]
Investment, Identifier [Axis]: Radiology Partners Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,755	[3]			$ 4,755	[12]
Investment interest rate	9.25%	[5],[6],[7],[8],[9]	9.25%	[5],[6],[7],[8],[9]	9.25%	[17],[18],[19],[20],[21]	9.25%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	25,405	[1],[3],[10]			24,692	[11],[12],[13]
Investment, Identifier [Axis]: Renaissance Holding Corp, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,542	[3],[10]			$ 3,542	[12],[13]
Investment interest rate	11.38%	[10]	11.38%	[10]	10.12%	[13]	10.12%	[13]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,920	[1],[2],[3],[10],[14]			$ 11,393	[11],[12],[13],[15],[16]
Investment interest rate	12.98%	[1],[2],[10],[14]	12.98%	[1],[2],[10],[14]	11.92%	[11],[13],[15],[16]	11.92%	[11],[13],[15],[16]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 36,092	[1],[3],[10],[14]			$ 37,656	[11],[12],[13],[16]
Investment interest rate	12.98%	[1],[10],[14]	12.98%	[1],[10],[14]	11.92%	[11],[13],[16]	11.92%	[11],[13],[16]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[10]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,010	[3],[10]
Investment interest rate	12.52%	[10]	12.52%	[10]
Investment, Identifier [Axis]: SM Wellness Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,395	[1],[10]
Investment interest rate	9.42%	[10]	9.42%	[10]
Investment, Identifier [Axis]: SM Wellness Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,109	[1],[3],[10]			$ 9,109	[11],[12],[13]
Investment interest rate	12.67%	[1],[10]	12.67%	[1],[10]	10.74%	[11],[13]	10.74%	[11],[13]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,496	[3],[10]
Investment interest rate	8.92%	[10]	8.92%	[10]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 1,500	[12],[13]
Investment interest rate					7.63%	[13]	7.63%	[13]
Investment, Identifier [Axis]: SVP-Singer Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 20,714	[1],[3],[10]			$ 20,766	[11],[12],[13]
Investment interest rate	11.48%	[1],[10]	11.48%	[1],[10]	10.42%	[11],[13]	10.42%	[11],[13]
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan, LIBOR+4.50% cash due 12/10/2026
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 1,691	[12],[13]
Investment interest rate					7.63%	[13]	7.63%	[13]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 931	[1],[2],[3],[10]
Investment interest rate	14.32%	[1],[2],[10]	14.32%	[1],[2],[10]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 27,848	[3],[10]
Investment interest rate	14.32%	[10]	14.32%	[10]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 112,656	[1],[2],[3],[10],[14]			$ 96,250	[11],[12],[13],[15],[16]
Investment interest rate	10.17%	[1],[2],[10],[14]	10.17%	[1],[2],[10],[14]	8.80%	[11],[13],[15],[16]	8.80%	[11],[13],[15],[16]	8%
Investment, Identifier [Axis]: SiO Medical Products Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 47,112	[1],[3]			$ 46,121	[11],[12]
Investment interest rate	5.50%	[1],[5],[6],[7],[8],[9]	5.50%	[1],[5],[6],[7],[8],[9]	5.50%	[11],[17],[18],[19],[20],[21]	5.50%	[11],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: SonicWall US Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,195	[1],[3],[10]			$ 3,195	[11],[12],[13]
Investment interest rate	12.20%	[1],[10]	12.20%	[1],[10]	10.48%	[11],[13]	10.48%	[11],[13]
Investment, Identifier [Axis]: Spanx LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 330	[1],[2],[3],[10]			$ 866	[11],[12],[13],[15]
Investment interest rate	9.29%	[1],[2],[10]	9.29%	[1],[2],[10]	8.03%	[11],[13],[15]	8.03%	[11],[13],[15]
Investment, Identifier [Axis]: Spanx LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,523	[1],[3],[10]			$ 4,534	[11],[12],[13]
Investment interest rate	9.64%	[1],[10]	9.64%	[1],[10]	8.30%	[11],[13]	8.30%	[11],[13]
Investment, Identifier [Axis]: SumUp Holdings Luxembourg SÀRL, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 16,911	[1],[3],[10],[14]					€ 16,911	[11],[12],[13],[16]
Investment interest rate	10.49%	[1],[10],[14]	10.49%	[1],[10],[14]	10%	[11],[13],[16]	10%	[11],[13],[16]
Investment, Identifier [Axis]: Sunland Asphalt & Construction LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 42,510	[1],[3],[10]			$ 42,618	[11],[12],[13]
Investment interest rate	11.15%	[1],[10]	11.15%	[1],[10]	8.88%	[11],[13]	8.88%	[11],[13]
Investment, Identifier [Axis]: Superior Industries International Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 39,774	[10]
Investment interest rate	12.32%	[10]	12.32%	[10]
Investment, Identifier [Axis]: Supermoose Borrower LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,457	[3],[10]			$ 3,466	[12],[13]
Investment interest rate	8.48%	[10]	8.48%	[10]	7.42%	[13]	7.42%	[13]
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,500	[1],[3],[10]			$ 12,500	[11],[12],[13]
Investment interest rate	11.14%	[1],[10]	11.14%	[1],[10]	9.81%	[11],[13]	9.81%	[11],[13]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,984	[1],[3],[4],[14]			$ 4,984	[11],[12],[16],[22]
Investment interest rate	11.50%	[1],[4],[5],[6],[7],[8],[9],[14]	11.50%	[1],[4],[5],[6],[7],[8],[9],[14]	11.50%	[11],[13],[16],[17],[18],[19],[20],[21]	11.50%	[11],[13],[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: TIBCO Software Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 12,032	[3],[10]			$ 12,032	[12],[13]
Investment interest rate	9.18%	[10]	9.18%	[10]	8.15%	[13]	8.15%	[13]
Investment, Identifier [Axis]: Tacala LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,448	[3],[10]			$ 9,448	[12],[13]
Investment interest rate	11.88%	[10]	11.88%	[10]	10.62%	[13]	10.62%	[13]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10],[14]			$ 0	[11],[12],[13],[15],[16]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 23,215	[1],[3],[10],[14]			$ 23,215	[11],[12],[13],[16]
Investment interest rate	10.29%	[1],[10],[14]	10.29%	[1],[10],[14]	8.68%	[11],[13],[16]	8.68%	[11],[13],[16]
Investment, Identifier [Axis]: Tecta America Corp, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,203	[1],[3],[10]			$ 5,203	[11],[12],[13]
Investment interest rate	12.94%	[1],[10]	12.94%	[1],[10]	11.62%	[11],[13]	11.62%	[11],[13]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,231	[1],[2],[3],[10]			$ 1,231	[11],[12],[13]
Investment interest rate	13.67%	[1],[2],[10]	13.67%	[1],[2],[10]	12.20%	[11],[13]	12.20%	[11],[13]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 18,276	[1],[3],[10]			$ 18,323	[11],[12],[13]
Investment interest rate	13.67%	[1],[10]	13.67%	[1],[10]	12.11%	[11],[13]	12.11%	[11],[13]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 29,663	[1],[3],[10]			$ 29,663	[11],[12],[13]
Investment interest rate	13.88%	[1],[10]	13.88%	[1],[10]	13.17%	[11],[13]	13.17%	[11],[13]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 15,674	[11],[12],[13]
Investment interest rate					10.44%	[11],[13]	10.44%	[11],[13]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 15,301	[1],[3],[10]
Investment interest rate	11.69%	[1],[10]	11.69%	[1],[10]
Investment, Identifier [Axis]: The Avery, Subordinated Debt in T8 Senior Mezz LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,706	[1],[3],[10]			$ 3,789	[11],[12],[13]
Investment interest rate	17.24%	[1],[10]	17.24%	[1],[10]	16.17%	[11],[13]	16.17%	[11],[13]
Investment, Identifier [Axis]: Thrasio LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 37,399	[1],[3],[10]			$ 37,494	[11],[12],[13]
Investment interest rate	11.17%	[1],[10]	11.17%	[1],[10]	11.17%	[11],[13]	11.17%	[11],[13]
Investment, Identifier [Axis]: Touchstone Acquisition Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,001	[1],[3],[10]			$ 6,016	[11],[12],[13]
Investment interest rate	10.38%	[1],[10]	10.38%	[1],[10]	9.12%	[11],[13]	9.12%	[11],[13]
Investment, Identifier [Axis]: Trinitas CLO XV, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,000	[10],[14]
Investment interest rate	11.77%	[10],[14]	11.77%	[10],[14]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,500	[3],[14]			$ 4,500	[12],[16]
Investment interest rate	6.50%	[5],[6],[7],[8],[9],[14]	6.50%	[5],[6],[7],[8],[9],[14]	6.50%	[16],[17],[18],[19],[20],[21]	6.50%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 300	[3],[14]			$ 300	[12],[16]
Investment interest rate	4.75%	[5],[6],[7],[8],[9],[14]	4.75%	[5],[6],[7],[8],[9],[14]	4.75%	[16],[17],[18],[19],[20],[21]	4.75%	[16],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: WP CPP Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,545	[3],[10]			$ 7,564	[12],[13]
Investment interest rate	8.17%	[10]	8.17%	[10]	6.56%	[13]	6.56%	[13]
Investment, Identifier [Axis]: WP CPP Holdings LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,000	[1],[3],[10]			$ 6,000	[11],[12],[13]
Investment interest rate	12.17%	[1],[10]	12.17%	[1],[10]	10.56%	[11],[13]	10.56%	[11],[13]
Investment, Identifier [Axis]: WPEngine Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 40,536	[1],[3],[10]			$ 40,536	[11],[12],[13]
Investment interest rate	10.19%	[1],[10]	10.19%	[1],[10]	10.19%	[11],[13]	10.19%	[11],[13]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 5,000	[11],[12],[13]
Investment interest rate					10.67%	[11],[13]	10.67%	[11],[13]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,000	[1],[3],[10]
Investment interest rate	11.73%	[1],[10]	11.73%	[1],[10]
Investment, Identifier [Axis]: Win Brands Group LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,238	[1],[3],[10]			$ 2,316	[11],[12],[13]
Investment interest rate	20.75%	[1],[10]	20.75%	[1],[10]	19.64%	[11],[13]	19.64%	[11],[13]
Investment, Identifier [Axis]: Windstream Services II LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 25,432	[3],[10]			$ 25,499	[12],[13]
Investment interest rate	10.67%	[10]	10.67%	[10]	9.37%	[13]	9.37%	[13]
Investment, Identifier [Axis]: Zayo Group Holdings Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 250	[3]			$ 250	[12]
Investment interest rate	4%	[5],[6],[7],[8],[9]	4%	[5],[6],[7],[8],[9]	4%	[17],[18],[19],[20],[21]	4%	[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: Zep Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 19,578	[1],[3],[10],[13]			$ 19,578	[11],[12],[13]
Investment interest rate	12.98%	[1],[10]	12.98%	[1],[10]	11.92%	[11],[13]	11.92%	[11],[13]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 18,000	[1],[3],[10],[13],[14]			$ 18,000	[11],[12],[13],[16]
Investment interest rate	10.96%	[1],[10],[14]	10.96%	[1],[10],[14]	9.72%	[11],[13],[16]	9.72%	[11],[13],[16]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc.,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate					10.75%	[11],[17],[18],[19],[20],[21]	10.75%	[11],[17],[18],[19],[20],[21]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	10.75%	[1],[5],[6],[7],[8],[9]	10.75%	[1],[5],[6],[7],[8],[9]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[3],[10]			$ 0	[11],[12],[13],[15]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	0	[1],[2],[3],[10]			0	[11],[12],[13],[15]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 19,203	[11],[12],[13]
Investment interest rate					9.49%	[11],[13]	9.49%	[11],[13]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 19,203	[1],[3],[10]
Investment interest rate	7.14%	[1],[10]	7.14%	[1],[10]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,944	[1],[10]
Investment interest rate	11.52%	[1],[10]	11.52%	[1],[10]
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[2],[10]
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,212	[1],[3],[10]
Investment interest rate	11.75%	[1],[10]	11.75%	[1],[10]
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 382,148				$ 383,194
Number of borrowers in the Glick JV | borrower	59		59		60		60
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,413				$ 8,518
Investment interest rate	11.34%		11.34%		9.80%		9.80%
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolve
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 0
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,166				$ 4,176
Investment interest rate	10.38%		10.38%		9.67%		9.67%
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,067				$ 10,093
Investment interest rate	7.82%		7.82%		6.82%		6.82%
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,992				$ 3,000
Investment interest rate	8.65%		8.65%		6.91%		6.91%
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,150				$ 9,267
Investment interest rate	12.23%		12.23%		11.20%		11.20%
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,995
Investment interest rate	8.38%		8.38%
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,860				$ 4,873
Investment interest rate	10.61%		10.61%		9.03%		9.03%
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,780				$ 7,800
Investment interest rate	8.98%		8.98%		7.92%		7.92%
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,535				$ 1,539
Investment interest rate	8.48%		8.48%		7.42%		7.42%
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 231				$ 154
Investment interest rate	9.94%		9.94%		8.46%		8.46%
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,615				$ 4,615
Investment interest rate	9.94%		9.94%		8.46%		8.46%
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,052				$ 5,052
Investment interest rate	9.63%		9.63%		8.37%		8.37%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,988				$ 5,000
Investment interest rate	8.68%		8.68%		7.70%		7.70%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,346				$ 4,346
Investment interest rate	9.63%		9.63%		8.37%		8.37%
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,321				$ 6,338
Investment interest rate	10.32%		10.32%		8.78%		8.78%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,767				$ 1,771
Investment interest rate	9.73%		9.73%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,354				$ 6,371
Investment interest rate	9.07%		9.07%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,425				$ 7,444
Investment interest rate	10.70%		10.70%		8.98%		8.98%
SLF JV I | Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,550				$ 9,575
Investment interest rate	7.08%		7.08%		6.03%		6.03%
SLF JV I | Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,994
Investment interest rate	8.13%		8.13%
SLF JV I | Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 7,038
Investment interest rate					9.37%		9.37%
SLF JV I | Investment, Identifier [Axis]: Cengage Learning, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,992
Investment interest rate	7.81%		7.81%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 449
Investment interest rate					9.12%		9.12%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0				$ 0
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,345				$ 4,358
Investment interest rate	10.43%		10.43%		9.12%		9.12%
SLF JV I | Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 6,451
Investment interest rate					6.48%		6.48%
SLF JV I | Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,354				$ 7,373
Investment interest rate	9.38%		9.38%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,375				$ 5,375
Investment interest rate	9.58%		9.58%		7.65%		7.65%
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,800				$ 5,820
Investment interest rate	8.73%		8.73%		7.67%		7.67%
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 997
Investment interest rate	8.98%		8.98%
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,980				$ 8,000
Investment interest rate	8.84%		8.84%		7.33%		7.33%
SLF JV I | Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,992
Investment interest rate					7.37%		7.37%
SLF JV I | Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 6,035
Investment interest rate					8.49%		8.49%
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,277				$ 6,436
Investment interest rate	9.38%		9.38%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,090				$ 4,100
Investment interest rate	9.79%		9.79%		8.26%		8.26%
SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 4,478
Investment interest rate					7.80%		7.80%
SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 51,990				$ 48,139
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,425				$ 7,444
Investment interest rate	9.13%		9.13%		7.94%		7.94%
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,260
Investment interest rate	8.42%		8.42%
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 1,979
Investment interest rate					7.37%		7.37%
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,192
Investment interest rate					6.81%		6.81%
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,980				$ 8,000
Investment interest rate	9.67%		9.67%		8.38%		8.38%
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,375				$ 9,500
Investment interest rate	10.48%		10.48%		9.42%		9.42%
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,388				$ 7,406
Investment interest rate	10.09%		10.09%		8.80%		8.80%
SLF JV I | Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,988				$ 5,000
Investment interest rate	8.94%		8.94%		7.89%		7.89%
SLF JV I | Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,992
Investment interest rate	9.38%		9.38%
SLF JV I | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,347				$ 7,366
Investment interest rate	7.88%		7.88%		6.37%		6.37%
SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 11,337				$ 10,093
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,425				$ 7,444
Investment interest rate	9.76%		9.76%		8.23%		8.23%
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 11,337				$ 7,367
Investment interest rate	9.73%		9.73%		8.67%		8.67%
SLF JV I | Investment, Identifier [Axis]: LogMeIn, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,840				$ 7,860
Investment interest rate	9.14%		9.14%		7.80%		7.80%
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0				$ 0
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,611				$ 6,139
Investment interest rate	10.23%		10.23%		9.17%		9.17%
SLF JV I | Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,995
Investment interest rate	7.97%		7.97%
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0				$ 0
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,668				$ 4,687
Investment interest rate	11.72%		11.72%		10.64%		10.64%
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,668				$ 6,685
Investment interest rate	9.23%		9.23%		7.87%		7.87%
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,757				$ 7,777
Investment interest rate	8.42%		8.42%		7.12%		7.12%
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,900				$ 4,925
Investment interest rate	9.42%		9.42%		8.13%		8.13%
SLF JV I | Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 5,486
Investment interest rate					8.35%		8.35%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,435
Investment interest rate	8.73%		8.73%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,503				$ 4,503
Investment interest rate	11.98%		11.98%		10.92%		10.92%
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 212				$ 0
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,796				$ 6,796
Investment interest rate	11.83%		11.83%		10.68%		10.68%
SLF JV I | Investment, Identifier [Axis]: RevSpring, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 9,600				$ 9,625
Investment interest rate	8.73%		8.73%		7.67%		7.67%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,179				$ 8,201
Investment interest rate	9.66%		9.66%		8.06%		8.06%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 138				$ 138
Investment interest rate	9.64%		9.64%		8.04%		8.04%
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 10,075				$ 7,500
Investment interest rate	8.92%		8.92%		7.63%		7.63%
SLF JV I | Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,536
Investment interest rate					7.63%		7.63%
SLF JV I | Investment, Identifier [Axis]: Sorenson Communications, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,478				$ 2,553
Investment interest rate	10.23%		10.23%		9.17%		9.17%
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 8,910				$ 8,933
Investment interest rate	9.64%		9.64%		8.30%		8.30%
SLF JV I | Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,723				$ 7,743
Investment interest rate	8.48%		8.48%		7.42%		7.42%
SLF JV I | Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,044				$ 3,377
Investment interest rate	8.05%		8.05%		6.51%		6.51%
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,256				$ 6,256
Investment interest rate	9.18%		9.18%		8.15%		8.15%
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,267				$ 7,285
Investment interest rate	10.38%		10.38%		9.12%		9.12%
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,354				$ 6,365
Investment interest rate	9.73%		9.73%		8.67%		8.67%
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,980				$ 1,985
Investment interest rate	8.17%		8.17%		6.56%		6.56%
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,000				$ 6,000
Investment interest rate	12.17%		12.17%		10.56%		10.56%
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,798				$ 7,818
Investment interest rate	10.67%		10.67%		9.37%		9.37%
SLF JV I | Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,155				$ 2,155
Investment interest rate	7.38%		7.38%		6.12%		6.12%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 109
Investment interest rate	7.82%		7.82%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,558
Investment interest rate	7.82%		7.82%
SLF JV I | Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,811				$ 7,331
Investment interest rate	8.88%		8.88%		7.62%		7.62%
SLF JV I | Senior secured loans
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 382,148				$ 383,194
SLF JV I | Weighted Average
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	9.55%		9.55%		8.33%		8.33%
Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 143,225
Number of borrowers in the Glick JV | borrower	40		40		43		43
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,589				$ 4,647
Investment interest rate	11.34%		11.34%		9.80%		9.80%
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0				$ 0
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,729				$ 1,734
Investment interest rate	10.38%		10.38%		9.67%		9.67%
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 6,562
Investment interest rate					11.20%		11.20%
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,479
Investment interest rate	12.23%		12.23%
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 997
Investment interest rate	8.38%		8.38%
Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,882				$ 2,889
Investment interest rate	10.61%		10.61%		9.03%		9.03%
Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,918				$ 2,925
Investment interest rate	8.98%		8.98%		7.92%		7.92%
Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 914				$ 917
Investment interest rate	8.48%		8.48%		7.42%		7.42%
Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,078				$ 2,078
Investment interest rate	9.63%		9.63%		8.37%		8.37%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,995				$ 2,000
Investment interest rate	8.68%		8.68%		7.70%		7.70%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,423				$ 2,423
Investment interest rate	9.63%		9.63%		8.37%		8.37%
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,647				$ 3,656
Investment interest rate	10.32%		10.32%		8.78%		8.78%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 808
Investment interest rate					8.12%		8.12%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 3,398
Investment interest rate					8.12%		8.12%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,389
Investment interest rate	9.07%		9.07%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 806
Investment interest rate	9.73%		9.73%
Glick JV LLC | Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,960				$ 3,970
Investment interest rate	10.70%		10.70%		8.98%		8.98%
Glick JV LLC | Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 3,519
Investment interest rate					9.37%		9.37%
Glick JV LLC | Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,481
Investment interest rate					6.48%		6.48%
Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,280				$ 2,280
Investment interest rate	9.58%		9.58%		7.65%		7.65%
Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,863				$ 2,870
Investment interest rate	8.73%		8.73%		7.67%		7.67%
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,993				$ 3,000
Investment interest rate	8.84%		8.84%		7.33%		7.33%
Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,663				$ 2,730
Investment interest rate	9.38%		9.38%		8.12%		8.12%
Glick JV LLC | Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,497				$ 2,503
Investment interest rate	9.79%		9.79%		8.26%		8.26%
Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,488
Investment interest rate					7.80%		7.80%
Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 29,830				$ 28,973
Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,960				$ 3,970
Investment interest rate	9.13%		9.13%		7.94%		7.94%
Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,990				$ 4,000
Investment interest rate	9.67%		9.67%		8.38%		8.38%
Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,344				$ 2,375
Investment interest rate	10.48%		10.48%		9.42%		9.42%
Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,940				$ 3,950
Investment interest rate	10.09%		10.09%		8.80%		8.80%
Glick JV LLC | Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,995				$ 2,000
Investment interest rate	8.94%		8.94%		7.89%		7.89%
Glick JV LLC | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,355				$ 1,358
Investment interest rate	7.88%		7.88%		6.37%		6.37%
Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,476				$ 6,562
Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,960				$ 3,970
Investment interest rate	9.76%		9.76%		8.23%		8.23%
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revovlver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,642
Investment interest rate	10.23%		10.23%
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 1,647
Investment interest rate					9.17%		9.17%
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 0
Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,239				$ 5,252
Investment interest rate	9.23%		9.23%		7.87%		7.87%
Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,878				$ 3,888
Investment interest rate	8.42%		8.42%		7.12%		7.12%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 688
Investment interest rate	8.73%		8.73%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,842
Investment interest rate	11.98%		11.98%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 2,842
Investment interest rate					10.92%		10.92%
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 158				$ 0
Investment interest rate	12.36%		12.36%
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,465				$ 4,465
Investment interest rate	11.83%		11.83%		10.68%		10.68%
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 6,078				$ 6,094
Investment interest rate	9.66%		9.66%		8.06%		8.06%
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 102				$ 102
Investment interest rate	9.64%		9.64%		8.04%		8.04%
Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 5,985				$ 6,000
Investment interest rate	8.92%		8.92%		7.63%		7.63%
Glick JV LLC | Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 1,691
Investment interest rate					7.63%		7.63%
Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,950				$ 4,962
Investment interest rate	9.64%		9.64%		8.30%		8.30%
Glick JV LLC | Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,813				$ 2,820
Investment interest rate	8.48%		8.48%		7.42%		7.42%
Glick JV LLC | Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,044				$ 3,377
Investment interest rate	8.05%		8.05%		6.51%		6.51%
Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,654				$ 2,654
Investment interest rate	9.18%		9.18%		8.15%		8.15%
Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,016				$ 3,024
Investment interest rate	10.38%		10.38%		9.12%		9.12%
Glick JV LLC | Investment, Identifier [Axis]: Tribe Buyer LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 1,578				$ 1,583
Investment interest rate	8.88%		8.88%		7.62%		7.62%
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 990				$ 993
Investment interest rate	8.17%		8.17%		6.56%		6.56%
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 3,000				$ 3,000
Investment interest rate	12.17%		12.17%		10.56%		10.56%
Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 4,874				$ 4,886
Investment interest rate	10.67%		10.67%		9.37%		9.37%
Glick JV LLC | Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 2,438				$ 2,444
Investment interest rate	8.88%		8.88%		7.62%		7.62%
Glick JV LLC | Senior secured loans
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 134,080				$ 143,225
Glick JV LLC | Weighted Average
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment interest rate	9.86%		9.86%		8.52%		8.52%
[1] As of December 31, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

Portfolio Investments - Portf_3

Portfolio Investments - Portfolio Listing (Details) € in Thousands, $ in Thousands	Dec. 31, 2022 USD ($) shares		Dec. 31, 2022 EUR (€) shares		Sep. 30, 2022 USD ($) shares		Sep. 30, 2022 EUR (€) shares		Dec. 31, 2021 shares
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	$ 2,778,014				$ 2,617,754
Fair Value	2,642,870				2,494,111
Apptio Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	35,130				34,600
Fair Value	35,063				34,584
athenahealth Group Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	18,264				18,264
Fair Value	15,606				16,575
BAART Programs Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	14,598				13,632
Fair Value	14,218				13,149
C5 Technology Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	34,984				34,984
Fair Value	27,638				27,638
Global Medical Response Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	865				5,435
Fair Value	899				4,848
MRI Software LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	25,368				29,103
Fair Value	24,673				28,587
Pluralsight LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	49,709				47,898
Fair Value	49,149				47,044
WP CPP Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	12,895				12,844
Fair Value	11,653				11,865
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	382,148				383,194
Cost	380,682				382,673
Fair Value	355,427				359,625
SLF JV I | Apptio Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	4,846				4,769
Cost	4,812				4,731
Fair Value	4,746				4,665
SLF JV I | ASP-R-PAC Acquisition Co LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	4,166				4,176
Cost	4,089				4,094
Fair Value	3,994				4,069
SLF JV I | Asurion, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	9,334				9,346
Cost	8,747				8,734
Fair Value	7,867				7,623
SLF JV I | athenahealth Group Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	2,667
Cost	2,427
Fair Value	2,384
SLF JV I | BAART Programs Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	8,121				8,142
Cost	8,042				8,062
Fair Value	7,858				7,812
SLF JV I | C5 Technology Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	7,194				7,194
Fair Value	5,683				5,683
SLF JV I | Centerline Communications, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	6,345				4,807
Cost	6,232				4,708
Fair Value	6,221				4,682
SLF JV I | Curium Bidco S.à.r.l.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	8,797
Cost	8,704
Fair Value	8,619
SLF JV I | Global Medical Response Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					4,171
Cost					4,144
Fair Value					3,634
SLF JV I | Mindbody, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	4,668				4,687
Cost	4,633				4,647
Fair Value	4,556				4,558
SLF JV I | MRI Software LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	10,611				6,139
Cost	10,413				6,101
Fair Value	10,215				5,956
SLF JV I | Planview Parent, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	6,938
Cost	6,729
Fair Value	6,315
SLF JV I | Pluralsight LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	7,008				6,796
Cost	6,904				6,688
Fair Value	6,827				6,569
SLF JV I | SHO Holding I Corporation
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	8,317				8,339
Cost	8,311				8,332
Fair Value	6,459				7,297
SLF JV I | WP CPP Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	7,980				7,985
Cost	7,887				7,882
Fair Value	6,787				6,853
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					143,225
Cost	131,077				140,083
Fair Value	123,339				133,144
OCSI Glick JV LLC | Alvogen Pharma Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	7,476
Cost	7,331
Fair Value	7,388
OCSI Glick JV LLC | ASP-R-PAC Acquisition Co LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	1,729				1,734
Cost	1,698				1,700
Fair Value	1,658				1,689
OCSI Glick JV LLC | Asurion, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	4,418				4,423
Cost	4,121				4,113
Fair Value	3,683				3,577
OCSI Glick JV LLC | BAART Programs Inc
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	4,195				4,206
Cost	4,155				4,166
Fair Value	4,062				4,039
OCSI Glick JV LLC | MRI Software LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	1,642				1,647
Cost	1,628				1,631
Fair Value	1,577				1,596
OCSI Glick JV LLC | Planview Parent, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	3,530
Cost	3,448
Fair Value	3,194
OCSI Glick JV LLC | Pluralsight LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	4,623				4,465
Cost	4,554				4,393
Fair Value	4,504				4,315
OCSI Glick JV LLC | SHO Holding I Corporation
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	6,180				6,196
Cost	6,170				6,184
Fair Value	4,799				5,422
OCSI Glick JV LLC | WP CPP Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	3,990				3,993
Cost	3,943				3,941
Fair Value	$ 3,392				$ 3,426
Investment, Identifier [Axis]: - Van Houten Real LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	12%	[1],[2],[3],[4],[5],[6],[7],[8]	12%	[1],[2],[3],[4],[5],[6],[7],[8]
Principal	$ 3,239	[1],[6],[8],[9]
Cost	3,167	[1],[6],[8]
Fair Value	$ 3,159	[1],[6],[8]
Investment, Identifier [Axis]: ADB Companies LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%	[1],[2],[3],[4],[5],[7],[10]	6.25%	[1],[2],[3],[4],[5],[7],[10]	6.25%	[10],[11],[12],[13],[14],[15],[16]	6.25%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	11.34%	[1],[10]	11.34%	[1],[10]	9.80%	[12],[17]	9.80%	[12],[17]
Principal	$ 14,505	[1],[9],[10]			$ 14,685	[12],[17],[18]
Cost	14,079	[1],[10]			14,217	[12],[17]
Fair Value	$ 14,254	[1],[10]			$ 14,431	[12],[17]
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%		6.25%		6.25%		6.25%
Cash Interest Rate	11.34%		11.34%		9.80%		9.80%
Principal	$ 8,413				$ 8,518
Cost	8,296				8,389
Fair Value	$ 8,267				$ 8,371
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%		6.25%		6.25%		6.25%
Cash Interest Rate	11.34%		11.34%		9.80%		9.80%
Principal	$ 4,589				$ 4,647
Cost	4,528				4,579
Fair Value	$ 4,510				$ 4,567
Investment, Identifier [Axis]: ADC Therapeutics SA, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	28,948	[1],[2],[3],[4],[5],[7],[19]	28,948	[1],[2],[3],[4],[5],[7],[19]	28,948	[11],[12],[13],[14],[15],[16],[20]	28,948	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 174	[1],[19]			$ 174	[12],[20]
Fair Value	$ 50	[1],[19]			$ 73	[12],[20]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	7.50%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	7.50%	[10],[11],[12],[13],[14],[15],[16],[20],[21]	7.50%	[10],[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 0	[1],[6],[9],[10],[19]			$ 0	[12],[17],[18],[20],[21]
Cost	(38)	[1],[6],[10],[19]			(38)	[12],[17],[20],[21]
Fair Value	$ (35)	[1],[6],[10],[19]			$ (37)	[12],[17],[20],[21]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[10],[19]	7.50%	[1],[2],[3],[4],[5],[7],[10],[19]	7.50%	[10],[11],[12],[13],[14],[15],[16],[20]	7.50%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	12.23%	[1],[10],[19]	12.23%	[1],[10],[19]	11.20%	[12],[17],[20]	11.20%	[12],[17],[20]
Principal	$ 6,589	[1],[9],[10],[19]			$ 6,589	[12],[17],[18],[20]
Cost	6,269	[1],[10],[19]			6,256	[12],[17],[20]
Fair Value	$ 6,274	[1],[10],[19]			$ 6,262	[12],[17],[20]
Investment, Identifier [Axis]: AI Sirona Luxembourg Acquisition Sarl, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[7],[10],[19]	7.25%	[1],[2],[3],[4],[5],[7],[10],[19]	7.25%	[10],[11],[12],[13],[14],[15],[16],[20]	7.25%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	9.15%	[1],[10],[19]	9.15%	[1],[10],[19]	7.94%	[12],[17],[20]	7.94%	[12],[17],[20]
Principal	$ 24,838	[1],[9],[10],[19]			$ 24,838	[12],[17],[18],[20]
Cost	27,775	[1],[10],[19]			27,752	[12],[17],[20]
Fair Value	$ 24,255	[1],[10],[19]			$ 22,143	[12],[17],[20]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Common Units in RD Holding LP
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	14,410	[1],[2],[3],[4],[5],[7]	14,410	[1],[2],[3],[4],[5],[7]	14,410	[11],[12],[13],[14],[15],[16]	14,410	[11],[12],[13],[14],[15],[16]
Cost	$ 1,352	[1]			$ 1,352	[12]
Fair Value	$ 1,528	[1]			$ 1,291	[12]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.75%	[1],[2],[3],[4],[5],[7],[10]	7.75%	[1],[2],[3],[4],[5],[7],[10]	7.75%	[10],[11],[12],[13],[14],[15],[16]	7.75%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	12.17%	[1],[10]	12.17%	[1],[10]	10.88%	[12],[17]	10.88%	[12],[17]
Principal	$ 14,414	[1],[9],[10]			$ 14,414	[12],[17],[18]
Cost	14,163	[1],[10]			14,154	[12],[17]
Fair Value	$ 13,960	[1],[10]			$ 13,910	[12],[17]
Investment, Identifier [Axis]: AMMC CLO 27, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.89%	[2],[3],[4],[5],[7],[10],[19]	8.89%	[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	13.49%	[10]	13.49%	[10]
Principal	$ 2,275	[10]
Cost	2,037	[10],[19]
Fair Value	$ 2,087	[10],[19]
Investment, Identifier [Axis]: APX Group Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	5.75%	[2],[3],[4],[5],[7],[19]	5.75%	[2],[3],[4],[5],[7],[19]	5.75%	[11],[13],[14],[15],[16],[20]	5.75%	[11],[13],[14],[15],[16],[20]
Principal	$ 2,075	[9],[19]			$ 2,075	[18],[20]
Cost	1,742	[19]			1,733	[20]
Fair Value	$ 1,721	[19]			$ 1,645	[20]
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					7.50%	[11],[13],[14],[15],[16]	7.50%	[11],[13],[14],[15],[16]
Principal					$ 5,500	[18]
Cost					5,408
Fair Value					$ 3,641
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					5.25%	[11],[13],[14],[15],[16]	5.25%	[11],[13],[14],[15],[16]
Principal					$ 2,500	[18]
Cost					2,220
Fair Value					$ 1,926
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolve | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%
Principal	$ 0
Cost	(8)
Fair Value	$ (18)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6%		6%
Principal					$ 0
Cost					(9)
Fair Value					$ (11)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Principal	$ 0				$ 0
Cost	(3)				(4)
Fair Value	$ (8)				$ (5)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.38%		10.38%		9.67%		9.67%
Principal	$ 4,166				$ 4,176
Cost	4,097				4,103
Fair Value	$ 4,012				$ 4,080
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.38%		10.38%		9.67%		9.67%
Principal	$ 1,729				$ 1,734
Cost	1,701				1,704
Fair Value	$ 1,666				1,694
Investment, Identifier [Axis]: AT Holdings II Ltd, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	14.25%	[1],[2],[3],[4],[5],[7],[19]	14.25%	[1],[2],[3],[4],[5],[7],[19]
Principal	$ 15,939	[1],[9],[19]
Cost	15,939	[1],[19]
Fair Value	15,939	[1],[19]
Investment, Identifier [Axis]: AT Holdings II SÀRL, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	15,643	[1],[9],[19]			33,997	[12],[18],[20]
Cost	15,640	[1],[19]			33,960	[12],[20]
Fair Value	$ 15,722	[1],[19]			$ 34,891	[12],[20]
Investment, interest rate, paid in kind	12.50%	[1],[2],[3],[4],[5],[7],[19]	12.50%	[1],[2],[3],[4],[5],[7],[19]	10.50%	[11],[12],[13],[14],[15],[16],[20]	10.50%	[11],[12],[13],[14],[15],[16],[20]
Investment, Identifier [Axis]: Access CIG LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.75%	[1],[2],[3],[4],[5],[7],[10]	7.75%	[1],[2],[3],[4],[5],[7],[10]	7.75%	[10],[11],[13],[14],[15],[16]	7.75%	[10],[11],[13],[14],[15],[16]
Cash Interest Rate	11.82%	[10]	11.82%	[10]	10.82%	[17]	10.82%	[17]
Principal	$ 20,000	[9],[10]			$ 20,000	[17],[18]
Cost	19,932	[10]			19,927	[17]
Fair Value	$ 17,800	[10]			$ 19,075	[17]
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	7.82%		7.82%		6.82%		6.82%
Principal	$ 10,067				$ 10,093
Cost	10,008				10,028
Fair Value	$ 9,883				$ 9,692
Investment, Identifier [Axis]: Accupac Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[10],[11],[12],[13],[14],[15],[16],[21]	5.50%	[10],[11],[12],[13],[14],[15],[16],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	0	[1],[6],[10]			0	[12],[17],[21]
Fair Value	$ (6)	[1],[6],[10]			$ (6)	[12],[17],[21]
Investment, Identifier [Axis]: Accupac Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[10],[11],[12],[13],[14],[15],[16],[21]	5.50%	[10],[11],[12],[13],[14],[15],[16],[21]
Cash Interest Rate	10.17%	[1],[6],[10]	10.17%	[1],[6],[10]	9.14%	[12],[17],[21]	9.14%	[12],[17],[21]
Principal	$ 908	[1],[6],[9],[10]			$ 500	[12],[17],[18],[21]
Cost	874	[1],[6],[10]			462	[12],[17],[21]
Fair Value	$ 904	[1],[6],[10]			$ 495	[12],[17],[21]
Investment, Identifier [Axis]: Accupac Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[10],[11],[12],[13],[14],[15],[16]	5.50%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	10.16%	[1],[10]	10.16%	[1],[10]	9.12%	[12],[17]	9.12%	[12],[17]
Principal	$ 15,935	[1],[9],[10]			$ 15,976	[12],[17],[18]
Cost	15,668	[1],[10]			15,686	[12],[17]
Fair Value	$ 15,903	[1],[10]			$ 15,944	[12],[17]
Investment, Identifier [Axis]: Acquia Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[10],[11],[12],[13],[14],[15],[16]	7%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	12.18%	[1],[6],[10]	12.18%	[1],[6],[10]	10.64%	[12],[17],[21]	10.64%	[12],[17],[21]
Principal	$ 1,317	[1],[6],[9],[10]			$ 914	[12],[17],[18],[21]
Cost	1,296	[1],[6],[10]			890	[12],[17],[21]
Fair Value	$ 1,308	[1],[6],[10]			$ 898	[12],[17],[21]
Investment, Identifier [Axis]: Acquia Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[10],[11],[12],[13],[14],[15],[16]	7%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	10.74%	[1],[10]	10.74%	[1],[10]	9.63%	[12],[17]	9.63%	[12],[17]
Principal	$ 27,349	[1],[9],[10]			$ 27,349	[12],[17],[18]
Cost	27,064	[1],[10]			27,038	[12],[17]
Fair Value	$ 27,240	[1],[10]			$ 27,158	[12],[17]
Investment, Identifier [Axis]: Aden & Anais Merger Sub Inc, Common Units in Aden & Anais Holdings, Inc.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	51,645	[1],[2],[3],[4],[5],[7]	51,645	[1],[2],[3],[4],[5],[7]	51,645	[11],[12],[13],[14],[15],[16]	51,645	[11],[12],[13],[14],[15],[16]
Cost	$ 5,165	[1]			$ 5,165	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: AirStrip Technologies Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	5,715	[1],[2],[3],[4],[5],[7]	5,715	[1],[2],[3],[4],[5],[7]	5,715	[11],[12],[13],[14],[15],[16]	5,715	[11],[12],[13],[14],[15],[16]
Cost	$ 90	[1]			$ 90	[12]
Fair Value	$ 0	[1]			0	[12]
Investment, Identifier [Axis]: All Web Leads Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	1%	[1],[2],[3],[4],[5],[7],[10]	1%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	5.73%	[1],[10]	5.73%	[1],[10]
Principal	$ 23,562	[1],[9],[10]			23,338	[12],[17],[18]
Cost	22,547	[1],[10]			22,057	[12],[17]
Fair Value	$ 22,354	[1],[10]			$ 22,141	[12],[17]
Investment, interest rate, paid in kind	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[10],[11],[12],[13],[14],[15],[16]	8.50%	[10],[11],[12],[13],[14],[15],[16]
Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.65%		8.65%		6.91%		6.91%
Principal	$ 2,992				$ 3,000
Cost	2,844				2,841
Fair Value	$ 2,791				$ 2,730
Investment, Identifier [Axis]: Altice France SA, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.50%	[11],[13],[14],[15],[16],[20]	5.50%	[11],[13],[14],[15],[16],[20]
Cash Interest Rate	5.50%	[1],[2],[3],[4],[5],[7],[19]	5.50%	[1],[2],[3],[4],[5],[7],[19]
Principal	$ 4,050	[9],[19]			$ 4,050	[18],[20]
Cost	3,533	[19]			3,518	[20]
Fair Value	$ 3,095	[19]			$ 3,057	[20]
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	166,414	[1],[2],[3],[4],[5],[7]	166,414	[1],[2],[3],[4],[5],[7]
Cost	$ 642	[1]
Fair Value	$ 629	[1]
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	12.68%	[1],[10]	12.68%	[1],[10]
Principal	$ 8,640	[1],[9],[10]
Cost	7,904	[1],[10]
Fair Value	$ 7,930	[1],[10]
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[7],[10]	3.50%	[1],[2],[3],[4],[5],[7],[10]
Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7.50%		7.50%
Cash Interest Rate					11.20%		11.20%
Principal					$ 6,562
Cost					6,489
Fair Value					$ 6,529
Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%		7.50%
Cash Interest Rate	12.23%		12.23%
Principal	$ 6,479
Cost	6,413
Fair Value	$ 6,447
Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%
Cash Interest Rate	8.38%		8.38%
Principal	$ 997
Cost	918
Fair Value	$ 941
Investment, Identifier [Axis]: Alvogen Pharma US Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[10],[11],[12],[13],[14],[15],[16]	7.50%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	12.23%	[1],[10]	12.23%	[1],[10]	11.20%	[12],[17]	11.20%	[12],[17]
Principal	$ 12,968	[1],[9],[10]			$ 13,134	[12],[17],[18]
Cost	12,711	[1],[10]			12,847	[12],[17]
Fair Value	$ 12,903	[1],[10]			$ 13,068	[12],[17]
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%		7.50%		7.50%		7.50%
Cash Interest Rate	12.23%		12.23%		11.20%		11.20%
Principal	$ 9,150				$ 9,267
Cost	9,060				9,166
Fair Value	$ 9,104				$ 9,221
Investment, Identifier [Axis]: Alvotech Holdings SA, Common Shares in Alvotech SA
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	587,930	[2],[3],[4],[5],[7],[19]	587,930	[2],[3],[4],[5],[7],[19]	587,930	[11],[13],[14],[15],[16],[20]	587,930	[11],[13],[14],[15],[16],[20]
Cost	$ 5,308	[19]			$ 5,308	[20]
Fair Value	$ 5,879	[19]			$ 3,974	[20]
Investment, Identifier [Axis]: Alvotech Holdings SA, Seller Earn Out Shares in Alvotech SA
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					124,780	[11],[12],[13],[14],[15],[16],[20]	124,780	[11],[12],[13],[14],[15],[16],[20]
Cost					$ 485	[12],[20]
Fair Value					$ 212	[12],[20]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche A Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	8.50%	[1],[2],[3],[4],[5],[7],[19]	8.50%	[1],[2],[3],[4],[5],[7],[19]	10%	[11],[12],[13],[14],[15],[16],[20]	10%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 26,179	[1],[9],[19]			$ 24,043	[12],[18],[20]
Cost	25,798	[1],[19]			23,747	[12],[20]
Fair Value	$ 25,684	[1],[19]			$ 23,923	[12],[20]
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[7],[19]	3.50%	[1],[2],[3],[4],[5],[7],[19]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche B Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	8.50%	[1],[2],[3],[4],[5],[7],[19]	8.50%	[1],[2],[3],[4],[5],[7],[19]	10%	[11],[12],[13],[14],[15],[16],[20]	10%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 25,612	[1],[9],[19]			$ 23,522	[12],[18],[20]
Cost	25,264	[1],[19]			23,264	[12],[20]
Fair Value	$ 25,128	[1],[19]			$ 23,404	[12],[20]
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[7],[19]	3.50%	[1],[2],[3],[4],[5],[7],[19]
Investment, Identifier [Axis]: American Auto Auction Group LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[7],[10]	8.75%	[1],[2],[3],[4],[5],[7],[10]	8.75%	[10],[11],[12],[13],[14],[15],[16]	8.75%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	13.33%	[1],[10]	13.33%	[1],[10]	12.30%	[12],[17]	12.30%	[12],[17]
Principal	$ 14,760	[1],[9],[10]			$ 14,760	[12],[17],[18]
Cost	14,503	[1],[10]			14,492	[12],[17]
Fair Value	$ 11,439	[1],[10]			$ 13,284	[12],[17]
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%
Cash Interest Rate	8.38%		8.38%
Principal	$ 1,995
Cost	1,836
Fair Value	$ 1,883
Investment, Identifier [Axis]: American Tire Distributors Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%	[2],[3],[4],[5],[7],[10]	6.25%	[2],[3],[4],[5],[7],[10]	6.25%	[10],[11],[13],[14],[15],[16]	6.25%	[10],[11],[13],[14],[15],[16]
Cash Interest Rate	10.61%	[10]	10.61%	[10]	9.03%	[17]	9.03%	[17]
Principal	$ 9,870	[9],[10]			$ 9,895	[17],[18]
Cost	9,747	[10]			9,772	[17]
Fair Value	$ 9,081	[10]			$ 9,293	[17]
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%		6.25%		6.25%		6.25%
Cash Interest Rate	10.61%		10.61%		9.03%		9.03%
Principal	$ 4,860				$ 4,873
Cost	4,800				4,812
Fair Value	$ 4,471				$ 4,576
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%		6.25%		6.25%		6.25%
Cash Interest Rate	10.61%		10.61%		9.03%		9.03%
Principal	$ 2,882				$ 2,889
Cost	2,846				2,853
Fair Value	$ 2,652				$ 2,714
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.25%	[1],[2],[3],[4],[5],[7],[10],[19]	4.25%	[1],[2],[3],[4],[5],[7],[10],[19]	4.25%	[10],[11],[12],[13],[14],[15],[16],[20]	4.25%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	8.98%	[1],[10],[19]	8.98%	[1],[10],[19]	7.92%	[12],[17],[20]	7.92%	[12],[17],[20]
Principal	$ 15,181	[1],[9],[10],[19]			$ 15,220	[12],[17],[18],[20]
Cost	14,014	[1],[10],[19]			13,973	[12],[17],[20]
Fair Value	$ 14,637	[1],[10],[19]			$ 14,687	[12],[17],[20]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10],[19]	8%	[1],[2],[3],[4],[5],[7],[10],[19]	8%	[10],[11],[12],[13],[14],[15],[16],[20]	8%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	12.73%	[1],[10],[19]	12.73%	[1],[10],[19]	11.67%	[12],[17],[20]	11.67%	[12],[17],[20]
Principal	$ 12,500	[1],[9],[10],[19]			$ 12,500	[12],[17],[18],[20]
Cost	12,188	[1],[10],[19]			12,188	[12],[17],[20]
Fair Value	$ 11,833	[1],[10],[19]			$ 11,958	[12],[17],[20]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.25%		4.25%		4.25%		4.25%
Cash Interest Rate	8.98%		8.98%		7.92%		7.92%
Principal	$ 7,780				$ 7,800
Cost	7,702				7,722
Fair Value	$ 7,501				$ 7,527
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.25%		4.25%		4.25%		4.25%
Cash Interest Rate	8.98%		8.98%		7.92%		7.92%
Principal	$ 2,918				$ 2,925
Cost	2,888				2,896
Fair Value	$ 2,813				$ 2,823
Investment, Identifier [Axis]: Anastasia Parent LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%	[2],[3],[4],[5],[7],[10]	3.75%	[2],[3],[4],[5],[7],[10]	3.75%	[10],[11],[13],[14],[15],[16]	3.75%	[10],[11],[13],[14],[15],[16]
Cash Interest Rate	8.48%	[10]	8.48%	[10]	7.42%	[17]	7.42%	[17]
Principal	$ 2,729	[9],[10]			$ 2,736	[17],[18]
Cost	2,254	[10]			2,260	[17]
Fair Value	$ 2,043	[10]			$ 2,189	[17]
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.48%		8.48%		7.42%		7.42%
Principal	$ 1,535				$ 1,539
Cost	1,200				1,203
Fair Value	$ 1,149				$ 1,232
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.48%		8.48%		7.42%		7.42%
Principal	$ 914				$ 917
Cost	711				712
Fair Value	$ 685				$ 734
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[10],[11],[12],[13],[14],[15],[16]	8%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	12.36%	[1],[10]	12.36%	[1],[10]	10.78%	[12],[17]	10.78%	[12],[17]
Principal	$ 2,996	[1],[9],[10]			$ 4,346	[12],[17],[18]
Cost	2,951	[1],[10]			4,281	[12],[17]
Fair Value	$ 2,558	[1],[10]			$ 3,813	[12],[17]
Investment, Identifier [Axis]: Apptio Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[6],[7],[10]	6%	[1],[2],[3],[4],[5],[6],[7],[10]	6%	[10],[11],[12],[13],[14],[15],[16],[21]	6%	[10],[11],[12],[13],[14],[15],[16],[21]
Cash Interest Rate	9.94%	[1],[6],[10]	9.94%	[1],[6],[10]	8.46%	[12],[17],[21]	8.46%	[12],[17],[21]
Principal	$ 1,338	[1],[6],[9],[10]			$ 892	[12],[17],[18],[21]
Cost	1,312	[1],[6],[10]			863	[12],[17],[21]
Fair Value	$ 1,294	[1],[6],[10]			$ 846	[12],[17],[21]
Investment, Identifier [Axis]: Apptio Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[10],[11],[12],[13],[14],[15],[16]	6%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	9.94%	[1],[10]	9.94%	[1],[10]	8.46%	[12],[17]	8.46%	[12],[17]
Principal	$ 34,458	[1],[9],[10]			$ 34,458	[12],[17],[18]
Cost	33,818	[1],[10]			33,737	[12],[17]
Fair Value	$ 33,769	[1],[10]			$ 33,738	[12],[17]
Investment, Identifier [Axis]: Apptio, Inc., First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	9.94%		9.94%		8.46%		8.46%
Principal	$ 231				$ 154
Cost	228				151
Fair Value	$ 223				$ 146
Investment, Identifier [Axis]: Apptio, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	9.94%		9.94%		8.46%		8.46%
Principal	$ 4,615				$ 4,615
Cost	4,584				4,580
Fair Value	$ 4,523				$ 4,519
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[7],[10],[19]	5.75%	[1],[2],[3],[4],[5],[7],[10],[19]	5.75%	[10],[11],[12],[13],[14],[15],[16],[20],[21]	5.75%	[10],[11],[12],[13],[14],[15],[16],[20],[21]
Cash Interest Rate	7.48%	[1],[10],[19]	7.48%	[1],[10],[19]
Principal	$ 3,649	[1],[6],[9],[10],[19]			$ 0	[12],[17],[18],[20],[21]
Cost	3,666	[1],[6],[10],[19]			(44)	[12],[17],[20],[21]
Fair Value	$ 3,908	[1],[6],[10],[19]			$ 0	[12],[17],[20],[21]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10],[19]	7%	[1],[2],[3],[4],[5],[7],[10],[19]	7%	[10],[11],[12],[13],[14],[15],[16],[20]	7%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	8%	[1],[10],[19]	8%	[1],[10],[19]	8%	[12],[17],[20]	8%	[12],[17],[20]
Principal	$ 1,964	[1],[9],[10],[19]			$ 1,964	[12],[17],[18],[20]
Cost	2,176	[1],[10],[19]			2,176	[12],[17],[20]
Fair Value	$ 2,103	[1],[10],[19]			$ 1,927	[12],[17],[20]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10],[19]	7%	[1],[2],[3],[4],[5],[7],[10],[19]	7%	[10],[11],[12],[13],[14],[15],[16],[20]	7%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	10.43%	[1],[10],[19]	10.43%	[1],[10],[19]	9.19%	[12],[17],[20]	9.19%	[12],[17],[20]
Principal	$ 18,636	[1],[9],[10],[19]			$ 18,636	[12],[17],[18],[20]
Cost	23,058	[1],[10],[19]			23,139	[12],[17],[20]
Fair Value	$ 22,485	[1],[10],[19]			$ 20,826	[12],[17],[20]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[7],[10],[19]	5.75%	[1],[2],[3],[4],[5],[7],[10],[19]	5.75%	[10],[11],[12],[13],[14],[15],[16],[20]	5.75%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	8.81%	[1],[10],[19]	8.81%	[1],[10],[19]	8.81%	[12],[17],[20]	8.81%	[12],[17],[20]
Principal	$ 10,519	[1],[9],[10],[19]			$ 10,519	[12],[17],[18],[20]
Cost	10,368	[1],[10],[19]			10,357	[12],[17],[20]
Fair Value	$ 10,561	[1],[10],[19]			$ 10,328	[12],[17],[20]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,609,201	[1],[2],[3],[4],[5],[7]	1,609,201	[1],[2],[3],[4],[5],[7]					1,609,201
Cost	$ 764	[1]
Fair Value	$ 354	[1]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					1,609,201	[11],[12],[13],[14],[15],[16]	1,609,201	[11],[12],[13],[14],[15],[16]
Cost					$ 764	[12]
Fair Value					$ 370	[12]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	70,424.5641	[1],[2],[3],[4],[5],[7]	70,424.5641	[1],[2],[3],[4],[5],[7]	70,424.5641	[11],[12],[13],[14],[15],[16]	70,424.5641	[11],[12],[13],[14],[15],[16]	70,424.5641
Cost	$ 0	[1]			$ 0	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[10],[11],[12],[13],[14],[15],[16],[21]	6.75%	[10],[11],[12],[13],[14],[15],[16],[21]	6.75%
Cash Interest Rate	11.48%	[1],[6],[10]	11.48%	[1],[6],[10]	10.42%	[12],[17],[21]	10.42%	[12],[17],[21]	7.75%
Principal	$ 21,464	[1],[6],[9],[10]			$ 24,490	[12],[17],[18],[21]
Cost	21,464	[1],[6],[10]			24,490	[12],[17],[21]
Fair Value	$ 21,252	[1],[6],[10]			$ 24,225	[12],[17],[21]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					1,019,168.8	[11],[12],[13],[14],[15],[16]	1,019,168.8	[11],[12],[13],[14],[15],[16]
Cash Interest Rate					6%	[11],[12],[13],[14],[15],[16]	6%	[11],[12],[13],[14],[15],[16]
Cost					$ 1,019	[12]
Fair Value					$ 1,223	[12]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,019,168.8	[1],[2],[3],[4],[5],[7]	1,019,168.8	[1],[2],[3],[4],[5],[7]					1,019,168.8
Cash Interest Rate	6%	[1],[2],[3],[4],[5],[7]	6%	[1],[2],[3],[4],[5],[7]					6%
Cost	$ 1,019	[1]
Fair Value	$ 1,243	[1]
Investment, Identifier [Axis]: Associated Asphalt Partners LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%	[2],[3],[4],[5],[7],[10]	5.25%	[2],[3],[4],[5],[7],[10]	5.25%	[10],[11],[13],[14],[15],[16]	5.25%	[10],[11],[13],[14],[15],[16]
Cash Interest Rate	9.63%	[10]	9.63%	[10]	8.06%	[17]	8.06%	[17]
Principal	$ 2,493	[9],[10]			$ 2,501	[17],[18]
Cost	2,353	[10]			2,331	[17]
Fair Value	$ 1,928	[10]			$ 1,934	[17]
Investment, Identifier [Axis]: Astra Acquisition Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%	[2],[3],[4],[5],[7],[10]	5.25%	[2],[3],[4],[5],[7],[10]	5.25%	[10],[11],[13],[14],[15],[16]	5.25%	[10],[11],[13],[14],[15],[16]
Cash Interest Rate	9.63%	[10]	9.63%	[10]	8.37%	[17]	8.37%	[17]
Principal	$ 5,640	[9],[10]			$ 5,640	[17],[18]
Cost	5,489	[10]			5,482	[17]
Fair Value	$ 5,006	[10]			$ 4,822	[17]
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.63%		9.63%		8.37%		8.37%
Principal	$ 5,052				$ 5,052
Cost	4,866				4,858
Fair Value	$ 4,484				$ 4,319
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.63%		9.63%		8.37%		8.37%
Principal	$ 2,078				$ 2,078
Cost	2,034				2,033
Fair Value	$ 1,844				$ 1,777
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.68%		8.68%		7.70%		7.70%
Principal	$ 4,988				$ 5,000
Cost	4,752				4,753
Fair Value	$ 4,463				$ 4,276
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.68%		8.68%		7.70%		7.70%
Principal	$ 1,995				$ 2,000
Cost	1,901				1,901
Fair Value	$ 1,785				$ 1,711
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.63%		9.63%		8.37%		8.37%
Principal	$ 4,346				$ 4,346
Cost	3,995				3,981
Fair Value	$ 3,404				$ 3,347
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.63%		9.63%		8.37%		8.37%
Principal	$ 2,423				$ 2,423
Cost	2,220				2,212
Fair Value	$ 1,898				$ 1,866
Investment, Identifier [Axis]: Athenex Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	328,149	[1],[2],[3],[4],[5],[7],[19]	328,149	[1],[2],[3],[4],[5],[7],[19]	328,149	[11],[12],[13],[14],[15],[16],[20]	328,149	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 973	[1],[19]			$ 973	[12],[20]
Fair Value	7	[1],[19]			16	[12],[20]
Investment, Identifier [Axis]: Athenex Inc, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	8,649	[1],[9],[19]			8,309	[12],[18],[20]
Cost	8,604	[1],[19]			8,264	[12],[20]
Fair Value	$ 8,649	[1],[19]			$ 8,309	[12],[20]
Investment, Identifier [Axis]: Athenex Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					11%	[11],[12],[13],[14],[15],[16],[20]	11%	[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate	11%	[1],[2],[3],[4],[5],[7],[19]	11%	[1],[2],[3],[4],[5],[7],[19]
Principal	$ 12,556	[1],[9],[19]			$ 13,346	[12],[18],[20]
Cost	12,191	[1],[19]			12,929	[12],[20]
Fair Value	$ 12,036	[1],[19]			$ 12,812	[12],[20]
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.32%		10.32%		8.78%		8.78%
Principal	$ 6,321				$ 6,338
Cost	6,232				6,242
Fair Value	$ 6,012				$ 6,027
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.32%		10.32%		8.78%		8.78%
Principal	$ 3,647				$ 3,656
Cost	3,595				3,601
Fair Value	$ 3,468				$ 3,476
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6%	[10],[11],[12],[13],[14],[15],[16],[20]	6%	[10],[11],[12],[13],[14],[15],[16],[20]
Cash Interest Rate					8.78%	[12],[17],[20]	8.78%	[12],[17],[20]
Principal					$ 22,425	[12],[17],[18],[20]
Cost					22,086	[12],[17],[20]
Fair Value					$ 21,326	[12],[17],[20]
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10],[19]	6%	[1],[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	10.32%	[1],[10],[19]	10.32%	[1],[10],[19]
Principal	$ 22,368	[1],[9],[10],[19]
Cost	22,050	[1],[10],[19]
Fair Value	$ 21,274	[1],[10],[19]
Investment, Identifier [Axis]: Avalara Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[6],[7],[10]	7.25%	[1],[2],[3],[4],[5],[6],[7],[10]
Principal	$ 0	[1],[6],[9],[10]
Cost	(100)	[1],[6],[10]
Fair Value	$ (104)	[1],[6],[10]
Investment, Identifier [Axis]: Avalara Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[7],[10]	7.25%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	11.83%	[10]	11.83%	[10]
Principal	$ 41,467	[1],[9],[10]
Cost	40,466	[1],[10]
Fair Value	$ 40,430	[1],[10]
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5%	[10],[11],[12],[13],[14],[15],[16],[21]	5%	[10],[11],[12],[13],[14],[15],[16],[21]
Cash Interest Rate					8.12%	[12],[17],[21]	8.12%	[12],[17],[21]
Principal					$ 2,546	[12],[17],[18],[21]
Cost					2,503	[12],[17],[21]
Fair Value					$ 2,395	[12],[17],[21]
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[6],[7],[10]	5%	[1],[2],[3],[4],[5],[6],[7],[10]
Cash Interest Rate	9.73%	[1],[6],[10]	9.73%	[1],[6],[10]
Principal	$ 2,541	[1],[6],[9],[10]
Cost	2,497	[1],[6],[10]
Fair Value	$ 2,420	[1],[6],[10]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[6],[7],[10]	8.50%	[1],[2],[3],[4],[5],[6],[7],[10]	8.50%	[10],[11],[12],[13],[14],[15],[16],[21]	8.50%	[10],[11],[12],[13],[14],[15],[16],[21]
Cash Interest Rate	13.23%	[1],[6],[10]	13.23%	[1],[6],[10]	11.62%	[12],[17],[21]	11.62%	[12],[17],[21]
Principal	$ 5,197	[1],[6],[9],[10]			$ 4,227	[12],[17],[18],[21]
Cost	5,042	[1],[6],[10]			4,070	[12],[17],[21]
Fair Value	$ 4,854	[1],[6],[10]			$ 3,839	[12],[17],[21]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[10],[11],[12],[13],[14],[15],[16]	8.50%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	13.23%	[1],[10]	13.23%	[1],[10]	11.62%	[12],[17]	11.62%	[12],[17]
Principal	$ 7,166	[1],[9],[10]			$ 7,166	[12],[17],[18]
Cost	7,059	[1],[10]			7,059	[12],[17]
Fair Value	$ 6,944	[1],[10]			$ 6,915	[12],[17]
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Draw Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.73%		9.73%		8.12%		8.12%
Principal	$ 1,767				$ 1,771
Cost	1,747				1,751
Fair Value	$ 1,682				$ 1,664
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5%		5%
Cash Interest Rate					8.12%		8.12%
Principal					$ 808
Cost					800
Fair Value					$ 760
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.07%		9.07%		8.12%		8.12%
Principal	$ 6,354				$ 6,371
Cost	6,295				6,311
Fair Value	$ 6,176				$ 6,148
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5%		5%
Cash Interest Rate					8.12%		8.12%
Principal					$ 3,398
Cost					3,366
Fair Value					$ 3,279
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%
Cash Interest Rate	9.07%		9.07%
Principal	$ 3,389
Cost	3,357
Fair Value	$ 3,294
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%
Cash Interest Rate	9.73%		9.73%
Principal	$ 806
Cost	798
Fair Value	$ 768
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.70%		10.70%		8.98%		8.98%
Principal	$ 7,425				$ 7,444
Cost	7,335				7,347
Fair Value	$ 5,988				$ 5,455
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.70%		10.70%		8.98%		8.98%
Principal	$ 3,960				$ 3,970
Cost	3,912				3,919
Fair Value	$ 3,193				$ 2,909
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%	[1],[2],[3],[4],[5],[6],[7],[10]	4.50%	[1],[2],[3],[4],[5],[6],[7],[10]	4.50%	[11],[12],[13],[14],[15],[16],[17],[21]	4.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	12%	[1],[6],[10]	12%	[1],[6],[10]	10.75%	[12],[17],[21]	10.75%	[12],[17],[21]
Principal	$ 897	[1],[6],[9],[10]			$ 1,702	[12],[17],[18],[21]
Cost	859	[1],[6],[10]			1,660	[12],[17],[21]
Fair Value	$ 857	[1],[6],[10]			$ 1,617	[12],[17],[21]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[11],[12],[13],[14],[15],[16],[17]	5.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.91%	[1],[10]	9.91%	[1],[10]	8.31%	[12],[17]	8.31%	[12],[17]
Principal	$ 32,995	[1],[9],[10]			$ 33,078	[12],[17],[18]
Cost	32,555	[1],[10]			32,612	[12],[17]
Fair Value	$ 32,533	[1],[10]			$ 32,053	[12],[17]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	21,177	[1],[2],[3],[4],[5],[7],[19]	21,177	[1],[2],[3],[4],[5],[7],[19]	21,177	[11],[12],[13],[14],[15],[16],[20]	21,177	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 125	[1],[19]			$ 125	[12],[20]
Fair Value	$ 275	[1],[19]			$ 98	[12],[20]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	8%	[1],[2],[3],[4],[5],[6],[7],[19]	8%	[1],[2],[3],[4],[5],[6],[7],[19]	10.25%	[11],[12],[13],[14],[15],[16],[20],[21]	10.25%	[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 0	[1],[6],[9],[19]			$ 0	[12],[18],[20],[21]
Cost	0	[1],[6],[19]			0	[12],[20],[21]
Fair Value	$ 0	[1],[6],[19]			0	[12],[20],[21]
Investment, interest rate, paid in kind	2.25%	[1],[2],[3],[4],[5],[6],[7],[19]	2.25%	[1],[2],[3],[4],[5],[6],[7],[19]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Revenue Interest Financing Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 0	[1],[6],[9],[19]			0	[12],[18],[20],[21]
Cost	0	[1],[6],[19]			0	[12],[20],[21]
Fair Value	0	[1],[6],[19]			0	[12],[20],[21]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	2,432	[1],[9],[19]			2,353	[12],[18],[20]
Cost	2,432	[1],[19]			2,353	[12],[20]
Fair Value	$ 2,432	[1],[19]			$ 2,353	[12],[20]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	8%	[1],[2],[3],[4],[5],[7],[19]	8%	[1],[2],[3],[4],[5],[7],[19]	10.25%	[11],[12],[13],[14],[15],[16],[20]	10.25%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 5,383	[1],[9],[19]			$ 5,322	[12],[18],[20]
Cost	5,184	[1],[19]			5,111	[12],[20]
Fair Value	$ 5,028	[1],[19]			$ 5,114	[12],[20]
Investment, interest rate, paid in kind	2.25%	[1],[2],[3],[4],[5],[7],[19]	2.25%	[1],[2],[3],[4],[5],[7],[19]
Investment, Identifier [Axis]: Blackhawk Network Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[2],[3],[4],[5],[7],[10]	7%	[2],[3],[4],[5],[7],[10]	7%	[11],[13],[14],[15],[16],[17]	7%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	10.94%	[10]	10.94%	[10]	9.50%	[17]	9.50%	[17]
Principal	$ 30,625	[9],[10]			$ 30,625	[17],[18]
Cost	30,300	[10]			30,276	[17]
Fair Value	$ 26,391	[10]			$ 29,017	[17]
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3%		3%		3%		3%
Cash Interest Rate	7.08%		7.08%		6.03%		6.03%
Principal	$ 9,550				$ 9,575
Cost	9,542				9,566
Fair Value	$ 9,331				$ 8,977
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Common Units in Unstoppable Automotive AMV, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	298,460	[1],[2],[3],[4],[5],[7]	298,460	[1],[2],[3],[4],[5],[7]	298,460	[11],[12],[13],[14],[15],[16]	298,460	[11],[12],[13],[14],[15],[16]
Cost	$ 298	[1]			$ 298	[12]
Fair Value	$ 379	[1]			$ 349	[12]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					9%	[11],[12],[13],[14],[15],[16]	9%	[11],[12],[13],[14],[15],[16]
Cash Interest Rate	9%	[1],[2],[3],[4],[5],[7]	9%	[1],[2],[3],[4],[5],[7]
Principal	$ 3,979	[1],[9]			$ 3,979	[12],[18]
Cost	3,980	[1]			3,980	[12]
Fair Value	$ 3,960	[1]			$ 3,960	[12]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Preferred Units in Unstoppable Automotive AMV, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,293,324	[1],[2],[3],[4],[5],[7]	1,293,324	[1],[2],[3],[4],[5],[7]	1,293,324	[11],[12],[13],[14],[15],[16]	1,293,324	[11],[12],[13],[14],[15],[16]
Cost	$ 1,293	[1]			$ 1,293	[12]
Fair Value	$ 1,267	[1]			$ 1,280	[12]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Preferred Units in Unstoppable Automotive VMV, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	298,460	[1],[2],[3],[4],[5],[7]	298,460	[1],[2],[3],[4],[5],[7]	298,460	[11],[12],[13],[14],[15],[16]	298,460	[11],[12],[13],[14],[15],[16]
Cost	$ 298	[1]			$ 298	[12]
Fair Value	$ 292	[1]			$ 295	[12]
Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%
Cash Interest Rate	8.13%		8.13%
Principal	$ 1,994
Cost	1,917
Fair Value	$ 1,914
Investment, Identifier [Axis]: C Technology Holdings LLC, Common Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	829	[1],[2],[3],[4],[5],[7]	829	[1],[2],[3],[4],[5],[7]	829	[10],[11],[12],[13],[14],[15],[16]	829	[10],[11],[12],[13],[14],[15],[16]	829
Cost	$ 0	[1]			$ 0	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: C Technology Holdings LLC, Preferred Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	34,984,460.37	[1],[2],[3],[4],[5],[7]	34,984,460.37	[1],[2],[3],[4],[5],[7]	34,984,460.37	[10],[11],[12],[13],[14],[15],[16]	34,984,460.37	[10],[11],[12],[13],[14],[15],[16]	34,984,460.37
Cost	$ 34,984	[1]			$ 34,984	[12]
Fair Value	$ 27,638	[1]			$ 27,638	[12]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Units | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	171		171		171		171
Cost	$ 0				$ 0
Fair Value	$ 0				$ 0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Units | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	7,193,539.63		7,193,539.63		7,193,539.63		7,193,539.63
Cost	$ 7,194				$ 7,194
Fair Value	$ 5,683				$ 5,683
Investment, Identifier [Axis]: CCO Holdings LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					4.50%	[11],[13],[14],[15],[16],[20]	4.50%	[11],[13],[14],[15],[16],[20]
Principal					$ 2,097	[18],[20]
Cost					1,746	[20]
Fair Value					$ 1,603	[20]
Investment, Identifier [Axis]: CITGO Holding Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					9.25%	[11],[12],[13],[14],[15],[16],[17]	9.25%	[11],[12],[13],[14],[15],[16],[17]
Principal					$ 7,857	[18]
Cost					7,857
Fair Value					$ 7,807
Investment, Identifier [Axis]: CITGO Petroleum Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6.25%	[11],[13],[14],[15],[16],[17]	6.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate					9.37%	[17]	9.37%	[17]
Principal					$ 795	[17],[18]
Cost					770	[17]
Fair Value					$ 797	[17]
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6.25%		6.25%
Cash Interest Rate					9.37%		9.37%
Principal					$ 3,519
Cost					3,484
Fair Value					$ 3,529
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan, | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6.25%		6.25%
Cash Interest Rate					9.37%		9.37%
Principal					$ 7,038
Cost					6,967
Fair Value					$ 7,057
Investment, Identifier [Axis]: Cadence Aerospace LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[11],[12],[13],[14],[15],[16],[17]	6.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.92%	[1],[10]	10.92%	[1],[10]	9.31%	[12],[17]	9.31%	[12],[17]
Principal	$ 14,332	[1],[9],[10]			$ 14,294	[12],[17],[18]
Cost	13,700	[1],[10]			13,471	[12],[17]
Fair Value	$ 13,178	[1],[10]			$ 13,143	[12],[17]
Investment, interest rate, paid in kind	2%	[1],[2],[3],[4],[5],[7],[10]	2%	[1],[2],[3],[4],[5],[7],[10]	2%	[11],[12],[13],[14],[15],[16],[17]	2%	[11],[12],[13],[14],[15],[16],[17]
Investment, Identifier [Axis]: Caregiver Services Inc, Series A Preferred Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,080,399		1,080,399		1,080,399	[11],[12],[13],[14],[15],[16]	1,080,399	[11],[12],[13],[14],[15],[16]	1,080,399
Cash Interest Rate	10%	[1],[2],[3],[4],[5],[7]	10%	[1],[2],[3],[4],[5],[7]	10%	[11],[12],[13],[14],[15],[16]	10%	[11],[12],[13],[14],[15],[16]	10%
Cost	$ 1,080	[1]			$ 1,080	[12]
Fair Value	$ 324	[1]			$ 378	[12]
Investment, Identifier [Axis]: Carvana Co, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					5.625%	[11],[13],[14],[15],[16],[20]	5.625%	[11],[13],[14],[15],[16],[20]
Principal					$ 6,700	[18],[20]
Cost					5,825	[20]
Fair Value					$ 4,724	[20]
Investment, Identifier [Axis]: Cengage Learning, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%		4.75%
Cash Interest Rate	7.81%		7.81%
Principal	$ 2,992
Cost	2,734
Fair Value	$ 2,698
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Delayed Draw Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.50%		5.50%
Cash Interest Rate					9.12%		9.12%
Principal					$ 449
Cost					432
Fair Value					$ 413
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%		5.50%		5.50%
Principal	$ 0				$ 0
Cost	(10)				(10)
Fair Value	$ (10)				$ (11)
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.50%		5.50%
Cash Interest Rate	10.43%		10.43%		9.12%		9.12%
Principal	$ 6,345				$ 4,358
Cost	6,242				4,286
Fair Value	$ 6,231				$ 4,280
Investment, Identifier [Axis]: CircusTrix Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[11],[12],[13],[14],[15],[16],[17]	5.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.57%	[1],[10]	9.57%	[1],[10]	8.62%	[12],[17]	8.62%	[12],[17]
Principal	$ 10,668	[1],[9],[10]			$ 10,692	[12],[17],[18]
Cost	10,201	[1],[10]			10,004	[12],[17]
Fair Value	$ 10,465	[1],[10]			$ 10,209	[12],[17]
Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					3.50%		3.50%
Cash Interest Rate					6.48%		6.48%
Principal					$ 6,451
Cost					6,419
Fair Value					$ 6,166
Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					3.50%		3.50%
Cash Interest Rate					6.48%		6.48%
Principal					$ 2,481
Cost					2,469
Fair Value					$ 2,372
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	7.50%	[2],[3],[4],[5],[7],[19]	7.50%	[2],[3],[4],[5],[7],[19]	7.50%	[11],[13],[14],[15],[16],[20]	7.50%	[11],[13],[14],[15],[16],[20]
Principal	$ 4,311	[9],[19]			$ 4,311	[18],[20]
Cost	4,311	[19]			4,311	[20]
Fair Value	$ 3,174	[19]			$ 3,132	[20]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	7.75%	[2],[3],[4],[5],[7],[19]	7.75%	[2],[3],[4],[5],[7],[19]	5.125%	[11],[13],[14],[15],[16],[20]	5.125%	[11],[13],[14],[15],[16],[20]
Principal	$ 676	[9],[19]			$ 1,374	[18],[20]
Cost	649	[19]			1,229	[20]
Fair Value	$ 494	[19]			$ 1,163	[20]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					7.75%	[11],[13],[14],[15],[16],[20]	7.75%	[11],[13],[14],[15],[16],[20]
Principal					$ 676	[18],[20]
Cost					648	[20]
Fair Value					$ 512	[20]
Investment, Identifier [Axis]: Condor Merger Sub Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	7.375%	[2],[3],[4],[5],[7]	7.375%	[2],[3],[4],[5],[7]	7.375%	[11],[12],[13],[14],[15],[16],[17]	7.375%	[11],[12],[13],[14],[15],[16],[17]
Principal	$ 8,420	[9]			$ 8,420	[18]
Cost	8,248				8,243
Fair Value	6,785				6,900
Investment, Identifier [Axis]: Continental Intermodal Group LP, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	648	[1]			648	[12]
Fair Value	$ 220	[1]			$ 457	[12]
Investment, Identifier [Axis]: Continental Intermodal Group LP, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17]	8.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.88%	[1],[10]	12.88%	[1],[10]	11.62%	[12],[17]	11.62%	[12],[17]
Principal	$ 19,992	[1],[9],[10]			$ 22,537	[12],[17],[18]
Cost	19,286	[1],[10]			21,642	[12],[17]
Fair Value	$ 17,893	[1],[10]			$ 20,396	[12],[17]
Investment, Identifier [Axis]: Convergeone Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[2],[3],[4],[5],[7],[10]	5%	[2],[3],[4],[5],[7],[10]	5%	[11],[13],[14],[15],[16],[17]	5%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	9.38%	[10]	9.38%	[10]	8.12%	[17]	8.12%	[17]
Principal	$ 11,882	[9],[10]			$ 11,913	[17],[18]
Cost	11,684	[10]			11,697	[17]
Fair Value	$ 6,963	[10]			$ 8,596	[17]
Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.38%		9.38%		8.12%		8.12%
Principal	$ 7,354				$ 7,373
Cost	7,200				7,206
Fair Value	$ 4,309				$ 5,320
Investment, Identifier [Axis]: Conviva Inc, Shares of Series D Preferred Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	517,851	[1],[2],[3],[4],[5],[7]	517,851	[1],[2],[3],[4],[5],[7]
Cost	$ 605	[1]
Fair Value	$ 894	[1]
Investment, Identifier [Axis]: Conviva Inc,Shares of Series D Preferred Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					517,851	[11],[12],[13],[14],[15],[16]	517,851	[11],[12],[13],[14],[15],[16]
Cost					$ 605	[12]
Fair Value					$ 894	[12]
Investment, Identifier [Axis]: CorEvitas LLC, Class A2 Common Units in CorEvitas Holdings, L.P.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,099	[1],[2],[3],[4],[5],[7]	1,099	[1],[2],[3],[4],[5],[7]	1,099	[11],[12],[13],[14],[15],[16]	1,099	[11],[12],[13],[14],[15],[16]
Cost	$ 690	[1]			$ 690	[12]
Fair Value	$ 2,340	[1]			$ 2,340	[12]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%	[1],[2],[3],[4],[5],[6],[7],[10]	4.75%	[1],[2],[3],[4],[5],[6],[7],[10]	4.75%	[11],[12],[13],[14],[15],[16],[17],[21]	4.75%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	12.25%	[1],[6],[10]	12.25%	[1],[6],[10]	11%	[12],[17],[21]	11%	[12],[17],[21]
Principal	$ 305	[1],[6],[9],[10]			$ 916	[12],[17],[18],[21]
Cost	289	[1],[6],[10]			898	[12],[17],[21]
Fair Value	$ 261	[1],[6],[10]			$ 898	[12],[17],[21]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.125%	[1],[2],[3],[4],[5],[7],[10]	6.125%	[1],[2],[3],[4],[5],[7],[10]	5.75%	[11],[12],[13],[14],[15],[16],[17]	5.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.55%	[1],[10]	10.55%	[1],[10]	8.88%	[12],[17]	8.88%	[12],[17]
Principal	$ 13,677	[1],[9],[10]			$ 13,712	[12],[17],[18]
Cost	13,527	[1],[10]			13,554	[12],[17]
Fair Value	$ 13,344	[1],[10]			$ 13,583	[12],[17]
Investment, Identifier [Axis]: Covetrus Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[2],[3],[4],[5],[7],[10]	5%	[2],[3],[4],[5],[7],[10]	5%	[11],[13],[14],[15],[16],[17]	5%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	9.58%	[10]	9.58%	[10]	7.65%	[17]	7.65%	[17]
Principal	$ 10,336	[9],[10]			$ 10,336	[17],[18]
Cost	9,733	[10]			9,716	[17]
Fair Value	$ 9,711	[10]			$ 9,681	[17]
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.58%		9.58%		7.65%		7.65%
Principal	$ 5,375				$ 5,375
Cost	5,053				5,053
Fair Value	$ 5,050				$ 5,035
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.58%		9.58%		7.65%		7.65%
Principal	$ 2,280				$ 2,280
Cost	2,143				2,143
Fair Value	$ 2,142				$ 2,136
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[6],[7],[10]	6%	[1],[2],[3],[4],[5],[6],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17],[21]	6%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(13)	[1],[6],[10]			(13)	[12],[17],[21]
Fair Value	$ (26)	[1],[6],[10]			$ (26)	[12],[17],[21]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.41%	[1],[10]	10.41%	[1],[10]	8.81%	[12],[17]	8.81%	[12],[17]
Principal	$ 18,153	[1],[9],[10]			$ 18,200	[12],[17],[18]
Cost	17,766	[1],[10]			17,790	[12],[17]
Fair Value	$ 17,798	[1],[10]			$ 17,843	[12],[17]
Investment, Identifier [Axis]: Cuppa Bidco BV, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%	[2],[3],[4],[5],[7],[10]	4.75%	[2],[3],[4],[5],[7],[10]
Cash Interest Rate	7.50%	[10],[19]	7.50%	[10],[19]
Principal	$ 12,340	[9],[10],[19]
Cost	10,521	[10],[19]
Fair Value	$ 10,997	[10],[19]
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.73%		8.73%		7.67%		7.67%
Principal	$ 7,800				$ 5,820
Cost	7,726				5,776
Fair Value	$ 7,644				$ 5,587
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.73%		8.73%		7.67%		7.67%
Principal	$ 2,863				$ 2,870
Cost	2,842				2,849
Fair Value	$ 2,806				$ 2,756
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan, | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.25%		4.25%
Cash Interest Rate	8.98%		8.98%
Principal	$ 997
Cost	978
Fair Value	$ 975
Investment, Identifier [Axis]: DTI Holdco Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%	[2],[3],[4],[5],[7],[10]	4.75%	[2],[3],[4],[5],[7],[10]	4.75%	[11],[13],[14],[15],[16],[17]	4.75%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	8.84%	[10]	8.84%	[10]	7.33%	[17]	7.33%	[17]
Principal	$ 4,988	[9],[10]			$ 5,000	[17],[18]
Cost	4,897	[10]			4,906	[17]
Fair Value	$ 4,607	[10]			$ 4,760	[17]
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%		4.75%		4.75%		4.75%
Cash Interest Rate	8.84%		8.84%		7.33%		7.33%
Principal	$ 7,980				$ 8,000
Cost	7,835				7,849
Fair Value	$ 7,372				$ 7,616
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%		4.75%		4.75%		4.75%
Cash Interest Rate	8.84%		8.84%		7.33%		7.33%
Principal	$ 2,993				$ 3,000
Cost	2,938				2,943
Fair Value	$ 2,764				$ 2,856
Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.25%		4.25%
Cash Interest Rate					7.37%		7.37%
Principal					$ 2,992
Cost					2,935
Fair Value					$ 2,924
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.75%	[11],[13],[14],[15],[16],[17],[20]	5.75%	[11],[13],[14],[15],[16],[17],[20]
Cash Interest Rate					8.49%	[17],[20]	8.49%	[17],[20]
Principal					$ 4,988	[17],[18],[20]
Cost					4,882	[17],[20]
Fair Value					$ 4,757	[17],[20]
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.75%		5.75%
Cash Interest Rate					8.49%		8.49%
Principal					$ 6,035
Cost					5,876
Fair Value					$ 5,756
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Units in Delta Financial Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	2.09	[1],[2],[3],[4],[5],[7]	2.09	[1],[2],[3],[4],[5],[7]	2.09	[11],[12],[13],[14],[15],[16],[20]	2.09	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 2	[1],[19]			$ 2	[12],[20]
Fair Value	$ 2	[1],[19]			$ 2	[12],[20]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	31.37	[1],[2],[3],[4],[5],[7]	31.37	[1],[2],[3],[4],[5],[7]	31.37	[11],[12],[13],[14],[15],[16],[20]	31.37	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 0	[1],[19]			$ 0	[12],[20]
Fair Value	$ 0	[1],[19]			$ 0	[12],[20]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Series C Preferred Units in Delta Financial Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	419	[1],[2],[3],[4],[5],[7]	419	[1],[2],[3],[4],[5],[7]	419	[11],[12],[13],[14],[15],[16],[20]	419	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 419	[1],[19]			$ 419	[12],[20]
Fair Value	$ 419	[1],[19]			$ 419	[12],[20]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Subordinated Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	10%	[1],[2],[3],[4],[5],[6],[7]	10%	[1],[2],[3],[4],[5],[6],[7]	10%	[11],[12],[13],[14],[15],[16],[20],[21]	10%	[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 8,365	[1],[6],[9],[19]			$ 4,183	[12],[18],[20],[21]
Cost	8,365	[1],[6],[19]			4,183	[12],[20],[21]
Fair Value	$ 8,365	[1],[6],[19]			$ 4,183	[12],[20],[21]
Investment, Identifier [Axis]: Delta Topco Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[2],[3],[4],[5],[7],[10]	7.25%	[2],[3],[4],[5],[7],[10]	7.25%	[11],[13],[14],[15],[16],[17]	7.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	11.65%	[10]	11.65%	[10]	9.34%	[17]	9.34%	[17]
Principal	$ 6,680	[9],[10]			$ 6,680	[17],[18]
Cost	6,647	[10]			6,647	[17]
Fair Value	$ 5,319	[10]			$ 5,934	[17]
Investment, Identifier [Axis]: Dialyze Holdings LLC, Class A Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	5,403,823	[1],[2],[3],[4],[5],[7]	5,403,823	[1],[2],[3],[4],[5],[7]	5,403,823	[11],[12],[13],[14],[15],[16]	5,403,823	[11],[12],[13],[14],[15],[16]
Cost	$ 1,405	[1]			$ 1,405	[12]
Fair Value	$ 1,297	[1]			$ 1,297	[12]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					9%	[11],[12],[13],[14],[15],[16],[17],[21]	9%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal					$ 0	[12],[17],[18],[21]
Cost					(135)	[12],[17],[21]
Fair Value					$ (129)	[12],[17],[21]
Investment, interest rate, paid in kind					2%	[11],[12],[13],[14],[15],[16],[17],[21]	2%	[11],[12],[13],[14],[15],[16],[17],[21]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	9%	[1],[2],[3],[4],[5],[7],[10]	9%	[1],[2],[3],[4],[5],[7],[10]	9%	[11],[12],[13],[14],[15],[16],[17]	9%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	13.73%	[1],[10]	13.73%	[1],[10]	12.67%	[12],[17]	12.67%	[12],[17]
Principal	$ 20,965	[1],[9],[10]			$ 24,396	[12],[17],[18]
Cost	19,913	[1],[10]			23,083	[12],[17]
Fair Value	20,912	[1],[10]			$ 22,993	[12],[17]
Investment, interest rate, paid in kind					2%	[11],[12],[13],[14],[15],[16],[17]	2%	[11],[12],[13],[14],[15],[16],[17]
Investment, Identifier [Axis]: Dialyze Holdings LLC, Subordinated Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	520	[1],[6],[9],[10]
Cost	520	[1],[6],[10]
Fair Value	$ 494	[1],[6],[10]
Investment, interest rate, paid in kind	8%	[1],[2],[3],[4],[5],[7]	8%	[1],[2],[3],[4],[5],[7]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[1],[2],[3],[4],[5],[6],[7],[10]	6.50%	[11],[12],[13],[14],[15],[16],[17],[21]	6.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	11.59%	[1],[6],[10]	11.59%	[1],[6],[10]	9.41%	[12],[17],[21]	9.41%	[12],[17],[21]
Principal	$ 251	[1],[6],[9],[10]			$ 251	[12],[17],[18],[21]
Cost	229	[1],[6],[10]			228	[12],[17],[21]
Fair Value	$ 239	[1],[6],[10]			$ 239	[12],[17],[21]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.09%	[1],[10]	11.09%	[1],[10]	9.91%	[12],[17]	9.91%	[12],[17]
Principal	$ 9,877	[1],[9],[10]			$ 9,902	[12],[17],[18]
Cost	9,593	[1],[10]			9,599	[12],[17]
Fair Value	$ 9,768	[1],[10]			$ 9,793	[12],[17]
Investment, Identifier [Axis]: DirecTV Financing LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[2],[3],[4],[5],[7],[10]	5%	[2],[3],[4],[5],[7],[10]	5%	[11],[13],[14],[15],[16],[17]	5%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	9.38%	[10]	9.38%	[10]	8.12%	[17]	8.12%	[17]
Principal	$ 8,166	[9],[10]			$ 19,242	[17],[18]
Cost	8,012	[10]			18,970	[17]
Fair Value	$ 7,968	[10]			$ 17,973	[17]
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.38%		9.38%		8.12%		8.12%
Principal	$ 6,277				$ 6,436
Cost	6,178				6,332
Fair Value	$ 6,124				$ 6,012
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.38%		9.38%		8.12%		8.12%
Principal	$ 2,663				$ 2,730
Cost	2,636				2,703
Fair Value	$ 2,598				$ 2,549
Investment, Identifier [Axis]: Dominion Diagnostics LLC, Common Units in DD Healthcare Services Holdings, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	30,030.8	[1],[2],[3],[4],[5],[7]	30,030.8	[1],[2],[3],[4],[5],[7]	30,030.8	[11],[12],[13],[14],[15],[16]	30,030.8	[11],[12],[13],[14],[15],[16]	30,030.8
Cost	$ 15,222	[1]			$ 15,222	[12]
Fair Value	$ 4,227	[1]			$ 4,946	[12]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[6],[7],[10]	5%	[1],[2],[3],[4],[5],[6],[7],[10]	5%	[10],[11],[12],[13],[14],[15],[16],[21]	5%	[10],[11],[12],[13],[14],[15],[16],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	0	[1],[6],[10]			0	[12],[17],[21]
Fair Value	$ 0	[1],[6],[10]			$ 0	[12],[17],[21]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[7],[10]	5%	[1],[2],[3],[4],[5],[7],[10]	5%	[10],[11],[12],[13],[14],[15],[16]	5%	[10],[11],[12],[13],[14],[15],[16]	5%
Cash Interest Rate	9.73%	[1],[10]	9.73%	[1],[10]	8.68%	[12],[17]	8.68%	[12],[17]
Principal	$ 14,297	[1],[9],[10]			$ 14,333	[12],[17],[18]
Cost	14,297	[1],[10]			14,333	[12],[17]
Fair Value	$ 14,297	[1],[10]			$ 14,333	[12],[17]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	9.73%		9.73%						6%
Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%		5.50%		5.50%
Cash Interest Rate	9.79%		9.79%		8.26%		8.26%
Principal	$ 4,090				$ 4,100
Cost	4,055				4,065
Fair Value	$ 3,926				$ 3,921
Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%		5.50%		5.50%
Cash Interest Rate	9.79%		9.79%		8.26%		8.26%
Principal	$ 2,497				$ 2,503
Cost	2,472				2,478
Fair Value	$ 2,397				$ 2,394
Investment, Identifier [Axis]: Dryden 66 Euro CLO 2018, Class DR Notes, Class DR Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.35%	[2],[3],[4],[5],[7],[10],[19]	3.35%	[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	4.75%	[10],[19]	4.75%	[10],[19]
Principal	$ 1,500	[9],[10],[19]
Cost	1,335	[10],[19]
Fair Value	$ 1,389	[10],[19]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units, 12%
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	487.5	[1],[2],[3],[4],[5],[7]	487.5	[1],[2],[3],[4],[5],[7]
Cash Interest Rate	12%	[1],[2],[3],[4],[5],[7]	12%	[1],[2],[3],[4],[5],[7]
Cost	$ 488	[1]
Fair Value	$ 1,067	[1]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					487.5	[11],[12],[13],[14],[15],[16]	487.5	[11],[12],[13],[14],[15],[16]
Cash Interest Rate					12%	[11],[12],[13],[14],[15],[16]	12%	[11],[12],[13],[14],[15],[16]
Cost					$ 488	[12]
Fair Value					$ 966	[12]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class B Common Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	12,500	[1],[2],[3],[4],[5],[7]	12,500	[1],[2],[3],[4],[5],[7]	12,500	[11],[12],[13],[14],[15],[16]	12,500	[11],[12],[13],[14],[15],[16]
Cost	$ 0	[1]			$ 0	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.25%		4.25%
Cash Interest Rate					7.80%		7.80%
Principal					$ 4,478
Cost					4,373
Fair Value					$ 4,367
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.25%		4.25%
Cash Interest Rate					7.80%		7.80%
Principal					$ 2,488
Cost					2,429
Fair Value					$ 2,426
Investment, Identifier [Axis]: Eagleview Technology Corporation, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[11],[12],[13],[14],[15],[16],[17]	7.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.23%	[1],[10]	12.23%	[1],[10]	11.17%	[12],[17]	11.17%	[12],[17]
Principal	$ 8,974	[1],[9],[10]			$ 8,974	[12],[18]
Cost	8,884	[1],[10]			8,884	[12]
Fair Value	$ 7,897	[1],[10]			$ 8,503	[12]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	3%	[1],[2],[3],[4],[5],[6],[7],[19]	3%	[1],[2],[3],[4],[5],[6],[7],[19]	3%	[11],[12],[13],[14],[15],[16],[20],[21]	3%	[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 1,694	[1],[6],[9],[19]
Cost	1,667	[1],[6],[19]			$ 3	[12],[20],[21]
Fair Value	$ 1,694	[1],[6],[19]			$ 0	[12],[20],[21]
Investment, interest rate, paid in kind	6%	[1],[2],[3],[4],[5],[6],[7],[19]	6%	[1],[2],[3],[4],[5],[6],[7],[19]	6%	[11],[12],[13],[14],[15],[16],[20],[21]	6%	[11],[12],[13],[14],[15],[16],[20],[21]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	3%	[1],[2],[3],[4],[5],[7],[19]	3%	[1],[2],[3],[4],[5],[7],[19]	3%	[11],[12],[13],[14],[15],[16],[20]	3%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 10,576	[1],[9],[19]			$ 10,418	[12],[18],[20]
Cost	10,441	[1],[19]			10,275	[12],[20]
Fair Value	$ 10,100	[1],[19]			$ 10,231	[12],[20]
Investment, interest rate, paid in kind	6%	[1],[2],[3],[4],[5],[7],[19]	6%	[1],[2],[3],[4],[5],[7],[19]	6%	[11],[12],[13],[14],[15],[16],[20]	6%	[11],[12],[13],[14],[15],[16],[20]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[2],[3],[4],[5],[7],[10]	6.75%	[2],[3],[4],[5],[7],[10]	6.75%	[11],[13],[14],[15],[16],[17]	6.75%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	11.13%	[10]	11.13%	[10]	9.87%	[17]	9.87%	[17]
Principal	$ 25,061	[9],[10]			$ 25,061	[17],[18]
Cost	24,685	[10]			24,685	[17]
Fair Value	$ 19,273	[10]			$ 21,646	[17]
Investment, Identifier [Axis]: Fair Street LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	12.50%	[1],[2],[3],[4],[5],[6],[7],[8]	12.50%	[1],[2],[3],[4],[5],[6],[7],[8]
Principal	$ 1,174	[1],[6],[8],[9]
Cost	1,111	[1],[6],[8]
Fair Value	$ 1,108	[1],[6],[8]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	9%	[1],[2],[3],[4],[5],[6],[7],[19]	9%	[1],[2],[3],[4],[5],[6],[7],[19]	9%	[11],[12],[13],[14],[15],[16],[21]	9%	[11],[12],[13],[14],[15],[16],[21]
Principal	$ 31,000	[1],[6],[9]			$ 27,850	[12],[18],[21]
Cost	31,000	[1],[6]			27,850	[12],[21]
Fair Value	$ 31,000	[1],[6]			$ 27,850	[12],[21]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Warrant Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	2,500	[1],[2],[3],[4],[5],[6],[7],[19]	2,500	[1],[2],[3],[4],[5],[6],[7],[19]	2,500	[11],[12],[13],[14],[15],[16],[20],[21]	2,500	[11],[12],[13],[14],[15],[16],[20],[21]
Cost	$ 0	[1],[6],[19]			$ 0	[12],[20]
Fair Value	3	[1],[6],[19]			3	[12],[20]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate									9%
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	51,990				48,139
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 29,830				$ 28,973
Investment, Identifier [Axis]: Fortress Biotech Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	331,200	[1],[2],[3],[4],[5],[7],[19]	331,200	[1],[2],[3],[4],[5],[7],[19]	331,200	[11],[12],[13],[14],[15],[16],[20]	331,200	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 405	[1],[19]			$ 405	[12],[20]
Fair Value	$ 26	[1],[19]			$ 66	[12],[20]
Investment, Identifier [Axis]: Fortress Biotech Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	11%	[1],[2],[3],[4],[5],[7],[19]	11%	[1],[2],[3],[4],[5],[7],[19]	11%	[11],[12],[13],[14],[15],[16],[20]	11%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 9,466	[1],[9],[19]			$ 9,466	[12],[18],[20]
Cost	9,106	[1],[19]			9,071	[12],[20]
Fair Value	$ 8,922	[1],[19]			$ 9,008	[12],[20]
Investment, Identifier [Axis]: Frontier Communications Holdings LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	6%	[2],[3],[4],[5],[7],[19]	6%	[2],[3],[4],[5],[7],[19]	6%	[11],[13],[14],[15],[16],[20]	6%	[11],[13],[14],[15],[16],[20]
Principal	$ 4,881	[9],[19]			$ 4,881	[18],[20]
Cost	4,432	[19]			4,420	[20]
Fair Value	$ 3,841	[19]			$ 3,845	[20]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17],[21]	7%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	11.75%	[1],[6],[10]	11.75%	[1],[6],[10]	10.60%	[12],[17],[21]	10.60%	[12],[17],[21]
Principal	$ 1,280	[1],[6],[9],[10]			$ 1,280	[12],[17],[18],[21]
Cost	1,272	[1],[6],[10]			1,268	[12],[17],[21]
Fair Value	$ 1,268	[1],[6],[10]			$ 1,262	[12],[17],[21]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.73%	[1],[10]	11.73%	[1],[10]	10.67%	[12],[17]	10.67%	[12],[17]
Principal	$ 24,819	[1],[9],[10]			$ 25,128	[12],[17],[18]
Cost	24,682	[1],[10]			24,915	[12],[17]
Fair Value	$ 24,641	[1],[10]			$ 24,851	[12],[17]
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.13%		9.13%		7.94%		7.94%
Principal	$ 7,425				$ 7,444
Cost	7,351				7,369
Fair Value	$ 5,495				$ 6,029
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.13%		9.13%		7.94%		7.94%
Principal	$ 3,960				$ 3,970
Cost	3,920				3,930
Fair Value	$ 2,930				$ 3,216
Investment, Identifier [Axis]: Global Medical Response Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.25%	[11],[13],[14],[15],[16],[17]	4.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate					7.37%	[17]	7.37%	[17]
Principal					$ 5,572	[17],[18]
Cost					5,435	[17]
Fair Value					$ 4,848	[17]
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.25%		4.25%
Cash Interest Rate	8.42%		8.42%
Principal	$ 1,260
Cost	1,246
Fair Value	$ 891
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.25%		4.25%
Cash Interest Rate					7.37%		7.37%
Principal					$ 1,979
Cost					1,979
Fair Value					$ 1,722
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.25%		4.25%
Cash Interest Rate					6.81%		6.81%
Principal					$ 2,192
Cost					2,165
Fair Value					$ 1,912
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2, Class D Notes, Class D Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	2.85%	[2],[3],[4],[5],[7],[10],[19]	2.85%	[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	4.31%	[10],[19]	4.31%	[10],[19]
Principal	$ 1,000	[9],[10]
Cost	865	[10]
Fair Value	$ 899	[10]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17],[21]	8%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(51)	[1],[6],[10]			(54)	[12],[17],[21]
Fair Value	$ (57)	[1],[6],[10]			$ (50)	[12],[17],[21]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17],[21]	8%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(26)	[1],[6],[10]			(27)	[12],[17],[21]
Fair Value	$ (29)	[1],[6],[10]			$ (25)	[12],[17],[21]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[2],[3],[4],[5],[7],[10]	8%	[2],[3],[4],[5],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17]	8%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.33%	[1],[10]	12.33%	[1],[10]	11.04%	[12],[17]	11.04%	[12],[17]
Principal	$ 14,275	[1],[9],[10]			$ 14,311	[12],[17],[18]
Cost	14,020	[1],[10]			14,041	[12],[17]
Fair Value	$ 13,990	[1],[10]			$ 14,060	[12],[17]
Investment, Identifier [Axis]: Harbor Purchaser Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%	[2],[3],[4],[5],[7],[10]	5.25%	[2],[3],[4],[5],[7],[10]	5.25%	[11],[13],[14],[15],[16],[17]	5.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	9.67%	[10]	9.67%	[10]	8.38%	[17]	8.38%	[17]
Principal	$ 9,369	[9],[10]			$ 9,392	[17],[18]
Cost	9,070	[10]			9,080	[17]
Fair Value	$ 8,938	[10]			$ 8,582	[17]
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.67%		9.67%		8.38%		8.38%
Principal	$ 7,980				$ 8,000
Cost	7,764				7,774
Fair Value	$ 7,613				$ 7,310
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.67%		9.67%		8.38%		8.38%
Principal	$ 3,990				$ 4,000
Cost	3,882				3,887
Fair Value	$ 3,807				$ 3,655
Investment, Identifier [Axis]: Hayfin Emerald CLO XI, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.12%	[2],[3],[4],[5],[7],[10],[19]	8.12%	[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	10.11%	[10],[19]	10.11%	[10],[19]
Principal	$ 2,250	[10],[19]
Cost	2,041	[10],[19]
Fair Value	$ 2,079	[10],[19]
Investment, Identifier [Axis]: Horizon Aircraft Finance I, Class A Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	4.458%	[2],[3],[4],[5],[7],[10],[19]	4.458%	[2],[3],[4],[5],[7],[10],[19]
Principal	$ 7,112	[10],[19]
Cost	5,697	[10],[19]
Fair Value	$ 5,838	[10],[19]
Investment, Identifier [Axis]: INW Manufacturing LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[7],[10]	5.75%	[1],[2],[3],[4],[5],[7],[10]	5.75%	[11],[12],[13],[14],[15],[16],[17]	5.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.48%	[1],[10]	10.48%	[1],[10]	9.42%	[12],[17]	9.42%	[12],[17]
Principal	$ 35,156	[1],[9],[10]			$ 35,625	[12],[17],[18]
Cost	34,394	[1],[10]			34,806	[12],[17]
Fair Value	$ 30,059	[1],[10]			$ 31,528	[12],[17]
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%		5.75%		5.75%		5.75%
Cash Interest Rate	10.48%		10.48%		9.42%		9.42%
Principal	$ 9,375				$ 9,500
Cost	9,172				9,282
Fair Value	$ 8,016				$ 8,408
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%		5.75%		5.75%		5.75%
Cash Interest Rate	10.48%		10.48%		9.42%		9.42%
Principal	$ 2,344				$ 2,375
Cost	2,293				2,320
Fair Value	$ 2,004				$ 2,102
Investment, Identifier [Axis]: IPC Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[11],[12],[13],[14],[15],[16],[17]	6.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.44%	[1],[10]	9.44%	[1],[10]	9.44%	[12],[17]	9.44%	[12],[17]
Principal	$ 34,357	[1],[9],[10]			$ 34,357	[12],[17],[18]
Cost	33,660	[1],[10]			33,612	[12],[17]
Fair Value	$ 32,553	[1],[10]			$ 32,639	[12],[17]
Investment, Identifier [Axis]: Immucor Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%	[1],[2],[3],[4],[5],[7],[10]	5.75%	[1],[2],[3],[4],[5],[7],[10]	5.75%	[11],[12],[13],[14],[15],[16],[17]	5.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.48%	[1],[10]	10.48%	[1],[10]	9.42%	[12],[17]	9.42%	[12],[17]
Principal	$ 8,547	[1],[9],[10]			$ 8,569	[12],[17],[18]
Cost	8,395	[1],[10]			8,401	[12],[17]
Fair Value	$ 8,635	[1],[10]			$ 8,407	[12],[17]
Investment, Identifier [Axis]: Immucor Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17]	8%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.73%	[1],[10]	12.73%	[1],[10]	11.67%	[12],[17]	11.67%	[12],[17]
Principal	$ 22,819	[1],[9],[10]			$ 22,619	[12],[17],[18]
Cost	22,401	[1],[10]			22,162	[12],[17]
Fair Value	$ 23,275	[1],[10]			$ 22,275	[12],[17]
Investment, interest rate, paid in kind	3.50%	[1],[2],[3],[4],[5],[7],[10]	3.50%	[1],[2],[3],[4],[5],[7],[10]	3.50%	[11],[12],[13],[14],[15],[16],[17]	3.50%	[11],[12],[13],[14],[15],[16],[17]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Revenue Interest Financing Term
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 13,482	[1],[9]
Cost	13,482	[1]
Fair Value	$ 13,428	[1]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Revenue Interest Financing Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal					$ 13,083	[12],[18]
Cost					13,083	[12]
Fair Value					$ 13,083	[12]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[7],[10]	8.75%	[1],[2],[3],[4],[5],[7],[10]	8.75%	[11],[12],[13],[14],[15],[16],[17]	8.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	13.20%	[1],[10]	13.20%	[1],[10]	12.45%	[12],[17]	12.45%	[12],[17]
Principal	$ 12,161	[1],[9],[10]			$ 12,161	[12],[17],[18]
Cost	11,956	[1],[10]			11,944	[12],[17]
Fair Value	$ 11,876	[1],[10]			$ 11,942	[12],[17]
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	10.09%		10.09%		8.80%		8.80%
Principal	$ 7,388				$ 7,406
Cost	7,282				7,293
Fair Value	$ 7,277				$ 7,286
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	10.09%		10.09%		8.80%		8.80%
Principal	$ 3,940				$ 3,950
Cost	3,884				3,890
Fair Value	$ 3,881				$ 3,886
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	11%	[1],[2],[3],[4],[5],[6],[7],[19]	11%	[1],[2],[3],[4],[5],[6],[7],[19]	11%	[11],[12],[13],[14],[15],[16],[20],[21]	11%	[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 0	[1],[6],[9],[19]			$ 0	[12],[18],[20],[21]
Cost	0	[1],[6],[19]			0	[12],[20],[21]
Fair Value	$ 0	[1],[6],[19]			$ 0	[12],[20],[21]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	11%	[1],[2],[3],[4],[5],[7],[19]	11%	[1],[2],[3],[4],[5],[7],[19]	11%	[11],[12],[13],[14],[15],[16],[20]	11%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 6,817	[1],[9],[19]			$ 6,817	[12],[18],[20]
Cost	6,569	[1],[19]			6,553	[12],[20]
Fair Value	$ 6,336	[1],[19]			$ 6,408	[12],[20]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Tranche A Warrant Shares
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					56,999	[11],[12],[13],[14],[15],[16],[20]	56,999	[11],[12],[13],[14],[15],[16],[20]
Cost					$ 135	[12],[20]
Fair Value					$ 609	[12],[20]
Investment, Identifier [Axis]: Integral Development Corporation, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,078,284	[1],[2],[3],[4],[5],[7]	1,078,284	[1],[2],[3],[4],[5],[7]	1,078,284	[11],[12],[13],[14],[15],[16]	1,078,284	[11],[12],[13],[14],[15],[16]
Cost	$ 113	[1]			$ 113	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: Inventus Power Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[7],[10]	5%	[1],[2],[3],[4],[5],[7],[10]	5%	[11],[12],[13],[14],[15],[16],[17]	5%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.84%	[1],[10]	9.84%	[1],[10]	8.55%	[12],[17]	8.55%	[12],[17]
Principal	$ 18,612	[1],[9],[10]			$ 18,660	[12],[17],[18]
Cost	18,536	[1],[10]			18,567	[12],[17]
Fair Value	$ 18,054	[1],[10]			$ 18,134	[12],[17]
Investment, Identifier [Axis]: Inventus Power Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17]	8.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	13.23%	[1],[10]	13.23%	[1],[10]	12.17%	[12],[17]	12.17%	[12],[17]
Principal	$ 13,674	[1],[9],[10]			$ 13,674	[12],[17],[18]
Cost	13,535	[1],[10]			13,514	[12],[17]
Fair Value	$ 13,195	[1],[10]			$ 13,154	[12],[17]
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%		4.75%		4.75%		4.75%
Cash Interest Rate	8.94%		8.94%		7.89%		7.89%
Principal	$ 4,988				$ 5,000
Cost	4,630				4,624
Fair Value	$ 4,548				$ 4,610
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%		4.75%		4.75%		4.75%
Cash Interest Rate	8.94%		8.94%		7.89%		7.89%
Principal	$ 1,995				$ 2,000
Cost	1,849				1,846
Fair Value	$ 1,819				$ 1,844
Investment, Identifier [Axis]: Ivanti Software Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[2],[3],[4],[5],[7],[10]	7.25%	[2],[3],[4],[5],[7],[10]	7.25%	[11],[13],[14],[15],[16],[17]	7.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	12.01%	[10]	12.01%	[10]	10.33%	[17]	10.33%	[17]
Principal	$ 10,247	[9],[10]			$ 10,247	[17],[18]
Cost	10,196	[10]			10,196	[17]
Fair Value	$ 5,994	[10]			$ 7,702	[17]
Investment, Identifier [Axis]: Jazz Acquisition Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[11],[12],[13],[14],[15],[16],[17]	7.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.88%	[1],[10]	11.88%	[1],[10]	10.62%	[12],[17]	10.62%	[12],[17]
Principal	$ 35,912	[1],[9],[10]			$ 36,234	[12],[17],[18]
Cost	34,918	[1],[10]			35,170	[12],[17]
Fair Value	$ 36,176	[1],[10]			$ 36,392	[12],[17]
Investment, Identifier [Axis]: Jazz Acquisition Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[2],[3],[4],[5],[7],[10]	8%	[2],[3],[4],[5],[7],[10]	8%	[11],[13],[14],[15],[16],[17]	8%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	12.38%	[10]	12.38%	[10]	11.12%	[17]	11.12%	[17]
Principal	$ 528	[9],[10]			$ 528	[17],[18]
Cost	480	[10]			478	[17]
Fair Value	$ 483	[10]			$ 481	[17]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[6],[7],[10]	6.50%	[1],[2],[3],[4],[5],[6],[7],[10]	6.50%	[11],[12],[13],[14],[15],[16],[17],[21]	6.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	11.75%	[1],[6],[10]	11.75%	[1],[6],[10]	10.17%	[12],[17],[21]	10.17%	[12],[17],[21]
Principal	$ 659	[1],[6],[9],[10]			$ 329	[12],[17],[18],[21]
Cost	640	[1],[6],[10]			311	[12],[17],[21]
Fair Value	$ 599	[1],[6],[10]			$ 292	[12],[17],[21]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[1],[2],[3],[4],[5],[7],[10]	6.50%	[11],[12],[13],[14],[15],[16],[17]	6.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.23%	[1],[10]	11.23%	[1],[10]	10.17%	[12],[17]	10.17%	[12],[17]
Principal	$ 13,589	[1],[9],[10]			$ 13,623	[12],[17],[18]
Cost	13,453	[1],[10]			13,487	[12],[17]
Fair Value	$ 13,153	[1],[10]			$ 13,351	[12],[17]
Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%
Cash Interest Rate	9.38%		9.38%
Principal	$ 2,992
Cost	2,858
Fair Value	$ 2,848
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17],[21]	6%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	10.38%	[1],[10]	10.38%	[1],[10]	9.12%	[12],[17],[21]	9.12%	[12],[17],[21]
Principal	$ 2,137	[1],[9],[10]			$ 1,710	[12],[17],[18],[21]
Cost	2,101	[1],[10]			1,672	[12],[17],[21]
Fair Value	$ 2,014	[1],[10]			$ 1,651	[12],[17],[21]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.38%	[1],[10]	10.38%	[1],[10]	9.12%	[12],[17]	9.12%	[12],[17]
Principal	$ 21,315	[1],[9],[10]			$ 19,236	[12],[17],[18]
Cost	20,839	[1],[10]			18,894	[12],[17]
Fair Value	$ 20,089	[1],[10]			$ 18,707	[12],[17]
Investment, Identifier [Axis]: LTI Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[2],[3],[4],[5],[7],[10]	6.75%	[2],[3],[4],[5],[7],[10]	6.75%	[11],[13],[14],[15],[16],[17]	6.75%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	11.13%	[10]	11.13%	[10]	9.87%	[17]	9.87%	[17]
Principal	$ 2,140	[9],[10]			$ 2,140	[17],[18]
Cost	2,095	[10]			2,092	[17]
Fair Value	$ 1,712	[10]			$ 1,890	[17]
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.50%		3.50%		3.25%		3.25%
Cash Interest Rate	7.88%		7.88%		6.37%		6.37%
Principal	$ 7,347				$ 7,366
Cost	7,270				7,282
Fair Value	$ 7,050				$ 6,835
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.50%		3.50%		3.25%		3.25%
Cash Interest Rate	7.88%		7.88%		6.37%		6.37%
Principal	$ 1,355				$ 1,358
Cost	1,203				1,192
Fair Value	1,300				1,260
Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	11,337				10,093
Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Principal	$ 7,476				$ 6,562
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%		5.75%		5.75%		5.75%
Cash Interest Rate	9.76%		9.76%		8.23%		8.23%
Principal	$ 7,425				$ 7,444
Cost	7,306				7,318
Fair Value	$ 7,295				$ 7,323
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.75%		5.75%		5.75%		5.75%
Cash Interest Rate	9.76%		9.76%		8.23%		8.23%
Principal	$ 3,960				$ 3,970
Cost	3,897				3,903
Fair Value	$ 3,891				$ 3,905
Investment, Identifier [Axis]: LaserShip Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7.50%	[11],[12],[13],[14],[15],[16],[17]	7.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate					10.38%	[12],[17]	10.38%	[12],[17]
Principal					$ 2,394	[12],[17],[18]
Cost					2,370	[12],[17]
Fair Value					$ 1,867	[12],[17]
Investment, Identifier [Axis]: Latam Airlines Group SA, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	9.50%	[2],[3],[4],[5],[7],[10],[19]	9.50%	[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	13.99%	[1],[10]	13.99%	[1],[10]
Principal	$ 26,205	[1],[9],[10]
Cost	24,034	[1],[10]
Fair Value	$ 25,864	[1],[10]
Investment, Identifier [Axis]: Lift Brands Holdings Inc, Class A Common Units in Snap Investments, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	2,000,000	[1],[2],[3],[4],[5],[7]	2,000,000	[1],[2],[3],[4],[5],[7]	2,000,000	[11],[12],[13],[14],[15],[16]	2,000,000	[11],[12],[13],[14],[15],[16]
Cost	$ 1,399	[1]			$ 1,399	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: Lightbox Intermediate LP, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[1],[2],[3],[4],[5],[7],[10]	5%	[1],[2],[3],[4],[5],[7],[10]	5%	[11],[12],[13],[14],[15],[16],[17]	5%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.73%	[1],[10]	9.73%	[1],[10]	8.67%	[12],[17]	8.67%	[12],[17]
Principal	$ 36,913	[1],[9],[10]			$ 41,008	[12],[17],[18]
Cost	36,233	[1],[10]			40,243	[12],[17]
Fair Value	$ 35,621	[1],[10]			$ 39,573	[12],[17]
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.73%		9.73%		8.67%		8.67%
Principal	$ 11,337				$ 7,367
Cost	11,152				7,315
Fair Value	$ 10,941				$ 7,109
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Class A2 Units in LES Group Holdings, L.P.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	450.75	[1],[2],[3],[4],[5],[7]	450.75	[1],[2],[3],[4],[5],[7]	450.75	[11],[12],[13],[14],[15],[16]	450.75	[11],[12],[13],[14],[15],[16]
Cost	$ 451	[1]			$ 451	[12]
Fair Value	$ 451	[1]			$ 451	[12]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[6],[7],[10]	8.50%	[1],[2],[3],[4],[5],[6],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17],[21]	8.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	12.94%	[1],[6],[10]	12.94%	[1],[6],[10]	11.38%	[12],[17],[21]	11.38%	[12],[17],[21]
Principal	$ 2,370	[1],[6],[9],[10]			$ 2,370	[12],[17],[18],[21]
Cost	2,323	[1],[6],[10]			2,323	[12],[17],[21]
Fair Value	$ 2,257	[1],[6],[10]			$ 2,265	[12],[17],[21]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17]	8.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.88%	[1],[10]	12.88%	[1],[10]	11.38%	[12],[17]	11.38%	[12],[17]
Principal	$ 4,357	[1],[9],[10]			$ 4,357	[12],[17],[18]
Cost	4,289	[1],[10]			4,285	[12],[17]
Fair Value	$ 4,215	[1],[10]			$ 4,226	[12],[17]
Investment, Identifier [Axis]: LogMeIn, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%		4.75%		4.75%		4.75%
Cash Interest Rate	9.14%		9.14%		7.80%		7.80%
Principal	$ 7,840				$ 7,860
Cost	7,736				7,751
Fair Value	$ 5,080				$ 5,494
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[6],[7],[10]	6%	[1],[2],[3],[4],[5],[6],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17],[21]	6%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	10.94%	[1],[6],[10]	10.94%	[1],[6],[10]
Principal	$ 200	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	178	[1],[6],[10]			(23)	[12],[17],[21]
Fair Value	$ 148	[1],[6],[10]			$ (54)	[12],[17],[21]
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.50%	[1],[10]	9.50%	[1],[10]	9.50%	[12],[17]	9.50%	[12],[17]
Principal	$ 18,344	[1],[9],[10]			$ 18,390	[12],[17],[18]
Cost	18,057	[1],[10]			18,088	[12],[17]
Fair Value	$ 17,678	[1],[10]			$ 17,691	[12],[17]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[11],[12],[13],[14],[15],[16],[17],[21]	5.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(11)	[1],[6],[10]			(12)	[12],[17],[21]
Fair Value	$ (95)	[1],[6],[10]			$ (96)	[12],[17],[21]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[1],[2],[3],[4],[5],[6],[7],[10]	5.50%	[11],[12],[13],[14],[15],[16],[17],[21]	5.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(13)	[1],[6],[10]			(13)	[12],[17],[21]
Fair Value	$ (65)	[1],[6],[10]			$ (51)	[12],[17],[21]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%		5.50%		5.50%
Principal	$ 0				$ 0
Cost	(3)				(3)
Fair Value	$ (12)				$ (10)
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revovlver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%
Principal	$ 0
Cost	(1)
Fair Value	$ (6)
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[1],[2],[3],[4],[5],[7],[10]	5.50%	[11],[12],[13],[14],[15],[16],[17]	5.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.23%	[1],[10]	10.23%	[1],[10]	9.17%	[12],[17]	9.17%	[12],[17]
Principal	$ 25,768	[1],[9],[10]			$ 29,565	[12],[17],[18]
Cost	25,392	[1],[10]			29,128	[12],[17]
Fair Value	$ 24,833	[1],[10]			$ 28,734	[12],[17]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%		5.50%		5.50%
Cash Interest Rate	10.23%		10.23%		9.17%		9.17%
Principal	$ 10,611				$ 6,139
Cost	10,416				6,104
Fair Value	$ 10,227				$ 5,966
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%
Cash Interest Rate	10.23%		10.23%
Principal	$ 1,642
Cost	1,629
Fair Value	$ 1,583
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.50%		5.50%
Cash Interest Rate					9.17%		9.17%
Principal					$ 1,647
Cost					1,632
Fair Value					$ 1,600
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					5.50%		5.50%
Principal					$ 0
Cost					(1)
Fair Value					$ (4)
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	11.50%	[1],[2],[3],[4],[5],[6],[7],[19]	11.50%	[1],[2],[3],[4],[5],[6],[7],[19]	11.50%	[11],[12],[13],[14],[15],[16],[20],[21]	11.50%	[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 0	[1],[6],[9],[19]			$ 0	[12],[18],[20],[21]
Cost	0	[1],[6],[19]			0	[12],[20],[21]
Fair Value	$ 0	[1],[6],[19]			$ 0	[12],[20],[21]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	11.50%	[1],[2],[3],[4],[5],[7],[19]	11.50%	[1],[2],[3],[4],[5],[7],[19]	11.50%	[11],[12],[13],[14],[15],[16],[20]	11.50%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 17,203	[1],[9],[19]			$ 17,203	[12],[18],[20]
Cost	16,972	[1],[19]			16,954	[12],[20]
Fair Value	$ 16,573	[1],[19]			$ 16,644	[12],[20]
Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%
Cash Interest Rate	7.97%		7.97%
Principal	$ 1,995
Cost	1,876
Fair Value	$ 1,862
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	8%	[1],[2],[3],[4],[5],[6],[7],[19]	8%	[1],[2],[3],[4],[5],[6],[7],[19]	8%	[11],[12],[13],[14],[15],[16],[20],[21]	8%	[11],[12],[13],[14],[15],[16],[20],[21]
Principal	$ 0	[1],[6],[9],[19]			$ 0	[12],[18],[20],[21]
Cost	1	[1],[6],[19]			1	[12],[20],[21]
Fair Value	$ 0	[1],[6],[19]			$ 0	[12],[20],[21]
Investment, interest rate, paid in kind	1.75%	[1],[2],[3],[4],[5],[6],[7],[19]	1.75%	[1],[2],[3],[4],[5],[6],[7],[19]	1.75%	[11],[12],[13],[14],[15],[16],[20],[21]	1.75%	[11],[12],[13],[14],[15],[16],[20],[21]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	8%	[1],[2],[3],[4],[5],[7],[19]	8%	[1],[2],[3],[4],[5],[7],[19]	8%	[11],[12],[13],[14],[15],[16],[20]	8%	[11],[12],[13],[14],[15],[16],[20]
Principal	$ 7,247	[1],[9],[19]			$ 7,215	[12],[18],[20]
Cost	6,717	[1],[19]			6,650	[12],[20]
Fair Value	$ 6,474	[1],[19]			$ 6,440	[12],[20]
Investment, interest rate, paid in kind	1.75%	[1],[2],[3],[4],[5],[7],[19]	1.75%	[1],[2],[3],[4],[5],[7],[19]	1.75%	[11],[12],[13],[14],[15],[16],[20]	1.75%	[11],[12],[13],[14],[15],[16],[20]
Investment, Identifier [Axis]: Mesoblast Inc, Warrant Shares
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					209,588	[11],[12],[13],[14],[15],[16],[20]	209,588	[11],[12],[13],[14],[15],[16],[20]
Cost					$ 480	[12],[20]
Fair Value					$ 170	[12],[20]
Investment, Identifier [Axis]: Mesoblast, Inc, Warrant Shares 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	209,588	[1],[2],[3],[4],[5],[7],[19]	209,588	[1],[2],[3],[4],[5],[7],[19]
Cost	$ 480	[1],[19]
Fair Value	$ 222	[1],[19]
Investment, Identifier [Axis]: Mesoblast, Inc, Warrant Shares 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	53,887	[1],[2],[3],[4],[5],[7],[19]	53,887	[1],[2],[3],[4],[5],[7],[19]
Cost	$ 0
Fair Value	$ 81
Investment, Identifier [Axis]: Mindbody Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17],[21]	8%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(48)	[1],[6],[10]			(54)	[12],[17],[21]
Fair Value	$ (88)	[1],[6],[10]			$ (100)	[12],[17],[21]
Investment, Identifier [Axis]: Mindbody Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.72%	[1],[10]	11.72%	[1],[10]	10.64%	[12],[17]	10.64%	[12],[17]
Principal	$ 45,487	[1],[9],[10]			$ 45,665	[12],[17],[18]
Cost	44,616	[1],[10]			44,689	[12],[17]
Fair Value	$ 44,486	[1],[10]			$ 44,523	[12],[17]
Investment, interest rate, paid in kind					1.50%	[11],[12],[13],[14],[15],[16],[17]	1.50%	[11],[12],[13],[14],[15],[16],[17]
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%		8%		8%		8%
Principal	$ 0				$ 0
Cost	(3)				(4)
Fair Value	$ (10)				$ (12)
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%		7%		7%		7%
Cash Interest Rate	11.72%		11.72%		10.64%		10.64%
Principal	$ 4,668				$ 4,687
Cost	4,636				4,651
Fair Value	$ 4,566				$ 4,570
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7%	[10],[11],[12],[13],[14],[15],[16],[21]	7%	[10],[11],[12],[13],[14],[15],[16],[21]
Principal					$ 0	[12],[17],[18],[21]
Cost					(31)	[12],[17],[21]
Fair Value					$ 0	[12],[17],[21]
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7%	[10],[11],[12],[13],[14],[15],[16]	7%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate					9.80%	[12],[17]	9.80%	[12],[17]
Principal					$ 389	[12],[17],[18]
Cost					387	[12],[17]
Fair Value					$ 727	[12],[17]
Investment, Identifier [Axis]: Mosaic Companies LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17]	6.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.93%	[1],[10]	10.93%	[1],[10]	9.89%	[12],[17]	9.89%	[12],[17]
Principal	$ 45,907	[1],[9],[10]			$ 46,499	[12],[17],[18]
Cost	45,266	[1],[10]			45,802	[12],[17]
Fair Value	$ 45,127	[1],[10]			$ 45,421	[12],[17]
Investment, Identifier [Axis]: NFP Corp, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	6.875%	[2],[3],[4],[5],[7]	6.875%	[2],[3],[4],[5],[7]	6.875%	[11],[13],[14],[15],[16]	6.875%	[11],[13],[14],[15],[16]
Principal	$ 10,191	[9]			$ 10,191	[18]
Cost	9,787				9,773
Fair Value	$ 8,423				$ 7,966
Investment, Identifier [Axis]: NN Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.88%	[1],[2],[3],[4],[5],[7],[10]	6.88%	[1],[2],[3],[4],[5],[7],[10]	6.88%	[11],[12],[13],[14],[15],[16],[17],[20]	6.88%	[11],[12],[13],[14],[15],[16],[17],[20]
Cash Interest Rate	11.26%	[1],[10],[19]	11.26%	[1],[10],[19]	9.99%	[12],[17],[20]	9.99%	[12],[17],[20]
Principal	$ 58,564	[1],[9],[10],[19]			$ 58,713	[12],[17],[18],[20]
Cost	57,577	[1],[10],[19]			57,655	[12],[17],[20]
Fair Value	$ 55,958	[1],[10],[19]			$ 56,805	[12],[17],[20]
Investment, Identifier [Axis]: Navisite LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17]	8.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	13.23%	[1],[10]	13.23%	[1],[10]	12.17%	[12],[17]	12.17%	[12],[17]
Principal	$ 22,560	[1],[9],[10]			$ 22,560	[12],[17],[18]
Cost	22,260	[1],[10]			22,241	[12],[17]
Fair Value	$ 21,545	[1],[10]			$ 21,524	[12],[17]
Investment, Identifier [Axis]: NeuAG LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	10.50%	[1],[2],[3],[4],[5],[7],[10]	10.50%	[1],[2],[3],[4],[5],[7],[10]	10.50%	[11],[12],[13],[14],[15],[16],[17]	10.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	15.23%	[1],[10]	15.23%	[1],[10]	14.17%	[12],[17]	14.17%	[12],[17]
Principal	$ 50,276	[1],[9],[10]			$ 50,459	[12],[17],[18]
Cost	49,271	[1],[10]			49,301	[12],[17]
Fair Value	$ 52,292	[1],[10]			$ 51,972	[12],[17]
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.75%		4.75%
Cash Interest Rate	9.23%		9.23%		7.87%		7.87%
Principal	$ 6,668				$ 6,685
Cost	6,657				6,673
Fair Value	$ 6,467				$ 6,484
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.75%		4.75%
Cash Interest Rate	9.23%		9.23%		7.87%		7.87%
Principal	$ 5,239				$ 5,252
Cost	5,230				5,243
Fair Value	$ 5,082				5,095
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class D Notes, Class D Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.06%	[2],[3],[4],[5],[7],[10]	6.06%	[2],[3],[4],[5],[7],[10]
Cash Interest Rate	8.05%	[10],[19]	8.05%	[10],[19]
Principal | €			€ 2,500	[10],[19]
Cost	$ 2,503	[10],[19]
Fair Value	$ 2,576	[10],[19]
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.87%	[2],[3],[4],[5],[7],[10]	6.87%	[2],[3],[4],[5],[7],[10]
Cash Interest Rate	8.86%	[10],[19]	8.86%	[10],[19]
Principal | €			€ 3,000	[10],[19]
Cost	$ 2,677	[10],[19]
Fair Value	2,728	[10],[19]
Investment, Identifier [Axis]: OCSI Glick JV LLC, LLC Equity Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	54,791	[6],[19],[22],[23]
Fair Value	24,108	[6],[19],[22],[23]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Equity Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost	0	[6],[19],[23]			0	[20],[21],[24]
Fair Value	$ 0	[6],[19],[23]			$ 0	[20],[21],[24]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	4.50%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	4.50%	[6],[10],[11],[12],[13],[14],[15],[16],[20]	4.50%	[6],[10],[11],[12],[13],[14],[15],[16],[20]	4.50%
Cash Interest Rate	7.67%	[1],[6],[10],[19]	7.67%	[1],[6],[10],[19]	6.30%	[12],[17],[20],[21]	6.30%	[12],[17],[20],[21]	4.58%
Principal	$ 59,049	[1],[6],[9],[10],[19]			$ 59,662	[12],[17],[18],[20],[21]
Cost	49,961	[1],[6],[10],[19]			50,194	[12],[17],[20],[21]
Fair Value	$ 49,536	[1],[6],[10],[19]			$ 50,283	[12],[17],[20],[21]
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%	[2],[3],[4],[5],[7],[10]	4%	[2],[3],[4],[5],[7],[10]	4%	[11],[13],[14],[15],[16],[17]	4%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	8.42%	[10]	8.42%	[10]	7.12%	[17]	7.12%	[17]
Principal	$ 3,315	[9],[10]			$ 3,323	[17],[18]
Cost	3,165	[10]			3,162	[17]
Fair Value	$ 3,167	[10]			$ 3,207	[17]
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.42%		8.42%		7.12%		7.12%
Principal	$ 7,757				$ 7,777
Cost	7,721				7,741
Fair Value	$ 7,411				$ 7,505
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.42%		8.42%		7.12%		7.12%
Principal	$ 3,878				$ 3,888
Cost	3,861				3,871
Fair Value	$ 3,705				$ 3,752
Investment, Identifier [Axis]: OEConnection LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.42%	[1],[10]	11.42%	[1],[10]	10.05%	[12],[17]	10.05%	[12],[17]
Principal	$ 7,519	[1],[9],[10]			$ 7,519	[12],[17],[18]
Cost	7,396	[1],[10]			7,389	[12],[17]
Fair Value	$ 7,221	[1],[10]			$ 7,237	[12],[17]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	2%	[1],[2],[3],[4],[5],[6],[7],[10]	2%	[1],[2],[3],[4],[5],[6],[7],[10]	2%	[11],[12],[13],[14],[15],[16],[17],[21]	2%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(30)	[1],[6],[10]			(31)	[12],[17],[21]
Fair Value	$ 0	[1],[6],[10]			$ 0	[12],[17],[21]
Investment, interest rate, paid in kind	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17],[21]	8%	[11],[12],[13],[14],[15],[16],[17],[21]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	2%	[1],[2],[3],[4],[5],[7],[10]	2%	[1],[2],[3],[4],[5],[7],[10]	2%	[11],[12],[13],[14],[15],[16],[17]	2%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	6.76%	[1],[10]	6.76%	[1],[10]	5.08%	[12],[17]	5.08%	[12],[17]
Principal	$ 21,993	[1],[9],[10]			$ 21,557	[12],[17],[18]
Cost	21,728	[1],[10]			21,267	[12],[17]
Fair Value	$ 21,993	[1],[10]			$ 21,557	[12],[17]
Investment, interest rate, paid in kind	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17]	8%	[11],[12],[13],[14],[15],[16],[17]
Investment, Identifier [Axis]: P & L Development LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	7.75%	[2],[3],[4],[5],[7]	7.75%	[2],[3],[4],[5],[7]	7.75%	[11],[13],[14],[15],[16]	7.75%	[11],[13],[14],[15],[16]
Principal	$ 7,776	[9]			$ 7,776	[18]
Cost	7,817				7,820
Fair Value	$ 6,318				$ 5,846
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[1],[2],[3],[4],[5],[6],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17],[21]	7%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	10.74%	[1],[6],[10]	10.74%	[1],[6],[10]	9.25%	[12],[17],[21]	9.25%	[12],[17],[21]
Principal	$ 2,228	[1],[6],[9],[10]			$ 2,228	[12],[17],[18],[21]
Cost	2,188	[1],[6],[10]			2,186	[12],[17],[21]
Fair Value	$ 2,184	[1],[6],[10]			$ 2,203	[12],[17],[21]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17],[21]	7%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	11.76%	[1],[10]	11.76%	[1],[10]
Principal	$ 1,252	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	1,232	[1],[6],[10]			(21)	[12],[17],[21]
Fair Value	$ 1,230	[1],[6],[10]			$ (13)	[12],[17],[21]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.74%	[1],[10]	10.74%	[1],[10]	9.28%	[12],[17]	9.28%	[12],[17]
Principal	$ 26,088	[1],[9],[10]			$ 26,154	[12],[17],[18]
Cost	25,674	[1],[10]			25,712	[12],[17]
Fair Value	$ 25,632	[1],[10]			$ 25,893	[12],[17]
Investment, Identifier [Axis]: PRGX Global Inc, Class B Common Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	80,515	[1],[2],[3],[4],[5],[7]	80,515	[1],[2],[3],[4],[5],[7]	80,515	[11],[12],[13],[14],[15],[16]	80,515	[11],[12],[13],[14],[15],[16]
Cost	$ 79	[1],[10]			$ 79	[12]
Fair Value	$ 121	[1],[10]			$ 89	[12]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17]	6.75%	[11],[12],[13],[14],[15],[16],[17]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(31)	[1],[6],[10]			(34)	[12],[17],[21]
Fair Value	$ (49)	[1],[6],[10]			$ (49)	[12],[17],[21]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17]	6.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.50%	[1],[10]	11.50%	[1],[10]	10.42%	[12],[17]	10.42%	[12],[17]
Principal	$ 31,186	[1],[9],[10]			$ 33,775	[12],[17],[18]
Cost	30,466	[1],[10]			32,931	[12],[17]
Fair Value	$ 30,578	[1],[10]			$ 33,116	[12],[17]
Investment, Identifier [Axis]: Park Place Technologies LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%	[2],[3],[4],[5],[7],[10]	5%	[2],[3],[4],[5],[7],[10]	5%	[11],[13],[14],[15],[16],[17]	5%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	9.42%	[10]	9.42%	[10]	8.13%	[17]	8.13%	[17]
Principal	$ 4,838	[9],[10]			$ 9,850	[17],[18]
Cost	4,703	[10]			9,460	[17]
Fair Value	$ 4,575	[10]			$ 9,374	[17]
Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.42%		9.42%		8.13%		8.13%
Principal	$ 9,900				$ 4,925
Cost	9,504				4,781
Fair Value	$ 9,362				$ 4,687
Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6.50%		6.50%
Cash Interest Rate					8.35%		8.35%
Principal					$ 5,486
Cost					5,251
Fair Value					$ 5,371
Investment, Identifier [Axis]: Performance Health Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.73%	[1],[10]	10.73%	[1],[10]	8.88%	[12],[17]	8.88%	[12],[17]
Principal	$ 17,976	[1],[9],[10]			$ 17,976	[12],[17],[18]
Cost	17,705	[1],[10]			17,690	[12],[17]
Fair Value	$ 17,537	[1],[10]			$ 17,537	[12],[17]
Investment, Identifier [Axis]: Planview Parent Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[7],[10]	7.25%	[1],[2],[3],[4],[5],[7],[10]	7.25%	[11],[12],[13],[14],[15],[16],[17]	7.25%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.98%	[1],[10]	11.98%	[1],[10]	10.92%	[12],[17]	10.92%	[12],[17]
Principal	$ 28,627	[1],[9],[10]			$ 28,627	[12],[17],[18]
Cost	28,198	[1],[10]			28,198	[12],[17]
Fair Value	$ 25,693	[1],[10]			$ 27,482	[12],[17]
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%
Cash Interest Rate	8.73%		8.73%
Principal	$ 2,435
Cost	2,294
Fair Value	$ 2,274
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%
Cash Interest Rate	8.73%		8.73%
Principal	$ 688
Cost	649
Fair Value	$ 643
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%		7.25%
Cash Interest Rate	11.98%		11.98%
Principal	$ 2,842
Cost	2,799
Fair Value	$ 2,551
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%		7.25%		7.25%		7.25%
Cash Interest Rate	11.98%		11.98%		10.92%		10.92%
Principal	$ 4,503				$ 4,503
Cost	4,435				4,435
Fair Value	$ 4,041				$ 4,323
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7.25%		7.25%
Cash Interest Rate					10.92%		10.92%
Principal					$ 2,842
Cost					2,799
Fair Value					$ 2,728
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[1],[2],[3],[4],[5],[6],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17],[21]	8%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	12.36%	[1],[6],[10]	12.36%	[1],[6],[10]
Principal	$ 1,766	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	1,716	[1],[6],[10]			(53)	[12],[17],[21]
Fair Value	$ 1,678	[1],[6],[10]			$ (111)	[12],[17],[21]
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17]	8%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.83%	[1],[10]	11.83%	[1],[10]	10.68%	[12],[17]	10.68%	[12],[17]
Principal	$ 48,689	[1],[9],[10]			$ 48,689	[12],[17],[18]
Cost	47,993	[1],[10]			47,951	[12],[17]
Fair Value	$ 47,471	[1],[10]			$ 47,155	[12],[17]
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%		8%		8%		8%
Principal	$ 212				$ 0
Cost	206				(6)
Fair Value	$ 201				$ (13)
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%		8%		8%		8%
Cash Interest Rate	12.36%		12.36%
Principal	$ 158				$ 0
Cost	153				(5)
Fair Value	$ 150				$ (10)
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%		8%		8%		8%
Cash Interest Rate	11.83%		11.83%		10.68%		10.68%
Principal	$ 6,796				$ 6,796
Cost	6,698				6,694
Fair Value	$ 6,626				$ 6,582
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%		8%		8%		8%
Cash Interest Rate	11.83%		11.83%		10.68%		10.68%
Principal	$ 4,465				$ 4,465
Cost	4,401				4,398
Fair Value	$ 4,354				$ 4,325
Investment, Identifier [Axis]: Profrac Holdings II LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[7],[10]	7.25%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17]	8.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.10%	[1],[10]	11.10%	[1],[10]	10.01%	[12],[17]	10.01%	[12],[17]
Principal	$ 22,984	[1],[9],[10]			$ 23,275	[12],[17],[18]
Cost	22,496	[1],[10]			22,722	[12],[17]
Fair Value	$ 22,432	[1],[10]			$ 22,810	[12],[17]
Investment, Identifier [Axis]: Project Boost Purchaser LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17]	8%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.38%	[1],[10]	12.38%	[1],[10]	11.12%	[12],[17]	11.12%	[12],[17]
Principal	$ 5,250	[1],[9],[10]			$ 5,250	[12],[17],[18]
Cost	5,173	[1],[10]			5,168	[12],[17]
Fair Value	$ 4,955	[1],[10]			$ 5,047	[12],[17]
Investment, Identifier [Axis]: Quantum Bidco Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10],[19]	6%	[1],[2],[3],[4],[5],[7],[10],[19]	6%	[11],[12],[13],[14],[15],[16],[17],[20]	6%	[11],[12],[13],[14],[15],[16],[17],[20]
Cash Interest Rate	9.63%	[1],[10],[19]	9.63%	[1],[10],[19]	8.39%	[12],[17],[20]	8.39%	[12],[17],[20]
Principal	$ 3,501	[1],[9],[10],[19]			$ 3,501	[12],[17],[18],[20]
Cost	4,655	[1],[10],[19]			4,646	[12],[17],[20]
Fair Value	$ 3,599	[1],[10],[19]			$ 3,367	[12],[17],[20]
Investment, Identifier [Axis]: QuorumLabs Inc, Junior-2 Preferred Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	64,887,669	[1],[2],[3],[4],[5],[7]	64,887,669	[1],[2],[3],[4],[5],[7]	64,887,669	[11],[12],[13],[14],[15],[16]	64,887,669	[11],[12],[13],[14],[15],[16]
Cost	$ 375	[1]			$ 375	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate					5.25%	[11],[13],[14],[15],[16]	5.25%	[11],[13],[14],[15],[16]
Principal					$ 1,325	[18]
Cost					1,218
Fair Value					$ 1,097
Investment, Identifier [Axis]: Radiology Partners Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.25%	[2],[3],[4],[5],[7],[10]	4.25%	[2],[3],[4],[5],[7],[10]	4.25%	[11],[13],[14],[15],[16],[17]	4.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	8.64%	[10]	8.64%	[10]	7.33%	[17]	7.33%	[17]
Principal	$ 3,400	[9],[10]			$ 3,400	[17],[18]
Cost	3,221	[10]			3,202	[17]
Fair Value	$ 2,870	[10]			$ 2,880	[17]
Investment, Identifier [Axis]: Radiology Partners Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	9.25%	[2],[3],[4],[5],[7]	9.25%	[2],[3],[4],[5],[7]	9.25%	[11],[13],[14],[15],[16]	9.25%	[11],[13],[14],[15],[16]
Principal	$ 4,755	[9]			$ 4,755	[18]
Cost	4,721				4,720
Fair Value	$ 2,677				$ 3,109
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.50%	[1],[2],[3],[4],[5],[6],[7],[10]	6.50%	[1],[2],[3],[4],[5],[6],[7],[10]	6.50%	[11],[12],[13],[14],[15],[16],[17],[21]	6.50%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(40)	[1],[6],[10]			(43)	[12],[17],[21]
Fair Value	$ (47)	[1],[6],[10]			(64)	[12],[17],[21]
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[1],[2],[3],[4],[5],[7],[10]
Principal	$ 25,405	[1],[9],[10]			24,692	[12],[17],[18]
Cost	25,002	[1],[10]			24,265	[12],[17]
Fair Value	$ 24,846	[1],[10]			$ 24,101	[12],[17]
Investment, interest rate, paid in kind					7.50%	[11],[12],[13],[14],[15],[16],[17]	7.50%	[11],[12],[13],[14],[15],[16],[17]
Investment, Identifier [Axis]: Renaissance Holding Corp, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[2],[3],[4],[5],[7],[10]	7%	[2],[3],[4],[5],[7],[10]	7%	[11],[13],[14],[15],[16],[17]	7%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	11.38%	[10]	11.38%	[10]	10.12%	[17]	10.12%	[17]
Principal	$ 3,542	[9],[10]			$ 3,542	[17],[18]
Cost	3,515	[10]			3,515	[17]
Fair Value	$ 3,315	[10]			$ 3,402	[17]
Investment, Identifier [Axis]: RevSpring, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4%		4%		4%		4%
Cash Interest Rate	8.73%		8.73%		7.67%		7.67%
Principal	$ 9,600				$ 9,625
Cost	9,583				9,607
Fair Value	$ 9,288				$ 9,304
Investment, Identifier [Axis]: RumbleOn Inc, Class B Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	164,660	[1],[2],[3],[4],[5],[7],[19]	164,660	[1],[2],[3],[4],[5],[7],[19]	164,660	[11],[12],[13],[14],[15],[16],[20]	164,660	[11],[12],[13],[14],[15],[16],[20]
Cost	$ 1,202	[1],[19]			$ 1,202	[12],[20]
Fair Value	$ 0	[1],[19]			$ 74	[12],[20]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.25%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	8.25%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	8.25%	[11],[12],[13],[14],[15],[16],[17],[20],[21]	8.25%	[11],[12],[13],[14],[15],[16],[17],[20],[21]
Cash Interest Rate	12.98%	[1],[6],[10],[19]	12.98%	[1],[6],[10],[19]	11.92%	[12],[17],[20],[21]	11.92%	[12],[17],[20],[21]
Principal	$ 10,920	[1],[6],[9],[10],[19]			$ 11,393	[12],[17],[18],[20],[21]
Cost	10,185	[1],[6],[10],[19]			10,583	[12],[17],[20],[21]
Fair Value	$ 10,243	[1],[6],[10],[19]			$ 10,760	[12],[17],[20],[21]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.25%	[1],[2],[3],[4],[5],[7],[10],[19]	8.25%	[1],[2],[3],[4],[5],[7],[10],[19]	8.25%	[11],[12],[13],[14],[15],[16],[17],[20]	8.25%	[11],[12],[13],[14],[15],[16],[17],[20]
Cash Interest Rate	12.98%	[1],[10],[19]	12.98%	[1],[10],[19]	11.92%	[12],[17],[20]	11.92%	[12],[17],[20]
Principal	$ 36,092	[1],[9],[10],[19]			$ 37,656	[12],[17],[18],[20]
Cost	34,407	[1],[10],[19]			35,775	[12],[17],[20]
Fair Value	$ 34,540	[1],[10],[19]			$ 36,187	[12],[17],[20]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Units in Eyesouth Co-Investor FT Aggregator LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	1,037	[1],[2],[3],[4],[5],[7]	1,037	[1],[2],[3],[4],[5],[7]
Cost	$ 1,037
Fair Value	$ 1,113
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[6],[7],[10]	8.75%	[1],[2],[3],[4],[5],[6],[7],[10]
Principal	$ 0	[1],[6],[10]
Cost	(35)	[6],[10]
Fair Value	$ (68)	[6],[10]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[7],[10]	8.75%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	12.52%	[10]	12.52%	[10]
Principal	$ 8,010	[9],[10]
Cost	7,777	[10]
Fair Value	$ 7,778	[10]
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.66%		9.66%		8.06%		8.06%
Principal	$ 8,179				$ 8,201
Cost	8,173				8,194
Fair Value	$ 6,339				$ 7,176
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.66%		9.66%		8.06%		8.06%
Principal	$ 6,078				$ 6,094
Cost	6,068				6,082
Fair Value	$ 4,710				$ 5,332
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.23%		5.23%		5.23%		5.23%
Cash Interest Rate	9.64%		9.64%		8.04%		8.04%
Principal	$ 138				$ 138
Cost	138				138
Fair Value	$ 120				$ 121
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.23%		5.23%		5.23%		5.23%
Cash Interest Rate	9.64%		9.64%		8.04%		8.04%
Principal	$ 102				$ 102
Cost	102				102
Fair Value	$ 89				$ 90
Investment, Identifier [Axis]: SM Wellness Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.75%	[1],[2],[3],[4],[5],[7],[10]	4.75%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	9.42%	[10]	9.42%	[10]
Principal	$ 3,395	[1],[10]
Cost	2,784	[1],[10]
Fair Value	$ 2,767	[1],[10]
Investment, Identifier [Axis]: SM Wellness Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[11],[12],[13],[14],[15],[16],[17]	8%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.67%	[1],[10]	12.67%	[1],[10]	10.74%	[12],[17]	10.74%	[12],[17]
Principal	$ 9,109	[1],[9],[10]			$ 9,109	[12],[17],[18]
Cost	8,972	[1],[10]			8,972	[12],[17]
Fair Value	$ 6,604	[1],[10]			$ 8,289	[12],[17]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%	[2],[3],[4],[5],[7],[10]	4.50%	[2],[3],[4],[5],[7],[10]
Cash Interest Rate	8.92%	[10]	8.92%	[10]
Principal	$ 1,496	[9],[10]
Cost	1,410	[10]
Fair Value	$ 1,401	[10]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.50%	[11],[13],[14],[15],[16],[17]	4.50%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate					7.63%	[17]	7.63%	[17]
Principal					$ 1,500	[17],[18]
Cost					1,410	[17]
Fair Value					$ 1,393	[17]
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	8.92%		8.92%		7.63%		7.63%
Principal	$ 10,075				$ 7,500
Cost	9,610				7,184
Fair Value	$ 9,436				$ 6,966
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	8.92%		8.92%		7.63%		7.63%
Principal	$ 5,985				$ 6,000
Cost	5,730				5,734
Fair Value	$ 5,605				$ 5,572
Investment, Identifier [Axis]: SVP-Singer Holdings Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17]	6.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.48%	[1],[10]	11.48%	[1],[10]	10.42%	[12],[17]	10.42%	[12],[17]
Principal	$ 20,714	[1],[9],[10]			$ 20,766	[12],[17],[18]
Cost	19,554	[1],[10]			19,550	[12],[17]
Fair Value	$ 17,917	[1],[10]			$ 18,188	[12],[17]
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.50%		4.50%
Cash Interest Rate					7.63%		7.63%
Principal					$ 2,536
Cost					2,511
Fair Value					$ 2,435
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.50%		4.50%
Cash Interest Rate					7.63%		7.63%
Principal					$ 1,691
Cost					1,674
Fair Value					$ 1,623
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan, LIBOR+4.50% cash due 12/10/2026
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					4.50%	[11],[13],[14],[15],[16],[17]	4.50%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate					7.63%	[17]	7.63%	[17]
Principal					$ 1,691	[17],[18]
Cost					1,610	[17]
Fair Value					1,623	[17]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	991,019	[1],[2],[3],[4],[5],[7]	991,019	[1],[2],[3],[4],[5],[7]
Cost	$ 327	[1]
Fair Value	$ 307	[1]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	10%	[1],[2],[3],[4],[5],[6],[7],[10]	10%	[1],[2],[3],[4],[5],[6],[7],[10]
Cash Interest Rate	14.32%	[1],[6],[10]	14.32%	[1],[6],[10]
Principal	$ 931	[1],[6],[9],[10]
Cost	812	[1],[6],[10]
Fair Value	$ 814	[1],[6],[10]
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	10%	[1],[2],[3],[4],[5],[7],[10]	10%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	14.32%	[10]	14.32%	[10]
Principal	$ 27,848	[9],[10]
Cost	26,787	[10]
Fair Value	$ 26,804	[10]
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	408,508	[1],[2],[3],[4],[5],[7],[19]	408,508	[1],[2],[3],[4],[5],[7],[19]
Cost	$ 0	[1],[19]
Fair Value	$ 4,081	[1],[19]
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Put Options on Common Shares in Alvotech SA
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	293,082	[1],[2],[3],[4],[5],[7],[19]	293,082	[1],[2],[3],[4],[5],[7],[19]
Cost	$ 0	[1],[19]
Fair Value	$ 580	[1],[19]
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Seller Earn Out Shares in Alvotech SA
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	124,780	[1],[2],[3],[4],[5],[7],[19]	124,780	[1],[2],[3],[4],[5],[7],[19]
Cost	$ 485	[1],[19]
Fair Value	$ 418	[1],[19]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, LLC Equity Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cost					49,322	[20],[21],[24],[25]
Fair Value					$ 20,715	[20],[21],[24],[25]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	7%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	7%	[6],[10],[11],[12],[13],[14],[15],[16],[20]	7%	[6],[10],[11],[12],[13],[14],[15],[16],[20]	7%
Cash Interest Rate	10.17%	[1],[6],[10],[19]	10.17%	[1],[6],[10],[19]	8.80%	[12],[17],[20],[21]	8.80%	[12],[17],[20],[21]	8%
Principal	$ 112,656	[1],[6],[9],[10],[19]			$ 96,250	[12],[17],[18],[20],[21]
Cost	112,656	[1],[6],[10],[19]			96,250	[12],[17],[20],[21]
Fair Value	$ 112,656	[1],[6],[10],[19]			$ 96,250	[12],[17],[20],[21]
Investment, Identifier [Axis]: ShareThis Inc, Series C Preferred Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	345,452	[1],[2],[3],[4],[5],[7]	345,452	[1],[2],[3],[4],[5],[7]	345,452	[11],[12],[13],[14],[15],[16]	345,452	[11],[12],[13],[14],[15],[16]
Cost	$ 367	[1]			$ 367	[12]
Fair Value	$ 0	[1]			$ 0	[12]
Investment, Identifier [Axis]: SiO Medical Products Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	415.34	[1],[2],[3],[4],[5],[7]	415.34	[1],[2],[3],[4],[5],[7]	415.34	[11],[12],[13],[14],[15],[16]	415.34	[11],[12],[13],[14],[15],[16]
Cost	$ 681	[1]			$ 681	[12]
Fair Value	$ 243	[1]			$ 681	[12]
Investment, Identifier [Axis]: SiO Medical Products Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	5.50%	[1],[2],[3],[4],[5],[7]	5.50%	[1],[2],[3],[4],[5],[7]	5.50%	[11],[12],[13],[14],[15],[16]	5.50%	[11],[12],[13],[14],[15],[16]
Principal	$ 47,112	[1],[9]			$ 46,121	[12],[18]
Cost	46,447	[1]			45,413	[12]
Fair Value	$ 44,520	[1]			$ 45,295	[12]
Investment, interest rate, paid in kind	8.50%	[1],[2],[3],[4],[5],[7]	8.50%	[1],[2],[3],[4],[5],[7]	8.50%	[11],[12],[13],[14],[15],[16]	8.50%	[11],[12],[13],[14],[15],[16]
Investment, Identifier [Axis]: SonicWall US Holdings Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[1],[2],[3],[4],[5],[7],[10]	7.50%	[11],[12],[13],[14],[15],[16],[17]	7.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.20%	[1],[10]	12.20%	[1],[10]	10.48%	[12],[17]	10.48%	[12],[17]
Principal	$ 3,195	[1],[9],[10]			$ 3,195	[12],[17],[18]
Cost	3,163	[1],[10]			3,163	[12],[17]
Fair Value	$ 2,971	[1],[10]			$ 2,997	[12],[17]
Investment, Identifier [Axis]: Sorenson Communications, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.50%		5.50%		5.50%		5.50%
Cash Interest Rate	10.23%		10.23%		9.17%		9.17%
Principal	$ 2,478				$ 2,553
Cost	2,454				2,528
Fair Value	$ 2,374				$ 2,454
Investment, Identifier [Axis]: Sorrento Therapeutics Inc, Common Stock Units
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	50,000	[2],[3],[4],[5],[7],[19]	50,000	[2],[3],[4],[5],[7],[19]	50,000	[11],[13],[14],[15],[16],[20]	50,000	[11],[13],[14],[15],[16],[20]
Cost	$ 197	[19]			$ 197	[20]
Fair Value	$ 44	[19]			$ 79	[20]
Investment, Identifier [Axis]: Spanx LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[6],[7],[10]	5.25%	[1],[2],[3],[4],[5],[6],[7],[10]	5.25%	[11],[12],[13],[14],[15],[16],[17],[21]	5.25%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	9.29%	[1],[6],[10]	9.29%	[1],[6],[10]	8.03%	[12],[17],[21]	8.03%	[12],[17],[21]
Principal	$ 330	[1],[6],[9],[10]			$ 866	[12],[17],[18],[21]
Cost	280	[1],[6],[10]			813	[12],[17],[21]
Fair Value	$ 260	[1],[6],[10]			$ 796	[12],[17],[21]
Investment, Identifier [Axis]: Spanx LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%	[1],[2],[3],[4],[5],[7],[10]	5.25%	[1],[2],[3],[4],[5],[7],[10]	5.25%	[11],[12],[13],[14],[15],[16],[17]	5.25%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	9.64%	[1],[10]	9.64%	[1],[10]	8.30%	[12],[17]	8.30%	[12],[17]
Principal	$ 4,523	[1],[9],[10]			$ 4,534	[12],[17],[18]
Cost	4,447	[1],[10]			4,455	[12],[17]
Fair Value	$ 4,415	[1],[10]			$ 4,427	[12],[17]
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.64%		9.64%		8.30%		8.30%
Principal	$ 8,910				$ 8,933
Cost	8,760				8,776
Fair Value	$ 8,699				$ 8,721
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5.25%		5.25%		5.25%		5.25%
Cash Interest Rate	9.64%		9.64%		8.30%		8.30%
Principal	$ 4,950				$ 4,962
Cost	4,867				4,876
Fair Value	$ 4,833				$ 4,845
Investment, Identifier [Axis]: SumUp Holdings Luxembourg SÀRL, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10],[19]	8.50%	[1],[2],[3],[4],[5],[7],[10],[19]	8.50%	[11],[12],[13],[14],[15],[16],[17],[20]	8.50%	[11],[12],[13],[14],[15],[16],[17],[20]
Cash Interest Rate	10.49%	[1],[10],[19]	10.49%	[1],[10],[19]	10%	[12],[17],[20]	10%	[12],[17],[20]
Principal	$ 16,911	[1],[9],[10],[19]					€ 16,911	[12],[17],[18],[20]
Cost	19,415	[1],[10],[19]			$ 19,414	[12],[17],[20]
Fair Value	$ 17,732	[1],[10],[19]			$ 16,360	[12],[17],[20]
Investment, Identifier [Axis]: Sunland Asphalt & Construction LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.15%	[1],[10]	11.15%	[1],[10]	8.88%	[12],[17]	8.88%	[12],[17]
Principal	$ 42,510	[1],[9],[10]			$ 42,618	[12],[17],[18]
Cost	41,624	[1],[10]			41,654	[12],[17]
Fair Value	$ 41,702	[1],[10]			$ 41,723	[12],[17]
Investment, Identifier [Axis]: Superior Industries International Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8%	[1],[2],[3],[4],[5],[7],[10]	8%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	12.32%	[10]	12.32%	[10]
Principal	$ 39,774	[10]
Cost	38,591	[1],[10]
Fair Value	$ 38,581	[1],[10]
Investment, Identifier [Axis]: Supermoose Borrower LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%	[2],[3],[4],[5],[7],[10]	3.75%	[2],[3],[4],[5],[7],[10]	3.75%	[11],[13],[14],[15],[16],[17]	3.75%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	8.48%	[10]	8.48%	[10]	7.42%	[17]	7.42%	[17]
Principal	$ 3,457	[9],[10]			$ 3,466	[17],[18]
Cost	3,162	[10]			3,141	[17]
Fair Value	$ 2,994	[10]			$ 3,056	[17]
Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.48%		8.48%		7.42%		7.42%
Principal	$ 7,723				$ 7,743
Cost	7,482				7,479
Fair Value	$ 6,688				$ 6,827
Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.48%		8.48%		7.42%		7.42%
Principal	$ 2,813				$ 2,820
Cost	2,714				2,712
Fair Value	$ 2,436				$ 2,487
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.05%		8.05%		6.51%		6.51%
Principal	$ 3,044				$ 3,377
Cost	3,034				3,365
Fair Value	$ 3,014				$ 3,213
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.05%		8.05%		6.51%		6.51%
Principal	$ 3,044				$ 3,377
Cost	3,034				3,365
Fair Value	$ 3,014				$ 3,213
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[1],[2],[3],[4],[5],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17]	6.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.14%	[1],[10]	11.14%	[1],[10]	9.81%	[12],[17]	9.81%	[12],[17]
Principal	$ 12,500	[1],[9],[10]			$ 12,500	[12],[17],[18]
Cost	12,476	[1],[10]			12,474	[12],[17]
Fair Value	$ 11,434	[1],[10]			$ 11,469	[12],[17]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	11.50%	[1],[2],[3],[4],[5],[7],[8],[19]	11.50%	[1],[2],[3],[4],[5],[7],[8],[19]	11.50%	[11],[12],[13],[14],[15],[16],[17],[20]	11.50%	[11],[12],[13],[14],[15],[16],[17],[20]
Principal	$ 4,984	[1],[8],[9],[19]			$ 4,984	[12],[18],[20],[26]
Cost	4,873	[1],[8],[19]			4,866	[12],[20],[26]
Fair Value	$ 4,847	[1],[8],[19]			$ 4,872	[12],[20],[26]
Investment, Identifier [Axis]: TIBCO Software Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%	[2],[3],[4],[5],[7],[10]	4.50%	[2],[3],[4],[5],[7],[10]	4.50%	[11],[13],[14],[15],[16],[17]	4.50%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	9.18%	[10]	9.18%	[10]	8.15%	[17]	8.15%	[17]
Principal	$ 12,032	[9],[10]			$ 12,032	[17],[18]
Cost	10,986	[10]			10,949	[17]
Fair Value	$ 10,775	[10]			$ 10,827	[17]
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	9.18%		9.18%		8.15%		8.15%
Principal	$ 6,256				$ 6,256
Cost	5,712				5,693
Fair Value	$ 5,602				$ 5,629
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	9.18%		9.18%		8.15%		8.15%
Principal	$ 2,654				$ 2,654
Cost	2,423				2,415
Fair Value	$ 2,377				$ 2,388
Investment, Identifier [Axis]: Tacala LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[2],[3],[4],[5],[7],[10]	7.50%	[2],[3],[4],[5],[7],[10]	7.50%	[11],[13],[14],[15],[16],[17]	7.50%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	11.88%	[10]	11.88%	[10]	10.62%	[17]	10.62%	[17]
Principal	$ 9,448	[9],[10]			$ 9,448	[17],[18]
Cost	9,343	[10]			9,338	[17]
Fair Value	$ 8,610	[10]			$ 8,692	[17]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	6%	[1],[2],[3],[4],[5],[6],[7],[10],[19]	6%	[11],[12],[13],[14],[15],[16],[17],[20],[21]	6%	[11],[12],[13],[14],[15],[16],[17],[20],[21]
Principal	$ 0	[1],[6],[9],[10],[19]			$ 0	[12],[17],[18],[20],[21]
Cost	(28)	[1],[6],[10],[19]			(29)	[12],[17],[20],[21]
Fair Value	$ (26)	[1],[6],[10],[19]			$ (28)	[12],[17],[20],[21]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10],[19]	6%	[1],[2],[3],[4],[5],[7],[10],[19]	6%	[11],[12],[13],[14],[15],[16],[17],[20]	6%	[11],[12],[13],[14],[15],[16],[17],[20]
Cash Interest Rate	10.29%	[1],[10],[19]	10.29%	[1],[10],[19]	8.68%	[12],[17],[20]	8.68%	[12],[17],[20]
Principal	$ 23,215	[1],[9],[10],[19]			$ 23,215	[12],[17],[18],[20]
Cost	22,833	[1],[10],[19]			22,815	[12],[17],[20]
Fair Value	$ 22,866	[1],[10],[19]			$ 22,843	[12],[17],[20]
Investment, Identifier [Axis]: Tecta America Corp, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[1],[2],[3],[4],[5],[7],[10]	8.50%	[11],[12],[13],[14],[15],[16],[17]	8.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.94%	[1],[10]	12.94%	[1],[10]	11.62%	[12],[17]	11.62%	[12],[17]
Principal	$ 5,203	[1],[9],[10]			$ 5,203	[12],[17],[18]
Cost	5,125	[1],[10]			5,125	[12],[17]
Fair Value	$ 4,982	[1],[10]			$ 5,034	[12],[17]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	9.75%	[1],[2],[3],[4],[5],[6],[7],[10]	9.75%	[1],[2],[3],[4],[5],[6],[7],[10]	9.25%	[11],[12],[13],[14],[15],[16],[17],[21]	9.25%	[11],[12],[13],[14],[15],[16],[17],[21]
Cash Interest Rate	13.67%	[1],[6],[10]	13.67%	[1],[6],[10]	12.20%	[12],[17]	12.20%	[12],[17]
Principal	$ 1,231	[1],[6],[9],[10]			$ 1,231	[12],[17],[18]
Cost	1,212	[1],[6],[10]			1,210	[12],[17]
Fair Value	$ 1,182	[1],[6],[10]			$ 1,187	[12],[17]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	9.75%	[1],[2],[3],[4],[5],[7],[10]	9.75%	[1],[2],[3],[4],[5],[7],[10]	9.25%	[11],[12],[13],[14],[15],[16],[17]	9.25%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	13.67%	[1],[10]	13.67%	[1],[10]	12.11%	[12],[17]	12.11%	[12],[17]
Principal	$ 18,276	[1],[9],[10]			$ 18,323	[12],[17],[18]
Cost	17,941	[1],[10]			17,956	[12],[17]
Fair Value	$ 17,765	[1],[10]			$ 17,865	[12],[17]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Common Units of TerSera Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	668,879	[1],[2],[3],[4],[5],[7]	668,879	[1],[2],[3],[4],[5],[7]	668,879	[11],[12],[13],[14],[15],[16]	668,879	[11],[12],[13],[14],[15],[16]
Cost	$ 2,028	[1]			$ 2,028	[12]
Fair Value	$ 4,662	[1]			$ 4,077	[12]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	9.50%	[1],[2],[3],[4],[5],[7],[10]	9.50%	[1],[2],[3],[4],[5],[7],[10]	9.50%	[11],[12],[13],[14],[15],[16],[17]	9.50%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	13.88%	[1],[10]	13.88%	[1],[10]	13.17%	[12],[17]	13.17%	[12],[17]
Principal	$ 29,663	[1],[9],[10]			$ 29,663	[12],[17],[18]
Cost	29,375	[1],[10]			29,352	[12],[17]
Fair Value	$ 29,057	[1],[10]			$ 29,031	[12],[17]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7.30%	[10],[11],[12],[13],[14],[15],[16]	7.30%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate					10.44%	[12],[17]	10.44%	[12],[17]
Principal					$ 15,674	[12],[17],[18]
Cost					15,605	[12],[17]
Fair Value					$ 15,682	[12],[17]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.30%	[1],[2],[3],[4],[5],[7],[10]	7.30%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	11.69%	[1],[10]	11.69%	[1],[10]
Principal	$ 15,301	[1],[9],[10]
Cost	15,279	[1],[10]
Fair Value	$ 15,391	[1],[10]
Investment, Identifier [Axis]: The Avery, Subordinated Debt in T8 Senior Mezz LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	12.50%	[1],[2],[3],[4],[5],[7],[10]	12.50%	[1],[2],[3],[4],[5],[7],[10]	12.50%	[10],[11],[12],[13],[14],[15],[16]	12.50%	[10],[11],[12],[13],[14],[15],[16]
Cash Interest Rate	17.24%	[1],[10]	17.24%	[1],[10]	16.17%	[12],[17]	16.17%	[12],[17]
Principal	$ 3,706	[1],[9],[10]			$ 3,789	[12],[17],[18]
Cost	3,701	[1],[10]			3,774	[12],[17]
Fair Value	$ 3,733	[1],[10]			$ 3,800	[12],[17]
Investment, Identifier [Axis]: Thrasio LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	11.17%	[1],[10]	11.17%	[1],[10]	11.17%	[12],[17]	11.17%	[12],[17]
Principal	$ 37,399	[1],[9],[10]			$ 37,494	[12],[17],[18]
Cost	36,532	[1],[10]			36,569	[12],[17]
Fair Value	$ 34,126	[1],[10]			$ 35,807	[12],[17]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	284,650.32	[1],[2],[3],[4],[5],[7]	284,650.32	[1],[2],[3],[4],[5],[7]	284,650.32	[11],[12],[13],[14],[15],[16]	284,650.32	[11],[12],[13],[14],[15],[16]
Cost	$ 2,409	[1]			$ 2,409	[12]
Fair Value	$ 1,882	[1]			$ 2,320	[12]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	8,434	[1],[2],[3],[4],[5],[7]	8,434	[1],[2],[3],[4],[5],[7]	8,434	[11],[12],[13],[14],[15],[16]	8,434	[11],[12],[13],[14],[15],[16]
Cost	$ 101	[1]			$ 101	[12]
Fair Value	$ 71	[1]			$ 69	[12]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series D Preferred Stock in Thrasio Holdings, Inc.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	48,352	[1],[2],[3],[4],[5],[7]	48,352	[1],[2],[3],[4],[5],[7]	48,352	[11],[12],[13],[14],[15],[16]	48,352	[11],[12],[13],[14],[15],[16]
Cost	$ 979	[1]			$ 979	[12]
Fair Value	$ 852	[1]			$ 979	[12]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series X Preferred Stock in Thrasio Holdings, Inc.
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	25,780	[1],[2],[3],[4],[5],[7]	25,780	[1],[2],[3],[4],[5],[7]	23,201	[11],[12],[13],[14],[15],[16],[21]	23,201	[11],[12],[13],[14],[15],[16],[21]
Cost	$ 25,564	[1],[6]			$ 22,986	[12],[21]
Fair Value	$ 29,070	[1],[6]			$ 26,487	[12],[21]
Investment, Identifier [Axis]: Touchstone Acquisition Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[2],[3],[4],[5],[7],[10]	6%	[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.38%	[1],[10]	10.38%	[1],[10]	9.12%	[12],[17]	9.12%	[12],[17]
Principal	$ 6,001	[1],[9],[10]			$ 6,016	[12],[17],[18]
Cost	5,897	[1],[10]			5,908	[12],[17]
Fair Value	$ 5,866	[1],[10]			$ 5,895	[12],[17]
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.38%		10.38%		9.12%		9.12%
Principal	$ 7,267				$ 7,285
Cost	7,142				7,155
Fair Value	$ 7,104				$ 7,140
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%		6%		6%		6%
Cash Interest Rate	10.38%		10.38%		9.12%		9.12%
Principal	$ 3,016				$ 3,024
Cost	2,964				2,970
Fair Value	$ 2,948				$ 2,963
Investment, Identifier [Axis]: Tranche A Warrant Shares, Tranche A Warrant Shares
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	56,999	[1],[2],[3],[4],[5],[7],[19]	56,999	[1],[2],[3],[4],[5],[7],[19]
Cost	$ 135	[1],[19]
Fair Value	$ 662	[1],[19]
Investment, Identifier [Axis]: Tribe Buyer LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	8.88%		8.88%		7.62%		7.62%
Principal	$ 1,578				$ 1,583
Cost	1,578				1,582
Fair Value	$ 987				$ 1,266
Investment, Identifier [Axis]: Trinitas CLO XV, Class E Notes, Class E Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.45%	[2],[3],[4],[5],[7],[10],[19]	7.45%	[2],[3],[4],[5],[7],[10],[19]
Cash Interest Rate	11.77%	[10],[19]	11.77%	[10],[19]
Principal	$ 1,000	[10],[19]
Cost	810	[10],[19]
Fair Value	$ 846	[10],[19]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	6.50%	[2],[3],[4],[5],[7],[19]	6.50%	[2],[3],[4],[5],[7],[19]	6.50%	[11],[13],[14],[15],[16],[20]	6.50%	[11],[13],[14],[15],[16],[20]
Principal	$ 4,500	[9],[19]			$ 4,500	[18],[20]
Cost	4,074	[19]			4,060	[20]
Fair Value	$ 2,990	[19]			$ 3,026	[20]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	4.75%	[2],[3],[4],[5],[7],[19]	4.75%	[2],[3],[4],[5],[7],[19]	4.75%	[11],[13],[14],[15],[16],[20]	4.75%	[11],[13],[14],[15],[16],[20]
Principal	$ 300	[9],[19]			$ 300	[18],[20]
Cost	260	[19]			258	[20]
Fair Value	$ 240	[19]			$ 238	[20]
Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	5%		5%		5%		5%
Cash Interest Rate	9.73%		9.73%		8.67%		8.67%
Principal	$ 6,354				$ 6,365
Cost	6,286				6,290
Fair Value	$ 4,515				$ 5,087
Investment, Identifier [Axis]: WP CPP Holdings LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%	[1],[2],[3],[4],[5],[7],[10]	3.75%	[1],[2],[3],[4],[5],[7],[10]	3.75%	[11],[13],[14],[15],[16],[17]	3.75%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	8.17%	[10]	8.17%	[10]	6.56%	[17]	6.56%	[17]
Principal	$ 7,545	[9],[10]			$ 7,564	[17],[18]
Cost	7,029	[10]			6,989	[17]
Fair Value	$ 6,598	[10]			$ 6,795	[17]
Investment, Identifier [Axis]: WP CPP Holdings LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.75%	[1],[2],[3],[4],[5],[7],[10]	7.75%	[1],[2],[3],[4],[5],[7],[10]	7.75%	[11],[12],[13],[14],[15],[16],[17]	7.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.17%	[1],[10]	12.17%	[1],[10]	10.56%	[12],[17]	10.56%	[12],[17]
Principal	$ 6,000	[1],[9],[10]			$ 6,000	[12],[17],[18]
Cost	5,866	[1],[10]			5,855	[12],[17]
Fair Value	$ 5,055	[1],[10]			$ 5,070	[12],[17]
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.17%		8.17%		6.56%		6.56%
Principal	$ 1,980				$ 1,985
Cost	1,913				1,910
Fair Value	$ 1,732				$ 1,783
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.75%		3.75%		3.75%		3.75%
Cash Interest Rate	8.17%		8.17%		6.56%		6.56%
Principal	$ 990				$ 993
Cost	956				955
Fair Value	$ 864				$ 892
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.75%		7.75%		7.75%		7.75%
Cash Interest Rate	12.17%		12.17%		10.56%		10.56%
Principal	$ 6,000				$ 6,000
Cost	5,974				5,972
Fair Value	$ 5,055				$ 5,070
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.75%		7.75%		7.75%		7.75%
Cash Interest Rate	12.17%		12.17%		10.56%		10.56%
Principal	$ 3,000				$ 3,000
Cost	2,987				2,986
Fair Value	$ 2,528				$ 2,534
Investment, Identifier [Axis]: WPEngine Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[1],[2],[3],[4],[5],[7],[10]	6%	[11],[12],[13],[14],[15],[16],[17]	6%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	10.19%	[1],[10]	10.19%	[1],[10]	10.19%	[12],[17]	10.19%	[12],[17]
Principal	$ 40,536	[1],[9],[10]			$ 40,536	[12],[17],[18]
Cost	39,991	[1],[10]			39,947	[12],[17]
Fair Value	$ 40,131	[1],[10]			$ 40,131	[12],[17]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					7%	[11],[12],[13],[14],[15],[16],[17]	7%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate					10.67%	[12],[17]	10.67%	[12],[17]
Principal					$ 5,000	[12],[17],[18]
Cost					4,925	[12],[17]
Fair Value					$ 4,538	[12],[17]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7%	[1],[2],[3],[4],[5],[7],[10]	7%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	11.73%	[1],[10]	11.73%	[1],[10]
Principal	$ 5,000	[1],[9],[10]
Cost	4,925	[1],[10]
Fair Value	$ 4,191	[1],[10]
Investment, Identifier [Axis]: Win Brands Group LLC, Class F Warrants in Brand Value Growth LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	3,621	[1],[2],[3],[4],[5],[7]	3,621	[1],[2],[3],[4],[5],[7]	3,621	[11],[12],[13],[14],[15],[16]	3,621	[11],[12],[13],[14],[15],[16]
Cost	$ 0	[1]			$ 0	[12]
Fair Value	$ 128	[1]			$ 192	[12]
Investment, Identifier [Axis]: Win Brands Group LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	15%	[1],[2],[3],[4],[5],[7],[10]	15%	[1],[2],[3],[4],[5],[7],[10]	15%	[11],[12],[13],[14],[15],[16],[17]	15%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	20.75%	[1],[10]	20.75%	[1],[10]	19.64%	[12],[17]	19.64%	[12],[17]
Principal	$ 2,238	[1],[9],[10]			$ 2,316	[12],[17],[18]
Cost	2,217	[1],[10]			2,293	[12],[17]
Fair Value	$ 2,137	[1],[10]			$ 2,264	[12],[17]
Investment, Identifier [Axis]: Windstream Services II LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%	[2],[3],[4],[5],[7],[10]	6.25%	[2],[3],[4],[5],[7],[10]	6.25%	[11],[13],[14],[15],[16],[17]	6.25%	[11],[13],[14],[15],[16],[17]
Cash Interest Rate	10.67%	[10]	10.67%	[10]	9.37%	[17]	9.37%	[17]
Principal	$ 25,432	[9],[10]			$ 25,499	[17],[18]
Cost	24,612	[10]			24,632	[17]
Fair Value	$ 23,131	[10]			$ 23,204	[17]
Investment, Identifier [Axis]: Windstream Services II LLC, Shares of Common Stock in Windstream Holdings II, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	18,032	[1],[2],[3],[4],[5],[7]	18,032	[1],[2],[3],[4],[5],[7]	18,032	[11],[12],[13],[14],[15],[16]	18,032	[11],[12],[13],[14],[15],[16]
Cost	$ 216	[1]			$ 216	[12]
Fair Value	$ 279	[1]			$ 296	[12]
Investment, Identifier [Axis]: Windstream Services II LLC, Warrants in Windstream Holdings II, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	109,420	[1],[2],[3],[4],[5],[7]	109,420	[1],[2],[3],[4],[5],[7]	109,420	[11],[12],[13],[14],[15],[16]	109,420	[11],[12],[13],[14],[15],[16]
Cost	$ 1,842	[1]			$ 1,842	[12]
Fair Value	$ 1,695	[1]			$ 1,799	[12]
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%		6.25%		6.25%		6.25%
Cash Interest Rate	10.67%		10.67%		9.37%		9.37%
Principal	$ 7,798				$ 7,818
Cost	7,587				7,596
Fair Value	$ 7,092				$ 7,115
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.25%		6.25%		6.25%		6.25%
Cash Interest Rate	10.67%		10.67%		9.37%		9.37%
Principal	$ 4,874				$ 4,886
Cost	4,742				4,747
Fair Value	$ 4,433				$ 4,447
Investment, Identifier [Axis]: Zayo Group Holdings Inc, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Cash Interest Rate	4%	[2],[3],[4],[5],[7]	4%	[2],[3],[4],[5],[7]	4%	[11],[13],[14],[15],[16]	4%	[11],[13],[14],[15],[16]
Principal	$ 250	[9]			$ 250	[18]
Cost	214				212
Fair Value	$ 185				$ 201
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3%		3%		3%		3%
Cash Interest Rate	7.38%		7.38%		6.12%		6.12%
Principal	$ 2,155				$ 2,155
Cost	2,009				2,000
Fair Value	$ 1,756				$ 1,812
Investment, Identifier [Axis]: Zep Inc, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.25%	[1],[2],[3],[4],[5],[7],[17]	8.25%	[1],[2],[3],[4],[5],[7],[17]	8.25%	[11],[12],[13],[14],[15],[16],[17]	8.25%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate	12.98%	[1],[10]	12.98%	[1],[10]	11.92%	[12],[17]	11.92%	[12],[17]
Principal	$ 19,578	[1],[9],[10],[17]			$ 19,578	[12],[17],[18]
Cost	19,545	[1],[10],[17]			19,542	[12],[17]
Fair Value	$ 13,704	[1],[10],[17]			$ 16,152	[12],[17]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.50%	[1],[2],[3],[4],[5],[7],[17],[19]	7.50%	[1],[2],[3],[4],[5],[7],[17],[19]	7.50%	[11],[12],[13],[14],[15],[16],[17],[20]	7.50%	[11],[12],[13],[14],[15],[16],[17],[20]
Cash Interest Rate	10.96%	[1],[10],[19]	10.96%	[1],[10],[19]	9.72%	[12],[17],[20]	9.72%	[12],[17],[20]
Principal	$ 18,000	[1],[9],[10],[17],[19]			$ 18,000	[12],[17],[18],[20]
Cost	23,839	[1],[10],[17],[19]			23,804	[12],[17],[20]
Fair Value	$ 16,369	[1],[10],[17],[19]			$ 16,552	[12],[17],[20]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc.,
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares					18,635	[11],[12],[13],[14],[15],[16]	18,635	[11],[12],[13],[14],[15],[16]
Cash Interest Rate					10.75%	[11],[12],[13],[14],[15],[16]	10.75%	[11],[12],[13],[14],[15],[16]
Cost					$ 18,264	[12]
Fair Value					$ 16,575	[12]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	18,635	[1],[2],[3],[4],[5],[7]	18,635	[1],[2],[3],[4],[5],[7]
Cash Interest Rate	10.75%	[1],[2],[3],[4],[5],[7]	10.75%	[1],[2],[3],[4],[5],[7]
Cost	$ 18,264	[1]
Fair Value	$ 15,606	[1]
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Delayed Draw Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.50%		3.50%
Cash Interest Rate	7.82%		7.82%
Principal	$ 109
Cost	74
Fair Value	$ 68
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.50%		3.50%
Cash Interest Rate	7.82%		7.82%
Principal	$ 2,558
Cost	2,353
Fair Value	$ 2,316
Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	8.88%		8.88%		7.62%		7.62%
Principal	$ 7,811				$ 7,331
Cost	7,681				7,258
Fair Value	$ 6,915				$ 6,859
Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	4.50%		4.50%		4.50%		4.50%
Cash Interest Rate	8.88%		8.88%		7.62%		7.62%
Principal	$ 2,438				$ 2,444
Cost	2,413				2,419
Fair Value	$ 2,158				$ 2,286
Investment, Identifier [Axis]: iCIMs Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17],[21]	6.75%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	0	[1],[6],[10]			0	[12],[17],[21]
Fair Value	$ 0	[1],[6],[10]			$ 0	[12],[17],[21]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[1],[2],[3],[4],[5],[6],[7],[10]	6.75%	[11],[12],[13],[14],[15],[16],[17],[21]	6.75%	[11],[12],[13],[14],[15],[16],[17],[21]
Principal	$ 0	[1],[6],[9],[10]			$ 0	[12],[17],[18],[21]
Cost	(30)	[1],[6],[10]			(31)	[12],[17],[21]
Fair Value	$ (75)	[1],[6],[10]			$ (32)	[12],[17],[21]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate					6.75%	[11],[12],[13],[14],[15],[16],[17]	6.75%	[11],[12],[13],[14],[15],[16],[17]
Cash Interest Rate					9.49%	[12],[17]	9.49%	[12],[17]
Principal					$ 19,203	[12],[17],[18]
Cost					18,874	[12],[17]
Fair Value					$ 18,867	[12],[17]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	3.375%	[1],[2],[3],[4],[5],[7],[10]	3.375%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	7.14%	[1],[10]	7.14%	[1],[10]
Principal	$ 19,203	[1],[9],[10]
Cost	18,888	[1],[10]
Fair Value	$ 18,420	[1],[10]
Investment, interest rate, paid in kind	3.875%	[1],[2],[3],[4],[5],[7],[10]	3.875%	[1],[2],[3],[4],[5],[7],[10]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	7.25%	[1],[2],[3],[4],[5],[7],[10]	7.25%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	11.52%	[1],[10]	11.52%	[1],[10]
Principal	$ 2,944	[1],[10]
Cost	2,895	[1],[10]
Fair Value	$ 2,885	[1],[10]
Investment, Identifier [Axis]: scPharmaceuticals Inc, Common Stock Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	53,700	[1],[2],[3],[4],[5],[7]	53,700	[1],[2],[3],[4],[5],[7]
Cost	$ 175	[1]
Fair Value	$ 262	[1]
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[6],[7],[10]	8.75%	[1],[2],[3],[4],[5],[6],[7],[10]
Principal	$ 0	[1],[6],[10]
Cost	0	[1],[6],[10]
Fair Value	$ 0	[1],[6],[10]
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	8.75%	[1],[2],[3],[4],[5],[7],[10]	8.75%	[1],[2],[3],[4],[5],[7],[10]
Cash Interest Rate	11.75%	[1],[10]	11.75%	[1],[10]
Principal	$ 5,212	[1],[9],[10]
Cost	4,945	[1],[10]
Fair Value	$ 4,957	[1],[10]
[1] As of December 31, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

Portfolio Investments - Summari

Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 2,642,870	$ 2,494,111
Cash and cash equivalents	17,382	23,528
Restricted cash	1,863	2,836
Other assets	4,210	1,665
Total assets	2,767,260	2,646,313
Credit facilities payable	860,000	700,000
Total liabilities	1,565,271	1,400,750
Total liabilities and net assets	2,767,260	2,646,313
Investment owned, at cost	2,778,014	2,617,754
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	355,427	359,625
Cash and cash equivalents	39,259	14,274
Restricted cash	6,612	5,642
Other assets	8,106	5,686
Total assets	409,404	385,227
Credit facilities payable	226,000	230,000
Notes payable at fair value	128,750	110,000
Other liabilities	27,094	21,539
Total liabilities	381,844	361,539
Members' equity	27,560	23,688
Total liabilities and net assets	409,404	385,227
Investment owned, at cost	380,682	382,673
Net proceeds	128,750	110,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	123,339	133,144
Cash and cash equivalents	9,777	7,021
Restricted cash	1,747	1,788
Other assets	2,592	4,855
Total assets	137,455	146,808
Credit facilities payable	76,082	82,082
Notes payable at fair value	56,614	57,463
Other liabilities	4,759	7,263
Total liabilities	137,455	146,808
Members' equity	0	0
Total liabilities and net assets	137,455	146,808
Investment owned, at cost	131,077	140,083
Net proceeds	$ 67,485	$ 68,185

Portfolio Investments - Summa_2

Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Investment Company, Nonconsolidated Subsidiary [Line Items]
Total investment income	$ 79,179	$ 64,941
Interest expense	20,719	9,400
Total expenses	41,043	30,088
Net investment income before taxes	38,886	35,603
Net increase (decrease) in net assets resulting from operations	13,172	39,408
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	3,403	2,160
Fee income	0	0
Total investment income	3,403	2,160
Other expenses	53	39
Total expenses	2,662	1,367
Net investment income before taxes	741	793
Net unrealized appreciation (depreciation)	(651)	(882)
Realized gain (loss)	(90)	89
Net increase (decrease) in net assets resulting from operations	0	0
OCSI Glick JV LLC | Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	1,285	510
OCSI Glick JV LLC | Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	1,324	818
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	8,781	5,423
Fee income	0	11
Total investment income	8,781	5,434
Other expenses	69	79
Total expenses	6,760	3,842
Net investment income before taxes	2,021	1,592
Net unrealized appreciation (depreciation)	(2,207)	(525)
Realized gain (loss)	(992)	374
Net increase (decrease) in net assets resulting from operations	(1,178)	1,441
SLF JV I | Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	3,709	1,514
SLF JV I | SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	$ 2,982	$ 2,249

Fee Income (Details)

Fee Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Fee income	$ 2,021	$ 912
Recurring fee income	$ 200	$ 200

Share Data and Net Assets - Sch

Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations		$ 13,172	$ 39,408
Weighted average common shares outstanding - basic (shares)	[1]	61,142,000	60,127,000
Weighted average common shares outstanding - diluted (shares)	[1]	61,142,000	60,127,000
Earnings (loss) per common share - basic (dollars per share)	[1]	$ 0.22	$ 0.66
Earnings (loss) per common share - diluted (dollars per share)	[1]	$ 0.22	$ 0.66
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Share Data and Net Assets - S_2

Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands		3 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)		61,125,000
Net assets at beginning of period		$ 1,245,563	$ 1,312,823
Net investment income		38,808	32,295
Net unrealized appreciation (depreciation)		(22,982)	(4,586)
Net realized gains (losses)		(3,203)	9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)		549	2,378
Net increase (decrease) in net assets from stockholder transactions		$ (58,679)	$ (27,956)
Issuance of common stock under dividend reinvestment plan (shares)	35,990,000	94,879,000	35,990,000
Issuance of common stock under dividend reinvestment plan	$ 800	$ 1,933	$ 786
End of period (shares)		61,220,000
Net assets at end of period	$ 1,325,061	$ 1,201,989	$ 1,325,061
Common Stock
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)		61,125,000	60,120,000
Net assets at beginning of period		$ 611	$ 601
Issuance of common stock under dividend reinvestment plan (shares)		95,000	36,000
Issuance of common stock under dividend reinvestment plan		$ 1	$ 1
End of period (shares)	60,156,000	61,220,000	60,156,000
Net assets at end of period	$ 602	$ 612	$ 602
Additional paid-in-capital
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period		1,827,721	1,805,557
Issuance of common stock under dividend reinvestment plan		1,932	785
Net assets at end of period	1,806,342	1,829,653	1,806,342
Accumulated Overdistributed Earnings
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period		(582,769)	(493,335)
Net investment income		38,808	32,295
Net unrealized appreciation (depreciation)		(22,982)	(4,586)
Net realized gains (losses)		(3,203)	9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)		549	2,378
Net increase (decrease) in net assets from stockholder transactions		(58,679)	(27,956)
Issuance of common stock under dividend reinvestment plan		0	0
Net assets at end of period	$ (481,883)	$ (628,276)	$ (481,883)

Share Data and Net Assets - S_3

Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Investment Company, Changes in Net Assets [Line Items]
Amount per share (dollars per share)		$ 0.465	$ 0.96	$ 0.465
Distributions to stockholders		$ 27,200	$ 56,800	$ 27,200
Issuance of common stock under dividend reinvestment plan (shares)		35,990,000	94,879,000	35,990,000
Issuance of common stock under dividend reinvestment plan		$ 800	$ 1,933	$ 786
Quarterly
Investment Company, Changes in Net Assets [Line Items]
Amount per share (dollars per share)	$ 0.54
Distributions to stockholders	$ 32,000
Issuance of common stock under dividend reinvestment plan (shares)	53,369,000
Issuance of common stock under dividend reinvestment plan	$ 1,100
Special
Investment Company, Changes in Net Assets [Line Items]
Amount per share (dollars per share)	$ 0.42
Distributions to stockholders	$ 24,800
Issuance of common stock under dividend reinvestment plan (shares)	41,510,000
Issuance of common stock under dividend reinvestment plan	$ 800

Share Data and Net Assets - Nar

Share Data and Net Assets - Narrative (Details) - USD ($) $ in Millions			3 Months Ended
	Feb. 07, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Issuance of common stock under dividend reinvestment plan (shares)		35,990,000	94,879,000	35,990,000
Aggregate offering price	$ 125

Borrowings (Details)

Borrowings (Details) - USD ($) $ in Thousands			3 Months Ended
	May 18, 2021	Feb. 25, 2020	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022
Line of Credit Facility [Line Items]
Borrowings outstanding			$ 860,000		$ 700,000
Asset coverage ratio			176.31%	200.81%
Interest rate swap
Line of Credit Facility [Line Items]
Interest rate			2.70%		2.70%
Floating interest rate			1.658%		1.658%
Notional amount			$ 350,000		$ 350,000
Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate	2.70%
Notional amount	$ 350,000
London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Interest rate			2%
London Interbank Offered Rate (LIBOR) | Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate	1.658%
Base Rate
Line of Credit Facility [Line Items]
Interest rate			1%
2025 Notes
Line of Credit Facility [Line Items]
Principal amount		$ 300,000	$ 300,000		300,000
Net proceeds		293,800
Unaccreted discount		2,500	$ 1,100		1,200
Underwriting commissions		3,000
Offering costs		$ 700
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)		3.50%	3.50%
Redemption price		100%
2027 Notes
Line of Credit Facility [Line Items]
Principal amount	$ 350,000		$ 350,000		350,000
Net proceeds	344,800
Unaccreted discount	1,000		$ 700		700
Underwriting commissions	3,500
Offering costs	$ 700
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	2.70%		2.70%
Redemption price	100%
Line of Credit | Revolving Credit Facility | Syndicated Facility
Line of Credit Facility [Line Items]
Borrowing capacity			$ 1,000,000
Accordion feature, increase limit			1,250,000
Borrowings outstanding			695,000		540,000
Fair value			$ 695,000		540,000
Weighted average interest rate			5.849%	2.174%
Interest expense inclusive of fees			$ 10,000	$ 3,800
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold			1.50
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold			2.25
Line of Credit | Revolving Credit Facility | Citibank Facility
Line of Credit Facility [Line Items]
Borrowing capacity			$ 200,000
Borrowings outstanding			165,000		160,000
Fair value			$ 165,000		$ 160,000
Weighted average interest rate			6.508%		1.83%
Interest expense inclusive of fees			$ 2,700	$ 800
Unused capacity, commitment fee			0.50%
Asset coverage ratio			150%
Line of Credit | Revolving Credit Facility | Citibank Facility, Broadly Syndicated Loans | London Interbank Offered Rate (LIBOR) | Minimum
Line of Credit Facility [Line Items]
Interest rate			1.25%
Line of Credit | Revolving Credit Facility | Citibank Facility, Broadly Syndicated Loans | London Interbank Offered Rate (LIBOR) | Maximum
Line of Credit Facility [Line Items]
Interest rate			2.20%
Line of Credit | Revolving Credit Facility | Citibank Facility, Other Eligible Loans | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Interest rate			2.25%

Borrowings - Components of the

Borrowings - Components of the Carrying Value of Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	May 18, 2021	Feb. 25, 2020
Debt Instrument [Line Items]
Unamortized financing costs	$ (4,650)	$ (5,020)
Net carrying value	1,463,624	1,301,043
2025 Notes
Debt Instrument [Line Items]
Principal amount	300,000	300,000		$ 300,000
Unamortized financing costs	(1,600)	(1,800)
Unaccreted discount	(1,100)	(1,200)		$ (2,500)
Interest rate swap fair value adjustment	0	0
Net carrying value	297,300	297,000
Fair Value	286,700	283,100
2027 Notes
Debt Instrument [Line Items]
Principal amount	350,000	350,000	$ 350,000
Unamortized financing costs	(3,100)	(3,200)
Unaccreted discount	(700)	(700)	$ (1,000)
Interest rate swap fair value adjustment	(39,900)	(42,000)
Net carrying value	306,300	304,100
Fair Value	$ 296,800	$ 294,000

Borrowings - Components of Inte

Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Effect of interest rate swap	$ 2.5	$ (0.7)
2025 Notes
Debt Instrument [Line Items]
Coupon interest	2.6	2.6
Amortization of financing costs and discount	0.3	0.3
Total interest expense	$ 2.9	$ 2.9
Coupon interest rate	3.50%	3.50%
2027 Notes
Debt Instrument [Line Items]
Coupon interest	$ 2.4	$ 2.4
Amortization of financing costs and discount	0.2	0.2
Total interest expense	$ 5.1	$ 1.9
Coupon interest rate	5.586%	1.782%

Taxable_Distributable Income _3

Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net	$ 523,700
Valuation allowance	11,400
Deferred tax assets	13,100
Deferred tax asset, net	1,722		$ 1,687
Provision (benefit) for taxes on net investment income	0	$ 3,308
(Provision) benefit for taxes on realized and unrealized gains (losses)	(549)	(2,378)
Income tax expense (benefit)		(1,400)
Deferred taxes	35	$ 959
Cost of investments			2,654,300
Unrealized appreciation			466,900
Unrealized depreciation			620,000
Unrealized appreciation (depreciation)			$ 153,100
Short-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net	64,500
Long-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net	$ 459,200

Taxable_Distributable Income _4

Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Net increase (decrease) in net assets resulting from operations	$ 13,172	$ 39,408
Net unrealized (appreciation) depreciation	22,982	4,586
Book/tax difference due to organizational costs	0	(22)
Book/tax difference due to capital losses utilized	8,013	(10,531)
Other book/tax differences	(12,910)	(11,171)
Taxable/Distributable Income	$ 31,257	$ 22,270

Taxable_Distributable Income _5

Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Undistributed ordinary income, net		$ (43,624)
Net realized capital losses		473,274
Unrealized losses, net		153,119
Accumulated overdistributed earnings	$ 628,276	$ 582,769

Realized Gains or Losses and _3

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (3,203)	$ 9,321
Net unrealized appreciation (depreciation)	(22,982)	(4,586)
Investments in debt securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(18,700)	1,800
Investments in equity securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	2,800	2,800
Exited Investments
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	3,900	4,700
Foreign currency forward contracts
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	$ (11,000)	$ 800

Realized Gains or Losses and _4

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (3,203)	$ 9,321
Foreign currency forward contracts
Schedule of Investments [Line Items]
Net realized gains (losses)	4,400	3,000
OmniSYS Acquisition Corporation
Schedule of Investments [Line Items]
Net realized gains (losses)	(2,800)	2,000
First Star Speir Aviation Limited
Schedule of Investments [Line Items]
Net realized gains (losses)	(2,100)	1,900
TigerConnect, Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,000)
Other Investments, Net
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (1,700)	$ 2,400

Related Party Transactions (Det

Related Party Transactions (Details)			3 Months Ended
	Mar. 19, 2021 USD ($)	May 03, 2019	Dec. 31, 2022 USD ($) component	Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)
Related Party Transaction [Line Items]
Base management fee and incentive fee payable			$ 16,871,000	$ 15,900,000	$ 15,940,000
Related party transaction, termination, notice period			60 days
Base management fee rate		1%	1.50%
Base management fee, threshold		200%
Base management fee			$ 9,917,000	9,952,000
Part I incentive fee			7,703,000	6,457,000
Administrator expense			400,000	500,000
General and administrative expenses			100,000	100,000
Due to affiliate			$ 3,260,000		$ 3,180,000
Oaktree Strategic Income Corporation Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived	$ 6,000,000
Contractual fee waived, period otherwise receivable	2 years
Contractual fee waived, per quarter	$ 750,000
Oaktree Strategic Income II, Inc. Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived	9,000,000
Oaktree Strategic Income II, Inc Merger, Year One
Related Party Transaction [Line Items]
Investment company, contractual fee waived	6,000,000
Contractual fee waived, per quarter	1,500,000
Oaktree Strategic Income II, Inc Merger, Year Two
Related Party Transaction [Line Items]
Investment company, contractual fee waived	3,000,000
Contractual fee waived, per quarter	$ 750,000
Investment Advisory Agreement
Related Party Transaction [Line Items]
Number of components | component			2
Related party transaction, termination, notice period			60 days
Base management fee			$ 9,200,000	9,200,000
Management incentive rate			1.50%
Part I incentive fee			$ 7,700,000	6,500,000
Incentive fee expense			$ 9,600,000
Incentive fee payable				$ 1,800,000
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up
Related Party Transaction [Line Items]
Management incentive rate			100%
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold
Related Party Transaction [Line Items]
Management incentive rate			1.8182%
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income
Related Party Transaction [Line Items]
Management incentive rate			17.50%
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains
Related Party Transaction [Line Items]
Management incentive rate			17.50%

Financial Highlights (Details)

Financial Highlights (Details) $ / shares in Units, $ in Thousands				3 Months Ended
		Jan. 20, 2023 shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Investment Company, Financial Highlights [Roll Forward]
Net asset value per share at beginning of period (dollars per share)				$ 20.38	$ 21.84
Net investment income per common share - basic and diluted (dollars per share)	[1]			0.63	0.54
Net unrealized appreciation (depreciation) (dollars per share)				(0.38)	(0.08)
Net realized gains (losses) (dollars per share)				(0.05)	0.16
(Provision) benefit for taxes on realized and unrealized gains (losses) (dollars per share)				0.01	0.04
Amount per share (dollars per share)			$ (0.465)	(0.96)	(0.465)
Net asset value per share at end of period (dollars per share)			22.03	19.63	22.03
Per share market value at beginning of period (dollars per share)				18	21.18
Per share market value at end of period (dollars per share)			$ 22.38	$ 20.61	$ 22.38
Total return				19.90%	7.92%
Common shares outstanding at beginning of period (shares) | shares				61,125,000	60,120,000
Common shares outstanding at end of period (shares) | shares			60,156,000	61,220,000	60,156,000
Net assets at beginning of period | $				$ 1,245,563	$ 1,312,823
Net assets at end of period | $			$ 1,325,061	1,201,989	1,325,061
Average net assets | $				$ 1,241,806	$ 1,327,934
Ratio of net investment income to average net assets				12.40%	9.65%
Ratio of total expenses to average net assets				13.11%	8.99%
Ratio of net expenses to average net assets				12.87%	8.77%
Ratio of portfolio turnover to average investments at fair value				4.24%	9.14%
Weighted average outstanding debt | $				$ 1,441,326	$ 1,331,141
Average debt per share (dollars per share)				$ 23.57	$ 22.14
Asset coverage ratio			200.81%	176.31%	200.81%
Subsequent Event
Investment Company, Financial Highlights [Roll Forward]
Common shares outstanding at end of period (shares) | shares		61,219,605
Stock split, conversion ratio		0.0033
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Due from broker	$ 39,760	$ 45,530

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross Amount of Recognized Assets		$ 6,789
Gross Amount of Recognized Liabilities	$ (4,211)	6,789
Interest rate swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	350,000	350,000
Gross Amount of Recognized Liabilities	39,928	41,969
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 9, 2023 | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	46,412
Notional Amount to be Sold	39,965
Gross Amount of Recognized Liabilities	(1,712)
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022 | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased		45,692
Notional Amount to be Sold		37,033
Gross Amount of Recognized Assets		4,323
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 19, 2022, 2 | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased		45,692
Notional Amount to be Sold		37,033
Gross Amount of Recognized Liabilities		4,323
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 9, 2023 | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	44,825
Notional Amount to be Sold	44,224
Gross Amount of Recognized Liabilities	$ (2,499)
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022 | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased		43,179
Notional Amount to be Sold		41,444
Gross Amount of Recognized Assets		2,466
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022, 1 | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased		43,179
Notional Amount to be Sold		41,444
Gross Amount of Recognized Liabilities		$ 2,466

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 198,868	$ 224,239
Debt and Equity Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	171,800	175,200
JV Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 27,100	$ 49,000

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Unfunded Commitments by Investment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 198,868	$ 224,239
Investment, Identifier [Axis]: 107 Fair Street LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,322	0
Investment, Identifier [Axis]: 109 Montgomery Owner LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	477
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,174	0
Investment, Identifier [Axis]: ADC Therapeutics SA
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,020	3,020
Investment, Identifier [Axis]: Accupac, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,197	4,605
Investment, Identifier [Axis]: Acquia Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	923	1,326
Investment, Identifier [Axis]: Apptio, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	892	1,338
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	4,372
Investment, Identifier [Axis]: Assembled Brands Capital LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,035	2,008
Investment, Identifier [Axis]: Avalara, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,147	0
Investment, Identifier [Axis]: BAART Programs, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,675	8,645
Investment, Identifier [Axis]: Berner Food & Beverage, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,197	1,392
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	11,785	11,785
Investment, Identifier [Axis]: CorEvitas, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,526	915
Investment, Identifier [Axis]: Coyote Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,333	1,333
Investment, Identifier [Axis]: Delta Leasing SVP II LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	23,004	27,187
Investment, Identifier [Axis]: Dialyze Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	3,431
Investment, Identifier [Axis]: Digital AI Software Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	826	826
Investment, Identifier [Axis]: Dominion Diagnostics, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	11,148	11,148
Investment, Identifier [Axis]: Establishment Labs Holdings Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,384	5,075
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	15,995	22,150
Investment, Identifier [Axis]: GKD Index Partners, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	320	320
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,293	4,293
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,195	4,195
Investment, Identifier [Axis]: Kings Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,208	1,537
Investment, Identifier [Axis]: LSL Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	427
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,115	1,115
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,229	1,429
Investment, Identifier [Axis]: MRI Software LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,427	5,196
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,734	5,734
Investment, Identifier [Axis]: Mesoblast, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,553	3,553
Investment, Identifier [Axis]: Mindbody, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,000	4,000
Investment, Identifier [Axis]: OCSI Glick JV LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,998	13,998
Investment, Identifier [Axis]: OTG Management, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,789	3,789
Investment, Identifier [Axis]: PFNY Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	275	1,527
Investment, Identifier [Axis]: PRGX Global, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,518	2,518
Investment, Identifier [Axis]: Pluralsight, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,766	3,532
Investment, Identifier [Axis]: Relativity ODA LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,218	2,218
Investment, Identifier [Axis]: RumbleOn, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,822	4,822
Investment, Identifier [Axis]: SCP Eye Care Services, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,356	0
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,171	0
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,125	35,000
Investment, Identifier [Axis]: Spanx, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,762	2,226
Investment, Identifier [Axis]: Tahoe Bidco B.V.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,741	1,741
Investment, Identifier [Axis]: Telestream Holdings Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	528	528
Investment, Identifier [Axis]: Thrasio, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,578
Investment, Identifier [Axis]: iCIMs, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,930	6,930
Investment, Identifier [Axis]: scPharmaceuticals Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 5,212	$ 0

Subsequent Events (Details)

Subsequent Events (Details) $ / shares in Units, $ in Thousands	May 26, 2023	Jan. 27, 2023 $ / shares	Jan. 23, 2023 USD ($) shares	Jan. 20, 2023 shares	Mar. 19, 2021 USD ($)	Dec. 31, 2022 USD ($) shares	Sep. 30, 2022 USD ($) shares	Dec. 31, 2021 shares	Sep. 30, 2021 shares
Subsequent Event [Line Items]
Common shares outstanding at end of period (shares) | shares						61,220,000	61,125,000	60,156,000	60,120,000
Credit facilities payable						$ 860,000	$ 700,000
Oaktree Strategic Income II, Inc. Merger
Subsequent Event [Line Items]
Investment company, contractual fee waived					$ 9,000
Subsequent Event
Subsequent Event [Line Items]
Common stock, dividends, per share, declared (in dollars per share) | $ / shares		$ 0.55
Common shares outstanding at end of period (shares) | shares			77,079,805	61,219,605
Stock split, conversion ratio				0.0033
Subsequent Event | OSI2 Merger
Subsequent Event [Line Items]
Consideration transferred, per share (in shares) | shares			0.9115
Number of shares issued (in shares) | shares			15,860,200
Subsequent Event | OSI2 Citibank Facility | Line of Credit | Revolving Credit Facility
Subsequent Event [Line Items]
Borrowing capacity			$ 250,000
Debt instrument, basis spread, variable rate			1.85%
Commitment fee, unused capacity threshold percentage			30%
Credit facilities payable			$ 225,000
Unused capacity, commitment fee			0.50%
Subsequent Event | OSI2 Citibank Facility | Line of Credit | Revolving Credit Facility | Forecast
Subsequent Event [Line Items]
Debt instrument, basis spread, variable rate	3%
Subsequent Event | OSI2 Citibank Facility, Syndicated Loans | Line of Credit | Revolving Credit Facility
Subsequent Event [Line Items]
Debt instrument, basis spread, variable rate			1.65%
Subsequent Event | OSI2 Citibank Facility, All Other Loans | Line of Credit | Revolving Credit Facility
Subsequent Event [Line Items]
Debt instrument, basis spread, variable rate			2.25%
Subsequent Event | Oaktree Strategic Income II, Inc. Merger
Subsequent Event [Line Items]
Investment company, contractual fee waived			$ 9,000

Schedule_12-14 - Schedule of In

Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Dec. 31, 2022		Dec. 31, 2021	Sep. 30, 2022
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
% of Total Net Assets		219.87%	[1],[2],[3],[4],[5]		200.24%	[6],[7],[8],[9],[10]
Control & Affiliate Investments
Schedule of Investments [Line Items]
Principal		$ 207,466		$ 196,670
Net Realized Gain (Loss)		0		1,868
Amount of Interest, Fees or Dividends Credited in Income		6,276		7,748
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		240,361		289,054
Gross Additions		22,330		5,074
Gross Reductions		(7,056)		(16,539)
Fair Value, Ending Balance		$ 255,635		$ 277,589
% of Total Net Assets		21.20%		21%
Control Investments
Schedule of Investments [Line Items]
Investment owned, ownership percentage	[6],[7],[8],[9],[10],[11],[12]				17.20%
Principal		$ 186,002		$ 180,688
Net Realized Gain (Loss)		0		1,868
Amount of Interest, Fees or Dividends Credited in Income		5,630		7,409
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		214,165		270,765
Gross Additions		22,255		1,555
Gross Reductions		(3,958)		(12,851)
Fair Value, Ending Balance		$ 232,462		$ 259,469
% of Total Net Assets		19.30%	[1],[2],[3],[4],[5],[13]	19.60%
Affiliate Investments
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10],[11],[12]				2.10%
Principal		$ 21,464		$ 15,982
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		646		339
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		26,196		18,289
Gross Additions		75		3,519
Gross Reductions		(3,098)		(3,688)
Fair Value, Ending Balance		$ 23,173		$ 18,120
% of Total Net Assets		1.90%	[1],[2],[3],[4],[5],[13]	1.40%
Investment, Identifier [Axis]: - Van Houten Real LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate	[1],[2],[3],[4],[5],[13],[14],[15]	12%
Investment, Identifier [Axis]: ADB Companies LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	6.25%	[1],[2],[3],[4],[5],[13]		6.25%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		11.34%	[12],[13]		9.80%	[11],[16]
Investment, Identifier [Axis]: ADC Therapeutics SA, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		28,948	[1],[2],[3],[4],[5],[13],[17]		28,948	[6],[7],[8],[9],[10],[11],[18]
Investment owned, exercise price (in dollars per share)		$ 8.297	[1],[2],[3],[4],[5],[13],[17]		$ 8.297	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7.50%	[1],[2],[3],[4],[5],[13],[14],[17]		7.50%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7.50%	[1],[2],[3],[4],[5],[13],[17]		7.50%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		12.23%	[12],[13],[17]		11.20%	[11],[16],[18]
Investment, Identifier [Axis]: AI Sirona Luxembourg Acquisition Sarl, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7.25%	[1],[2],[3],[4],[5],[13],[17]		7.25%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		9.15%	[12],[13],[17]		7.94%	[11],[16],[18]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Common Units in RD Holding LP
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		14,410	[1],[2],[3],[4],[5],[13]		14,410	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: AIP RD Buyer Corp, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7.75%	[1],[2],[3],[4],[5],[13]		7.75%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		12.17%	[12],[13]		10.88%	[11],[16]
Investment, Identifier [Axis]: AMMC CLO 27, Class E Notes, Class E Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[17]	8.89%
Cash Interest Rate	[12]	13.49%
Investment, Identifier [Axis]: APX Group Inc, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		5.75%	[1],[2],[3],[4],[5],[17]		5.75%	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10]				7.50%
Investment, Identifier [Axis]: ASP Unifrax Holdings Inc, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10]				5.25%
Investment, Identifier [Axis]: AT Holdings II Ltd, First Lien Revenue Interest Financing Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate	[1],[2],[3],[4],[5],[13],[17]	14.25%
Investment, Identifier [Axis]: Access CIG LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7.75%	[1],[2],[3],[4],[5],[13]		7.75%	[6],[7],[8],[9],[10]
Cash Interest Rate		11.82%	[12]		10.82%	[16]
Investment, Identifier [Axis]: Accupac Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.50%	[1],[2],[3],[4],[5],[13],[14]		5.50%	[6],[7],[8],[9],[10],[11],[19]
Investment, Identifier [Axis]: Accupac Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.50%	[1],[2],[3],[4],[5],[13],[14]		5.50%	[6],[7],[8],[9],[10],[11],[19]
Cash Interest Rate		10.17%	[12],[13],[14]		9.14%	[11],[16],[19]
Investment, Identifier [Axis]: Accupac Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.50%	[1],[2],[3],[4],[5],[13]		5.50%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		10.16%	[12],[13]		9.12%	[11],[16]
Investment, Identifier [Axis]: Acquia Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7%	[1],[2],[3],[4],[5],[13],[14]		7%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		12.18%	[12],[13],[14]		10.64%	[11],[16],[19]
Investment, Identifier [Axis]: Acquia Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7%	[1],[2],[3],[4],[5],[13]		7%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		10.74%	[12],[13]		9.63%	[11],[16]
Investment, Identifier [Axis]: Aden & Anais Merger Sub Inc, Common Units in Aden & Anais Holdings, Inc.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		51,645	[1],[2],[3],[4],[5],[13]		51,645	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: AirStrip Technologies Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		5,715	[1],[2],[3],[4],[5],[13]		5,715	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 139.99	[1],[2],[3],[4],[5],[13]		$ 139.99	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: All Web Leads Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	1%
Cash Interest Rate	[12],[13]	5.73%
Investment, Identifier [Axis]: Altice France SA, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[18]				5.50%
Cash Interest Rate	[1],[2],[3],[4],[5],[13],[17]	5.50%
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	166,414
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13]	$ 15.46
Investment, Identifier [Axis]: Alto Pharmacy Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	8%
Cash Interest Rate	[12],[13]	12.68%
Investment, Identifier [Axis]: Alvogen Pharma US Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7.50%	[1],[2],[3],[4],[5],[13]		7.50%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		12.23%	[12],[13]		11.20%	[11],[16]
Investment, Identifier [Axis]: Alvotech Holdings SA, Common Shares in Alvotech SA
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		587,930	[1],[2],[3],[4],[5],[17]		587,930	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: Alvotech Holdings SA, Seller Earn Out Shares in Alvotech SA
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11],[18]				124,780
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche A Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		8.50%	[1],[2],[3],[4],[5],[13],[17]		10%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Alvotech Holdings SA, Tranche B Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		8.50%	[1],[2],[3],[4],[5],[13],[17]		10%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: American Auto Auction Group LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	8.75%	[1],[2],[3],[4],[5],[13]		8.75%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		13.33%	[12],[13]		12.30%	[11],[16]
Investment, Identifier [Axis]: American Tire Distributors Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	6.25%	[1],[2],[3],[4],[5]		6.25%	[6],[7],[8],[9],[10]
Cash Interest Rate		10.61%	[12]		9.03%	[16]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	4.25%	[1],[2],[3],[4],[5],[13],[17]		4.25%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		8.98%	[12],[13],[17]		7.92%	[11],[16],[18]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	8%	[1],[2],[3],[4],[5],[13],[17]		8%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		12.73%	[12],[13],[17]		11.67%	[11],[16],[18]
Investment, Identifier [Axis]: Anastasia Parent LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	3.75%	[1],[2],[3],[4],[5]		3.75%	[6],[7],[8],[9],[10]
Cash Interest Rate		8.48%	[12]		7.42%	[16]
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	8%	[1],[2],[3],[4],[5],[13]		8%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		12.36%	[12],[13]		10.78%	[11],[16]
Investment, Identifier [Axis]: Apptio Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	6%	[1],[2],[3],[4],[5],[13],[14]		6%	[6],[7],[8],[9],[10],[11],[19]
Cash Interest Rate		9.94%	[12],[13],[14]		8.46%	[11],[16],[19]
Investment, Identifier [Axis]: Apptio Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	6%	[1],[2],[3],[4],[5],[13]		6%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		9.94%	[12],[13]		8.46%	[11],[16]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.75%	[1],[2],[3],[4],[5],[13],[17]		5.75%	[6],[7],[8],[9],[10],[11],[18],[19]
Cash Interest Rate	[12],[13],[17]	7.48%
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7%	[1],[2],[3],[4],[5],[13],[17]		7%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		8%	[12],[13],[17]		8%	[11],[16],[18]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	7%	[1],[2],[3],[4],[5],[13],[17]		7%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		10.43%	[12],[13],[17]		9.19%	[11],[16],[18]
Investment, Identifier [Axis]: Ardonagh Midco PLC, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.75%	[1],[2],[3],[4],[5],[13],[17]		5.75%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		8.81%	[12],[13],[17]		8.81%	[11],[16],[18]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		1,609,201	[1],[2],[3],[4],[5],[13]	1,609,201
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11]				1,609,201
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		370		587
Gross Additions		0		0
Gross Reductions		(16)		(201)
Fair Value, Ending Balance		$ 354		$ 386
% of Total Net Assets		0%		0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Class A Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		70,424.5641	[1],[2],[3],[4],[5],[13]	70,424.5641	70,424.5641	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 3.3778	[1],[2],[3],[4],[5],[13]	$ 3.3778	$ 3.3778	[6],[7],[8],[9],[10],[11]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0		0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0		$ 0
% of Total Net Assets		0%		0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13],[14]	6.75%	6.75%	[6],[7],[8],[9],[10],[11],[12],[19]
Cash Interest Rate		11.48%	[12],[13],[14]	7.75%	10.42%	[11],[16],[19]
Principal		$ 21,464		$ 15,982
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		646		339
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		24,225		15,712
Gross Additions		55		3,499
Gross Reductions		(3,028)		(3,487)
Fair Value, Ending Balance		$ 21,252		$ 15,724
% of Total Net Assets		1.80%		1.20%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11]				1,019,168.8
Cash Interest Rate	[6],[7],[8],[9],[10],[11]				6%
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		1,223		1,152
Gross Additions		20		20
Gross Reductions		0		0
Fair Value, Ending Balance		$ 1,243		$ 1,172
% of Total Net Assets		0.10%		0.10%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Units,
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		1,019,168.8	[1],[2],[3],[4],[5],[13]	1,019,168.8
Cash Interest Rate		6%	[1],[2],[3],[4],[5],[13]	6%
Investment, Identifier [Axis]: Associated Asphalt Partners LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.25%	[1],[2],[3],[4],[5]		5.25%	[6],[7],[8],[9],[10]
Cash Interest Rate		9.63%	[12]		8.06%	[16]
Investment, Identifier [Axis]: Astra Acquisition Corp, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5.25%	[1],[2],[3],[4],[5]		5.25%	[6],[7],[8],[9],[10]
Cash Interest Rate		9.63%	[12]		8.37%	[16]
Investment, Identifier [Axis]: Athenex Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		328,149	[1],[2],[3],[4],[5],[13],[17]		328,149	[6],[7],[8],[9],[10],[11],[18]
Investment owned, exercise price (in dollars per share)		$ 0.4955	[1],[2],[3],[4],[5],[13],[17]		$ 0.4955	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Athenex Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[18]				11%
Cash Interest Rate	[1],[2],[3],[4],[5],[13],[17]	11%
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[12],[18]				6%
Cash Interest Rate	[11],[16],[18]				8.78%
Investment, Identifier [Axis]: Aurora Lux Finco SÀRL, First Lien Term Loan,
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13],[17]	6%
Cash Interest Rate	[12],[13],[17]	10.32%
Investment, Identifier [Axis]: Avalara Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13],[14]	7.25%
Investment, Identifier [Axis]: Avalara Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	7.25%
Cash Interest Rate	[12]	11.83%
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[12],[19]				5%
Cash Interest Rate	[11],[16],[19]				8.12%
Investment, Identifier [Axis]: BAART Programs Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13],[14]	5%
Cash Interest Rate	[12],[13],[14]	9.73%
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	8.50%	[1],[2],[3],[4],[5],[13],[14]		8.50%	[6],[7],[8],[9],[10],[11],[19]
Cash Interest Rate		13.23%	[12],[13],[14]		11.62%	[11],[16],[19]
Investment, Identifier [Axis]: BAART Programs Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	8.50%	[1],[2],[3],[4],[5],[13]		8.50%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		13.23%	[12],[13]		11.62%	[11],[16]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[1],[2],[3],[4],[5],[12],[13],[14]		4.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		12%	[12],[13],[14]		10.75%	[11],[16],[19]
Investment, Identifier [Axis]: Berner Food & Beverage LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[2],[3],[4],[5],[12],[13]		5.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.91%	[12],[13]		8.31%	[11],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		21,177	[1],[2],[3],[4],[5],[13],[17]		21,177	[6],[7],[8],[9],[10],[11],[18]
Investment owned, exercise price (in dollars per share)		$ 20.04	[1],[2],[3],[4],[5],[13],[17]		$ 20.04	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		8%	[1],[2],[3],[4],[5],[13],[14],[17]		10.25%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: BioXcel Therapeutics Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		8%	[1],[2],[3],[4],[5],[13],[17]		10.25%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Blackhawk Network Holdings Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12]		7%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		10.94%	[12]		9.50%	[16]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Common Units in Unstoppable Automotive AMV, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		298,460	[1],[2],[3],[4],[5],[13]		298,460	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11]				9%
Cash Interest Rate	[1],[2],[3],[4],[5],[13]	9%
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Preferred Units in Unstoppable Automotive AMV, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		1,293,324	[1],[2],[3],[4],[5],[13]		1,293,324	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Blumenthal Temecula LLC, Preferred Units in Unstoppable Automotive VMV, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		298,460	[1],[2],[3],[4],[5],[13]		298,460	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: C Technology Holdings LLC, Common Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		829	[1],[2],[3],[4],[5],[13]	829	829	[6],[7],[8],[9],[10],[11],[12]
Investment, Identifier [Axis]: C Technology Holdings LLC, Preferred Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		34,984,460.37	[1],[2],[3],[4],[5],[13]	34,984,460.37	34,984,460.37	[6],[7],[8],[9],[10],[11],[12]
Investment, Identifier [Axis]: C5 Technology Holding, LLC, Common Units
Schedule of Investments [Line Items]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0		0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0		$ 0
% of Total Net Assets		0%		0%
Investment, Identifier [Axis]: C5 Technology Holding, LLC, Preferred Units
Schedule of Investments [Line Items]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		27,638		27,638
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 27,638		$ 27,638
% of Total Net Assets		2.30%		2.10%
Investment, Identifier [Axis]: CCO Holdings LLC, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10],[18]				4.50%
Investment, Identifier [Axis]: CITGO Holding Inc, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10],[11],[16]				9.25%
Investment, Identifier [Axis]: CITGO Petroleum Corp, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[16]				6.25%
Cash Interest Rate	[16]				9.37%
Investment, Identifier [Axis]: Cadence Aerospace LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[3],[4],[5],[12],[13]		6.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.92%	[12],[13]		9.31%	[11],[16]
Investment, Identifier [Axis]: Caregiver Services Inc, Series A Preferred Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		1,080,399		1,080,399	1,080,399	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		10%	[1],[2],[3],[4],[5],[13]	10%	10%	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Caregiver Services, Inc., Series A Preferred Stock
Schedule of Investments [Line Items]
Principal		$ 0		$ 0
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		378		838
Gross Additions		0		0
Gross Reductions		(54)		0
Fair Value, Ending Balance		$ 324		$ 838
% of Total Net Assets		0%		0.10%
Investment, Identifier [Axis]: Carvana Co, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10],[18]				5.625%
Investment, Identifier [Axis]: CircusTrix Holdings LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[2],[3],[4],[5],[12],[13]		5.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.57%	[12],[13]		8.62%	[11],[16]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Cash Interest Rate		7.50%	[1],[2],[3],[4],[5],[17]		7.50%	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Cash Interest Rate		7.75%	[1],[2],[3],[4],[5],[17]		5.125%	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings Inc, Fixed Rate Bond 3
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10],[18]				7.75%
Investment, Identifier [Axis]: Condor Merger Sub Inc, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		7.375%	[1],[2],[3],[4],[5]		7.375%	[6],[7],[8],[9],[10],[11],[16]
Investment, Identifier [Axis]: Continental Intermodal Group LP, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13]		8.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.88%	[12],[13]		11.62%	[11],[16]
Investment, Identifier [Axis]: Convergeone Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12]		5%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		9.38%	[12]		8.12%	[16]
Investment, Identifier [Axis]: Conviva Inc, Shares of Series D Preferred Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	517,851
Investment, Identifier [Axis]: Conviva Inc,Shares of Series D Preferred Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11]				517,851
Investment, Identifier [Axis]: CorEvitas LLC, Class A2 Common Units in CorEvitas Holdings, L.P.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		1,099	[1],[2],[3],[4],[5],[13]		1,099	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.75%	[1],[2],[3],[4],[5],[12],[13],[14]		4.75%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		12.25%	[12],[13],[14]		11%	[11],[16],[19]
Investment, Identifier [Axis]: CorEvitas LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.125%	[1],[2],[3],[4],[5],[12],[13]		5.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.55%	[12],[13]		8.88%	[11],[16]
Investment, Identifier [Axis]: Covetrus Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12]		5%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		9.58%	[12]		7.65%	[16]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13],[14]		6%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: Coyote Buyer LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.41%	[12],[13]		8.81%	[11],[16]
Investment, Identifier [Axis]: Cuppa Bidco BV, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12]	4.75%
Cash Interest Rate	[12],[17]	7.50%
Investment, Identifier [Axis]: DTI Holdco Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.75%	[1],[2],[3],[4],[5],[12]		4.75%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		8.84%	[12]		7.33%	[16]
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[16],[18]				5.75%
Cash Interest Rate	[16],[18]				8.49%
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Units in Delta Financial Holdings LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		2.09	[1],[2],[3],[4],[5],[13]		2.09	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		31.37	[1],[2],[3],[4],[5],[13]		31.37	[6],[7],[8],[9],[10],[11],[18]
Investment owned, exercise price (in dollars per share)		$ 1	[1],[2],[3],[4],[5],[13]		$ 1	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Series C Preferred Units in Delta Financial Holdings LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		419	[1],[2],[3],[4],[5],[13]		419	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Subordinated Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		10%	[1],[2],[3],[4],[5],[13],[14]		10%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: Delta Topco Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[3],[4],[5],[12]		7.25%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		11.65%	[12]		9.34%	[16]
Investment, Identifier [Axis]: Dialyze Holdings LLC, Class A Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		5,403,823	[1],[2],[3],[4],[5],[13]		5,403,823	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 1	[1],[2],[3],[4],[5],[13]		$ 1	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[16],[19]				9%
Investment, Identifier [Axis]: Dialyze Holdings LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9%	[1],[2],[3],[4],[5],[12],[13]		9%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		13.73%	[12],[13]		12.67%	[11],[16]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13],[14]		6.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		11.59%	[12],[13],[14]		9.41%	[11],[16],[19]
Investment, Identifier [Axis]: DigitalAI Software Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.09%	[12],[13]		9.91%	[11],[16]
Investment, Identifier [Axis]: DirecTV Financing LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12]		5%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		9.38%	[12]		8.12%	[16]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, Common Units in DD Healthcare Services Holdings, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		30,030.8	[1],[2],[3],[4],[5],[13]	30,030.8	30,030.8	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	5%	[1],[2],[3],[4],[5],[13],[14]		5%	[6],[7],[8],[9],[10],[11],[19]
Investment, Identifier [Axis]: Dominion Diagnostics LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12],[13]	5%	5%	[6],[7],[8],[9],[10],[11],[12]
Cash Interest Rate		9.73%	[12],[13]		8.68%	[11],[16]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Units In DD Healthcare Services Holdings, LLC
Schedule of Investments [Line Items]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		3,308
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		4,946		18,065
Gross Additions		0		0
Gross Reductions		(719)		0
Fair Value, Ending Balance		$ 4,227		$ 18,065
% of Total Net Assets		0.40%		1.40%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Loan
Schedule of Investments [Line Items]
Cash Interest Rate		9.73%		6%
Principal		$ 14,297		$ 23,201
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		331		430
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		14,333		27,381
Gross Additions		0		0
Gross Reductions		(36)		(4,180)
Fair Value, Ending Balance		$ 14,297		$ 23,201
% of Total Net Assets		1.20%		1.80%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver
Schedule of Investments [Line Items]
Principal		$ 0		$ 0
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		14		14
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0		0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0		$ 0
% of Total Net Assets		0%		0%
Investment, Identifier [Axis]: Dryden 66 Euro CLO 2018, Class DR Notes, Class DR Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[17]	3.35%
Cash Interest Rate	[12],[17]	4.75%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units, 12%
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	487.5
Cash Interest Rate	[1],[2],[3],[4],[5],[13]	12%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class A Preferred Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11]				487.5
Cash Interest Rate	[6],[7],[8],[9],[10],[11]				12%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings LLC, Class B Common Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		12,500	[1],[2],[3],[4],[5],[13]		12,500	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Eagleview Technology Corporation, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[3],[4],[5],[12],[13]		7.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.23%	[12],[13]		11.17%	[11],[16]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		3%	[1],[2],[3],[4],[5],[13],[14],[17]		3%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		3%	[1],[2],[3],[4],[5],[13],[17]		3%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12]		6.75%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		11.13%	[12]		9.87%	[16]
Investment, Identifier [Axis]: Fair Street LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate	[1],[2],[3],[4],[5],[13],[14],[15]	12.50%
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		9%	[1],[2],[3],[4],[5],[13],[14],[17]		9%	[6],[7],[8],[9],[10],[11],[19]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Warrant Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		2,500	[1],[2],[3],[4],[5],[13],[14],[17]		2,500	[6],[7],[8],[9],[10],[11],[18],[19]
Investment owned, exercise price (in dollars per share)		$ 0.01	[1],[2],[3],[4],[5],[13],[14],[17]		$ 0.01	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Equity Interest
Schedule of Investments [Line Items]
Principal
Net Realized Gain (Loss)				(5,632)
Amount of Interest, Fees or Dividends Credited in Income				158
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				698
Gross Additions				0
Gross Reductions				(698)
Fair Value, Ending Balance				$ 0
% of Total Net Assets				0%
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				9%
Investment owned, ownership percentage				100%
Principal				$ 0
Net Realized Gain (Loss)				7,500
Amount of Interest, Fees or Dividends Credited in Income				0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				7,500
Gross Additions				0
Gross Reductions				(7,500)
Fair Value, Ending Balance				$ 0
% of Total Net Assets				0%
Investment, Identifier [Axis]: Fortress Biotech Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		331,200	[1],[2],[3],[4],[5],[13],[17]		331,200	[6],[7],[8],[9],[10],[11],[18]
Investment owned, exercise price (in dollars per share)		$ 3.20	[1],[2],[3],[4],[5],[13],[17]		$ 3.20	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Fortress Biotech Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		11%	[1],[2],[3],[4],[5],[13],[17]		11%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Frontier Communications Holdings LLC, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		6%	[1],[2],[3],[4],[5],[17]		6%	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13],[14]		7%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		11.75%	[12],[13],[14]		10.60%	[11],[16],[19]
Investment, Identifier [Axis]: GKD Index Partners LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.73%	[12],[13]		10.67%	[11],[16]
Investment, Identifier [Axis]: Global Medical Response Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[16]				4.25%
Cash Interest Rate	[16]				7.37%
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2, Class D Notes, Class D Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[17]	2.85%
Cash Interest Rate	[12],[17]	4.31%
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13],[14]		8%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13],[14]		8%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12]		8%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.33%	[12],[13]		11.04%	[11],[16]
Investment, Identifier [Axis]: Harbor Purchaser Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[1],[2],[3],[4],[5],[12]		5.25%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		9.67%	[12]		8.38%	[16]
Investment, Identifier [Axis]: Hayfin Emerald CLO XI, Class E Notes, Class E Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[17]	8.12%
Cash Interest Rate	[12],[17]	10.11%
Investment, Identifier [Axis]: Horizon Aircraft Finance I, Class A Notes
Schedule of Investments [Line Items]
Cash Interest Rate	[1],[2],[3],[4],[5],[12],[17]	4.458%
Investment, Identifier [Axis]: INW Manufacturing LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.75%	[1],[2],[3],[4],[5],[12],[13]		5.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.48%	[12],[13]		9.42%	[11],[16]
Investment, Identifier [Axis]: IPC Corp, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[3],[4],[5],[12],[13]		6.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.44%	[12],[13]		9.44%	[11],[16]
Investment, Identifier [Axis]: Immucor Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.75%	[1],[2],[3],[4],[5],[12],[13]		5.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.48%	[12],[13]		9.42%	[11],[16]
Investment, Identifier [Axis]: Immucor Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13]		8%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.73%	[12],[13]		11.67%	[11],[16]
Investment, Identifier [Axis]: Impel Neuropharma Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[2],[3],[4],[5],[12],[13]		8.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		13.20%	[12],[13]		12.45%	[11],[16]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		11%	[1],[2],[3],[4],[5],[13],[14],[17]		11%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		11%	[1],[2],[3],[4],[5],[13],[17]		11%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Tranche A Warrant Shares
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11],[18]				56,999
Investment owned, exercise price (in dollars per share)	[6],[7],[8],[9],[10],[11],[18]				$ 4.23
Investment, Identifier [Axis]: Integral Development Corporation, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		1,078,284	[1],[2],[3],[4],[5],[13]		1,078,284	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 0.9274	[1],[2],[3],[4],[5],[13]		$ 0.9274	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Inventus Power Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12],[13]		5%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.84%	[12],[13]		8.55%	[11],[16]
Investment, Identifier [Axis]: Inventus Power Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13]		8.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		13.23%	[12],[13]		12.17%	[11],[16]
Investment, Identifier [Axis]: Ivanti Software Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[3],[4],[5],[12]		7.25%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		12.01%	[12]		10.33%	[16]
Investment, Identifier [Axis]: Jazz Acquisition Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[3],[4],[5],[12],[13]		7.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.88%	[12],[13]		10.62%	[11],[16]
Investment, Identifier [Axis]: Jazz Acquisition Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12]		8%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		12.38%	[12]		11.12%	[16]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[3],[4],[5],[12],[13],[14]		6.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		11.75%	[12],[13],[14]		10.17%	[11],[16],[19]
Investment, Identifier [Axis]: Kings Buyer LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[3],[4],[5],[12],[13]		6.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.23%	[12],[13]		10.17%	[11],[16]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		10.38%	[12],[13]		9.12%	[11],[16],[19]
Investment, Identifier [Axis]: LSL Holdco LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.38%	[12],[13]		9.12%	[11],[16]
Investment, Identifier [Axis]: LTI Holdings Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12]		6.75%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		11.13%	[12]		9.87%	[16]
Investment, Identifier [Axis]: LaserShip Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[16]				7.50%
Cash Interest Rate	[11],[16]				10.38%
Investment, Identifier [Axis]: Latam Airlines Group SA, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[17]	9.50%
Cash Interest Rate	[12],[13]	13.99%
Investment, Identifier [Axis]: Lift Brands Holdings Inc, Class A Common Units in Snap Investments, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		2,000,000	[1],[2],[3],[4],[5],[13]		2,000,000	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Lightbox Intermediate LP, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12],[13]		5%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.73%	[12],[13]		8.67%	[11],[16]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Class A2 Units in LES Group Holdings, L.P.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		450.75	[1],[2],[3],[4],[5],[13]		450.75	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13],[14]		8.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		12.94%	[12],[13],[14]		11.38%	[11],[16],[19]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13]		8.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.88%	[12],[13]		11.38%	[11],[16]
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13],[14]		6%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate	[12],[13],[14]	10.94%
Investment, Identifier [Axis]: MHE Intermediate Holdings LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.50%	[12],[13]		9.50%	[11],[16]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[2],[3],[4],[5],[12],[13],[14]		5.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[2],[3],[4],[5],[12],[13],[14]		5.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[2],[3],[4],[5],[12],[13]		5.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.23%	[12],[13]		9.17%	[11],[16]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		11.50%	[1],[2],[3],[4],[5],[13],[14],[17]		11.50%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: Marinus Pharmaceuticals Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		11.50%	[1],[2],[3],[4],[5],[13],[17]		11.50%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		8%	[1],[2],[3],[4],[5],[13],[14],[17]		8%	[6],[7],[8],[9],[10],[11],[18],[19]
Investment, Identifier [Axis]: Mesoblast Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		8%	[1],[2],[3],[4],[5],[13],[17]		8%	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: Mesoblast Inc, Warrant Shares
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11],[18]				209,588
Investment owned, exercise price (in dollars per share)	[6],[7],[8],[9],[10],[11],[18]				$ 7.26
Investment, Identifier [Axis]: Mesoblast, Inc, Warrant Shares 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13],[17]	209,588
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13],[17]	$ 7.26
Investment, Identifier [Axis]: Mesoblast, Inc, Warrant Shares 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13],[17]	53,887
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13],[17]	$ 3.70
Investment, Identifier [Axis]: Mindbody Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13],[14]		8%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: Mindbody Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.72%	[12],[13]		10.64%	[11],[16]
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[12],[19]				7%
Investment, Identifier [Axis]: Montgomery Owner LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[12]				7%
Cash Interest Rate	[11],[16]				9.80%
Investment, Identifier [Axis]: Mosaic Companies LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13]		6.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.93%	[12],[13]		9.89%	[11],[16]
Investment, Identifier [Axis]: NFP Corp, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		6.875%	[1],[2],[3],[4],[5]		6.875%	[6],[7],[8],[9],[10]
Investment, Identifier [Axis]: NN Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.88%	[1],[2],[3],[4],[5],[12],[13]		6.88%	[6],[7],[8],[9],[10],[11],[16],[18]
Cash Interest Rate		11.26%	[12],[13],[17]		9.99%	[11],[16],[18]
Investment, Identifier [Axis]: Navisite LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13]		8.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		13.23%	[12],[13]		12.17%	[11],[16]
Investment, Identifier [Axis]: NeuAG LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.50%	[1],[2],[3],[4],[5],[12],[13]		10.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		15.23%	[12],[13]		14.17%	[11],[16]
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class D Notes, Class D Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12]	6.06%
Cash Interest Rate	[12],[17]	8.05%
Investment, Identifier [Axis]: OCP, EURO CLO 2022-6, Class E Notes, Class E Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12]	6.87%
Cash Interest Rate	[12],[17]	8.86%
Investment, Identifier [Axis]: OCSI Glick JV LLC, LLC Equity Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage		87.50%	[1],[2],[3],[4],[5],[13],[14],[17],[20]	87.50%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Equity Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage		87.50%	[1],[2],[3],[4],[5],[13],[14],[17],[20]	87.50%	87.50%	[6],[7],[8],[9],[10],[14],[18],[21]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0		0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0		$ 0
% of Total Net Assets		0%		0%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[1],[2],[3],[4],[5],[12],[13],[14],[17]	4.50%	4.50%	[6],[7],[8],[9],[10],[11],[12],[14],[18]
Cash Interest Rate		7.67%	[12],[13],[14],[17]	4.58%	6.30%	[11],[16],[18],[19]
Principal		$ 59,049		$ 61,237
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		1,624		1,081
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		50,283		55,582
Gross Additions		380		745
Gross Reductions		(1,127)		(473)
Fair Value, Ending Balance		$ 49,536		$ 55,854
% of Total Net Assets		4.10%		4.20%
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4%	[1],[2],[3],[4],[5],[12]		4%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		8.42%	[12]		7.12%	[16]
Investment, Identifier [Axis]: OEConnection LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.42%	[12],[13]		10.05%	[11],[16]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		2%	[1],[2],[3],[4],[5],[12],[13],[14]		2%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: OTG Management LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		2%	[1],[2],[3],[4],[5],[12],[13]		2%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		6.76%	[12],[13]		5.08%	[11],[16]
Investment, Identifier [Axis]: P & L Development LLC, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		7.75%	[1],[2],[3],[4],[5]		7.75%	[6],[7],[8],[9],[10]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13],[14]		7%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		10.74%	[12],[13],[14]		9.25%	[11],[16],[19]
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate	[12],[13]	11.76%
Investment, Identifier [Axis]: PFNY Holdings LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.74%	[12],[13]		9.28%	[11],[16]
Investment, Identifier [Axis]: PRGX Global Inc, Class B Common Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		80,515	[1],[2],[3],[4],[5],[13]		80,515	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13],[14]		6.75%	[6],[7],[8],[9],[10],[11],[16]
Investment, Identifier [Axis]: PRGX Global Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13]		6.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.50%	[12],[13]		10.42%	[11],[16]
Investment, Identifier [Axis]: Park Place Technologies LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[3],[4],[5],[12]		5%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		9.42%	[12]		8.13%	[16]
Investment, Identifier [Axis]: Performance Health Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.73%	[12],[13]		8.88%	[11],[16]
Investment, Identifier [Axis]: Planview Parent Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[3],[4],[5],[12],[13]		7.25%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.98%	[12],[13]		10.92%	[11],[16]
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13],[14]		8%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate	[12],[13],[14]	12.36%
Investment, Identifier [Axis]: Pluralsight LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13]		8%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.83%	[12],[13]		10.68%	[11],[16]
Investment, Identifier [Axis]: Profrac Holdings II LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[3],[4],[5],[12],[13]		8.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.10%	[12],[13]		10.01%	[11],[16]
Investment, Identifier [Axis]: Project Boost Purchaser LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13]		8%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.38%	[12],[13]		11.12%	[11],[16]
Investment, Identifier [Axis]: Quantum Bidco Limited, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13],[17]		6%	[6],[7],[8],[9],[10],[11],[16],[18]
Cash Interest Rate		9.63%	[12],[13],[17]		8.39%	[11],[16],[18]
Investment, Identifier [Axis]: QuorumLabs Inc, Junior-2 Preferred Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		64,887,669	[1],[2],[3],[4],[5],[13]		64,887,669	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate	[6],[7],[8],[9],[10]				5.25%
Investment, Identifier [Axis]: Radiology Partners Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.25%	[1],[2],[3],[4],[5],[12]		4.25%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		8.64%	[12]		7.33%	[16]
Investment, Identifier [Axis]: Radiology Partners Inc, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		9.25%	[1],[2],[3],[4],[5]		9.25%	[6],[7],[8],[9],[10]
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[3],[4],[5],[12],[13],[14]		6.50%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: Relativity ODA LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	7.50%
Investment, Identifier [Axis]: Renaissance Holding Corp, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12]		7%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		11.38%	[12]		10.12%	[16]
Investment, Identifier [Axis]: RumbleOn Inc, Class B Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		164,660	[1],[2],[3],[4],[5],[13],[17]		164,660	[6],[7],[8],[9],[10],[11],[18]
Investment owned, exercise price (in dollars per share)		$ 31.50	[1],[2],[3],[4],[5],[13],[17]		$ 33	[6],[7],[8],[9],[10],[11],[18]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[2],[3],[4],[5],[12],[13],[14],[17]		8.25%	[6],[7],[8],[9],[10],[11],[16],[18],[19]
Cash Interest Rate		12.98%	[12],[13],[14],[17]		11.92%	[11],[16],[18],[19]
Investment, Identifier [Axis]: RumbleOn Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[2],[3],[4],[5],[12],[13],[17]		8.25%	[6],[7],[8],[9],[10],[11],[16],[18]
Cash Interest Rate		12.98%	[12],[13],[17]		11.92%	[11],[16],[18]
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Units in Eyesouth Co-Investor FT Aggregator LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	1,037
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13],[14]	8.75%
Investment, Identifier [Axis]: SCP Eye Care Services LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	8.75%
Cash Interest Rate	[12]	12.52%
Investment, Identifier [Axis]: SM Wellness Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	4.75%
Cash Interest Rate	[12]	9.42%
Investment, Identifier [Axis]: SM Wellness Holdings Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[3],[4],[5],[12],[13]		8%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.67%	[12],[13]		10.74%	[11],[16]
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12]	4.50%
Cash Interest Rate	[12]	8.92%
Investment, Identifier [Axis]: SPX Flow Inc, First Lien Term Loan,
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[16]				4.50%
Cash Interest Rate	[16]				7.63%
Investment, Identifier [Axis]: SVP-Singer Holdings Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13]		6.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.48%	[12],[13]		10.42%	[11],[16]
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan, LIBOR+4.50% cash due 12/10/2026
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[16]				4.50%
Cash Interest Rate	[16]				7.63%
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	991,019
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13]	$ 4.83
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13],[14]	10%
Cash Interest Rate	[12],[13],[14]	14.32%
Investment, Identifier [Axis]: Salus Workers' Compensation LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	10%
Cash Interest Rate	[12]	14.32%
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13],[17]	408,508
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13],[17]	$ 0.01
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Put Options on Common Shares in Alvotech SA
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13],[17]	293,082
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13],[17]	$ 10
Investment, Identifier [Axis]: Seller Earn Out Shares in Alvotech SA, Seller Earn Out Shares in Alvotech SA
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13],[17]	124,780
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Equity Interest
Schedule of Investments [Line Items]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		1,050		451
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		20,715		37,651
Gross Additions		5,469		810
Gross Reductions		(2,076)		0
Fair Value, Ending Balance		$ 24,108		$ 38,461
% of Total Net Assets		2%		2.90%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, LLC Equity Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage	[6],[7],[8],[9],[10],[12],[14],[18],[22]				87.50%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13],[14],[17]	7%	7%	[6],[7],[8],[9],[10],[11],[12],[14],[18]
Cash Interest Rate		10.17%	[12],[13],[14],[17]	8%	8.80%	[11],[16],[18],[19]
Principal		$ 112,656		$ 96,250
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		2,611		1,967
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		96,250		96,250
Gross Additions		16,406		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 112,656		$ 96,250
% of Total Net Assets		9.40%		7.30%
Investment, Identifier [Axis]: ShareThis Inc, Series C Preferred Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		345,452	[1],[2],[3],[4],[5],[13]		345,452	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 3.0395	[1],[2],[3],[4],[5],[13]		$ 3.0395	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: SiO Medical Products Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		415.34	[1],[2],[3],[4],[5],[13]		415.34	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 4,920.75	[1],[2],[3],[4],[5],[13]		$ 4,920.75	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: SiO Medical Products Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Cash Interest Rate		5.50%	[1],[2],[3],[4],[5],[13]		5.50%	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: SonicWall US Holdings Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[3],[4],[5],[12],[13]		7.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.20%	[12],[13]		10.48%	[11],[16]
Investment, Identifier [Axis]: Sorrento Therapeutics Inc, Common Stock Units
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		50,000	[1],[2],[3],[4],[5],[17]		50,000	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: Spanx LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[1],[2],[3],[4],[5],[12],[13],[14]		5.25%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		9.29%	[12],[13],[14]		8.03%	[11],[16],[19]
Investment, Identifier [Axis]: Spanx LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[1],[2],[3],[4],[5],[12],[13]		5.25%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		9.64%	[12],[13]		8.30%	[11],[16]
Investment, Identifier [Axis]: SumUp Holdings Luxembourg SÀRL, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13],[17]		8.50%	[6],[7],[8],[9],[10],[11],[16],[18]
Cash Interest Rate		10.49%	[12],[13],[17]		10%	[11],[16],[18]
Investment, Identifier [Axis]: Sunland Asphalt & Construction LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.15%	[12],[13]		8.88%	[11],[16]
Investment, Identifier [Axis]: Superior Industries International Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	8%
Cash Interest Rate	[12]	12.32%
Investment, Identifier [Axis]: Supermoose Borrower LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		3.75%	[1],[2],[3],[4],[5],[12]		3.75%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		8.48%	[12]		7.42%	[16]
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13]		6.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.14%	[12],[13]		9.81%	[11],[16]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Subordinated Debt
Schedule of Investments [Line Items]
Cash Interest Rate		11.50%	[1],[2],[3],[4],[5],[13],[15],[17]		11.50%	[6],[7],[8],[9],[10],[11],[16],[18]
Investment, Identifier [Axis]: TIBCO Software Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[1],[2],[3],[4],[5],[12]		4.50%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		9.18%	[12]		8.15%	[16]
Investment, Identifier [Axis]: Tacala LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[3],[4],[5],[12]		7.50%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		11.88%	[12]		10.62%	[16]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13],[14],[17]		6%	[6],[7],[8],[9],[10],[11],[16],[18],[19]
Investment, Identifier [Axis]: Tahoe Bidco BV, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13],[17]		6%	[6],[7],[8],[9],[10],[11],[16],[18]
Cash Interest Rate		10.29%	[12],[13],[17]		8.68%	[11],[16],[18]
Investment, Identifier [Axis]: Tecta America Corp, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[2],[3],[4],[5],[12],[13]		8.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.94%	[12],[13]		11.62%	[11],[16]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.75%	[1],[2],[3],[4],[5],[12],[13],[14]		9.25%	[6],[7],[8],[9],[10],[11],[16],[19]
Cash Interest Rate		13.67%	[12],[13],[14]		12.20%	[11],[16]
Investment, Identifier [Axis]: Telestream Holdings Corporation, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.75%	[1],[2],[3],[4],[5],[12],[13]		9.25%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		13.67%	[12],[13]		12.11%	[11],[16]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Common Units of TerSera Holdings LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		668,879	[1],[2],[3],[4],[5],[13]		668,879	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.50%	[1],[2],[3],[4],[5],[12],[13]		9.50%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		13.88%	[12],[13]		13.17%	[11],[16]
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[12]				7.30%
Cash Interest Rate	[11],[16]				10.44%
Investment, Identifier [Axis]: The Avery, First Lien Term Loan in T8 Urban Condo Owner, LLC
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	7.30%
Cash Interest Rate	[12],[13]	11.69%
Investment, Identifier [Axis]: The Avery, Subordinated Debt in T8 Senior Mezz LLC
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12]	12.50%	[1],[2],[3],[4],[5],[13]		12.50%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		17.24%	[12],[13]		16.17%	[11],[16]
Investment, Identifier [Axis]: Thrasio LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[3],[4],[5],[12],[13]		7%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		11.17%	[12],[13]		11.17%	[11],[16]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		284,650.32	[1],[2],[3],[4],[5],[13]		284,650.32	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		8,434	[1],[2],[3],[4],[5],[13]		8,434	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series D Preferred Stock in Thrasio Holdings, Inc.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		48,352	[1],[2],[3],[4],[5],[13]		48,352	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Thrasio LLC, Shares of Series X Preferred Stock in Thrasio Holdings, Inc.
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		25,780	[1],[2],[3],[4],[5],[13]		23,201	[6],[7],[8],[9],[10],[11],[19]
Investment, Identifier [Axis]: Touchstone Acquisition Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.38%	[12],[13]		9.12%	[11],[16]
Investment, Identifier [Axis]: Tranche A Warrant Shares, Tranche A Warrant Shares
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13],[17]	56,999
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13],[17]	$ 4.23
Investment, Identifier [Axis]: Trinitas CLO XV, Class E Notes, Class E Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[17]	7.45%
Cash Interest Rate	[12],[17]	11.77%
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Cash Interest Rate		6.50%	[1],[2],[3],[4],[5],[17]		6.50%	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Cash Interest Rate		4.75%	[1],[2],[3],[4],[5],[17]		4.75%	[6],[7],[8],[9],[10],[18]
Investment, Identifier [Axis]: WP CPP Holdings LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		3.75%	[1],[2],[3],[4],[5],[12],[13]		3.75%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		8.17%	[12]		6.56%	[16]
Investment, Identifier [Axis]: WP CPP Holdings LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[2],[3],[4],[5],[12],[13]		7.75%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		12.17%	[12],[13]		10.56%	[11],[16]
Investment, Identifier [Axis]: WPEngine Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[3],[4],[5],[12],[13]		6%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		10.19%	[12],[13]		10.19%	[11],[16]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[16]				7%
Cash Interest Rate	[11],[16]				10.67%
Investment, Identifier [Axis]: WWEX Uni Topco Holdings LLC, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	7%
Cash Interest Rate	[12],[13]	11.73%
Investment, Identifier [Axis]: Win Brands Group LLC, Class F Warrants in Brand Value Growth LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		3,621	[1],[2],[3],[4],[5],[13]		3,621	[6],[7],[8],[9],[10],[11]
Investment owned, exercise price (in dollars per share)		$ 0.01	[1],[2],[3],[4],[5],[13]		$ 0.01	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Win Brands Group LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		15%	[1],[2],[3],[4],[5],[12],[13]		15%	[6],[7],[8],[9],[10],[11],[16]
Cash Interest Rate		20.75%	[12],[13]		19.64%	[11],[16]
Investment, Identifier [Axis]: Windstream Services II LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.25%	[1],[2],[3],[4],[5],[12]		6.25%	[6],[7],[8],[9],[10],[16]
Cash Interest Rate		10.67%	[12]		9.37%	[16]
Investment, Identifier [Axis]: Windstream Services II LLC, Shares of Common Stock in Windstream Holdings II, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		18,032	[1],[2],[3],[4],[5],[13]		18,032	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Windstream Services II LLC, Warrants in Windstream Holdings II, LLC
Schedule of Investments [Line Items]
Investment owned, balance (in shares)		109,420	[1],[2],[3],[4],[5],[13]		109,420	[6],[7],[8],[9],[10],[11]
Investment, Identifier [Axis]: Zayo Group Holdings Inc, Fixed Rate Bond
Schedule of Investments [Line Items]
Cash Interest Rate		4%	[1],[2],[3],[4],[5]		4%	[6],[7],[8],[9],[10]
Investment, Identifier [Axis]: Zep Inc, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[16]	8.25%	[1],[2],[3],[4],[5],[13]		8.25%	[6],[7],[8],[9],[10],[11]
Cash Interest Rate		12.98%	[12],[13]		11.92%	[11],[16]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[16]	7.50%	[1],[2],[3],[4],[5],[13],[17]		7.50%	[6],[7],[8],[9],[10],[11],[18]
Cash Interest Rate		10.96%	[12],[13],[17]		9.72%	[11],[16],[18]
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc.,
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[6],[7],[8],[9],[10],[11]				18,635
Cash Interest Rate	[6],[7],[8],[9],[10],[11]				10.75%
Investment, Identifier [Axis]: athenahealth Group Inc, Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	18,635
Cash Interest Rate	[1],[2],[3],[4],[5],[13]	10.75%
Investment, Identifier [Axis]: iCIMs Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13],[14]		6.75%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[3],[4],[5],[12],[13],[14]		6.75%	[6],[7],[8],[9],[10],[11],[16],[19]
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[6],[7],[8],[9],[10],[11],[16]				6.75%
Cash Interest Rate	[11],[16]				9.49%
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	3.375%
Cash Interest Rate	[12],[13]	7.14%
Investment, Identifier [Axis]: iCIMs Inc, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	7.25%
Cash Interest Rate	[12],[13]	11.52%
Investment, Identifier [Axis]: scPharmaceuticals Inc, Common Stock Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares)	[1],[2],[3],[4],[5],[13]	53,700
Investment owned, exercise price (in dollars per share)	[1],[2],[3],[4],[5],[13]	$ 5.40
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Delayed Draw Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13],[14]	8.75%
Investment, Identifier [Axis]: scPharmaceuticals Inc, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[3],[4],[5],[12],[13]	8.75%
Cash Interest Rate	[12],[13]	11.75%
[1]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[2]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[3]Equity ownership may be held in shares or units of companies related to the portfolio companies.[4]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[5]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[6]All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.[7]Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.[8]Equity ownership may be held in shares or units of companies related to the portfolio companies.[9]Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.[10]See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.[11]As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.[12]The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the London Interbank Offered Rate ("LIBOR") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to the secured overnight financing rate ("SOFR") or the sterling overnight index average ("SONIA"). The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of December 31, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 4.38%, the 90-day LIBOR at 4.73%, the 180-day LIBOR at 5.15%, the PRIME at 7.50%, the 30-day SOFR at 4.32%, the 90-day SOFR at 4.58%, the 180-day SOFR at 4.79%, the SONIA at 3.43%, the 30-day EURIBOR at 1.90%, the 90-day EURIBOR at 1.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.[13] As of December 31, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

Uncategorized Items - ocsl-2022

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	$ 26,364,000
SLF JV I Notes [Member]
Interest Income, Operating	us-gaap_InterestIncomeOperating	2,600,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	2,000,000
Investment Owned, at Fair Value	us-gaap_InvestmentOwnedAtFairValue	112,700,000
Investment Owned, at Fair Value	us-gaap_InvestmentOwnedAtFairValue	$ 96,300,000
Investment, Basis Spread, Variable Rate	us-gaap-supplement_InvestmentBasisSpreadVariableRate	7%
Investment, Interest Rate, Floor	us-gaap-supplement_InvestmentInterestRateFloor	1%
Investment Owned, at Cost	us-gaap_InvestmentOwnedAtCost	$ 112,700,000
Investment Owned, at Cost	us-gaap_InvestmentOwnedAtCost	96,300,000
SLF JV I, LLC [Member]
Investment Owned, at Fair Value	us-gaap_InvestmentOwnedAtFairValue	24,100,000
Investment Owned, at Fair Value	us-gaap_InvestmentOwnedAtFairValue	20,700,000
Investment Owned, at Cost	us-gaap_InvestmentOwnedAtCost	54,800,000
Investment Owned, at Cost	us-gaap_InvestmentOwnedAtCost	49,300,000
Dividend Income, Operating	us-gaap_DividendIncomeOperating	1,100,000
Dividend Income, Operating	us-gaap_DividendIncomeOperating	500,000
Glick JV Notes [Member]
Interest Income, Operating	us-gaap_InterestIncomeOperating	1,600,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	$ 1,100,000
Investment, Basis Spread, Variable Rate	us-gaap-supplement_InvestmentBasisSpreadVariableRate	4.50%
OCSI Glick JV LLC [Member] | Glick JV LLC [Member]
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	87.50%
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	12.50%
Investment Owned, at Fair Value	us-gaap_InvestmentOwnedAtFairValue	$ 49,500,000
Investment Owned, at Cost	us-gaap_InvestmentOwnedAtCost	49,500,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	8,700,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	8,700,000
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	1,600,000
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	$ 1,600,000
OCSI Glick JV LLC [Member] | Glick JV Notes [Member]
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	12.50%
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	87.50%
Investment Owned, at Fair Value	us-gaap_InvestmentOwnedAtFairValue	$ 50,300,000
Investment Owned, at Cost	us-gaap_InvestmentOwnedAtCost	50,300,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	78,800,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	78,800,000
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	12,400,000
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	12,400,000
SLF JV I [Member] | SLF JV I Notes [Member]
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	9,800,000
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	26,200,000
Investment Company, Financial Support To Investee During Period	ocsl_InvestmentCompanyFinancialSupportToInvesteeDuringPeriod	16,400,000
SLF JV I [Member] | SLF JV I, LLC [Member]
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	3,300,000
Investment Company, Financial Commitment to Investee, Future Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	8,800,000
Investment Company, Financial Support To Investee During Period	ocsl_InvestmentCompanyFinancialSupportToInvesteeDuringPeriod	$ 5,500,000